<!DOCTYPE html>
<html>
<head>

      <meta http-equiv="Content-Type" content="text/html; charset=utf-8">

        <script> var url = encodeURIComponent('https://www.science.org/doi/10.1126/science.abl6251');</script>

        <script> var body_html = '<body > <div > <div > <div > <div > <div > <div > <div > <div > <div > <div > <span >Advertisement</span> </div> </div> </div> </div> </div> </div> </div> <header > <div ><div ><div ><div ><div ><div ><div ><a ><div >science</div></a></div></div><div ><div ><a ><div >science advances</div></a></div></div><div ><div ><a ><div >science immunology</div></a></div></div><div ><div ><a ><div >science robotics</div></a></div></div><div ><div ><a ><div >science signaling</div></a></div></div><div ><div ><a ><div >science translational medicine</div></a></div></div><div ><div ><a ><div >science partner journals</div></a></div></div></div></div></div></div></div> <div > <div > <div > <div > <div ><div ><div ><label >Searching:</label><div ><div ><div >AnywhereScience<a >Science Advances</a><a >Science Immunology</a><a >Science Robotics</a><a >Science Signaling</a><a >Science Translational Medicine</a></div></div></div></div><div > <a ><u>Advanced Search</u></a> </div></div></div> </div> </div> </div> <div > <div > <div > <h6 >Trending Terms:</h6> <ul > <li > <a >covid-19</a> </li> <li > <a >climate</a> </li> <li > <a >science policy</a> </li> <li > <a >genome editing</a> </li> <li > <a >batteries</a> </li> </ul> </div> </div> </div> </div> </header><div ><div ><div > <div > <div > <ul > <li > <a >Current Issue</a> </li> <li > <a >First release papers</a> </li> <li > <a >Archive</a> </li> <li > <div > <a >About</a> <div > <a >About Science</a> <a >Mission Scope</a> <a >Editors Advisory Boards</a> <a >Editorial Policies</a> <a >Information for Authors</a> <a >Information for Reviewers</a> <a >Journal Metrics</a> <a >Staff</a> <a >Contact Us</a> </div> </div> </li> </ul> </div> <div > <ul > <li > <a >Submit manuscript</a> </li> <li > <div > <a >More</a> </div> </li> </ul> </div> </div> <a >GET OUR E-ALERTS</a> </div></div></div> <main > <div ><div ><div ><div ><div > <div ><a >Home</a><a >Science</a><a >First Release</a>Structural basis for continued antibody evasion by the SARS-CoV-2 receptor binding domain</div><div >Back To First Release</div> </div> <article ><section ><header><div ><div ><div ><div >OPEN ACCESS</div><div >Research Article</div></div><div ><div > <div >Share on</div> </div></div></div><h1 >Structural basis for continued antibody evasion by the SARS-CoV-2 receptor binding domain</h1><div >Katherine G. Nabel https://orcid.org/0000-0002-4429-7075, Sarah A. Clark https://orcid.org/0000-0001-9944-0919, Sundaresh Shankar https://orcid.org/0000-0001-9340-9945, Junhua Pan https://orcid.org/0000-0002-0070-955X, Lars E. Clark https://orcid.org/0000-0002-6093-7597, Pan Yang, Adrian Coscia https://orcid.org/0000-0002-6836-9993, … Show All … , Lindsay G. A. McKay https://orcid.org/0000-0003-0369-9067, Haley H. Varnum, Vesna Brusic, Nicole V. Tolan, Guohai Zhou, Michaël Desjardins https://orcid.org/0000-0003-4028-8507, Sarah E. Turbett https://orcid.org/0000-0002-3603-8110, Sanjat Kanjilal https://orcid.org/0000-0002-1221-5725, Amy C. Sherman https://orcid.org/0000-0002-6075-3990, Anand Dighe, Regina C. LaRocque https://orcid.org/0000-0003-4558-0339, Edward T. Ryan, Casey Tylek, Joel F. Cohen-Solal https://orcid.org/0000-0002-1385-2566, Anhdao T. Darcy, Davide Tavella https://orcid.org/0000-0002-2030-2087, Anca Clabbers https://orcid.org/0000-0002-4258-9680, Yao Fan, Anthony Griffiths https://orcid.org/0000-0001-5435-8364, Ivan R. Correia https://orcid.org/0000-0003-2295-7199, Jane Seagal https://orcid.org/0000-0002-5959-5139, Lindsey R. Baden, Richelle C. Charles, and Jonathan Abraham https://orcid.org/0000-0002-7937-3920 [email protected] Show Fewer</div><div >Science • 2 Dec 2021 • First Release • DOI: 10.1126/science.abl6251</div><div ><div > <div > <a ><div ><div ><h6>PREVIOUS ARTICLE</h6><div>4′-Fluorouridine is an oral antiviral that blocks respiratory syncytial virus and SARS-CoV-2 replication</div></div></div>Previous</a><a ><div ><div ><h6>NEXT ARTICLE</h6><div>Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants</div></div></div>Next</a> </div> </div></div></div></header><div ><div ><section ><h2 >Abstract</h2><div >Many studies have examined the impact of SARS-CoV-2 variants on neutralizing antibody activity after they have become dominant strains. Here, we evaluate the consequences of further viral evolution. We demonstrate mechanisms through which the SARS-CoV-2 receptor binding domain (RBD) can tolerate large numbers of simultaneous antibody escape mutations and show that pseudotypes containing up to seven mutations, as opposed to the one to three found in previously studied variants of concern, are more resistant to neutralization by therapeutic antibodies and serum from vaccine recipients. We identify an antibody that binds the RBD core to neutralize pseudotypes for all tested variants but show that the RBD can acquire an N-linked glycan to escape neutralization. Our findings portend continued emergence of escape variants as SARS-CoV-2 adapts to humans.</div></section></div></div></section><section ><div ><div >As SARS-CoV-2 continues to replicate in humans under selective pressure from natural and vaccine induced immunity, variants of concern (VOCs) with increased transmissibility or virulence continue to emerge (<a ><i>1</i></a>). Through adaptive evolution, these variants acquire mutations in the spike protein receptor binding domain (RBD) that binds the cellular receptor human angiotensin-converting enzyme 2 (ACE2) (<a ><i>1</i></a>–<a ><i>3</i></a>). Many of these mutations are within the RBD “receptor binding motif” (RBM), a hypervariable loop that mediates most of the ACE2 contacts (<a ><i>2</i></a>, <a ><i>3</i></a>). The RBD is the primary target of neutralizing antibodies in naturally acquired or vaccine-elicited humoral immunity (<a ><i>4</i></a>, <a ><i>5</i></a>). The spike protein N-terminal domain (NTD) is also a target of neutralizing antibodies, and VOCs have NTD mutations including deletions at an antigenic supersite for neutralizing antibody binding (<a ><i>6</i></a>, <a ><i>7</i></a>). The effects of spike protein mutations on immune responses (<a ><i>8</i></a>–<a ><i>13</i></a>) make it important to monitor viral variants.</div><div >While previously studied VOCs contain one to three RBD mutations that at times overlap (<a ><i>1</i></a>), the potential for composite variants is being closely monitored. For example, the B.1.617.2 (Delta) variant can acquire the K417N<sub>RBD</sub> mutation found in the B.1.351 (Beta) variant, generating the Delta AY.2 variant, for a total of three RBD mutations (<a >Fig. 1A</a>). Similarly, as shown in recently deposited sequences from samples collected in Angola, the Beta variant can acquire the L452R<sub>RBD</sub> mutation found in the Delta and B.1.429/427 (Epsilon) variants, for a total of four RBD mutations (<a >Fig. 1A</a> and table S1). Further complicating matters, variant monitoring efforts are still under sampling viral evolution. For example, a virus recently sequenced from travelers returning from Tanzania contained a previously undocumented combination of RBD mutations (E484K<sub>RBD</sub>, T478R<sub>RBD</sub>, and R346K<sub>RBD</sub>) with NTD deletions that would likely alter the spike protein antigenic surface and result in antibody escape (table S1).</div><div >Here, we investigate the structural plasticity of the SARS-CoV-2 spike protein RBD and its capacity to evade neutralizing antibodies.</div><section ><h2>Results</h2><section ><h3>Structure of an evolved receptor binding domain ACE2 complex</h3><div >We previously generated two SARS-CoV-2 spike proteins that each contain six RBD changes that were detected during persistent infection of an immunocompromised individual infected with a SARS-CoV-2 strain containing the D614G<sub>S</sub> mutation (<a ><i>14</i></a>–<a ><i>16</i></a>). This individual received treatment with REGN-COV2 (<a ><i>17</i></a>, <a ><i>18</i></a>), but several of the RBD substitutions had occurred even prior to administration of this therapeutic antibody cocktail (<a ><i>14</i></a>–<a ><i>16</i></a>). Lentivirus pseudotypes bearing these spike proteins, denoted day 146* and day 152* (<a >Fig. 1A</a> and table S2), were refractory to neutralization by V<sub>H</sub>3-53-heavy chain gene-derived neutralizing antibodies, a potent class of neutralizing antibodies that have been repeatedly isolated from convalescent donors (<a ><i>19</i></a>–<a ><i>25</i></a>). These pseudotypes were also resistant to neutralization by components of REGN-COV2 (<a ><i>17</i></a>, <a ><i>18</i></a>) and by polyclonal immunoglobulins (IgG) purified from the serum of COVID-19 convalescent donors (<a ><i>14</i></a>). Substitutions in the day 146* and day 152* spike proteins, noted in samples sequenced from this individual in the spring and summer of 2020, foreshadowed those in currently circulating VOCs at three positions: N501<sub>RBD</sub>, E484<sub>RBD</sub>, and T478<sub>RBD</sub> (<a >Fig. 1A</a>). The day 146* and day 152* spike proteins also contain substitutions that are not in current dominant strains but could have serious effects if acquired. For example, the S494P<sub>RBD</sub> substitution is a therapeutic antibody (LY-CoV555) escape mutation (<a ><i>26</i></a>) that as of 27 September 2021 was present in over 12,000 human-derived SARS-CoV-2 sequences on public research databases (GISAID) (<a ><i>27</i></a>). Additionally, the Q493K<sub>RBD</sub> mutation, which is found in over one hundred human-derived SARS-CoV-2 sequences as of 27 September 2021 on GISAID, confers resistance to multiple therapeutic antibodies [REGN10933, CB6 (LY-CoV016), and LY-CoV555] and V<sub>H</sub>3-53-gene-derived antibodies (<a ><i>14</i></a>, <a ><i>16</i></a>, <a ><i>17</i></a>, <a ><i>28</i></a>).</div><div >To determine the impact of their combined mutations on human ACE2 binding, we generated recombinant RBDs for the day 146* and day 152* spike protein mutants. The affinity of the day 152* mutant monomeric RBD for monomeric ACE2 ectodomain was substantially lower (<i>K</i><sub>D</sub> of 2.4 μM) than that of wild-type (Wuhan-Hu-1) RBD (54 nM, consistent with other reports) (<a ><i>3</i></a>, <a ><i>29</i></a>), suggesting that its mutations also compromise ACE2 binding (fig. S1 and table S3). For comparison, the affinity we measured of the SARS-CoV RBD for human ACE2 was 0.26 μM, about nine-fold higher than the affinity for the day 152* RBD (fig. S1 and table S3). The affinity of the day 152* RBD for ACE2 is comparable to that of the RBDs of some bat coronaviruses that are closely related to SARS-CoV-2 and bind human ACE2 (e.g., RaTG13 virus RBD affinity of 3.9 μM) (<a ><i>30</i></a>). The day 146* RBD, however, had a similar affinity (<i>K</i><sub>D</sub> of 46 nM) for ACE2 as that of the Wuhan-Hu-1 SARS-CoV-2 RBD (fig. S1 and table S3).</div><div >We determined the X-ray crystal structure of the day 146* RBD bound to the human ACE2 ectodomain (<a >Fig. 1B</a>, fig. S2, and table S4). This structure is similar to previously determined structures of ACE2/SARS-CoV-2 RBD complexes (<a ><i>2</i></a>, <a ><i>3</i></a>), except we observed contacts between two N-linked glycans on ACE2 (attached to N53<sub>ACE2</sub> and N90<sub>ACE2</sub>) and the RBD (fig. S3). Removing the N90<sub>ACE2</sub> glycan, which interacts with the RBD in both copies of the crystal asymmetric unit (fig. S3), increased Wuhan-Hu-1 SARS-CoV-2 and day 146* RBD affinity for ACE2, although the effect was modest (fig. S1 and table S3). This finding is consistent with prior work implicating the N90<sub>ACE2</sub> glycan, which is removed in a human polymorphism (T92I<sub>ACE2</sub>), as a barrier to SARS-CoV-2 RBD binding to ACE2 (<a ><i>31</i></a>, <a ><i>32</i></a>).</div><div >The N501Y<sub>RBD</sub> substitution is found in multiple variants of concern (<a >Fig. 1A</a>); once it surfaced in the immunocompromised individual, it was retained at later time points (<a ><i>14</i></a>–<a ><i>16</i></a>). As also shown in a cryo–electron microscopy (cryo-EM) structure of the SARS-CoV-2 spike protein containing the N501Y<sub>RBD</sub> substitution bound to ACE2 (<a ><i>33</i></a>), the side chain of Y501<sub>RBD</sub> interacts with Y41<sub>ACE2</sub> and K353<sub>ACE2</sub> with no significant structural change (<a >Fig. 1, C and D</a>). E484<sub>RBD</sub> is a critical target of antibodies against SARS-CoV-2 and is mutated in several variants (<a ><i>12</i></a>, <a ><i>34</i></a>, <a ><i>35</i></a>). In structures of Wuhan-Hu-1 SARS-CoV-2 RBD bound to ACE2, E484<sub>RBD</sub> is near but does not directly contact the receptor (<a >Fig. 1E</a>). In the day 146* RBD/ACE2 complex structure, the K493<sub>RBD</sub> sidechain reaches over the RBD surface to recruit the E484<sub>RBD</sub> side chain to form a new salt bridge with K31<sub>ACE2</sub> (<a >Fig. 1F</a>). The nearby Y489H<sub>RBD</sub> mutation, which removes a polar contact with ACE2, better accommodates repositioning of E484<sub>RBD</sub> because the histidine is smaller than the tyrosine sidechain and would avoid potential steric clashes with E484<sub>RBD</sub> in this binding mode (<a >Fig. 1, E and F</a>). A second rotamer for residue H34<sub>ACE2</sub> forms new RBD contacts to fill a gap created by the reorganization of local interactions (<a >Fig. 1, E and F</a>). This structural plasticity may explain how the RBD tolerates a surprisingly large number of mutations during intra-host evolution yet retains the ability to bind ACE2 tightly. It is also consistent with the large sequence divergence in the RBD residues that contact ACE2 among SARS-related coronaviruses that share this cellular receptor.</div></section><section ><h3>Neutralization escape of therapeutic antibodies</h3><div >RBD-targeting antibodies can be categorized into classes based on whether they bind an overlapping footprint with ACE2 and recognize only an open or both an open and closed RBD on the spike protein trimer (<a ><i>36</i></a>). CB6 (equivalent to LY-CoV016 or etesevimab) is a class 1, V<sub>H</sub>3-66-derived antibody that blocks ACE2 binding and can only bind the RBD when it is open, and LY-CoV555 (bamlanivimab) is a class 2 antibody that blocks ACE2 binding but can bind both open or closed RBDs (<a ><i>21</i></a>, <a ><i>37</i></a>). LY-CoV016 and LY-CoV555 are used as a cocktail and bind epitopes that partially overlap on the RBM such that both cannot bind simultaneously (<a ><i>21</i></a>, <a ><i>37</i></a>). REGN10933 is a class 1 antibody, and REGN10987 is a class 3 antibody that sterically blocks ACE2 binding but binds the RBM outside the main ACE2 binding site; both are used as a cocktail (REGN-COV2) (<a ><i>17</i></a>, <a ><i>18</i></a>).</div><div >Structural plasticity at the RBD-ACE2 interface suggests that the RBD could tolerate many more mutations than found in current variants of concern. We next generated pseudotypes for spike protein variants that contain composite mutations. The Delta variant, which contains the L452R<sub>RBD</sub> and T478K<sub>RBD</sub> substitutions, has become a dominant strain across the globe (<a ><i>38</i></a>). We generated pseudotype for the Delta AY.2 variant, which contains the K417N<sub>RBD</sub> mutation that is usually found in the Beta variant, and a Delta variant containing the N501Y<sub>RBD</sub>, E484K<sub>RBD</sub>, and F490S<sub>RBD</sub> mutations usually found in Beta, P.1 (Gamma), and C.37 (Lambda) variants (referred to here as “Delta +3”) (<a >Fig. 1A</a> and tables S1 and S2). The set of RBD mutations for the latter strain occurred in deposited sequences from samples collected in Turkey (table S1). We also generated pseudotypes in which we combined spike protein substitutions detected in the immunocompromised host with mutations found in the Beta variant, which we chose because this VOC is highly resistant to antibody neutralization (<a ><i>10</i></a>, <a ><i>12</i></a>, <a ><i>39</i></a>). Starting with a day 146* spike protein sequence, which contains an NTD deletion, we incorporated either one (E484K<sub>RBD</sub>) or two additional substitutions (E484K<sub>RBD</sub> and K417N<sub>RBD</sub>); these are referred to as receptor binding mutant-1 (RBM-1) and RBM-2, respectively (<a >Fig. 1A</a> and table S2). Additionally, starting with the Beta variant spike protein sequence, we generated a variant pseudotype that contains two additional mutations associated with immune evasion (L452R<sub>RBD</sub> and N439K<sub>RBD</sub>) (<a ><i>40</i></a>, <a ><i>41</i></a>). This pseudotype is referred to as RBM-3 (<a >Fig. 1A</a> and table S2). An ACE2-Fc fusion protein neutralized RBM-1, RBM-2, and RBM-3 pseudotypes, suggesting that all entered cells by binding ACE2 (<a >Fig. 2B</a> and fig. S4A).</div><div >We tested the activity of therapeutic antibodies against Delta AY.2, Delta +3, RBM-1, RBM-2, RBM-3, and additional variant pseudotypes with known resistance profiles to serve as comparators in the same assay (<a >Fig. 2, A and B</a>, and fig. S4A). LY-CoV555 was the most impacted by escape mutations, followed by CB6 (from which LY-CoV016 is derived) (<a >Fig. 2, A and B</a>, and fig. S4A). The Q493K<sub>RBD</sub> mutation conferred absolute resistance to LY-CoV555, generated eightyfold resistance to CB6, and also compromised REGN10933 activity, consistent with previous reports (<a >Fig. 2, A and B</a>, and fig. S4A) (<a ><i>14</i></a>, <a ><i>16</i></a>, <a ><i>17</i></a>, <a ><i>26</i></a>). In addition to the expected loss of activity of LY-CoV555 and CB6 against Beta and Gamma variants (<a ><i>9</i></a>, <a ><i>11</i></a>, <a ><i>12</i></a>, <a ><i>42</i></a>), LY-CoV555 and CB6 lost all activity against day 146*, day 152*, RBM-1, RBM-2, and RBM-3 pseudotypes (<a >Fig. 2, A and B</a>, and fig. S4A). While the Delta variant is known to resist neutralization by LY-CoV555 but retain sensitivity to neutralization by CB6/LY-CoV016 (<a ><i>38</i></a>), Delta AY.2 pseudotype was resistant to both agents (<a >Fig. 2, A and B</a>, and fig. S4A). This is expected because CB6/LY-CoV016 is derived from a V<sub>H</sub>3-66 antibody (<a ><i>21</i></a>), and the additional mutation the Delta AY.2 variant contains with respect to Delta (K417N<sub>RBD</sub>) confers resistance to CB6/LY-CoV16 and other members of the V<sub>H</sub>3-53/V<sub>H</sub>3-66 class of neutralizing antibodies (<a ><i>9</i></a>, <a ><i>14</i></a>, <a ><i>16</i></a>, <a ><i>26</i></a>, <a ><i>43</i></a>). Delta +3 pseudotype, which despite containing six RBD mutations does not contain the K417N<sub>RBD</sub> substitution, only escaped neutralization by LY-CoV555 (<a >Fig. 2, A and B</a>; fig. S4A; and table S2). Although the distribution of LY-CoV016 and LY-CoV555 was paused in the United States in the summer of 2021 as the prevalence of Gamma and Beta VOCs increased, the distribution of this antibody cocktail has since been resumed with the rise of Delta as the predominant strain. However, our findings emphasize the importance of close monitoring of Delta AY.2 and of other Delta variants for acquisition of the K417N<sub>RBD</sub> mutation.</div><div >Although REGN10933 lost substantial activity against the Beta variant, which is consistent with other reports (<a ><i>9</i></a>, <a ><i>12</i></a>, <a ><i>42</i></a>), it still had an IC<sub>50</sub> value of less than 1 μg ml<sup>−1</sup> in our assays (<a >Fig. 2, A and B</a>, and fig. S4A). However, resistance markedly worsened with the day 146*, day 152*, RBM-1, RBM-2, and RBM-3 pseudotypes, with 800- to 1900-fold loss in neutralizing activity (IC<sub>50</sub> values ranging from 20 to 47 μg ml<sup>−1</sup>). REGN10987 potently neutralized many of the variant pseudotypes we examined. While we observed expected resistance to REGN10987 neutralization by variants containing the N439K<sub>RBD</sub> or the adjacent N440D<sub>RBD</sub> substitutions (<a ><i>14</i></a>, <a ><i>16</i></a>), we also observed some loss of activity against Epsilon and B.1.617.1 (Kappa), which was less expected because none of their substitutions fall within the REGN10987 RBD footprint (<a >Fig. 1A</a> and <a >Movie 1</a>). Other reports, nonetheless, have also noted varying degrees of modest in vitro resistance of Epsilon and Kappa variants to REGN10987 neutralization (<a ><i>39</i></a>, <a ><i>42</i></a>). Notably, the day 146* and RBM-3 pseudotypes were the only ones to gain resistance to both antibodies in REGN-COV2 because they contain substitutions in the REGN10933 (e.g., Q493K<sub>RBD</sub>, or E484K<sub>RBD</sub> and K417N<sub>RBD</sub>) and the REGN10987 binding sites (N439K<sub>RBD</sub> or N440D<sub>RBD</sub>) (<a >Fig. 2, A and B</a>; fig. S4A; and <a >Movie 1</a>) (<a ><i>14</i></a>). We observed on GISAID instances of “day-146*-like” viruses that would be expected to resist neutralization by LY-CoV555, LY-CoV016, REGN10933, and REGN10987 because they contain the Q493K<sub>RBD</sub> and N439K<sub>RBD</sub> substitutions. One strain contains the N501Y<sub>RBD</sub>, Q493K<sub>RBD</sub>, and N439K<sub>RBD</sub> mutations (sequenced once in South Africa), and the other contains the N501Y<sub>RBD</sub>, Q493K<sub>RBD</sub>, L452R<sub>RBD</sub>, N439K<sub>RBD</sub>, and N440F<sub>RBD</sub> mutations (sequenced once in the United Kingdom) (table S1).</div><div >The broadly neutralizing antibody S309 (<a ><i>44</i></a>), a class 3 antibody that binds the RBD but does not interfere with ACE2 binding, and from which the therapeutic antibody sotrovimab is derived, was active against all variants we tested (fig. S4A). However, we could not calculate reliable neutralization IC<sub>50</sub> values because of variable non-neutralizable pseudotype fractions (fig. S4A). The presence of a non-neutralizable fraction is unexplained but has been noted in other reports when human cells overexpressing ACE2, as opposed to African green monkey (Vero) target cells, were used to examine S309 neutralizing activity (<a ><i>45</i></a>, <a ><i>46</i></a>).</div></section><section ><h3>Neutralization escape of mRNA vaccine recipient sera</h3><div >Messenger RNA (mRNA)–based vaccines encoding the SARS-CoV-2 spike protein elicit robust neutralizing antibody responses (<a ><i>47</i></a>–<a ><i>49</i></a>). We directly compared immune evasion of the day 146*, day 152*, and RBM-2 pseudotypes to the B.1.1.7 (Alpha), Beta, and Gamma pseudotypes in sera obtained from individuals who had received a 2-dose series of an mRNA vaccine (BNT162b2 or mRNA-1273) (<a >Fig. 2, C and D</a>, and fig. S5). In addition to RBD substitutions, day 146*, day 152*, RBM-1, and RBM-2 spike proteins all contain NTD deletions spanning residues 141–144, which are positioned near NTD mutations in Alpha, Beta, and Delta in a key antigenic supersite (table S2) (<a ><i>6</i></a>, <a ><i>7</i></a>). As similar NTD deletions found in Alpha, Beta, and Delta prevent binding of some neutralizing antibodies (<a ><i>6</i></a>, <a ><i>7</i></a>, <a ><i>46</i></a>), they would be expected to escape neutralization by some NTD-targeting antibodies in addition to escaping neutralization by RBD-targeting antibodies. After first immunization but prior to the second dose, we observed a loss in neutralizing activity for all variants, although the severity varied. Variants that contain any substitution at E484<sub>RBD,</sub> combined with an NTD deletion (Beta, day 152*, and RBM-2), were more effective at evading antibody responses than variants that had an E484<sub>RBD</sub> substitution without an NTD deletion (Gamma) or an NTD deletion but no E484<sub>RBD</sub> substitution (day 146*) (<a >Fig. 2, C and D</a>; fig. S5; and table S2). These findings are consistent with the role of E484<sub>RBD</sub> as a major driver in neutralization escape of polyclonal antibody responses to SARS-CoV-2 (<a ><i>35</i></a>) and observations that Beta more robustly escapes antibody neutralization than Gamma (<a ><i>9</i></a>, <a ><i>13</i></a>). They further suggest that variants that have an NTD supersite deletion and an E484<sub>RBD</sub> substitution are the most concerning when it comes to resistance to polyclonal antibodies.</div><div >One quarter of sampled individuals had no detectable activity against the Beta and RBM-2 pseudotypes after a single immunization (<a >Fig. 2, C and D</a>). However, sampling at 7 and 28 days after the second immunization revealed detectable neutralizing activity against all variants in all vaccine recipients, including against the RBM-2 pseudotype, which contains seven RBD mutations (<a >Fig. 2, C and D</a>, and fig. S5). Thus, repeated administration of an mRNA vaccine encoding constructs of the SARS-CoV-2 spike protein used in current formulations may provide sufficient neutralizing antibody breadth and potency to yield baseline serum neutralizing activity against variants that are more extensively mutated than the current dominant strains.</div></section><section ><h3>Identification of SARS-CoV cross-reactive antibodies</h3><div >The RBD is also the major target of neutralizing antibodies against SARS-CoV, which caused a small outbreak of viral pneumonia from 2003 to 2004, though with a much higher case fatality rate (<a ><i>50</i></a>, <a ><i>51</i></a>). Polyclonal antibody responses against SARS-CoV-2 poorly cross-neutralize SARS-CoV (<a ><i>52</i></a>, <a ><i>53</i></a>). To identify barriers that restrict neutralization breadth, we performed single memory B cell sorting with the SARS-CoV spike protein to mine the memory B cell repertoire of a COVID-19 convalescent individual (“C1”). Polyclonal IgG from C1 plasma neutralized SARS-CoV-2 pseudotype but had weak activity against SARS-CoV pseudotype (fig. S6A). From C1 peripheral blood mononuclear cells (PBMCs), using a pre-fusion stabilized SARS-CoV spike protein (S2P) (<a ><i>54</i></a>), we cloned 17 cross-reactive antibodies. Of these, 11 antibodies bound both SARS-CoV and SARS-CoV-2 spike protein in an ELISA (fig. S6C and table S5). Only the two RBD-binding antibodies, C1C-A3 (“A3”) and C1C-C6 (“C6”), neutralized SARS-CoV-2 pseudotypes in our assays (<a >Figs. 2B</a> and <a >3A</a> and fig. S6F). Despite binding to SARS-CoV spike protein and RBD by ELISA, A3 and C6 did not neutralize SARS-CoV pseudotype (fig. S6, F and G). We also included C1A-A6 (“A6”) in these assays, a SARS-CoV-2 neutralizing antibody we previously isolated from the C1 donor using pre-fusion stabilized SARS-CoV-2 S2P in single B cell sorting experiments (<a ><i>14</i></a>). Unlike A3 and C6, A6 neutralized SARS-CoV pseudotypes (<a >Figs. 2B</a> and <a >3A</a> and fig. S6F). We determined Fab RBD binding affinities using biolayer interferometry (BLI) (fig. S7 and table S3) and confirmed A3 and A6 activity against infectious SARS-CoV-2 in a plaque reduction neutralization assay (fig. S4B).</div><div >A3 neutralized almost all SARS-CoV-2 variant pseudotypes with a neutralization IC<sub>50</sub> value of less than 1 μg ml<sup>−1</sup>, including Beta, Gamma, Delta AY.2, Delta +3, RBM-1, RBM-2, and RBM-3 pseudotypes; the Epsilon variant was the only exception, with an IC<sub>50</sub> value of 1.9 μg ml<sup>−1</sup> (<a >Figs. 2B</a> and <a >3A</a> and fig. S4A). C6 and A6 also broadly neutralized variants but with higher baseline IC<sub>50</sub> values, even against D614G<sub>S</sub> pseudotypes (ranging from 2.0 to 11.4 μg ml<sup>−1</sup>) (<a >Figs. 2B</a> and <a >3A</a> and fig. S4A).</div><div >To determine where on the RBD A3, C6, and A6 bind, we carried out competition studies with C1A-B12 (<a ><i>14</i></a>), a class 1 antibody; REGN10987 (<a ><i>17</i></a>, <a ><i>18</i></a>) and S309 (<a ><i>44</i></a>), two class 3 antibodies; and CR3022 (<a ><i>55</i></a>), a class 4 antibody (<a >Fig. 3B</a>, fig. S8, and <a >Movie 1</a>). A3 competed with CR3022 and REGN10987 for RBD binding, C6 competed with CR3022, and C6 and A6 competed with each other (<a >Fig. 3B</a> and fig. S8). A6 did not compete with any of the other antibodies tested. Among A3, C6, and A6, only A3 competed with binding of an ACE2-Fc fusion protein, suggesting that A3 blocks cellular attachment.</div></section><section ><h3>Antibody C1C-A3 binds the conserved RBD core</h3><div >We determined the 3.1 Å cryo-EM structure of the A3 Fab bound to the SARS-CoV-2 spike protein ectodomain (<a >Fig. 4A</a>, figs. S9 and S10, and table S6). A3 binds the RBD core with the spike protein trapped in the three open RBD conformation (<a >Fig. 4A</a>). In agreement with competition assays (<a >Fig. 3B</a>), A3 interacts with RBD residues that overlap significantly with those of CR3022 (<a >Fig. 3, C, D, and F</a>, and <a >Movie 1</a>). A3 is therefore a class 4 antibody, a class that includes CR3022, S2A4, S304, S2X35, H014, COVA1-16, S2X259, and DH1047 (<a ><i>4</i></a>, <a ><i>56</i></a>–<a ><i>59</i></a>) (<a >Movie 1</a> and fig. S11). Although the A3 and S309 footprints on the RBD do not overlap and S309 (a class 3 antibody) can bind the closed spike protein trimer (<a ><i>44</i></a>), both antibodies contact the N-linked glycan attached to N343<sub>RBD</sub> but approach it from different faces (<a >Fig. 3C</a> and <a >Movie 1</a>).</div><div >The A3 Fab avoids the RBD-ACE2 interface, which contains the majority of key antibody escape mutations, but like other class 4 antibodies, nonetheless binds the RBD in a manner that would sterically interfere with ACE2 binding (<a >Fig. 4, B to E</a>, and fig. S11). Based on its epitope, in addition to retaining activity against all variants we tested, A3 would also have activity against emergent and pre-emergent SARS-CoV-2 variants; these include a virus sequenced from travelers from Tanzania that contains the E484K<sub>RBD</sub>, T478R<sub>RBD</sub>, and R346K<sub>RBD</sub> mutations, and B.1.621 (Mu), a variant detected early in 2021 in Colombia that has since spread internationally and contains the E484K<sub>RBD</sub>, N501Y<sub>RBD</sub>, and R346K<sub>RBD</sub> mutations (<a >Figs. 1G</a> and <a >4D</a> and table S1). The R346K<sub>RBD</sub> mutation falls within the RBD core and is in the S309 binding site but is not within A3’s footprint (<a >Fig. 3, D and E</a>, and <a >Movie 1</a>). However, S309 would likely retain activity against SARS-CoV-2 variants that contain the R346K<sub>RBD</sub> mutation, as the residue that is at the position analogous to SARS-CoV R346<sub>RBD</sub> is a lysine in SARS-CoV, and S309 neutralizes both SARS-CoV and SARS-CoV-2 (<a ><i>44</i></a>, <a ><i>60</i></a>).</div></section><section ><h3>RBD core glycan addition drives neutralization escape</h3><div >Despite A3’s breadth against SARS-CoV-2 variant pseudotypes (<a >Figs. 2B</a> and <a >3A</a>), A3 does not neutralize SARS-CoV pseudotype (fig. S6, F and G). The A3 epitope is highly conserved between SARS-CoV-2 and SARS-CoV; however, N370<sub>RBD</sub> is a site of N-linked glycosylation in SARS-CoV (N357<sub>RBD</sub> in SARS-CoV numbering) and in animal coronaviruses but not in SARS-CoV-2 (<a >Fig. 5, A, B, C, and F</a>) (<a ><i>61</i></a>). An N-linked glycan attached to SARS-CoV-2 N370<sub>RBD</sub> would introduce steric clashes with the A3 antibody heavy and light chains (<a >Fig. 5D</a>). Furthermore, calculations of antibody accessible surface areas using molecular dynamic trajectories of a fully glycosylated SARS-CoV-2 spike protein with a modeled N370<sub>RBD</sub> glycan suggest that its addition would restrict A3 epitope access and could also impact binding of other class 4 antibodies (fig. S12) (<a ><i>61</i></a>, <a ><i>62</i></a>).</div><div >Partial occupancy of the glycan attached to SARS-CoV N357<sub>RBD</sub> in recombinant protein preparations may explain how we observed spike protein and RBD binding but lack of SARS-CoV pseudotype neutralization (fig. S6, F and G). In surface plasmon resonance binding assays, A3 IgG bound tightly to the SARS-CoV RBD only when the RBD was enzymatically deglycosylated (fig. S13 and table S7). Consistent with the role of the SARS-CoV N357<sub>RBD</sub> N-linked glycan as a barrier to A3 neutralization, introducing a substitution that would prevent its addition (T359A<sub>RBD</sub>) sensitized SARS-CoV pseudotypes to A3 neutralization (IC<sub>50</sub> value of 5 μg ml<sup>−1</sup>) (<a >Fig. 2B</a> and fig. S4A).</div><div >The A372S/T<sub>RBD</sub> mutations, which would introduce an N-linked glycosylation motif and allow for modification of N370<sub>RBD</sub> in the SARS-CoV-2 spike protein, are found in human-derived SARS-CoV-2 sequences (GISAID) (<a ><i>27</i></a>), including on sequences for VOCs Alpha and Delta, without apparent geographic restriction (48 sequence counts as of 10 October 2021 and detected in at least 14 countries) (<a >Fig. 5F</a> and table S8). Although the mutations are currently rare, their presence in sequence databases suggest that SARS-CoV-2 strains containing these mutations can replicate in humans. To confirm that an N-linked glycan could be added to N370<sub>RBD</sub>, we conducted glycan analysis on recombinant SARS-CoV-2 RBD containing the A372S<sub>RBD</sub> substitution and observed 90% occupancy of an N-linked glycan at position N370<sub>RBD</sub> (fig. S13B)</div><div >Because acquisition of a putative N-linked glycan at N370<sub>RBD</sub> was the most frequent on the Alpha variant at the time of our initial analysis, we generated an Alpha pseudotype that contains the A372T<sub>RBD</sub> substitution (Alpha A372T). We tested the effect of this substitution on three class 4 antibodies: A3, the antibody we isolated here, S2A4, an antibody that does not cross-react with the SARS-CoV RBD (<a ><i>4</i></a>) and COVA1-16, an antibody that has weak cross-neutralizing activity against SARS-CoV (<a ><i>57</i></a>). The mutation resulted in eightfold resistance to A3 neutralization (IC<sub>50</sub> value of 1.1 μg ml<sup>−1</sup>, as compared to 0.14 μg ml<sup>−1</sup> with Alpha pseudotype) and complete resistance to S2A4 neutralization (<a >Figs. 2B</a>, <a >3A</a>, and <a >5, G and H</a>, and fig. S4A). S2A4 and COVA1-16 neutralized variants with potency that was overall comparable to A3 in most cases (<a >Figs. 2B</a> and <a >3A</a> and fig. S4A). COVA1-16, probably because it has some activity against SARS-CoV (above the limit of detection in our assays but 29 μg ml<sup>−1</sup> as reported by Liu <i>et al</i>.) (<a ><i>57</i></a>), retained activity against Alpha A372T pseudotype (<a >Figs. 2B</a>, <a >3A</a>, and <a >5H</a>, and fig. S4A). The Fab binding pose of certain class 4 antibodies, therefore, may allow them to avoid steric hindrance from an N-linked glycan attached to N370<sub>RBD</sub> (S2X259 is an example of one such antibody) (<a >Movie 1</a>) (<a ><i>56</i></a>).</div></section><section ><h3>Antibody C1C-A3 neutralizes a related coronavirus</h3><div >Coronaviruses that circulate in animals and have spike protein RBDs that can bind human ACE2 are a continued threat. RaTG13 virus, which is closely related to SARS-CoV-2 phylogenetically, is an example of one such virus (<a ><i>63</i></a>). The RaTG13 virus spike protein contains a threonine at RBD position 372, which would allow for N370<sub>RBD</sub> glycosylation (<a >Fig. 5F</a>). Despite the presence of the N-linked glycan, A3 potently neutralized RaTG13 virus pseudotype (neutralization IC<sub>50</sub> value of 21 ng ml<sup>−1</sup>), suggesting that A3 neutralization breadth extends to pre-emergent coronaviruses that are closely related to SARS-CoV-2 (<a >Fig. 5, G and H</a>). Structural superposition reveals that the N370<sub>RBD</sub> glycan on the RaTG13 RBD is positioned in a manner that may not block A3 epitope access but, rather, could interfere with binding of other antibodies that bind nearby epitopes on the RBD core (<a >Fig. 5E</a>).</div></section></section><section ><h2>Discussion</h2><div >As variants containing composite mutations begin to emerge, continued SARS-CoV-2 immune evasion will remain a significant concern. We found that accumulation of large numbers of RBD mutations, which mimics accelerated spike protein evolution occurring in a persistently infected immunocompromised host (<a ><i>14</i></a>–<a ><i>16</i></a>), is facilitated by structural plasticity at the ACE2-RBD interface (<a >Fig. 1, B to F</a>). The severity of the phenotypes we observed in vitro suggest that further evolved variants will more adeptly escape therapeutic antibody neutralization than currently circulating variants of concern, with potential resistance to two-component antibody cocktails (<a >Fig. 2, A and B</a>).</div><div >After two mRNA vaccine immunizations and as early as 7 days after the second dose, all mRNA vaccine recipients had detectable neutralizing activity against pseudotypes containing an NTD supersite deletion and RBDs with six to seven mutations (e.g., day 146*, day 152*, and RBM-2), with mean neutralization ID<sub>50</sub> values decreased by 2.3 to 6.1-fold (<a >Fig. 2, C and D</a>, and fig. S5). While the precise epitopes targeted by this residual vaccine-elicited serum neutralizing activity remain to be determined, we surmise that antibodies targeting the RBD core (e.g., those that bind away from the RBM), at least in part account for some of this activity. As the RBD is a major target of vaccine elicited and naturally acquired humoral immunity to SARS-CoV-2 (<a ><i>4</i></a>, <a ><i>5</i></a>) and the RBM is a critical site of potent neutralizing antibody binding (<a ><i>19</i></a>, <a ><i>21</i></a>–<a ><i>25</i></a>, <a ><i>64</i></a>) that is the most antibody accessible and the least masked by glycan and conformational shielding (fig. S12), continued RBM evolution may guide antibody responses toward more conserved neutralizing epitopes on the RBD core.</div><div >We mined genome sequences in the GISAID database for substitutions that would introduce additional N-linked glycans onto the RBD. This analysis identified D364N<sub>RBD</sub> as an additional mutation that would introduce a putative N-linked glycosylation site in a surface exposed loop in the footprint of some class 4 antibodies (<a >Movie 1</a>). The independent acquisition of N-linked glycosylation sites (through the A372S/T<sub>RBD</sub> and D364N<sub>RBD</sub> substitutions) on the same surface of the RBD core, but not on other RBD sites, suggests that this region may be a target of immune selective pressure.</div><div >While glycan addition may allow neutralization escape, this change could come at a cost to viral fitness and infectivity. Indeed, the A1114G:T372A mutation that removed the glycan in the SARS-CoV-2 RBD appeared under selective pressure, and addition of the glycan decreases viral replication in human lung epithelial (Calu-3) cells by over sixty-fold (<a ><i>65</i></a>). A recent molecular dynamics study suggests that introducing the glycan at N370<sub>RBD</sub> in SARS-CoV-2 would favor the closed conformation with the N370<sub>RBD</sub> glycan stabilizing the closed RBD structure on the trimeric spike protein (<a ><i>66</i></a>). A lack of a glycan at position N370<sub>RBD</sub>, therefore, may increase SARS-CoV-2 ACE2-binding and infectivity by favoring the open state, but may also make SARS-CoV-2 more vulnerable to neutralizing antibodies that can only bind the RBD in the open conformation.</div><div >Although addition of the N370<sub>RBD</sub> glycan may be associated with a cost to viral fitness, should the selective immune pressure be significant at this site over a long enough time scale, this may also afford the virus an opportunity to acquire permissive secondary mutations during evolution that restore viral fitness, as is observed in influenza virus drug resistance (<a ><i>67</i></a>). Such compensatory mutations would be ones that promote ACE2 binding and RBD opening; for example, the D614G<sub>S</sub> mutation (<a ><i>68</i></a>), which favors the open conformation, and the N501Y<sub>RBD</sub> mutation, which introduces more favorable interactions with ACE2 (<a >Fig. 1D</a>).</div><div >As parts of the world continue to face waves of infection and mitigation strategies are relaxed, viral replication in human hosts under antibody selective pressure will continue to shape the antigenic landscape of the SARS-CoV-2 spike protein. With vigorous variant monitoring efforts underway to help design next-generation antibody-based therapeutics, and with mRNA- or DNA-based vaccines that can be updated to rapidly adapt to new variants, proactively examining the consequences of further viral evolution before the next highly antibody resistant strain emerges is of utmost importance.</div></section><section ><h2>Materials and methods summary</h2><div >We isolated monoclonal antibodies from the blood of a COVID-19 convalescent individual using single B cell sorting with prefusion stabilized SARS-CoV spike protein ectodomain as bait and using established protocols (<a ><i>14</i></a>, <a ><i>54</i></a>). We obtained venous blood samples from healthy mRNA-1273 and BNT162b2 vaccine recipients. We produced recombinant glycoproteins and antibodies or Fabs in transiently transfected mammalian cells grown in suspension culture and purified these proteins using affinity-based methods. We used ELISAs to measure antibody binding and biolayer interferometry or surface plasmon resonance to determine kinetic parameters of binding. We packaged lentivirus pseudotypes by transient transfection of HEK293T cells as previously described (<a ><i>14</i></a>). We used HEK293T cells expressing human ACE2 in pseudotype neutralization assays or Vero E6 cells and plaque reduction neutralization tests as previously described (<a ><i>14</i></a>). We collected X-ray diffraction data on crystals of a day 146*:SARS-CoV-2 RBD complex at the Advanced Photon Source (APS, Argonne, IL) NE-CAT beamline and used established procedures for data processing, molecular replacement, atomic model building, and refinement (<a ><i>37</i></a>, <a ><i>69</i></a>–<a ><i>73</i></a>). We used mass spectrometry to perform glycopeptide analysis. After data collection on a Titan Krios cryo-electron microscope equipped with a Gatan K3 camera, we used single-particle cryo-EM to determine the structure of a prefusion stabilized SARS-CoV-2 spike protein ectodomain (7) complexed with C1C-A3 Fab complex using established procedures for image processing, atomic model building, and refinement (<a ><i>72</i></a>–<a ><i>77</i></a>).</div></section><section ><h2>Acknowledgments</h2><div >This work is based upon research conducted at the Northeastern Collaborative Access Team (NE-CAT)beamlines, which are funded by the National Institute of General Medical Sciences from the NationalInstitutes of Health (P30 GM124165). The Pilatus 6M detector on 24-ID-C beam line is funded by aNIH-ORIP HEI grant (S10 RR029205). This research used resources of the Advanced Photon Source, aU.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office ofScience by Argonne National Laboratory under Contract No. DE-AC02-06CH11357. We thank the staff atNE-CAT for assistance with X-ray data collection. Cryo-EM data were collected at the HarvardCryo-Electron Microscopy Center for Structural Biology. We thank Harvard Cryo-EM Center staffmembers for assistance with cryo-EM data collection. We acknowledge support for COVID-19 relatedstructural biology research at Harvard from the Nancy Lurie Marks Family Foundation. We thank B.Chen for providing a human ACE2 ectodomain expressing cell line, and H. Choe for providing cDNAencoding the SARS-CoV spike protein. <b>Funding:</b> This work was funded in part by theMassachusetts Consortium on Pathogen Readiness (MassCPR) (J.A.). J.A. was also supported by theStar-Friedman Award Challenge for Promising Scientific Research. L.R.B. is supported by the HarvardClinical and Translational Science Center, from the National Center for Advancing TranslationalScience (1UL1TR002541-01); by Barbara and Amos Hostetter; and by the Chleck Family Foundation.S.E.T., R.C.L., E.T.R., and R.C.C. receive grant support from the Centers for Disease Control andPrevention (U01CK000490). K.G.N., A.C., and H.H.V. are supported by Award Number T32GM007753 fromthe National Institute of General Medical Sciences. The content is solely the responsibility of theauthors and does not necessarily represent the official views of the National Institute of GeneralMedical Sciences or the National Institutes of Health. <b>Author contributions:</b>Conceptualization: KGN, SAC, SS, JP, LEC, PY, AC, LGAM, NVT, MD, SET, SK, ACS, AD, CT, JFC, ATD,ATD, DT, AC, YF, AG, IRC, JS, LRB, RCC, JA. Methodology: KGN, SAC, SS, JP, LEC, PY, AC, LGAM, HHV,NVT, GZ, MD, SET, SK, ACS, AD, RCL, ETR, CT, JFC, ATD, DT, AC, YF, AG, IRC, JS, LRB, RC, JA.Investigation: KGN, SAC, SS, JP, LEC, PY, AC, LGAM, HHV, VB, NVT, SET, SK, MJ, ACS, CT, JFC, ATD,DT, AC, YF, AG, IRC, JS, LRB, RC, JA. Visualization: KGN, SAC, SS, JP, LEC, PY, AC, LGAM, HHV, NVT,GZ, MD, SET, SK, ACS, CT, JFC, ATD, DT, AC, YF, AG, IRC, JS, LRB, RCC, JA. Funding acquisition: RCL,ETR, RCC, JA. Project administration: KGN, SAC, SS, JP, NVT, MD, SET, SK, ACS, AG, IRC, JS, LRB,RCC, JA. Supervision: AD, JFC, YF, AG, IRC, JS, LRB, RCC, JA. Writing – original draft: JA.Writing – review editing: KGN, SAC, SS, JP, LEC, AC, LGAM, HHV, GZ, MD, SET, SK, ACS,RCL, ETR, CT, JFC, ATD, DT, AC, YF, AG, IRC, JS, LRB, RCC, JA. <b>Competing interests:</b>SAC, LEC, and JA are inventors on a provisional patent application that covers antibodies describedin this publication filed by the President and Fellows of Harvard University. S.E.T. receivesmonetary compensation from UpToDate, which provides clinical decision support. <b>Data andmaterials availability:</b> C1C-A3 antibody heavy chain and light chain variable region genesequences have been deposited in GenBank under accession codes OL621229 and OL621230, respectively.Protein Data Bank (PBD) identification numbers for the day 146* RBD human ACE2 ectodomain complex,the unliganded C1C-A3 Fab, the C1C-A3 Fab SARS-CoV-2 spike protein ectodomain complex, and focusedrefinement of the C1C-A3 Fab/RBD region are 7SN0, 7SN1, 7SN3, and 7SN2, respectively. ElectronMicroscopy Database (EMDB) accession numbers for the C1C-A3 Fab SARS-CoV-2 spike protein ectodomaincomplex and focused refinement of the C1C-A3 Fab/RBD region are EMD-25210 and EMD-2509,respectively. All materials are available upon request. This work is licensed under a CreativeCommons Attribution 4.0 International (CC BY 4.0) license, which permits unrestricted use,distribution, and reproduction in any medium, provided the original work is properly cited. To viewa copy of this license, visit <a >https://creativecommons.org/licenses/by/4.0/</a>. This license does not apply tofigures/photos/artwork or other content included in the article that is credited to a third party;obtain authorization from the rights holder before using such material.</div></section> </div></section><section ><div ><section ><h2>Supplementary Material</h2><section><h3>Summary</h3><div ><a >science.org/doi/10.1126/science.abl6251</a></div><div >Materials and Methods</div><div >Figs. S1 to S13</div><div >Tables S1 to S9</div><div >References (<a ><i>80</i></a>–<a ><i>100</i></a>)</div><div >MDAR Reproducibility Checklist</div></section><section><h3>Resources</h3><div ><div ><div >File (science.abl6251-il1.tif)</div><div >Download</div></div><div ><div >File (science.abl6251-il1.mp4)</div><div >Download</div></div><div ><div >File (science.abl6251_mdar_reproducibility_checklist.pdf)</div><div >Download</div></div><div ><div >File (science.abl6251_sm.pdf)</div><div >Download</div></div><div ><div >File (thumbs.db)</div><div >Download</div></div></div></section></section><section ><h2>References and Notes</h2><div ><div >1</div><div ><div ><div >W. T. Harvey, A. M. Carabelli, B. Jackson, R. K. Gupta, E. C. Thomson, E. M. Harrison, C. Ludden, R. Reeve, A. Rambaut, S. J. Peacock, D. L. Robertson; COVID-19 Genomics UK (COG-UK) Consortium, SARS-CoV-2 variants, spike mutations and immune escape. Nat. Rev. Microbiol. <b>19</b>, 409–424 (2021).</div><div ><div>Crossref</div><div>PubMed</div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >2</div><div ><div ><div >J. Lan, J. Ge, J. Yu, S. Shan, H. Zhou, S. Fan, Q. Zhang, X. Shi, Q. Wang, L. Zhang, X. Wang, Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature <b>581</b>, 215–220 (2020).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >3</div><div ><div ><div >J. Shang, G. Ye, K. Shi, Y. Wan, C. Luo, H. Aihara, Q. Geng, A. Auerbach, F. Li, Structural basis of receptor recognition by SARS-CoV-2. Nature <b>581</b>, 221–224 (2020).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >4</div><div ><div ><div >L. Piccoli, Y.-J. Park, M. A. Tortorici, N. Czudnochowski, A. C. Walls, M. Beltramello, C. Silacci-Fregni, D. Pinto, L. E. Rosen, J. E. Bowen, O. J. Acton, S. Jaconi, B. Guarino, A. Minola, F. Zatta, N. Sprugasci, J. Bassi, A. Peter, A. De Marco, J. C. Nix, F. Mele, S. Jovic, B. F. Rodriguez, S. V. Gupta, F. Jin, G. Piumatti, G. Lo Presti, A. F. Pellanda, M. Biggiogero, M. Tarkowski, M. S. Pizzuto, E. Cameroni, C. Havenar-Daughton, M. Smithey, D. Hong, V. Lepori, E. Albanese, A. Ceschi, E. Bernasconi, L. Elzi, P. Ferrari, C. Garzoni, A. Riva, G. Snell, F. Sallusto, K. Fink, H. W. Virgin, A. Lanzavecchia, D. Corti, D. Veesler, Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology. Cell <b>183</b>, 1024–1042.e21 (2020).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >5</div><div ><div ><div >A. J. Greaney, A. N. Loes, L. E. Gentles, K. H. D. Crawford, T. N. Starr, K. D. Malone, H. Y. Chu, J. D. Bloom, Antibodies elicited by mRNA-1273 vaccination bind more broadly to the receptor binding domain than do those from SARS-CoV-2 infection. Sci. Transl. Med. <b>13</b>, eabi9915 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >6</div><div ><div ><div >K. R. McCarthy, L. J. Rennick, S. Nambulli, L. R. Robinson-McCarthy, W. G. Bain, G. Haidar, W. P. Duprex, Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape. Science <b>371</b>, 1139–1142 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >7</div><div ><div ><div >M. McCallum, A. De Marco, F. A. Lempp, M. A. Tortorici, D. Pinto, A. C. Walls, M. Beltramello, A. Chen, Z. Liu, F. Zatta, S. Zepeda, J. di Iulio, J. E. Bowen, M. Montiel-Ruiz, J. Zhou, L. E. Rosen, S. Bianchi, B. Guarino, C. S. Fregni, R. Abdelnabi, S. C. Foo, P. W. Rothlauf, L.-M. Bloyet, F. Benigni, E. Cameroni, J. Neyts, A. Riva, G. Snell, A. Telenti, S. P. J. Whelan, H. W. Virgin, D. Corti, M. S. Pizzuto, D. Veesler, N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2. Cell <b>184</b>, 2332–2347.e16 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >8</div><div ><div ><div >P. Supasa, D. Zhou, W. Dejnirattisai, C. Liu, A. J. Mentzer, H. M. Ginn, Y. Zhao, H. M. E. Duyvesteyn, R. Nutalai, A. Tuekprakhon, B. Wang, G. C. Paesen, J. Slon-Campos, C. López-Camacho, B. Hallis, N. Coombes, K. R. Bewley, S. Charlton, T. S. Walter, E. Barnes, S. J. Dunachie, D. Skelly, S. F. Lumley, N. Baker, I. Shaik, H. E. Humphries, K. Godwin, N. Gent, A. Sienkiewicz, C. Dold, R. Levin, T. Dong, A. J. Pollard, J. C. Knight, P. Klenerman, D. Crook, T. Lambe, E. Clutterbuck, S. Bibi, A. Flaxman, M. Bittaye, S. Belij-Rammerstorfer, S. Gilbert, D. R. Hall, M. A. Williams, N. G. Paterson, W. James, M. W. Carroll, E. E. Fry, J. Mongkolsapaya, J. Ren, D. I. Stuart, G. R. Screaton, Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera. Cell <b>184</b>, 2201–2211.e7 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >9</div><div ><div ><div >W. Dejnirattisai, D. Zhou, P. Supasa, C. Liu, A. J. Mentzer, H. M. Ginn, Y. Zhao, H. M. E. Duyvesteyn, A. Tuekprakhon, R. Nutalai, B. Wang, C. López-Camacho, J. Slon-Campos, T. S. Walter, D. Skelly, S. A. Costa Clemens, F. G. Naveca, V. Nascimento, F. Nascimento, C. Fernandes da Costa, P. C. Resende, A. Pauvolid-Correa, M. M. Siqueira, C. Dold, R. Levin, T. Dong, A. J. Pollard, J. C. Knight, D. Crook, T. Lambe, E. Clutterbuck, S. Bibi, A. Flaxman, M. Bittaye, S. Belij-Rammerstorfer, S. C. Gilbert, M. W. Carroll, P. Klenerman, E. Barnes, S. J. Dunachie, N. G. Paterson, M. A. Williams, D. R. Hall, R. J. G. Hulswit, T. A. Bowden, E. E. Fry, J. Mongkolsapaya, J. Ren, D. I. Stuart, G. R. Screaton, Antibody evasion by the P.1 strain of SARS-CoV-2. Cell <b>184</b>, 2939–2954.e9 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >10</div><div ><div ><div >D. Planas, T. Bruel, L. Grzelak, F. Guivel-Benhassine, I. Staropoli, F. Porrot, C. Planchais, J. Buchrieser, M. M. Rajah, E. Bishop, M. Albert, F. Donati, M. Prot, S. Behillil, V. Enouf, M. Maquart, M. Smati-Lafarge, E. Varon, F. Schortgen, L. Yahyaoui, M. Gonzalez, J. De Sèze, H. Péré, D. Veyer, A. Sève, E. Simon-Lorière, S. Fafi-Kremer, K. Stefic, H. Mouquet, L. Hocqueloux, S. van der Werf, T. Prazuck, O. Schwartz, Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies. Nat. Med. <b>27</b>, 917–924 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >11</div><div ><div ><div >P. Wang, R. G. Casner, M. S. Nair, M. Wang, J. Yu, G. Cerutti, L. Liu, P. D. Kwong, Y. Huang, L. Shapiro, D. D. Ho, Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization. Cell Host Microbe <b>29</b>, 747–751.e4 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >12</div><div ><div ><div >P. Wang, M. S. Nair, L. Liu, S. Iketani, Y. Luo, Y. Guo, M. Wang, J. Yu, B. Zhang, P. D. Kwong, B. S. Graham, J. R. Mascola, J. Y. Chang, M. T. Yin, M. Sobieszczyk, C. A. Kyratsous, L. Shapiro, Z. Sheng, Y. Huang, D. D. Ho, Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7. Nature <b>593</b>, 130–135 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >13</div><div ><div ><div >W. F. Garcia-Beltran, E. C. Lam, K. St. Denis, A. D. Nitido, Z. H. Garcia, B. M. Hauser, J. Feldman, M. N. Pavlovic, D. J. Gregory, M. C. Poznansky, A. Sigal, A. G. Schmidt, A. J. Iafrate, V. Naranbhai, A. B. Balazs, Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity. Cell <b>184</b>, 2523 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >14</div><div ><div ><div >S. A. Clark, L. E. Clark, J. Pan, A. Coscia, L. G. A. McKay, S. Shankar, R. I. Johnson, V. Brusic, M. C. Choudhary, J. Regan, J. Z. Li, A. Griffiths, J. Abraham, SARS-CoV-2 evolution in an immunocompromised host reveals shared neutralization escape mechanisms. Cell <b>184</b>, 2605–2617.e18 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >15</div><div ><div ><div >B. Choi, M. C. Choudhary, J. Regan, J. A. Sparks, R. F. Padera, X. Qiu, I. H. Solomon, H.-H. Kuo, J. Boucau, K. Bowman, U. D. Adhikari, M. L. Winkler, A. A. Mueller, T. Y.-T. Hsu, M. Desjardins, L. R. Baden, B. T. Chan, B. D. Walker, M. Lichterfeld, M. Brigl, D. S. Kwon, S. Kanjilal, E. T. Richardson, A. H. Jonsson, G. Alter, A. K. Barczak, W. P. Hanage, X. G. Yu, G. D. Gaiha, M. S. Seaman, M. Cernadas, J. Z. Li, Persistence and evolution of SARS-CoV-2 in an immunocompromised host. N. Engl. J. Med. <b>383</b>, 2291–2293 (2020).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >16</div><div ><div ><div >T. N. Starr, A. J. Greaney, A. Addetia, W. W. Hannon, M. C. Choudhary, A. S. Dingens, J. Z. Li, J. D. Bloom, Prospective mapping of viral mutations that escape antibodies used to treat COVID-19. Science <b>371</b>, 850–854 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >17</div><div ><div ><div >A. Baum, B. O. Fulton, E. Wloga, R. Copin, K. E. Pascal, V. Russo, S. Giordano, K. Lanza, N. Negron, M. Ni, Y. Wei, G. S. Atwal, A. J. Murphy, N. Stahl, G. D. Yancopoulos, C. A. Kyratsous, Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies. Science <b>369</b>, 1014–1018 (2020).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >18</div><div ><div ><div >J. Hansen, A. Baum, K. E. Pascal, V. Russo, S. Giordano, E. Wloga, B. O. Fulton, Y. Yan, K. Koon, K. Patel, K. M. Chung, A. Hermann, E. Ullman, J. Cruz, A. Rafique, T. Huang, J. Fairhurst, C. Libertiny, M. Malbec, W. Y. Lee, R. Welsh, G. Farr, S. Pennington, D. Deshpande, J. Cheng, A. Watty, P. Bouffard, R. Babb, N. Levenkova, C. Chen, B. Zhang, A. Romero Hernandez, K. Saotome, Y. Zhou, M. Franklin, S. Sivapalasingam, D. C. Lye, S. Weston, J. Logue, R. Haupt, M. Frieman, G. Chen, W. Olson, A. J. Murphy, N. Stahl, G. D. Yancopoulos, C. A. Kyratsous, Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail. Science <b>369</b>, 1010–1014 (2020).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >19</div><div ><div ><div >M. Yuan, H. Liu, N. C. Wu, C. D. Lee, X. Zhu, F. Zhao, D. Huang, W. Yu, Y. Hua, H. Tien, T. F. Rogers, E. Landais, D. Sok, J. G. Jardine, D. R. Burton, I. A. Wilson, Structural basis of a shared antibody response to SARS-CoV-2. Science <b>369</b>, 1119–1123 (2020).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >20</div><div ><div ><div >T. F. Rogers, F. Zhao, D. Huang, N. Beutler, A. Burns, W. T. He, O. Limbo, C. Smith, G. Song, J. Woehl, L. Yang, R. K. Abbott, S. Callaghan, E. Garcia, J. Hurtado, M. Parren, L. Peng, S. Ramirez, J. Ricketts, M. J. Ricciardi, S. A. Rawlings, N. C. Wu, M. Yuan, D. M. Smith, D. Nemazee, J. R. Teijaro, J. E. Voss, I. A. Wilson, R. Andrabi, B. Briney, E. Landais, D. Sok, J. G. Jardine, D. R. Burton, Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model. Science <b>369</b>, 956–963 (2020).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >21</div><div ><div ><div >R. Shi, C. Shan, X. Duan, Z. Chen, P. Liu, J. Song, T. Song, X. Bi, C. Han, L. Wu, G. Gao, X. Hu, Y. Zhang, Z. Tong, W. Huang, W. J. Liu, G. Wu, B. Zhang, L. Wang, J. Qi, H. Feng, F.-S. Wang, Q. Wang, G. F. Gao, Z. Yuan, J. Yan, A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2. Nature <b>584</b>, 120–124 (2020).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >22</div><div ><div ><div >E. Seydoux, L. J. Homad, A. J. MacCamy, K. R. Parks, N. K. Hurlburt, M. F. Jennewein, N. R. Akins, A. B. Stuart, Y.-H. Wan, J. Feng, R. E. Whaley, S. Singh, M. Boeckh, K. W. Cohen, M. J. McElrath, J. A. Englund, H. Y. Chu, M. Pancera, A. T. McGuire, L. Stamatatos, Analysis of a SARS-CoV-2-infected individual reveals development of potent neutralizing antibodies with limited somatic mutation. Immunity <b>53</b>, 98–105.e5 (2020).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >23</div><div ><div ><div >D. F. Robbiani, C. Gaebler, F. Muecksch, J. C. C. Lorenzi, Z. Wang, A. Cho, M. Agudelo, C. O. Barnes, A. Gazumyan, S. Finkin, T. Hägglöf, T. Y. Oliveira, C. Viant, A. Hurley, H.-H. Hoffmann, K. G. Millard, R. G. Kost, M. Cipolla, K. Gordon, F. Bianchini, S. T. Chen, V. Ramos, R. Patel, J. Dizon, I. Shimeliovich, P. Mendoza, H. Hartweger, L. Nogueira, M. Pack, J. Horowitz, F. Schmidt, Y. Weisblum, E. Michailidis, A. W. Ashbrook, E. Waltari, J. E. Pak, K. E. Huey-Tubman, N. Koranda, P. R. Hoffman, A. P. West Jr., C. M. Rice, T. Hatziioannou, P. J. Bjorkman, P. D. Bieniasz, M. Caskey, M. C. Nussenzweig, Convergent antibody responses to SARS-CoV-2 in convalescent individuals. Nature <b>584</b>, 437–442 (2020).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >24</div><div ><div ><div >S. Du, Y. Cao, Q. Zhu, P. Yu, F. Qi, G. Wang, X. Du, L. Bao, W. Deng, H. Zhu, J. Liu, J. Nie, Y. Zheng, H. Liang, R. Liu, S. Gong, H. Xu, A. Yisimayi, Q. Lv, B. Wang, R. He, Y. Han, W. Zhao, Y. Bai, Y. Qu, X. Gao, C. Ji, Q. Wang, N. Gao, W. Huang, Y. Wang, X. S. Xie, X. D. Su, J. Xiao, C. Qin, Structurally resolved SARS-CoV-2 antibody shows high efficacy in severely infected hamsters and provides a potent cocktail pairing strategy. Cell <b>183</b>, 1013–1023.e13 (2020).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >25</div><div ><div ><div >Y. Wu, F. Wang, C. Shen, W. Peng, D. Li, C. Zhao, Z. Li, S. Li, Y. Bi, Y. Yang, Y. Gong, H. Xiao, Z. Fan, S. Tan, G. Wu, W. Tan, X. Lu, C. Fan, Q. Wang, Y. Liu, C. Zhang, J. Qi, G. F. Gao, F. Gao, L. Liu, A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2. Science <b>368</b>, 1274–1278 (2020).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >26</div><div ><div ><div >T. N. Starr, A. J. Greaney, A. S. Dingens, J. D. Bloom, Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016. Cell Rep. Med. <b>2</b>, 100255 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >27</div><div ><div ><div >S. Elbe, G. Buckland-Merrett, Data, disease and diplomacy: GISAID’s innovative contribution to global health. Glob. Chall. <b>1</b>, 33–46 (2017).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >28</div><div ><div ><div >Y. Weisblum, F. Schmidt, F. Zhang, J. DaSilva, D. Poston, J. C. C. Lorenzi, F. Muecksch, M. Rutkowska, H.-H. Hoffmann, E. Michailidis, C. Gaebler, M. Agudelo, A. Cho, Z. Wang, A. Gazumyan, M. Cipolla, L. Luchsinger, C. D. Hillyer, M. Caskey, D. F. Robbiani, C. M. Rice, M. C. Nussenzweig, T. Hatziioannou, P. D. Bieniasz, Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants. eLife <b>9</b>, e61312 (2020).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >29</div><div ><div ><div >D. Wrapp, N. Wang, K. S. Corbett, J. A. Goldsmith, C.-L. Hsieh, O. Abiona, B. S. Graham, J. S. McLellan, Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science <b>367</b>, 1260–1263 (2020).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >30</div><div ><div ><div >K. Liu, X. Pan, L. Li, F. Yu, A. Zheng, P. Du, P. Han, Y. Meng, Y. Zhang, L. Wu, Q. Chen, C. Song, Y. Jia, S. Niu, D. Lu, C. Qiao, Z. Chen, D. Ma, X. Ma, S. Tan, X. Zhao, J. Qi, G. F. Gao, Q. Wang, Binding and molecular basis of the bat coronavirus RaTG13 virus to ACE2 in humans and other species. Cell <b>184</b>, 3438–3451.e10 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >31</div><div ><div ><div >K. Suryamohan, D. Diwanji, E. W. Stawiski, R. Gupta, S. Miersch, J. Liu, C. Chen, Y.-P. Jiang, F. A. Fellouse, J. F. Sathirapongsasuti, P. K. Albers, T. Deepak, R. Saberianfar, A. Ratan, G. Washburn, M. Mis, D. Santhosh, S. Somasekar, G. H. Hiranjith, D. Vargas, S. Mohan, S. Phalke, B. Kuriakose, A. Antony, M. Ustav Jr., S. C. Schuster, S. Sidhu, J. R. Junutula, N. Jura, S. Seshagiri, Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2. Commun. Biol. <b>4</b>, 475 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >32</div><div ><div ><div >A. R. Mehdipour, G. Hummer, Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike. Proc. Natl. Acad. Sci. U.S.A. <b>118</b>, e2100425118 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >33</div><div ><div ><div >X. Zhu, D. Mannar, S. S. Srivastava, A. M. Berezuk, J.-P. Demers, J. W. Saville, K. Leopold, W. Li, D. S. Dimitrov, K. S. Tuttle, S. Zhou, S. Chittori, S. Subramaniam, Cryo-electron microscopy structures of the N501Y SARS-CoV-2 spike protein in complex with ACE2 and 2 potent neutralizing antibodies. PLOS Biol. <b>19</b>, e3001237 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >34</div><div ><div ><div >R. E. Chen, X. Zhang, J. B. Case, E. S. Winkler, Y. Liu, L. A. VanBlargan, J. Liu, J. M. Errico, X. Xie, N. Suryadevara, P. Gilchuk, S. J. Zost, S. Tahan, L. Droit, J. S. Turner, W. Kim, A. J. Schmitz, M. Thapa, D. Wang, A. C. M. Boon, R. M. Presti, J. A. O’Halloran, A. H. J. Kim, P. Deepak, D. Pinto, D. H. Fremont, J. E. Crowe Jr., D. Corti, H. W. Virgin, A. H. Ellebedy, P.-Y. Shi, M. S. Diamond, Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies. Nat. Med. <b>27</b>, 717–726 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >35</div><div ><div ><div >A. J. Greaney, A. N. Loes, K. H. D. Crawford, T. N. Starr, K. D. Malone, H. Y. Chu, J. D. Bloom, Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies. Cell Host Microbe <b>29</b>, 463–476.e6 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >36</div><div ><div ><div >C. O. Barnes, C. A. Jette, M. E. Abernathy, K. A. Dam, S. R. Esswein, H. B. Gristick, A. G. Malyutin, N. G. Sharaf, K. E. Huey-Tubman, Y. E. Lee, D. F. Robbiani, M. C. Nussenzweig, A. P. West Jr., P. J. Bjorkman, SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies. Nature <b>588</b>, 682–687 (2020).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >37</div><div ><div ><div >B. E. Jones, P. L. Brown-Augsburger, K. S. Corbett, K. Westendorf, J. Davies, T. P. Cujec, C. M. Wiethoff, J. L. Blackbourne, B. A. Heinz, D. Foster, R. E. Higgs, D. Balasubramaniam, L. Wang, Y. Zhang, E. S. Yang, R. Bidshahri, L. Kraft, Y. Hwang, S. Žentelis, K. R. Jepson, R. Goya, M. A. Smith, D. W. Collins, S. J. Hinshaw, S. A. Tycho, D. Pellacani, P. Xiang, K. Muthuraman, S. Sobhanifar, M. H. Piper, F. J. Triana, J. Hendle, A. Pustilnik, A. C. Adams, S. J. Berens, R. S. Baric, D. R. Martinez, R. W. Cross, T. W. Geisbert, V. Borisevich, O. Abiona, H. M. Belli, M. de Vries, A. Mohamed, M. Dittmann, M. I. Samanovic, M. J. Mulligan, J. A. Goldsmith, C.-L. Hsieh, N. V. Johnson, D. Wrapp, J. S. McLellan, B. C. Barnhart, B. S. Graham, J. R. Mascola, C. L. Hansen, E. Falconer, The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates. Sci. Transl. Med. <b>13</b>, eabf1906 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >38</div><div ><div ><div >D. Planas, D. Veyer, A. Baidaliuk, I. Staropoli, F. Guivel-Benhassine, M. M. Rajah, C. Planchais, F. Porrot, N. Robillard, J. Puech, M. Prot, F. Gallais, P. Gantner, A. Velay, J. Le Guen, N. Kassis-Chikhani, D. Edriss, L. Belec, A. Seve, L. Courtellemont, H. Péré, L. Hocqueloux, S. Fafi-Kremer, T. Prazuck, H. Mouquet, T. Bruel, E. Simon-Lorière, F. A. Rey, O. Schwartz, Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization. Nature <b>596</b>, 276–280 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >39</div><div ><div ><div >R. E. Chen, E. S. Winkler, J. B. Case, I. D. Aziati, T. L. Bricker, A. Joshi, T. L. Darling, B. Ying, J. M. Errico, S. Shrihari, L. A. VanBlargan, X. Xie, P. Gilchuk, S. J. Zost, L. Droit, Z. Liu, S. Stumpf, D. Wang, S. A. Handley, W. B. Stine Jr., P.-Y. Shi, M. E. Davis-Gardner, M. S. Suthar, M. G. Knight, R. Andino, C. Y. Chiu, A. H. Ellebedy, D. H. Fremont, S. P. J. Whelan, J. E. Crowe Jr., L. Purcell, D. Corti, A. C. M. Boon, M. S. Diamond, In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains. Nature <b>596</b>, 103–108 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >40</div><div ><div ><div >M. McCallum, J. Bassi, A. De Marco, A. Chen, A. C. Walls, J. Di Iulio, M. A. Tortorici, M.-J. Navarro, C. Silacci-Fregni, C. Saliba, K. R. Sprouse, M. Agostini, D. Pinto, K. Culap, S. Bianchi, S. Jaconi, E. Cameroni, J. E. Bowen, S. W. Tilles, M. S. Pizzuto, S. B. Guastalla, G. Bona, A. F. Pellanda, C. Garzoni, W. C. Van Voorhis, L. E. Rosen, G. Snell, A. Telenti, H. W. Virgin, L. Piccoli, D. Corti, D. Veesler, SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern. Science <b>373</b>, 648–654 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >41</div><div ><div ><div >E. C. Thomson, L. E. Rosen, J. G. Shepherd, R. Spreafico, A. da Silva Filipe, J. A. Wojcechowskyj, C. Davis, L. Piccoli, D. J. Pascall, J. Dillen, S. Lytras, N. Czudnochowski, R. Shah, M. Meury, N. Jesudason, A. De Marco, K. Li, J. Bassi, A. O’Toole, D. Pinto, R. M. Colquhoun, K. Culap, B. Jackson, F. Zatta, A. Rambaut, S. Jaconi, V. B. Sreenu, J. Nix, I. Zhang, R. F. Jarrett, W. G. Glass, M. Beltramello, K. Nomikou, M. Pizzuto, L. Tong, E. Cameroni, T. I. Croll, N. Johnson, J. Di Iulio, A. Wickenhagen, A. Ceschi, A. M. Harbison, D. Mair, P. Ferrari, K. Smollett, F. Sallusto, S. Carmichael, C. Garzoni, J. Nichols, M. Galli, J. Hughes, A. Riva, A. Ho, M. Schiuma, M. G. Semple, P. J. M. Openshaw, E. Fadda, J. K. Baillie, J. D. Chodera, S. J. Rihn, S. J. Lycett, H. W. Virgin, A. Telenti, D. Corti, D. L. Robertson, G. Snell; ISARIC4C Investigators; COVID-19 Genomics UK (COG-UK) Consortium, Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity. Cell <b>184</b>, 1171–1187.e20 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >42</div><div ><div ><div >L. Wang, T. Zhou, Y. Zhang, E. S. Yang, C. A. Schramm, W. Shi, A. Pegu, O. K. Oloniniyi, A. R. Henry, S. Darko, S. R. Narpala, C. Hatcher, D. R. Martinez, Y. Tsybovsky, E. Phung, O. M. Abiona, A. Antia, E. M. Cale, L. A. Chang, M. Choe, K. S. Corbett, R. L. Davis, A. T. DiPiazza, I. J. Gordon, S. H. Hait, T. Hermanus, P. Kgagudi, F. Laboune, K. Leung, T. Liu, R. D. Mason, A. F. Nazzari, L. Novik, S. O’Connell, S. O’Dell, A. S. Olia, S. D. Schmidt, T. Stephens, C. D. Stringham, C. A. Talana, I.-T. Teng, D. A. Wagner, A. T. Widge, B. Zhang, M. Roederer, J. E. Ledgerwood, T. J. Ruckwardt, M. R. Gaudinski, P. L. Moore, N. A. Doria-Rose, R. S. Baric, B. S. Graham, A. B. McDermott, D. C. Douek, P. D. Kwong, J. R. Mascola, N. J. Sullivan, J. Misasi, Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants. Science <b>373</b>, eabh1766 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >43</div><div ><div ><div >M. Yuan, D. Huang, C. D. Lee, N. C. Wu, A. M. Jackson, X. Zhu, H. Liu, L. Peng, M. J. van Gils, R. W. Sanders, D. R. Burton, S. M. Reincke, H. Prüss, J. Kreye, D. Nemazee, A. B. Ward, I. A. Wilson, Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants. Science <b>373</b>, 818–823 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >44</div><div ><div ><div >D. Pinto, Y.-J. Park, M. Beltramello, A. C. Walls, M. A. Tortorici, S. Bianchi, S. Jaconi, K. Culap, F. Zatta, A. De Marco, A. Peter, B. Guarino, R. Spreafico, E. Cameroni, J. B. Case, R. E. Chen, C. Havenar-Daughton, G. Snell, A. Telenti, H. W. Virgin, A. Lanzavecchia, M. S. Diamond, K. Fink, D. Veesler, D. Corti, Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody. Nature <b>583</b>, 290–295 (2020).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >45</div><div ><div ><div >C. G. Rappazzo, L. V. Tse, C. I. Kaku, D. Wrapp, M. Sakharkar, D. Huang, L. M. Deveau, T. J. Yockachonis, A. S. Herbert, M. B. Battles, C. M. O’Brien, M. E. Brown, J. C. Geoghegan, J. Belk, L. Peng, L. Yang, Y. Hou, T. D. Scobey, D. R. Burton, D. Nemazee, J. M. Dye, J. E. Voss, B. M. Gunn, J. S. McLellan, R. S. Baric, L. E. Gralinski, L. M. Walker, Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody. Science <b>371</b>, 823–829 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >46</div><div ><div ><div >C. Liu, H. M. Ginn, W. Dejnirattisai, P. Supasa, B. Wang, A. Tuekprakhon, R. Nutalai, D. Zhou, A. J. Mentzer, Y. Zhao, H. M. E. Duyvesteyn, C. López-Camacho, J. Slon-Campos, T. S. Walter, D. Skelly, S. A. Johnson, T. G. Ritter, C. Mason, S. A. Costa Clemens, F. Gomes Naveca, V. Nascimento, F. Nascimento, C. Fernandes da Costa, P. C. Resende, A. Pauvolid-Correa, M. M. Siqueira, C. Dold, N. Temperton, T. Dong, A. J. Pollard, J. C. Knight, D. Crook, T. Lambe, E. Clutterbuck, S. Bibi, A. Flaxman, M. Bittaye, S. Belij-Rammerstorfer, S. C. Gilbert, T. Malik, M. W. Carroll, P. Klenerman, E. Barnes, S. J. Dunachie, V. Baillie, N. Serafin, Z. Ditse, K. Da Silva, N. G. Paterson, M. A. Williams, D. R. Hall, S. Madhi, M. C. Nunes, P. Goulder, E. E. Fry, J. Mongkolsapaya, J. Ren, D. I. Stuart, G. R. Screaton, Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum. Cell <b>184</b>, 4220–4236.e13 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >47</div><div ><div ><div >L. R. Baden, H. M. El Sahly, B. Essink, K. Kotloff, S. Frey, R. Novak, D. Diemert, S. A. Spector, N. Rouphael, C. B. Creech, J. McGettigan, S. Khetan, N. Segall, J. Solis, A. Brosz, C. Fierro, H. Schwartz, K. Neuzil, L. Corey, P. Gilbert, H. Janes, D. Follmann, M. Marovich, J. Mascola, L. Polakowski, J. Ledgerwood, B. S. Graham, H. Bennett, R. Pajon, C. Knightly, B. Leav, W. Deng, H. Zhou, S. Han, M. Ivarsson, J. Miller, T. Zaks; COVE Study Group, Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N. Engl. J. Med. <b>384</b>, 403–416 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >48</div><div ><div ><div >F. P. Polack, S. J. Thomas, N. Kitchin, J. Absalon, A. Gurtman, S. Lockhart, J. L. Perez, G. Pérez Marc, E. D. Moreira, C. Zerbini, R. Bailey, K. A. Swanson, S. Roychoudhury, K. Koury, P. Li, W. V. Kalina, D. Cooper, R. W. Frenck Jr., L. L. Hammitt, Ö. Türeci, H. Nell, A. Schaefer, S. Ünal, D. B. Tresnan, S. Mather, P. R. Dormitzer, U. Şahin, K. U. Jansen, W. C. Gruber; C4591001 Clinical Trial Group, Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine. N. Engl. J. Med. <b>383</b>, 2603–2615 (2020).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >49</div><div ><div ><div >L. A. Jackson, E. J. Anderson, N. G. Rouphael, P. C. Roberts, M. Makhene, R. N. Coler, M. P. McCullough, J. D. Chappell, M. R. Denison, L. J. Stevens, A. J. Pruijssers, A. McDermott, B. Flach, N. A. Doria-Rose, K. S. Corbett, K. M. Morabito, S. O’Dell, S. D. Schmidt, P. A. Swanson 2nd, M. Padilla, J. R. Mascola, K. M. Neuzil, H. Bennett, W. Sun, E. Peters, M. Makowski, J. Albert, K. Cross, W. Buchanan, R. Pikaart-Tautges, J. E. Ledgerwood, B. S. Graham, J. H. Beigel; mRNA-1273 Study Group, An mRNA vaccine against SARS-CoV-2 — Preliminary report. N. Engl. J. Med. <b>383</b>, 1920–1931 (2020).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >50</div><div ><div ><div >T. G. Ksiazek, D. Erdman, C. S. Goldsmith, S. R. Zaki, T. Peret, S. Emery, S. Tong, C. Urbani, J. A. Comer, W. Lim, P. E. Rollin, S. F. Dowell, A.-E. Ling, C. D. Humphrey, W.-J. Shieh, J. Guarner, C. D. Paddock, P. Rota, B. Fields, J. DeRisi, J.-Y. Yang, N. Cox, J. M. Hughes, J. W. LeDuc, W. J. Bellini, L. J. Anderson; SARS Working Group, A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med. <b>348</b>, 1953–1966 (2003).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >51</div><div ><div ><div >Z. Chen, L. Zhang, C. Qin, L. Ba, C. E. Yi, F. Zhang, Q. Wei, T. He, W. Yu, J. Yu, H. Gao, X. Tu, A. Gettie, M. Farzan, K. Y. Yuen, D. D. Ho, Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region. J. Virol. <b>79</b>, 2678–2688 (2005).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >52</div><div ><div ><div >Y. Zhu, D. Yu, Y. Han, H. Yan, H. Chong, L. Ren, J. Wang, T. Li, Y. He, Cross-reactive neutralization of SARS-CoV-2 by serum antibodies from recovered SARS patients and immunized animals. Sci. Adv. <b>6</b>, eabc9999 (2020).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >53</div><div ><div ><div >H. Lv, N. C. Wu, O. T.-Y. Tsang, M. Yuan, R. A. P. M. Perera, W. S. Leung, R. T. Y. So, J. M. C. Chan, G. K. Yip, T. S. H. Chik, Y. Wang, C. Y. C. Choi, Y. Lin, W. W. Ng, J. Zhao, L. L. M. Poon, J. S. M. Peiris, I. A. Wilson, C. K. P. Mok, Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections. Cell Rep. <b>31</b>, 107725 (2020).</div><div ><div><a >Crossref</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >54</div><div ><div ><div >J. Pallesen, N. Wang, K. S. Corbett, D. Wrapp, R. N. Kirchdoerfer, H. L. Turner, C. A. Cottrell, M. M. Becker, L. Wang, W. Shi, W.-P. Kong, E. L. Andres, A. N. Kettenbach, M. R. Denison, J. D. Chappell, B. S. Graham, A. B. Ward, J. S. McLellan, Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen. Proc. Natl. Acad. Sci. U.S.A. <b>114</b>, E7348–E7357 (2017).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >55</div><div ><div ><div >M. Yuan, N. C. Wu, X. Zhu, C. D. Lee, R. T. Y. So, H. Lv, C. K. P. Mok, I. A. Wilson, A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV. Science <b>368</b>, 630–633 (2020).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >56</div><div ><div ><div >M. A. Tortorici, N. Czudnochowski, T. N. Starr, R. Marzi, A. C. Walls, F. Zatta, J. E. Bowen, S. Jaconi, J. Di Iulio, Z. Wang, A. De Marco, S. K. Zepeda, D. Pinto, Z. Liu, M. Beltramello, I. Bartha, M. P. Housley, F. A. Lempp, L. E. Rosen, E. Dellota Jr., H. Kaiser, M. Montiel-Ruiz, J. Zhou, A. Addetia, B. Guarino, K. Culap, N. Sprugasci, C. Saliba, E. Vetti, I. Giacchetto-Sasselli, C. S. Fregni, R. Abdelnabi, S. C. Foo, C. Havenar-Daughton, M. A. Schmid, F. Benigni, E. Cameroni, J. Neyts, A. Telenti, H. W. Virgin, S. P. J. Whelan, G. Snell, J. D. Bloom, D. Corti, D. Veesler, M. S. Pizzuto, Broad sarbecovirus neutralization by a human monoclonal antibody. Nature <b>597</b>, 103–108 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >57</div><div ><div ><div >H. Liu, N. C. Wu, M. Yuan, S. Bangaru, J. L. Torres, T. G. Caniels, J. van Schooten, X. Zhu, C. D. Lee, P. J. M. Brouwer, M. J. van Gils, R. W. Sanders, A. B. Ward, I. A. Wilson, Cross-neutralization of a SARS-CoV-2 antibody to a functionally conserved site is mediated by avidity. Immunity <b>53</b>, 1272–1280.e5 (2020).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >58</div><div ><div ><div >Z. Lv, Y.-Q. Deng, Q. Ye, L. Cao, C.-Y. Sun, C. Fan, W. Huang, S. Sun, Y. Sun, L. Zhu, Q. Chen, N. Wang, J. Nie, Z. Cui, D. Zhu, N. Shaw, X.-F. Li, Q. Li, L. Xie, Y. Wang, Z. Rao, C.-F. Qin, X. Wang, Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody. Science <b>369</b>, 1505–1509 (2020).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >59</div><div ><div ><div >D. Li, R. J. Edwards, K. Manne, D. R. Martinez, A. Schäfer, S. M. Alam, K. Wiehe, X. Lu, R. Parks, L. L. Sutherland, T. H. Oguin 3rd, C. McDanal, L. G. Perez, K. Mansouri, S. M. C. Gobeil, K. Janowska, V. Stalls, M. Kopp, F. Cai, E. Lee, A. Foulger, G. E. Hernandez, A. Sanzone, K. Tilahun, C. Jiang, L. V. Tse, K. W. Bock, M. Minai, B. M. Nagata, K. Cronin, V. Gee-Lai, M. Deyton, M. Barr, T. Von Holle, A. N. Macintyre, E. Stover, J. Feldman, B. M. Hauser, T. M. Caradonna, T. D. Scobey, W. Rountree, Y. Wang, M. A. Moody, D. W. Cain, C. T. DeMarco, T. N. Denny, C. W. Woods, E. W. Petzold, A. G. Schmidt, I.-T. Teng, T. Zhou, P. D. Kwong, J. R. Mascola, B. S. Graham, I. N. Moore, R. Seder, H. Andersen, M. G. Lewis, D. C. Montefiori, G. D. Sempowski, R. S. Baric, P. Acharya, B. F. Haynes, K. O. Saunders, In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies. Cell <b>184</b>, 4203–4219.e32 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >60</div><div ><div ><div >T. N. Starr, N. Czudnochowski, Z. Liu, F. Zatta, Y.-J. Park, A. Addetia, D. Pinto, M. Beltramello, P. Hernandez, A. J. Greaney, R. Marzi, W. G. Glass, I. Zhang, A. S. Dingens, J. E. Bowen, M. A. Tortorici, A. C. Walls, J. A. Wojcechowskyj, A. De Marco, L. E. Rosen, J. Zhou, M. Montiel-Ruiz, H. Kaiser, J. R. Dillen, H. Tucker, J. Bassi, C. Silacci-Fregni, M. P. Housley, J. di Iulio, G. Lombardo, M. Agostini, N. Sprugasci, K. Culap, S. Jaconi, M. Meury, E. Dellota Jr., R. Abdelnabi, S. C. Foo, E. Cameroni, S. Stumpf, T. I. Croll, J. C. Nix, C. Havenar-Daughton, L. Piccoli, F. Benigni, J. Neyts, A. Telenti, F. A. Lempp, M. S. Pizzuto, J. D. Chodera, C. M. Hebner, H. W. Virgin, S. P. J. Whelan, D. Veesler, D. Corti, J. D. Bloom, G. Snell, SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape. Nature <b>597</b>, 97–102 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >61</div><div ><div ><div >Y. Watanabe, Z. T. Berndsen, J. Raghwani, G. E. Seabright, J. D. Allen, O. G. Pybus, J. S. McLellan, I. A. Wilson, T. A. Bowden, A. B. Ward, M. Crispin, Vulnerabilities in coronavirus glycan shields despite extensive glycosylation. Nat. Commun. <b>11</b>, 2688 (2020).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >62</div><div ><div ><div >O. C. Grant, D. Montgomery, K. Ito, R. J. Woods, Analysis of the SARS-CoV-2 spike protein glycan shield reveals implications for immune recognition. Sci. Rep. <b>10</b>, 14991 (2020).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >63</div><div ><div ><div >M. F. Boni, P. Lemey, X. Jiang, T. T.-Y. Lam, B. W. Perry, T. A. Castoe, A. Rambaut, D. L. Robertson, Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic. Nat. Microbiol. <b>5</b>, 1408–1417 (2020).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >64</div><div ><div ><div >N. K. Hurlburt, E. Seydoux, Y.-H. Wan, V. V. Edara, A. B. Stuart, J. Feng, M. S. Suthar, A. T. McGuire, L. Stamatatos, M. Pancera, Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation. Nat. Commun. <b>11</b>, 5413 (2020).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >65</div><div ><div ><div >L. Kang, G. He, A. K. Sharp, X. Wang, A. M. Brown, P. Michalak, J. Weger-Lucarelli, A selective sweep in the Spike gene has driven SARS-CoV-2 human adaptation. Cell <b>184</b>, 4392–4400.e4 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >66</div><div ><div ><div >A. M. Harbison, C. A. Fogarty, T. Phung, A. Satheesan, B. L. Schulz, E. Fadda, Fine-tuning the Spike: Role of the nature and topology of the glycan shield in the structure and dynamics of SARS-CoV-2 S. Chem. Sci. 10.1039/D1SC04832E (2021).</div><div ><div><a >Crossref</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >67</div><div ><div ><div >J. D. Bloom, L. I. Gong, D. Baltimore, Permissive secondary mutations enable the evolution of influenza oseltamivir resistance. Science <b>328</b>, 1272–1275 (2010).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >68</div><div ><div ><div >L. Yurkovetskiy, X. Wang, K. E. Pascal, C. Tomkins-Tinch, T. P. Nyalile, Y. Wang, A. Baum, W. E. Diehl, A. Dauphin, C. Carbone, K. Veinotte, S. B. Egri, S. F. Schaffner, J. E. Lemieux, J. B. Munro, A. Rafique, A. Barve, P. C. Sabeti, C. A. Kyratsous, N. V. Dudkina, K. Shen, J. Luban, Structural and functional analysis of the D614G SARS-CoV-2 spike protein variant. Cell <b>183</b>, 739–751.e8 (2020).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >69</div><div ><div ><div >W. Kabsch, XDS. Acta Crystallogr. D <b>66</b>, 125–132 (2010).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >70</div><div ><div ><div >P. R. Evans, G. N. Murshudov, How good are my data and what is the resolution? Acta Crystallogr. D <b>69</b>, 1204–1214 (2013).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >71</div><div ><div ><div >G. Bricogne, E. Blanc, M. Brandl, C. Flensburg, P. Keller, W. Paciorek, P. Roversi, A. Sharff, O. S. Smart, C. Vonrhein, T. O. Womack, BUSTER version 2.10.3 (Global Phasing Ltd., 2017).</div><div ><div><a >Google Scholar</a></div></div></div></div></div><div ><div >72</div><div ><div ><div >P. Emsley, B. Lohkamp, W. G. Scott, K. Cowtan, Features and development of <i>Coot</i>. Acta Crystallogr. D <b>66</b>, 486–501 (2010).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >73</div><div ><div ><div >P. D. Adams, P. V. Afonine, G. Bunkóczi, V. B. Chen, I. W. Davis, N. Echols, J. J. Headd, L.-W. Hung, G. J. Kapral, R. W. Grosse-Kunstleve, A. J. McCoy, N. W. Moriarty, R. Oeffner, R. J. Read, D. C. Richardson, J. S. Richardson, T. C. Terwilliger, P. H. Zwart, <i>PHENIX</i>: A comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D <b>66</b>, 213–221 (2010).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >74</div><div ><div ><div >S. Q. Zheng, E. Palovcak, J.-P. Armache, K. A. Verba, Y. Cheng, D. A. Agard, MotionCor2: Anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods <b>14</b>, 331–332 (2017).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >75</div><div ><div ><div >A. Rohou, N. Grigorieff, CTFFIND4: Fast and accurate defocus estimation from electron micrographs. J. Struct. Biol. <b>192</b>, 216–221 (2015).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >76</div><div ><div ><div >T. Wagner, F. Merino, M. Stabrin, T. Moriya, C. Antoni, A. Apelbaum, P. Hagel, O. Sitsel, T. Raisch, D. Prumbaum, D. Quentin, D. Roderer, S. Tacke, B. Siebolds, E. Schubert, T. R. Shaikh, P. Lill, C. Gatsogiannis, S. Raunser, SPHIRE-crYOLO is a fast and accurate fully automated particle picker for cryo-EM. Commun. Biol. <b>2</b>, 218 (2019).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >77</div><div ><div ><div >A. Punjani, J. L. Rubinstein, D. J. Fleet, M. A. Brubaker, cryoSPARC: Algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods <b>14</b>, 290–296 (2017).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >78</div><div ><div ><div >A. C. Walls, Y.-J. Park, M. A. Tortorici, A. Wall, A. T. McGuire, D. Veesler, Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell <b>181</b>, 281–292.e6 (2020).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >79</div><div ><div ><div >S. Zhang, S. Qiao, J. Yu, J. Zeng, S. Shan, L. Tian, J. Lan, L. Zhang, X. Wang, Bat and pangolin coronavirus spike glycoprotein structures provide insights into SARS-CoV-2 evolution. Nat. Commun. <b>12</b>, 1607 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >80</div><div ><div ><div >T. Xiao, J. Lu, J. Zhang, R. I. Johnson, L. G. A. McKay, N. Storm, C. L. Lavine, H. Peng, Y. Cai, S. Rits-Volloch, S. Lu, B. D. Quinlan, M. Farzan, M. S. Seaman, A. Griffiths, B. Chen, A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent. Nat. Struct. Mol. Biol. <b>28</b>, 202–209 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >81</div><div ><div ><div >J. Harcourt, A. Tamin, X. Lu, S. Kamili, S. K. Sakthivel, J. Murray, K. Queen, Y. Tao, C. R. Paden, J. Zhang, Y. Li, A. Uehara, H. Wang, C. Goldsmith, H. A. Bullock, L. Wang, B. Whitaker, B. Lynch, R. Gautam, C. Schindewolf, K. G. Lokugamage, D. Scharton, J. A. Plante, D. Mirchandani, S. G. Widen, K. Narayanan, S. Makino, T. G. Ksiazek, K. S. Plante, S. C. Weaver, S. Lindstrom, S. Tong, V. D. Menachery, N. J. Thornburg, Severe acute respiratory syndrome coronavirus 2 from patient with coronavirus disease, United States. Emerg. Infect. Dis. <b>26</b>, 1266–1273 (2020).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >82</div><div ><div ><div >A. R. Aricescu, W. Lu, E. Y. Jones, A time- and cost-efficient system for high-level protein production in mammalian cells. Acta Crystallogr. D <b>62</b>, 1243–1250 (2006).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >83</div><div ><div ><div >C. L. Hsieh, J. A. Goldsmith, J. M. Schaub, A. M. DiVenere, H.-C. Kuo, K. Javanmardi, K. C. Le, D. Wrapp, A. G. Lee, Y. Liu, C.-W. Chou, P. O. Byrne, C. K. Hjorth, N. V. Johnson, J. Ludes-Meyers, A. W. Nguyen, J. Park, N. Wang, D. Amengor, J. J. Lavinder, G. C. Ippolito, J. A. Maynard, I. J. Finkelstein, J. S. McLellan, Structure-based design of prefusion-stabilized SARS-CoV-2 spikes. Science <b>369</b>, 1501–1505 (2020).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >84</div><div ><div ><div >J. Misasi, M. S. A. Gilman, M. Kanekiyo, M. Gui, A. Cagigi, S. Mulangu, D. Corti, J. E. Ledgerwood, A. Lanzavecchia, J. Cunningham, J. J. Muyembe-Tamfun, U. Baxa, B. S. Graham, Y. Xiang, N. J. Sullivan, J. S. McLellan, Structural and molecular basis for Ebola virus neutralization by protective human antibodies. Science <b>351</b>, 1343–1346 (2016).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >85</div><div ><div ><div >X. Brochet, M. P. Lefranc, V. Giudicelli, IMGT/V-QUEST: The highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucleic Acids Res. <b>36</b> (suppl. 2), W503–W508 (2008).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >86</div><div ><div ><div >A. J. McCoy, R. W. Grosse-Kunstleve, P. D. Adams, M. D. Winn, L. C. Storoni, R. J. Read, Phaser crystallographic software. J. Appl. Crystallogr. <b>40</b>, 658–674 (2007).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >87</div><div ><div ><div >T. A. Jones, J. Y. Zou, S. W. Cowan, M. Kjeldgaard, Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A <b>47</b>, 110–119 (1991).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >88</div><div ><div ><div >C. J. Williams, J. J. Headd, N. W. Moriarty, M. G. Prisant, L. L. Videau, L. N. Deis, V. Verma, D. A. Keedy, B. J. Hintze, V. B. Chen, S. Jain, S. M. Lewis, W. B. Arendall 3rd, J. Snoeyink, P. D. Adams, S. C. Lovell, J. S. Richardson, D. C. Richardson, MolProbity: More and better reference data for improved all-atom structure validation. Protein Sci. <b>27</b>, 293–315 (2018).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >89</div><div ><div ><div >D. D. Pless, W. J. Lennarz, Enzymatic conversion of proteins to glycoproteins. Proc. Natl. Acad. Sci. U.S.A. <b>74</b>, 134–138 (1977).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >90</div><div ><div ><div >Y. Watanabe, J. D. Allen, D. Wrapp, J. S. McLellan, M. Crispin, Site-specific glycan analysis of the SARS-CoV-2 spike. Science <b>369</b>, 330–333 (2020).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >91</div><div ><div ><div >J. Zivanov, T. Nakane, B. O. Forsberg, D. Kimanius, W. J. H. Hagen, E. Lindahl, S. H. W. Scheres, New tools for automated high-resolution cryo-EM structure determination in RELION-3. eLife <b>7</b>, e42166 (2018).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >92</div><div ><div ><div >T. Zhou, Y. Tsybovsky, J. Gorman, M. Rapp, G. Cerutti, G.-Y. Chuang, P. S. Katsamba, J. M. Sampson, A. Schön, J. Bimela, J. C. Boyington, A. Nazzari, A. S. Olia, W. Shi, M. Sastry, T. Stephens, J. Stuckey, I.-T. Teng, P. Wang, S. Wang, B. Zhang, R. A. Friesner, D. D. Ho, J. R. Mascola, L. Shapiro, P. D. Kwong, Cryo-EM structures of SARS-CoV-2 spike without and with ACE2 reveal a pH-dependent switch to mediate endosomal positioning of receptor-binding domains. Cell Host Microbe <b>28</b>, 867–879.e5 (2020).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >93</div><div ><div ><div >S. Mitternacht, FreeSASA: An open source C library for solvent accessible surface area calculations. F1000Res. <b>5</b>, 189 (2016).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >94</div><div ><div ><div >B. Lee, F. M. Richards, The interpretation of protein structures: Estimation of static accessibility. J. Mol. Biol. <b>55</b>, 379–400 (1971).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >95</div><div ><div ><div >J. Novotný, C. Auffray, A program for prediction of protein secondary structure from nucleotide sequence data: Application to histocompatibility antigens. Nucleic Acids Res. <b>12</b>, 243–255 (1984).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >96</div><div ><div ><div >A. Pavlova, Z. Zhang, A. Acharya, D. L. Lynch, Y. T. Pang, Z. Mou, J. M. Parks, C. Chipot, J. C. Gumbart, Machine learning reveals the critical interactions for SARS-CoV-2 spike protein binding to ACE2. J. Phys. Chem. Lett. <b>12</b>, 5494–5502 (2021).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >97</div><div ><div ><div >F. Li, W. Li, M. Farzan, S. C. Harrison, Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science <b>309</b>, 1864–1868 (2005).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >98</div><div ><div ><div >M. Mirdita, S. Ovchinnikov, M. Steinegger, ColabFold - Making protein folding accessible to all. bioRxiv 2021.2008.2015.456425 [Preprint] (2021). <a >https://doi.org/10.1101/2021.08.15.456425</a>.</div><div ><div><a >Google Scholar</a></div></div></div></div></div><div ><div >99</div><div ><div ><div >M. A. Tortorici, M. Beltramello, F. A. Lempp, D. Pinto, H. V. Dang, L. E. Rosen, M. McCallum, J. Bowen, A. Minola, S. Jaconi, F. Zatta, A. De Marco, B. Guarino, S. Bianchi, E. J. Lauron, H. Tucker, J. Zhou, A. Peter, C. Havenar-Daughton, J. A. Wojcechowskyj, J. B. Case, R. E. Chen, H. Kaiser, M. Montiel-Ruiz, M. Meury, N. Czudnochowski, R. Spreafico, J. Dillen, C. Ng, N. Sprugasci, K. Culap, F. Benigni, R. Abdelnabi, S. C. Foo, M. A. Schmid, E. Cameroni, A. Riva, A. Gabrieli, M. Galli, M. S. Pizzuto, J. Neyts, M. S. Diamond, H. W. Virgin, G. Snell, D. Corti, K. Fink, D. Veesler, Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms. Science <b>370</b>, 950–957 (2020).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div><div ><div >100</div><div ><div ><div >Z. Ke, J. Oton, K. Qu, M. Cortese, V. Zila, L. McKeane, T. Nakane, J. Zivanov, C. J. Neufeldt, B. Cerikan, J. M. Lu, J. Peukes, X. Xiong, H.-G. Kräusslich, S. H. W. Scheres, R. Bartenschlager, J. A. G. Briggs, Structures and distributions of SARS-CoV-2 spike proteins on intact virions. Nature <b>588</b>, 498–502 (2020).</div><div ><div><a >Crossref</a></div><div><a >PubMed</a></div><div><a >Google Scholar</a></div></div></div></div></div></section></div></section><div ><div ><header><h2>Information Authors</h2></header><section ><h3>Information</h3><section ><h4>Published In</h4><div > <div ><div >Science</div><div >First Release</div></div></div></section><section ><h4>Copyright</h4><div > Copyright © 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution License 4.0 (CC BY).</div><div >https://creativecommons.org/licenses/by/4.0/</div><div >This is an open-access article distributed under the terms of the <a >Creative Commons Attribution license</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</div></section><section ><h4>Submission history</h4><div><b >Received</b>: 28 July 2021</div><div><b >Accepted</b>: 29 November 2021</div></section><section ><h4>Permissions</h4><div>Request permissions for this article.</div><div><a >Request Permissions</a></div></section><section ><h4>Acknowledgments</h4><div >This work is based upon research conducted at the Northeastern Collaborative Access Team (NE-CAT)beamlines, which are funded by the National Institute of General Medical Sciences from the NationalInstitutes of Health (P30 GM124165). The Pilatus 6M detector on 24-ID-C beam line is funded by aNIH-ORIP HEI grant (S10 RR029205). This research used resources of the Advanced Photon Source, aU.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office ofScience by Argonne National Laboratory under Contract No. DE-AC02-06CH11357. We thank the staff atNE-CAT for assistance with X-ray data collection. Cryo-EM data were collected at the HarvardCryo-Electron Microscopy Center for Structural Biology. We thank Harvard Cryo-EM Center staffmembers for assistance with cryo-EM data collection. We acknowledge support for COVID-19 relatedstructural biology research at Harvard from the Nancy Lurie Marks Family Foundation. We thank B.Chen for providing a human ACE2 ectodomain expressing cell line, and H. Choe for providing cDNAencoding the SARS-CoV spike protein. <b>Funding:</b> This work was funded in part by theMassachusetts Consortium on Pathogen Readiness (MassCPR) (J.A.). J.A. was also supported by theStar-Friedman Award Challenge for Promising Scientific Research. L.R.B. is supported by the HarvardClinical and Translational Science Center, from the National Center for Advancing TranslationalScience (1UL1TR002541-01); by Barbara and Amos Hostetter; and by the Chleck Family Foundation.S.E.T., R.C.L., E.T.R., and R.C.C. receive grant support from the Centers for Disease Control andPrevention (U01CK000490). K.G.N., A.C., and H.H.V. are supported by Award Number T32GM007753 fromthe National Institute of General Medical Sciences. The content is solely the responsibility of theauthors and does not necessarily represent the official views of the National Institute of GeneralMedical Sciences or the National Institutes of Health. <b>Author contributions:</b>Conceptualization: KGN, SAC, SS, JP, LEC, PY, AC, LGAM, NVT, MD, SET, SK, ACS, AD, CT, JFC, ATD,ATD, DT, AC, YF, AG, IRC, JS, LRB, RCC, JA. Methodology: KGN, SAC, SS, JP, LEC, PY, AC, LGAM, HHV,NVT, GZ, MD, SET, SK, ACS, AD, RCL, ETR, CT, JFC, ATD, DT, AC, YF, AG, IRC, JS, LRB, RC, JA.Investigation: KGN, SAC, SS, JP, LEC, PY, AC, LGAM, HHV, VB, NVT, SET, SK, MJ, ACS, CT, JFC, ATD,DT, AC, YF, AG, IRC, JS, LRB, RC, JA. Visualization: KGN, SAC, SS, JP, LEC, PY, AC, LGAM, HHV, NVT,GZ, MD, SET, SK, ACS, CT, JFC, ATD, DT, AC, YF, AG, IRC, JS, LRB, RCC, JA. Funding acquisition: RCL,ETR, RCC, JA. Project administration: KGN, SAC, SS, JP, NVT, MD, SET, SK, ACS, AG, IRC, JS, LRB,RCC, JA. Supervision: AD, JFC, YF, AG, IRC, JS, LRB, RCC, JA. Writing – original draft: JA.Writing – review editing: KGN, SAC, SS, JP, LEC, AC, LGAM, HHV, GZ, MD, SET, SK, ACS,RCL, ETR, CT, JFC, ATD, DT, AC, YF, AG, IRC, JS, LRB, RCC, JA. <b>Competing interests:</b>SAC, LEC, and JA are inventors on a provisional patent application that covers antibodies describedin this publication filed by the President and Fellows of Harvard University. S.E.T. receivesmonetary compensation from UpToDate, which provides clinical decision support. <b>Data andmaterials availability:</b> C1C-A3 antibody heavy chain and light chain variable region genesequences have been deposited in GenBank under accession codes OL621229 and OL621230, respectively.Protein Data Bank (PBD) identification numbers for the day 146* RBD human ACE2 ectodomain complex,the unliganded C1C-A3 Fab, the C1C-A3 Fab SARS-CoV-2 spike protein ectodomain complex, and focusedrefinement of the C1C-A3 Fab/RBD region are 7SN0, 7SN1, 7SN3, and 7SN2, respectively. ElectronMicroscopy Database (EMDB) accession numbers for the C1C-A3 Fab SARS-CoV-2 spike protein ectodomaincomplex and focused refinement of the C1C-A3 Fab/RBD region are EMD-25210 and EMD-2509,respectively. All materials are available upon request. This work is licensed under a CreativeCommons Attribution 4.0 International (CC BY 4.0) license, which permits unrestricted use,distribution, and reproduction in any medium, provided the original work is properly cited. To viewa copy of this license, visit <a >https://creativecommons.org/licenses/by/4.0/</a>. This license does not apply tofigures/photos/artwork or other content included in the article that is credited to a third party;obtain authorization from the rights holder before using such material.</div></section></section><section ><h3>Authors</h3><section ><h4>Affiliations</h4><div ><div >Katherine G. Nabel<sup >†</sup> <a >https://orcid.org/0000-0002-4429-7075</a></div><div ><div ><div >Department of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA.</div></div><div ><a >View all articles by this author</a></div></div></div><div ><div >Sarah A. Clark<sup >†</sup> https://orcid.org/0000-0001-9944-0919</div><div ><div ><div >Department of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA.</div></div><div ><a >View all articles by this author</a></div></div></div><div ><div >Sundaresh Shankar<sup >†</sup> <a >https://orcid.org/0000-0001-9340-9945</a></div><div ><div ><div >Department of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA.</div></div><div ><a >View all articles by this author</a></div></div></div><div ><div >Junhua Pan<sup >†</sup> https://orcid.org/0000-0002-0070-955X</div><div ><div ><div >Department of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA.</div></div><div ><a >View all articles by this author</a></div></div></div><div ><div >Lars E. Clark https://orcid.org/0000-0002-6093-7597</div><div ><div ><div >Department of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA.</div></div><div ><a >View all articles by this author</a></div></div></div><div ><div >Pan Yang</div><div ><div ><div >Department of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA.</div></div><div >View all articles by this author</div></div></div><div ><div >Adrian Coscia https://orcid.org/0000-0002-6836-9993</div><div ><div ><div >Department of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA.</div></div><div >View all articles by this author</div></div></div><div ><div >Lindsay G. A. McKay https://orcid.org/0000-0003-0369-9067</div><div ><div ><div >Department of Microbiology and National Emerging Infectious Diseases Laboratories, Boston University School of Medicine, Boston, MA 02118, USA.</div></div><div >View all articles by this author</div></div></div><div ><div >Haley H. Varnum</div><div ><div ><div >Department of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA.</div></div><div >View all articles by this author</div></div></div><div ><div >Vesna Brusic</div><div ><div ><div >Department of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA.</div></div><div >View all articles by this author</div></div></div><div ><div >Nicole V. Tolan</div><div ><div ><div >Department of Pathology, Brigham and Women’s Hospital, Boston, MA 02115, USA.</div></div><div >View all articles by this author</div></div></div><div ><div >Guohai Zhou</div><div ><div ><div >Center for Clinical Investigation, Brigham and Women’s Hospital, Boston, MA 02115, USA.</div></div><div >View all articles by this author</div></div></div><div ><div >Michaël Desjardins https://orcid.org/0000-0003-4028-8507</div><div ><div ><div >Division of Infectious Diseases, Department of Medicine, Brigham and Women’s Hospital, Boston, MA 02115, USA.</div><div >Division of Infectious Diseases, Department of Medicine, Centre Hospitalier de l’Université de Montréal, Montreal QC H2X 0C1, Canada.</div></div><div >View all articles by this author</div></div></div><div ><div >Sarah E. Turbett https://orcid.org/0000-0002-3603-8110</div><div ><div ><div >Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA.</div><div >Department of Pathology, Massachusetts General Hospital, Boston, MA 02114, USA.</div></div><div >View all articles by this author</div></div></div><div ><div >Sanjat Kanjilal https://orcid.org/0000-0002-1221-5725</div><div ><div ><div >Division of Infectious Diseases, Department of Medicine, Brigham and Women’s Hospital, Boston, MA 02115, USA.</div><div >Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA 02215, USA.</div></div><div >View all articles by this author</div></div></div><div ><div >Amy C. Sherman https://orcid.org/0000-0002-6075-3990</div><div ><div ><div >Division of Infectious Diseases, Department of Medicine, Brigham and Women’s Hospital, Boston, MA 02115, USA.</div></div><div >View all articles by this author</div></div></div><div ><div >Anand Dighe</div><div ><div ><div >Department of Pathology, Massachusetts General Hospital, Boston, MA 02114, USA.</div></div><div >View all articles by this author</div></div></div><div ><div >Regina C. LaRocque https://orcid.org/0000-0003-4558-0339</div><div ><div ><div >Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA.</div></div><div >View all articles by this author</div></div></div><div ><div >Edward T. Ryan</div><div ><div ><div >Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA.</div><div >Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA 02215, USA.</div></div><div >View all articles by this author</div></div></div><div ><div >Casey Tylek</div><div ><div ><div >AbbVie Bioresearch Center, Worcester, MA 01605, USA.</div></div><div >View all articles by this author</div></div></div><div ><div >Joel F. Cohen-Solal https://orcid.org/0000-0002-1385-2566</div><div ><div ><div >AbbVie Bioresearch Center, Worcester, MA 01605, USA.</div></div><div >View all articles by this author</div></div></div><div ><div >Anhdao T. Darcy</div><div ><div ><div >AbbVie Bioresearch Center, Worcester, MA 01605, USA.</div></div><div >View all articles by this author</div></div></div><div ><div >Davide Tavella https://orcid.org/0000-0002-2030-2087</div><div ><div ><div >AbbVie Bioresearch Center, Worcester, MA 01605, USA.</div></div><div >View all articles by this author</div></div></div><div ><div >Anca Clabbers https://orcid.org/0000-0002-4258-9680</div><div ><div ><div >AbbVie Bioresearch Center, Worcester, MA 01605, USA.</div></div><div >View all articles by this author</div></div></div><div ><div >Yao Fan</div><div ><div ><div >AbbVie Bioresearch Center, Worcester, MA 01605, USA.</div></div><div >View all articles by this author</div></div></div><div ><div >Anthony Griffiths https://orcid.org/0000-0001-5435-8364</div><div ><div ><div >Department of Microbiology and National Emerging Infectious Diseases Laboratories, Boston University School of Medicine, Boston, MA 02118, USA.</div></div><div >View all articles by this author</div></div></div><div ><div >Ivan R. Correia https://orcid.org/0000-0003-2295-7199</div><div ><div ><div >AbbVie Bioresearch Center, Worcester, MA 01605, USA.</div></div><div >View all articles by this author</div></div></div><div ><div >Jane Seagal https://orcid.org/0000-0002-5959-5139</div><div ><div ><div >AbbVie Bioresearch Center, Worcester, MA 01605, USA.</div></div><div >View all articles by this author</div></div></div><div ><div >Lindsey R. Baden</div><div ><div ><div >Center for Clinical Investigation, Brigham and Women’s Hospital, Boston, MA 02115, USA.</div><div >Division of Infectious Diseases, Department of Medicine, Brigham and Women’s Hospital, Boston, MA 02115, USA.</div><div >Massachusetts Consortium on Pathogen Readiness, Boston, MA, USA.</div></div><div >View all articles by this author</div></div></div><div ><div >Richelle C. Charles</div><div ><div ><div >Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA.</div></div><div >View all articles by this author</div></div></div><div ><div >Jonathan Abraham<sup >*</sup> https://orcid.org/0000-0002-7937-3920 [email protected]</div><div ><div ><div >Department of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA.</div><div >Division of Infectious Diseases, Department of Medicine, Brigham and Women’s Hospital, Boston, MA 02115, USA.</div><div >Massachusetts Consortium on Pathogen Readiness, Boston, MA, USA.</div><div >Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.</div></div><div >View all articles by this author</div></div></div></section><section ><h4>Funding Information</h4><div >National Institutes of Health: T32GM007753</div><div >Centers for Disease Control and Prevention: U01CK000490</div><div >National Center for Advancing Translational Sciences: 1UL1TR002541-01</div><div ><a >Translational Science Center, Wake Forest University</a>: 1UL1TR002541-01</div><div >Massachusetts Consortium on Pathogen Readiness: No grant number</div><div >Barbara and Amos Hostetter and the Chleck Foundation: N/A</div><div ><a >Translational Science Center, Wake Forest University</a>: T32GM007753</div></section><section ><h4>Notes</h4><div ><div >†</div><div >These authors contributed equally to this work.</div></div><div >*Corresponding author. Email: <a >[email protected]</a></div></section></section></div><div ><header><h2>Metrics Citations</h2></header><section ><h3>Metrics</h3><section > <h5 > Article Usage </h5> </section><section > <h5 > Altmetrics </h5> </section></section><section ><h3>Citations</h3><section > <div > <h5 >Export citation</h5> <p>Select the format you want to export the citation of this publication.</p> </div> </section></section></div><div ><header><h2>View Options</h2></header><div ><h3>View options</h3><section ><h4>PDF format</h4><p>Download this article as a PDF file</p><a >Download PDF</a></section></div><div ><h3>Get Access</h3><section > <div ><h5>Log in to view the full text</h5> <p><a >AAAS Log in</a></p> <p>AAAS login provides access to Science for AAAS members, and access to other journals in the Science family to users who have purchased individual subscriptions.</p> <ul > <li >Become a AAAS Member</li> <li ><a >Activate your Account</a></li> <li ><a >Purchase Access to Other Journals in the Science Family</a></li> <li><a >Account Help</a></li> </ul> <div > <div >Log in via OpenAthens. <div ><a >via OpenAthens</a></div> </div> <div >Log in via Shibboleth. <div ><a >via Shibboleth</a></div> </div> </div> </div> <div ><h5>More options</h5><p><a >Purchase digital access to this article</a></p><p >Download and print this article for your personal scholarly, research, and educational use.</p><p><a >Purchase this issue in print</a></p><p>Buy a single issue of Science for just $15 USD.</p></div> </section></div></div><div ><header><h2>Media</h2></header><section ><h3>Figures</h3></section><section ><h3>Multimedia</h3></section></div><div ><header><h2>Tables</h2></header></div><div ><header><h2>Share</h2></header><h3>Share</h3><div ><section ><h4>Share article link</h4><div ><a >Copy Link</a><div ><p >Copied!</p><p >Copying failed.</p></div></div></section><section ><h4>Share on social media</h4><div ><a >facebook</a><a >twitter</a><a >linkedin</a><a >email</a></div></section></div></div></div></article><section ><div ><div ><div ><div ><h3 >Submit a Response to This Article</h3></div></div></div></div> <div > <div > <h2 >(0)eLetters</h2> </div> <p >eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all. eLetters are not edited, proofread, or indexed. Please read our Terms of Service before submitting your own eLetter.</p> Log In to Submit a Response <p >No eLetters have been published for this article yet.</p> </div> </section> <div ><a >View Full Text</a><a >Download PDF</a></div> </div></div></div></div><div ><div ><div ><div ><section><div ><h4 > Current Issue </h4><div ><div > <div ><div><article ><div ><div ><h3 ><a >Cell-by-cell dissection of phloem development links a maturation gradient to cell specialization</a></h3><ul ><li >By<ul > <li >Pawel Roszak</li> <li >Jung-ok Heo</li> <li >et al.</li> </ul> </li></ul></div></div></article><article ><div ><div ><h3 >The energetics of uniquely human subsistence strategies</h3><ul ><li >By<ul > <li >Thomas S. Kraft</li> <li >Vivek V. Venkataraman</li> <li >et al.</li> </ul> </li></ul></div></div></article><article ><div ><div ><h3 >Early giant reveals faster evolution of large body size in ichthyosaurs than in cetaceans</h3><ul ><li >By<ul > <li >P. Martin Sander</li> <li >Eva Maria Griebeler</li> <li >et al.</li> </ul> </li></ul></div></div></article></div><div >Table of Contents</div></div> </div></div></div></section><section > <h4 >LATEST NEWS</h4> <div > <div ><div > <article > <div > <div > News<time >30 Dec 2021</time> </div> <div > Airborne DNA from plants could reveal invasive species, impact of climate change </div> </div> </article> <article > <div > <div > ScienceInsider<time >29 Dec 2021</time> </div> <div > <a > Once a ‘crazy idea,’ patent-pooling nonprofit will help bring COVID-19 pills to world’s poor </a> </div> </div> </article> <article > <div > <div > ScienceInsider<time >28 Dec 2021</time> </div> <div > The natural world loses two of its biggest advocates </div> </div> </article> <article > <div > <div > ScienceInsider<time >28 Dec 2021</time> </div> <div > <a > What the Charles Lieber verdict says about U.S. China Initiative </a> </div> </div> </article> <article > <div > <div > ScienceInsider<time >25 Dec 2021</time> </div> <div > NASA’s Webb telescope takes flight—a Christmas gift to astronomers everywhere </div> </div> </article> <article > <div > <div > News<time >23 Dec 2021</time> </div> <div > <a > More than a virus: Science’s areas to watch in 2022 </a> </div> </div> </article> </div></div> </div></section></div></div></div></div> </main> </div> </div> </div> </body>'</script>

      </head>
        <body class="valid" valid="valid" title="valid: True, node: 1, tag: body, level: 1" node_number="1"> <div class="valid" valid="valid" title="valid: True, node: 2, tag: div, level: 2" node_number="2"> <div class="valid" valid="valid" title="valid: True, node: 3, tag: div, level: 3" node_number="3"> <div class="valid" valid="valid" title="valid: True, node: 4, tag: div, level: 4" node_number="4"> <div class="valid" valid="valid" title="valid: True, node: 5, tag: div, level: 5" node_number="5"> <div class="valid" valid="valid" title="valid: True, node: 6, tag: div, level: 6" node_number="6"> <div class="valid" valid="valid" title="valid: True, node: 7, tag: div, level: 7" node_number="7"> <div class="valid" valid="valid" title="valid: True, node: 8, tag: div, level: 8" node_number="8"> <div class="valid" valid="valid" title="valid: True, node: 9, tag: div, level: 9" node_number="9"> <div class="valid" valid="valid" title="valid: True, node: 10, tag: div, level: 10" node_number="10"> <div class="valid" valid="valid" title="valid: True, node: 11, tag: div, level: 11" node_number="11"> <span class="valid" valid="valid" title="valid: True, node: 12, tag: span, level: 12" node_number="12">Advertisement</span> </div> </div> </div> </div> </div> </div> </div> <header class="valid" valid="valid" title="valid: True, node: 13, tag: header, level: 5" node_number="13"> <div class="valid" valid="valid" title="valid: True, node: 14, tag: div, level: 6" node_number="14"><div class="valid" valid="valid" title="valid: True, node: 15, tag: div, level: 7" node_number="15"><div class="valid" valid="valid" title="valid: True, node: 16, tag: div, level: 8" node_number="16"><div class="valid" valid="valid" title="valid: True, node: 17, tag: div, level: 9" node_number="17"><div class="valid" valid="valid" title="valid: True, node: 18, tag: div, level: 10" node_number="18"><div class="valid" valid="valid" title="valid: True, node: 19, tag: div, level: 11" node_number="19"><div class="valid" valid="valid" title="valid: True, node: 20, tag: div, level: 12" node_number="20"><a class="valid" valid="valid" title="valid: True, node: 21, tag: a, level: 13" node_number="21"><div class="valid" valid="valid" title="valid: True, node: 22, tag: div, level: 14" node_number="22">science</div></a></div></div><div class="valid" valid="valid" title="valid: True, node: 23, tag: div, level: 11" node_number="23"><div class="valid" valid="valid" title="valid: True, node: 24, tag: div, level: 12" node_number="24"><a class="valid" valid="valid" title="valid: True, node: 25, tag: a, level: 13" node_number="25"><div class="valid" valid="valid" title="valid: True, node: 26, tag: div, level: 14" node_number="26">science advances</div></a></div></div><div class="valid" valid="valid" title="valid: True, node: 27, tag: div, level: 11" node_number="27"><div class="valid" valid="valid" title="valid: True, node: 28, tag: div, level: 12" node_number="28"><a class="valid" valid="valid" title="valid: True, node: 29, tag: a, level: 13" node_number="29"><div class="valid" valid="valid" title="valid: True, node: 30, tag: div, level: 14" node_number="30">science immunology</div></a></div></div><div class="valid" valid="valid" title="valid: True, node: 31, tag: div, level: 11" node_number="31"><div class="valid" valid="valid" title="valid: True, node: 32, tag: div, level: 12" node_number="32"><a class="valid" valid="valid" title="valid: True, node: 33, tag: a, level: 13" node_number="33"><div class="valid" valid="valid" title="valid: True, node: 34, tag: div, level: 14" node_number="34">science robotics</div></a></div></div><div class="valid" valid="valid" title="valid: True, node: 35, tag: div, level: 11" node_number="35"><div class="valid" valid="valid" title="valid: True, node: 36, tag: div, level: 12" node_number="36"><a class="valid" valid="valid" title="valid: True, node: 37, tag: a, level: 13" node_number="37"><div class="valid" valid="valid" title="valid: True, node: 38, tag: div, level: 14" node_number="38">science signaling</div></a></div></div><div class="valid" valid="valid" title="valid: True, node: 39, tag: div, level: 11" node_number="39"><div class="valid" valid="valid" title="valid: True, node: 40, tag: div, level: 12" node_number="40"><a class="valid" valid="valid" title="valid: True, node: 41, tag: a, level: 13" node_number="41"><div class="valid" valid="valid" title="valid: True, node: 42, tag: div, level: 14" node_number="42">science translational medicine</div></a></div></div><div class="valid" valid="valid" title="valid: True, node: 43, tag: div, level: 11" node_number="43"><div class="valid" valid="valid" title="valid: True, node: 44, tag: div, level: 12" node_number="44"><a class="valid" valid="valid" title="valid: True, node: 45, tag: a, level: 13" node_number="45"><div class="valid" valid="valid" title="valid: True, node: 46, tag: div, level: 14" node_number="46">science partner journals</div></a></div></div></div></div></div></div></div> <div class="valid" valid="valid" title="valid: True, node: 47, tag: div, level: 6" node_number="47"> <div class="valid" valid="valid" title="valid: True, node: 48, tag: div, level: 7" node_number="48"> <div class="valid" valid="valid" title="valid: True, node: 49, tag: div, level: 8" node_number="49"> <div class="valid" valid="valid" title="valid: True, node: 50, tag: div, level: 9" node_number="50"> <div class="valid" valid="valid" title="valid: True, node: 51, tag: div, level: 10" node_number="51"><div class="valid" valid="valid" title="valid: True, node: 52, tag: div, level: 11" node_number="52"><div class="valid" valid="valid" title="valid: True, node: 53, tag: div, level: 12" node_number="53"><label class="valid" valid="valid" title="valid: True, node: 54, tag: label, level: 13" node_number="54">Searching:</label><div class="valid" valid="valid" title="valid: True, node: 55, tag: div, level: 13" node_number="55"><div class="valid" valid="valid" title="valid: True, node: 56, tag: div, level: 14" node_number="56"><div title="valid: False, node: 57, tag: div, level: 15" node_number="57">AnywhereScience<a title="valid: False, node: 58, tag: a, level: 16" node_number="58">Science Advances</a><a title="valid: False, node: 59, tag: a, level: 16" node_number="59">Science Immunology</a><a title="valid: False, node: 60, tag: a, level: 16" node_number="60">Science Robotics</a><a title="valid: False, node: 61, tag: a, level: 16" node_number="61">Science Signaling</a><a title="valid: False, node: 62, tag: a, level: 16" node_number="62">Science Translational Medicine</a></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 63, tag: div, level: 12" node_number="63"> <a class="valid" valid="valid" title="valid: True, node: 64, tag: a, level: 13" node_number="64"><u class="valid" valid="valid" title="valid: True, node: 65, tag: u, level: 14" node_number="65">Advanced Search</u></a> </div></div></div> </div> </div> </div> <div class="valid" valid="valid" title="valid: True, node: 66, tag: div, level: 7" node_number="66"> <div class="valid" valid="valid" title="valid: True, node: 67, tag: div, level: 8" node_number="67"> <div class="valid" valid="valid" title="valid: True, node: 68, tag: div, level: 9" node_number="68"> <h6 class="valid" valid="valid" title="valid: True, node: 69, tag: h6, level: 10" node_number="69">Trending Terms:</h6> <ul class="valid" valid="valid" title="valid: True, node: 70, tag: ul, level: 10" node_number="70"> <li class="valid" valid="valid" title="valid: True, node: 71, tag: li, level: 11" node_number="71"> <a class="valid" valid="valid" title="valid: True, node: 72, tag: a, level: 12" node_number="72">covid-19</a> </li> <li class="valid" valid="valid" title="valid: True, node: 73, tag: li, level: 11" node_number="73"> <a class="valid" valid="valid" title="valid: True, node: 74, tag: a, level: 12" node_number="74">climate</a> </li> <li class="valid" valid="valid" title="valid: True, node: 75, tag: li, level: 11" node_number="75"> <a class="valid" valid="valid" title="valid: True, node: 76, tag: a, level: 12" node_number="76">science policy</a> </li> <li class="valid" valid="valid" title="valid: True, node: 77, tag: li, level: 11" node_number="77"> <a class="valid" valid="valid" title="valid: True, node: 78, tag: a, level: 12" node_number="78">genome editing</a> </li> <li class="valid" valid="valid" title="valid: True, node: 79, tag: li, level: 11" node_number="79"> <a class="valid" valid="valid" title="valid: True, node: 80, tag: a, level: 12" node_number="80">batteries</a> </li> </ul> </div> </div> </div> </div> </header><div class="valid" valid="valid" title="valid: True, node: 81, tag: div, level: 5" node_number="81"><div class="valid" valid="valid" title="valid: True, node: 82, tag: div, level: 6" node_number="82"><div class="valid" valid="valid" title="valid: True, node: 83, tag: div, level: 7" node_number="83"> <div class="valid" valid="valid" title="valid: True, node: 84, tag: div, level: 8" node_number="84"> <div class="valid" valid="valid" title="valid: True, node: 85, tag: div, level: 9" node_number="85"> <ul class="valid" valid="valid" title="valid: True, node: 86, tag: ul, level: 10" node_number="86"> <li class="valid" valid="valid" title="valid: True, node: 87, tag: li, level: 11" node_number="87"> <a class="valid" valid="valid" title="valid: True, node: 88, tag: a, level: 12" node_number="88">Current Issue</a> </li> <li class="valid" valid="valid" title="valid: True, node: 89, tag: li, level: 11" node_number="89"> <a class="valid" valid="valid" title="valid: True, node: 90, tag: a, level: 12" node_number="90">First release papers</a> </li> <li class="valid" valid="valid" title="valid: True, node: 91, tag: li, level: 11" node_number="91"> <a class="valid" valid="valid" title="valid: True, node: 92, tag: a, level: 12" node_number="92">Archive</a> </li> <li class="valid" valid="valid" title="valid: True, node: 93, tag: li, level: 11" node_number="93"> <div class="valid" valid="valid" title="valid: True, node: 94, tag: div, level: 12" node_number="94"> <a class="valid" valid="valid" title="valid: True, node: 95, tag: a, level: 13" node_number="95">About</a> <div class="valid" valid="valid" title="valid: True, node: 96, tag: div, level: 13" node_number="96"> <a class="valid" valid="valid" title="valid: True, node: 97, tag: a, level: 14" node_number="97">About Science</a> <a class="valid" valid="valid" title="valid: True, node: 98, tag: a, level: 14" node_number="98">Mission Scope</a> <a class="valid" valid="valid" title="valid: True, node: 99, tag: a, level: 14" node_number="99">Editors Advisory Boards</a> <a class="valid" valid="valid" title="valid: True, node: 100, tag: a, level: 14" node_number="100">Editorial Policies</a> <a class="valid" valid="valid" title="valid: True, node: 101, tag: a, level: 14" node_number="101">Information for Authors</a> <a class="valid" valid="valid" title="valid: True, node: 102, tag: a, level: 14" node_number="102">Information for Reviewers</a> <a class="valid" valid="valid" title="valid: True, node: 103, tag: a, level: 14" node_number="103">Journal Metrics</a> <a class="valid" valid="valid" title="valid: True, node: 104, tag: a, level: 14" node_number="104">Staff</a> <a class="valid" valid="valid" title="valid: True, node: 105, tag: a, level: 14" node_number="105">Contact Us</a> </div> </div> </li> </ul> </div> <div class="valid" valid="valid" title="valid: True, node: 106, tag: div, level: 9" node_number="106"> <ul class="valid" valid="valid" title="valid: True, node: 107, tag: ul, level: 10" node_number="107"> <li class="valid" valid="valid" title="valid: True, node: 108, tag: li, level: 11" node_number="108"> <a class="valid" valid="valid" title="valid: True, node: 109, tag: a, level: 12" node_number="109">Submit manuscript</a> </li> <li class="valid" valid="valid" title="valid: True, node: 110, tag: li, level: 11" node_number="110"> <div class="valid" valid="valid" title="valid: True, node: 111, tag: div, level: 12" node_number="111"> <a class="valid" valid="valid" title="valid: True, node: 112, tag: a, level: 13" node_number="112">More</a> </div> </li> </ul> </div> </div> <a class="valid" valid="valid" title="valid: True, node: 113, tag: a, level: 8" node_number="113">GET OUR E-ALERTS</a> </div></div></div> <main class="valid" valid="valid" title="valid: True, node: 114, tag: main, level: 5" node_number="114"> <div class="valid" valid="valid" title="valid: True, node: 115, tag: div, level: 6" node_number="115"><div class="valid" valid="valid" title="valid: True, node: 116, tag: div, level: 7" node_number="116"><div class="valid" valid="valid" title="valid: True, node: 117, tag: div, level: 8" node_number="117"><div class="valid" valid="valid" title="valid: True, node: 118, tag: div, level: 9" node_number="118"><div class="valid" valid="valid" title="valid: True, node: 119, tag: div, level: 10" node_number="119"> <div class="valid" valid="valid" title="valid: True, node: 120, tag: div, level: 11" node_number="120"><a class="valid" valid="valid" title="valid: True, node: 121, tag: a, level: 12" node_number="121">Home</a><a class="valid" valid="valid" title="valid: True, node: 122, tag: a, level: 12" node_number="122">Science</a><a class="valid" valid="valid" title="valid: True, node: 123, tag: a, level: 12" node_number="123">First Release</a>Structural basis for continued antibody evasion by the SARS-CoV-2 receptor binding domain</div><div class="valid" valid="valid" title="valid: True, node: 124, tag: div, level: 11" node_number="124">Back To First Release</div> </div> <article class="valid" valid="valid" title="valid: True, node: 125, tag: article, level: 10" node_number="125"><section class="valid" valid="valid" title="valid: True, node: 126, tag: section, level: 11" node_number="126"><header class="valid" valid="valid" title="valid: True, node: 127, tag: header, level: 12" node_number="127"><div class="valid" valid="valid" title="valid: True, node: 128, tag: div, level: 13" node_number="128"><div class="valid" valid="valid" title="valid: True, node: 129, tag: div, level: 14" node_number="129"><div title="valid: False, node: 130, tag: div, level: 15" node_number="130"><div title="valid: False, node: 131, tag: div, level: 16" node_number="131">OPEN ACCESS</div><div title="valid: False, node: 132, tag: div, level: 16" node_number="132">Research Article</div></div><div title="valid: False, node: 133, tag: div, level: 15" node_number="133"><div title="valid: False, node: 134, tag: div, level: 16" node_number="134"> <div title="valid: False, node: 135, tag: div, level: 17" node_number="135">Share on</div> </div></div></div><h1 class="valid" valid="valid" title="valid: True, node: 136, tag: h1, level: 14" node_number="136">Structural basis for continued antibody evasion by the SARS-CoV-2 receptor binding domain</h1><div class="valid" valid="valid" title="valid: True, node: 137, tag: div, level: 14" node_number="137">Katherine G. Nabel https://orcid.org/0000-0002-4429-7075, Sarah A. Clark https://orcid.org/0000-0001-9944-0919, Sundaresh Shankar https://orcid.org/0000-0001-9340-9945, Junhua Pan https://orcid.org/0000-0002-0070-955X, Lars E. Clark https://orcid.org/0000-0002-6093-7597, Pan Yang, Adrian Coscia https://orcid.org/0000-0002-6836-9993, &#8230; Show All &#8230; , Lindsay G. A. McKay https://orcid.org/0000-0003-0369-9067, Haley H. Varnum, Vesna Brusic, Nicole V. Tolan, Guohai Zhou, Micha&#235;l Desjardins https://orcid.org/0000-0003-4028-8507, Sarah E. Turbett https://orcid.org/0000-0002-3603-8110, Sanjat Kanjilal https://orcid.org/0000-0002-1221-5725, Amy C. Sherman https://orcid.org/0000-0002-6075-3990, Anand Dighe, Regina C. LaRocque https://orcid.org/0000-0003-4558-0339, Edward T. Ryan, Casey Tylek, Joel F. Cohen-Solal https://orcid.org/0000-0002-1385-2566, Anhdao T. Darcy, Davide Tavella https://orcid.org/0000-0002-2030-2087, Anca Clabbers https://orcid.org/0000-0002-4258-9680, Yao Fan, Anthony Griffiths https://orcid.org/0000-0001-5435-8364, Ivan R. Correia https://orcid.org/0000-0003-2295-7199, Jane Seagal https://orcid.org/0000-0002-5959-5139, Lindsey R. Baden, Richelle C. Charles, and Jonathan Abraham https://orcid.org/0000-0002-7937-3920 [email&#160;protected] Show Fewer</div><div class="valid" valid="valid" title="valid: True, node: 138, tag: div, level: 14" node_number="138">Science &#8226; 2 Dec 2021 &#8226; First Release &#8226; DOI: 10.1126/science.abl6251</div><div class="valid" valid="valid" title="valid: True, node: 139, tag: div, level: 14" node_number="139"><div title="valid: False, node: 140, tag: div, level: 15" node_number="140"> <div title="valid: False, node: 141, tag: div, level: 16" node_number="141"> <a title="valid: False, node: 142, tag: a, level: 17" node_number="142"><div title="valid: False, node: 143, tag: div, level: 18" node_number="143"><div title="valid: False, node: 144, tag: div, level: 19" node_number="144"><h6 title="valid: False, node: 145, tag: h6, level: 20" node_number="145">PREVIOUS ARTICLE</h6><div title="valid: False, node: 146, tag: div, level: 20" node_number="146">4&#8242;-Fluorouridine is an oral antiviral that blocks respiratory syncytial virus and SARS-CoV-2 replication</div></div></div>Previous</a><a title="valid: False, node: 147, tag: a, level: 17" node_number="147"><div title="valid: False, node: 148, tag: div, level: 18" node_number="148"><div title="valid: False, node: 149, tag: div, level: 19" node_number="149"><h6 title="valid: False, node: 150, tag: h6, level: 20" node_number="150">NEXT ARTICLE</h6><div title="valid: False, node: 151, tag: div, level: 20" node_number="151">Heterologous infection and vaccination shapes immunity against SARS-CoV-2 variants</div></div></div>Next</a> </div> </div></div></div></header><div class="valid" valid="valid" title="valid: True, node: 152, tag: div, level: 12" node_number="152"><div class="valid" valid="valid" title="valid: True, node: 153, tag: div, level: 13" node_number="153"><section class="valid" valid="valid" title="valid: True, node: 154, tag: section, level: 14" node_number="154"><h2 title="valid: False, node: 155, tag: h2, level: 15" node_number="155">Abstract</h2><div title="valid: False, node: 156, tag: div, level: 15" node_number="156">Many studies have examined the impact of SARS-CoV-2 variants on neutralizing antibody activity after they have become dominant strains. Here, we evaluate the consequences of further viral evolution. We demonstrate mechanisms through which the SARS-CoV-2 receptor binding domain (RBD) can tolerate large numbers of simultaneous antibody escape mutations and show that pseudotypes containing up to seven mutations, as opposed to the one to three found in previously studied variants of concern, are more resistant to neutralization by therapeutic antibodies and serum from vaccine recipients. We identify an antibody that binds the RBD core to neutralize pseudotypes for all tested variants but show that the RBD can acquire an N-linked glycan to escape neutralization. Our findings portend continued emergence of escape variants as SARS-CoV-2 adapts to humans.</div></section></div></div></section><section class="valid" valid="valid" title="valid: True, node: 157, tag: section, level: 11" node_number="157"><div class="valid" valid="valid" title="valid: True, node: 158, tag: div, level: 12" node_number="158"><div class="valid" valid="valid" title="valid: True, node: 159, tag: div, level: 13" node_number="159">As SARS-CoV-2 continues to replicate in humans under selective pressure from natural and vaccine induced immunity, variants of concern (VOCs) with increased transmissibility or virulence continue to emerge (<a class="valid" valid="valid" title="valid: True, node: 160, tag: a, level: 14" node_number="160"><i title="valid: False, node: 161, tag: i, level: 15" node_number="161">1</i></a>). Through adaptive evolution, these variants acquire mutations in the spike protein receptor binding domain (RBD) that binds the cellular receptor human angiotensin-converting enzyme 2 (ACE2) (<a class="valid" valid="valid" title="valid: True, node: 162, tag: a, level: 14" node_number="162"><i title="valid: False, node: 163, tag: i, level: 15" node_number="163">1</i></a>&#8211;<a class="valid" valid="valid" title="valid: True, node: 164, tag: a, level: 14" node_number="164"><i title="valid: False, node: 165, tag: i, level: 15" node_number="165">3</i></a>). Many of these mutations are within the RBD &#8220;receptor binding motif&#8221; (RBM), a hypervariable loop that mediates most of the ACE2 contacts (<a class="valid" valid="valid" title="valid: True, node: 166, tag: a, level: 14" node_number="166"><i title="valid: False, node: 167, tag: i, level: 15" node_number="167">2</i></a>, <a class="valid" valid="valid" title="valid: True, node: 168, tag: a, level: 14" node_number="168"><i title="valid: False, node: 169, tag: i, level: 15" node_number="169">3</i></a>). The RBD is the primary target of neutralizing antibodies in naturally acquired or vaccine-elicited humoral immunity (<a class="valid" valid="valid" title="valid: True, node: 170, tag: a, level: 14" node_number="170"><i title="valid: False, node: 171, tag: i, level: 15" node_number="171">4</i></a>, <a class="valid" valid="valid" title="valid: True, node: 172, tag: a, level: 14" node_number="172"><i title="valid: False, node: 173, tag: i, level: 15" node_number="173">5</i></a>). The spike protein N-terminal domain (NTD) is also a target of neutralizing antibodies, and VOCs have NTD mutations including deletions at an antigenic supersite for neutralizing antibody binding (<a class="valid" valid="valid" title="valid: True, node: 174, tag: a, level: 14" node_number="174"><i title="valid: False, node: 175, tag: i, level: 15" node_number="175">6</i></a>, <a class="valid" valid="valid" title="valid: True, node: 176, tag: a, level: 14" node_number="176"><i title="valid: False, node: 177, tag: i, level: 15" node_number="177">7</i></a>). The effects of spike protein mutations on immune responses (<a class="valid" valid="valid" title="valid: True, node: 178, tag: a, level: 14" node_number="178"><i title="valid: False, node: 179, tag: i, level: 15" node_number="179">8</i></a>&#8211;<a class="valid" valid="valid" title="valid: True, node: 180, tag: a, level: 14" node_number="180"><i title="valid: False, node: 181, tag: i, level: 15" node_number="181">13</i></a>) make it important to monitor viral variants.</div><div class="valid" valid="valid" title="valid: True, node: 182, tag: div, level: 13" node_number="182">While previously studied VOCs contain one to three RBD mutations that at times overlap (<a class="valid" valid="valid" title="valid: True, node: 183, tag: a, level: 14" node_number="183"><i title="valid: False, node: 184, tag: i, level: 15" node_number="184">1</i></a>), the potential for composite variants is being closely monitored. For example, the B.1.617.2 (Delta) variant can acquire the K417N<sub class="valid" valid="valid" title="valid: True, node: 185, tag: sub, level: 14" node_number="185">RBD</sub> mutation found in the B.1.351 (Beta) variant, generating the Delta AY.2 variant, for a total of three RBD mutations (<a class="valid" valid="valid" title="valid: True, node: 186, tag: a, level: 14" node_number="186">Fig. 1A</a>). Similarly, as shown in recently deposited sequences from samples collected in Angola, the Beta variant can acquire the L452R<sub class="valid" valid="valid" title="valid: True, node: 187, tag: sub, level: 14" node_number="187">RBD</sub> mutation found in the Delta and B.1.429/427 (Epsilon) variants, for a total of four RBD mutations (<a class="valid" valid="valid" title="valid: True, node: 188, tag: a, level: 14" node_number="188">Fig. 1A</a> and table S1). Further complicating matters, variant monitoring efforts are still under sampling viral evolution. For example, a virus recently sequenced from travelers returning from Tanzania contained a previously undocumented combination of RBD mutations (E484K<sub class="valid" valid="valid" title="valid: True, node: 189, tag: sub, level: 14" node_number="189">RBD</sub>, T478R<sub class="valid" valid="valid" title="valid: True, node: 190, tag: sub, level: 14" node_number="190">RBD</sub>, and R346K<sub class="valid" valid="valid" title="valid: True, node: 191, tag: sub, level: 14" node_number="191">RBD</sub>) with NTD deletions that would likely alter the spike protein antigenic surface and result in antibody escape (table S1).</div><div class="valid" valid="valid" title="valid: True, node: 192, tag: div, level: 13" node_number="192">Here, we investigate the structural plasticity of the SARS-CoV-2 spike protein RBD and its capacity to evade neutralizing antibodies.</div><section class="valid" valid="valid" title="valid: True, node: 193, tag: section, level: 13" node_number="193"><h2 class="valid" valid="valid" title="valid: True, node: 194, tag: h2, level: 14" node_number="194">Results</h2><section class="valid" valid="valid" title="valid: True, node: 195, tag: section, level: 14" node_number="195"><h3 title="valid: False, node: 196, tag: h3, level: 15" node_number="196">Structure of an evolved receptor binding domain ACE2 complex</h3><div title="valid: False, node: 197, tag: div, level: 15" node_number="197">We previously generated two SARS-CoV-2 spike proteins that each contain six RBD changes that were detected during persistent infection of an immunocompromised individual infected with a SARS-CoV-2 strain containing the D614G<sub title="valid: False, node: 198, tag: sub, level: 16" node_number="198">S</sub> mutation (<a title="valid: False, node: 199, tag: a, level: 16" node_number="199"><i title="valid: False, node: 200, tag: i, level: 17" node_number="200">14</i></a>&#8211;<a title="valid: False, node: 201, tag: a, level: 16" node_number="201"><i title="valid: False, node: 202, tag: i, level: 17" node_number="202">16</i></a>). This individual received treatment with REGN-COV2 (<a title="valid: False, node: 203, tag: a, level: 16" node_number="203"><i title="valid: False, node: 204, tag: i, level: 17" node_number="204">17</i></a>, <a title="valid: False, node: 205, tag: a, level: 16" node_number="205"><i title="valid: False, node: 206, tag: i, level: 17" node_number="206">18</i></a>), but several of the RBD substitutions had occurred even prior to administration of this therapeutic antibody cocktail (<a title="valid: False, node: 207, tag: a, level: 16" node_number="207"><i title="valid: False, node: 208, tag: i, level: 17" node_number="208">14</i></a>&#8211;<a title="valid: False, node: 209, tag: a, level: 16" node_number="209"><i title="valid: False, node: 210, tag: i, level: 17" node_number="210">16</i></a>). Lentivirus pseudotypes bearing these spike proteins, denoted day 146* and day 152* (<a title="valid: False, node: 211, tag: a, level: 16" node_number="211">Fig. 1A</a> and table S2), were refractory to neutralization by V<sub title="valid: False, node: 212, tag: sub, level: 16" node_number="212">H</sub>3-53-heavy chain gene-derived neutralizing antibodies, a potent class of neutralizing antibodies that have been repeatedly isolated from convalescent donors (<a title="valid: False, node: 213, tag: a, level: 16" node_number="213"><i title="valid: False, node: 214, tag: i, level: 17" node_number="214">19</i></a>&#8211;<a title="valid: False, node: 215, tag: a, level: 16" node_number="215"><i title="valid: False, node: 216, tag: i, level: 17" node_number="216">25</i></a>). These pseudotypes were also resistant to neutralization by components of REGN-COV2 (<a title="valid: False, node: 217, tag: a, level: 16" node_number="217"><i title="valid: False, node: 218, tag: i, level: 17" node_number="218">17</i></a>, <a title="valid: False, node: 219, tag: a, level: 16" node_number="219"><i title="valid: False, node: 220, tag: i, level: 17" node_number="220">18</i></a>) and by polyclonal immunoglobulins (IgG) purified from the serum of COVID-19 convalescent donors (<a title="valid: False, node: 221, tag: a, level: 16" node_number="221"><i title="valid: False, node: 222, tag: i, level: 17" node_number="222">14</i></a>). Substitutions in the day 146* and day 152* spike proteins, noted in samples sequenced from this individual in the spring and summer of 2020, foreshadowed those in currently circulating VOCs at three positions: N501<sub title="valid: False, node: 223, tag: sub, level: 16" node_number="223">RBD</sub>, E484<sub title="valid: False, node: 224, tag: sub, level: 16" node_number="224">RBD</sub>, and T478<sub title="valid: False, node: 225, tag: sub, level: 16" node_number="225">RBD</sub> (<a title="valid: False, node: 226, tag: a, level: 16" node_number="226">Fig. 1A</a>). The day 146* and day 152* spike proteins also contain substitutions that are not in current dominant strains but could have serious effects if acquired. For example, the S494P<sub title="valid: False, node: 227, tag: sub, level: 16" node_number="227">RBD</sub> substitution is a therapeutic antibody (LY-CoV555) escape mutation (<a title="valid: False, node: 228, tag: a, level: 16" node_number="228"><i title="valid: False, node: 229, tag: i, level: 17" node_number="229">26</i></a>) that as of 27 September 2021 was present in over 12,000 human-derived SARS-CoV-2 sequences on public research databases (GISAID) (<a title="valid: False, node: 230, tag: a, level: 16" node_number="230"><i title="valid: False, node: 231, tag: i, level: 17" node_number="231">27</i></a>). Additionally, the Q493K<sub title="valid: False, node: 232, tag: sub, level: 16" node_number="232">RBD</sub> mutation, which is found in over one hundred human-derived SARS-CoV-2 sequences as of 27 September 2021 on GISAID, confers resistance to multiple therapeutic antibodies [REGN10933, CB6 (LY-CoV016), and LY-CoV555] and V<sub title="valid: False, node: 233, tag: sub, level: 16" node_number="233">H</sub>3-53-gene-derived antibodies (<a title="valid: False, node: 234, tag: a, level: 16" node_number="234"><i title="valid: False, node: 235, tag: i, level: 17" node_number="235">14</i></a>, <a title="valid: False, node: 236, tag: a, level: 16" node_number="236"><i title="valid: False, node: 237, tag: i, level: 17" node_number="237">16</i></a>, <a title="valid: False, node: 238, tag: a, level: 16" node_number="238"><i title="valid: False, node: 239, tag: i, level: 17" node_number="239">17</i></a>, <a title="valid: False, node: 240, tag: a, level: 16" node_number="240"><i title="valid: False, node: 241, tag: i, level: 17" node_number="241">28</i></a>).</div><div title="valid: False, node: 242, tag: div, level: 15" node_number="242">To determine the impact of their combined mutations on human ACE2 binding, we generated recombinant RBDs for the day 146* and day 152* spike protein mutants. The affinity of the day 152* mutant monomeric RBD for monomeric ACE2 ectodomain was substantially lower (<i title="valid: False, node: 243, tag: i, level: 16" node_number="243">K</i><sub title="valid: False, node: 244, tag: sub, level: 16" node_number="244">D</sub> of 2.4 &#956;M) than that of wild-type (Wuhan-Hu-1) RBD (54 nM, consistent with other reports) (<a title="valid: False, node: 245, tag: a, level: 16" node_number="245"><i title="valid: False, node: 246, tag: i, level: 17" node_number="246">3</i></a>, <a title="valid: False, node: 247, tag: a, level: 16" node_number="247"><i title="valid: False, node: 248, tag: i, level: 17" node_number="248">29</i></a>), suggesting that its mutations also compromise ACE2 binding (fig. S1 and table S3). For comparison, the affinity we measured of the SARS-CoV RBD for human ACE2 was 0.26 &#956;M, about nine-fold higher than the affinity for the day 152* RBD (fig. S1 and table S3). The affinity of the day 152* RBD for ACE2 is comparable to that of the RBDs of some bat coronaviruses that are closely related to SARS-CoV-2 and bind human ACE2 (e.g., RaTG13 virus RBD affinity of 3.9 &#956;M) (<a title="valid: False, node: 249, tag: a, level: 16" node_number="249"><i title="valid: False, node: 250, tag: i, level: 17" node_number="250">30</i></a>). The day 146* RBD, however, had a similar affinity (<i title="valid: False, node: 251, tag: i, level: 16" node_number="251">K</i><sub title="valid: False, node: 252, tag: sub, level: 16" node_number="252">D</sub> of 46 nM) for ACE2 as that of the Wuhan-Hu-1 SARS-CoV-2 RBD (fig. S1 and table S3).</div><div title="valid: False, node: 253, tag: div, level: 15" node_number="253">We determined the X-ray crystal structure of the day 146* RBD bound to the human ACE2 ectodomain (<a title="valid: False, node: 254, tag: a, level: 16" node_number="254">Fig. 1B</a>, fig. S2, and table S4). This structure is similar to previously determined structures of ACE2/SARS-CoV-2 RBD complexes (<a title="valid: False, node: 255, tag: a, level: 16" node_number="255"><i title="valid: False, node: 256, tag: i, level: 17" node_number="256">2</i></a>, <a title="valid: False, node: 257, tag: a, level: 16" node_number="257"><i title="valid: False, node: 258, tag: i, level: 17" node_number="258">3</i></a>), except we observed contacts between two N-linked glycans on ACE2 (attached to N53<sub title="valid: False, node: 259, tag: sub, level: 16" node_number="259">ACE2</sub> and N90<sub title="valid: False, node: 260, tag: sub, level: 16" node_number="260">ACE2</sub>) and the RBD (fig. S3). Removing the N90<sub title="valid: False, node: 261, tag: sub, level: 16" node_number="261">ACE2</sub> glycan, which interacts with the RBD in both copies of the crystal asymmetric unit (fig. S3), increased Wuhan-Hu-1 SARS-CoV-2 and day 146* RBD affinity for ACE2, although the effect was modest (fig. S1 and table S3). This finding is consistent with prior work implicating the N90<sub title="valid: False, node: 262, tag: sub, level: 16" node_number="262">ACE2</sub> glycan, which is removed in a human polymorphism (T92I<sub title="valid: False, node: 263, tag: sub, level: 16" node_number="263">ACE2</sub>), as a barrier to SARS-CoV-2 RBD binding to ACE2 (<a title="valid: False, node: 264, tag: a, level: 16" node_number="264"><i title="valid: False, node: 265, tag: i, level: 17" node_number="265">31</i></a>, <a title="valid: False, node: 266, tag: a, level: 16" node_number="266"><i title="valid: False, node: 267, tag: i, level: 17" node_number="267">32</i></a>).</div><div title="valid: False, node: 268, tag: div, level: 15" node_number="268">The N501Y<sub title="valid: False, node: 269, tag: sub, level: 16" node_number="269">RBD</sub> substitution is found in multiple variants of concern (<a title="valid: False, node: 270, tag: a, level: 16" node_number="270">Fig. 1A</a>); once it surfaced in the immunocompromised individual, it was retained at later time points (<a title="valid: False, node: 271, tag: a, level: 16" node_number="271"><i title="valid: False, node: 272, tag: i, level: 17" node_number="272">14</i></a>&#8211;<a title="valid: False, node: 273, tag: a, level: 16" node_number="273"><i title="valid: False, node: 274, tag: i, level: 17" node_number="274">16</i></a>). As also shown in a cryo&#8211;electron microscopy (cryo-EM) structure of the SARS-CoV-2 spike protein containing the N501Y<sub title="valid: False, node: 275, tag: sub, level: 16" node_number="275">RBD</sub> substitution bound to ACE2 (<a title="valid: False, node: 276, tag: a, level: 16" node_number="276"><i title="valid: False, node: 277, tag: i, level: 17" node_number="277">33</i></a>), the side chain of Y501<sub title="valid: False, node: 278, tag: sub, level: 16" node_number="278">RBD</sub> interacts with Y41<sub title="valid: False, node: 279, tag: sub, level: 16" node_number="279">ACE2</sub> and K353<sub title="valid: False, node: 280, tag: sub, level: 16" node_number="280">ACE2</sub> with no significant structural change (<a title="valid: False, node: 281, tag: a, level: 16" node_number="281">Fig. 1, C and D</a>). E484<sub title="valid: False, node: 282, tag: sub, level: 16" node_number="282">RBD</sub> is a critical target of antibodies against SARS-CoV-2 and is mutated in several variants (<a title="valid: False, node: 283, tag: a, level: 16" node_number="283"><i title="valid: False, node: 284, tag: i, level: 17" node_number="284">12</i></a>, <a title="valid: False, node: 285, tag: a, level: 16" node_number="285"><i title="valid: False, node: 286, tag: i, level: 17" node_number="286">34</i></a>, <a title="valid: False, node: 287, tag: a, level: 16" node_number="287"><i title="valid: False, node: 288, tag: i, level: 17" node_number="288">35</i></a>). In structures of Wuhan-Hu-1 SARS-CoV-2 RBD bound to ACE2, E484<sub title="valid: False, node: 289, tag: sub, level: 16" node_number="289">RBD</sub> is near but does not directly contact the receptor (<a title="valid: False, node: 290, tag: a, level: 16" node_number="290">Fig. 1E</a>). In the day 146* RBD/ACE2 complex structure, the K493<sub title="valid: False, node: 291, tag: sub, level: 16" node_number="291">RBD</sub> sidechain reaches over the RBD surface to recruit the E484<sub title="valid: False, node: 292, tag: sub, level: 16" node_number="292">RBD</sub> side chain to form a new salt bridge with K31<sub title="valid: False, node: 293, tag: sub, level: 16" node_number="293">ACE2</sub> (<a title="valid: False, node: 294, tag: a, level: 16" node_number="294">Fig. 1F</a>). The nearby Y489H<sub title="valid: False, node: 295, tag: sub, level: 16" node_number="295">RBD</sub> mutation, which removes a polar contact with ACE2, better accommodates repositioning of E484<sub title="valid: False, node: 296, tag: sub, level: 16" node_number="296">RBD</sub> because the histidine is smaller than the tyrosine sidechain and would avoid potential steric clashes with E484<sub title="valid: False, node: 297, tag: sub, level: 16" node_number="297">RBD</sub> in this binding mode (<a title="valid: False, node: 298, tag: a, level: 16" node_number="298">Fig. 1, E and F</a>). A second rotamer for residue H34<sub title="valid: False, node: 299, tag: sub, level: 16" node_number="299">ACE2</sub> forms new RBD contacts to fill a gap created by the reorganization of local interactions (<a title="valid: False, node: 300, tag: a, level: 16" node_number="300">Fig. 1, E and F</a>). This structural plasticity may explain how the RBD tolerates a surprisingly large number of mutations during intra-host evolution yet retains the ability to bind ACE2 tightly. It is also consistent with the large sequence divergence in the RBD residues that contact ACE2 among SARS-related coronaviruses that share this cellular receptor.</div></section><section class="valid" valid="valid" title="valid: True, node: 301, tag: section, level: 14" node_number="301"><h3 title="valid: False, node: 302, tag: h3, level: 15" node_number="302">Neutralization escape of therapeutic antibodies</h3><div title="valid: False, node: 303, tag: div, level: 15" node_number="303">RBD-targeting antibodies can be categorized into classes based on whether they bind an overlapping footprint with ACE2 and recognize only an open or both an open and closed RBD on the spike protein trimer (<a title="valid: False, node: 304, tag: a, level: 16" node_number="304"><i title="valid: False, node: 305, tag: i, level: 17" node_number="305">36</i></a>). CB6 (equivalent to LY-CoV016 or etesevimab) is a class 1, V<sub title="valid: False, node: 306, tag: sub, level: 16" node_number="306">H</sub>3-66-derived antibody that blocks ACE2 binding and can only bind the RBD when it is open, and LY-CoV555 (bamlanivimab) is a class 2 antibody that blocks ACE2 binding but can bind both open or closed RBDs (<a title="valid: False, node: 307, tag: a, level: 16" node_number="307"><i title="valid: False, node: 308, tag: i, level: 17" node_number="308">21</i></a>, <a title="valid: False, node: 309, tag: a, level: 16" node_number="309"><i title="valid: False, node: 310, tag: i, level: 17" node_number="310">37</i></a>). LY-CoV016 and LY-CoV555 are used as a cocktail and bind epitopes that partially overlap on the RBM such that both cannot bind simultaneously (<a title="valid: False, node: 311, tag: a, level: 16" node_number="311"><i title="valid: False, node: 312, tag: i, level: 17" node_number="312">21</i></a>, <a title="valid: False, node: 313, tag: a, level: 16" node_number="313"><i title="valid: False, node: 314, tag: i, level: 17" node_number="314">37</i></a>). REGN10933 is a class 1 antibody, and REGN10987 is a class 3 antibody that sterically blocks ACE2 binding but binds the RBM outside the main ACE2 binding site; both are used as a cocktail (REGN-COV2) (<a title="valid: False, node: 315, tag: a, level: 16" node_number="315"><i title="valid: False, node: 316, tag: i, level: 17" node_number="316">17</i></a>, <a title="valid: False, node: 317, tag: a, level: 16" node_number="317"><i title="valid: False, node: 318, tag: i, level: 17" node_number="318">18</i></a>).</div><div title="valid: False, node: 319, tag: div, level: 15" node_number="319">Structural plasticity at the RBD-ACE2 interface suggests that the RBD could tolerate many more mutations than found in current variants of concern. We next generated pseudotypes for spike protein variants that contain composite mutations. The Delta variant, which contains the L452R<sub title="valid: False, node: 320, tag: sub, level: 16" node_number="320">RBD</sub> and T478K<sub title="valid: False, node: 321, tag: sub, level: 16" node_number="321">RBD</sub> substitutions, has become a dominant strain across the globe (<a title="valid: False, node: 322, tag: a, level: 16" node_number="322"><i title="valid: False, node: 323, tag: i, level: 17" node_number="323">38</i></a>). We generated pseudotype for the Delta AY.2 variant, which contains the K417N<sub title="valid: False, node: 324, tag: sub, level: 16" node_number="324">RBD</sub> mutation that is usually found in the Beta variant, and a Delta variant containing the N501Y<sub title="valid: False, node: 325, tag: sub, level: 16" node_number="325">RBD</sub>, E484K<sub title="valid: False, node: 326, tag: sub, level: 16" node_number="326">RBD</sub>, and F490S<sub title="valid: False, node: 327, tag: sub, level: 16" node_number="327">RBD</sub> mutations usually found in Beta, P.1 (Gamma), and C.37 (Lambda) variants (referred to here as &#8220;Delta +3&#8221;) (<a title="valid: False, node: 328, tag: a, level: 16" node_number="328">Fig. 1A</a> and tables S1 and S2). The set of RBD mutations for the latter strain occurred in deposited sequences from samples collected in Turkey (table S1). We also generated pseudotypes in which we combined spike protein substitutions detected in the immunocompromised host with mutations found in the Beta variant, which we chose because this VOC is highly resistant to antibody neutralization (<a title="valid: False, node: 329, tag: a, level: 16" node_number="329"><i title="valid: False, node: 330, tag: i, level: 17" node_number="330">10</i></a>, <a title="valid: False, node: 331, tag: a, level: 16" node_number="331"><i title="valid: False, node: 332, tag: i, level: 17" node_number="332">12</i></a>, <a title="valid: False, node: 333, tag: a, level: 16" node_number="333"><i title="valid: False, node: 334, tag: i, level: 17" node_number="334">39</i></a>). Starting with a day 146* spike protein sequence, which contains an NTD deletion, we incorporated either one (E484K<sub title="valid: False, node: 335, tag: sub, level: 16" node_number="335">RBD</sub>) or two additional substitutions (E484K<sub title="valid: False, node: 336, tag: sub, level: 16" node_number="336">RBD</sub> and K417N<sub title="valid: False, node: 337, tag: sub, level: 16" node_number="337">RBD</sub>); these are referred to as receptor binding mutant-1 (RBM-1) and RBM-2, respectively (<a title="valid: False, node: 338, tag: a, level: 16" node_number="338">Fig. 1A</a> and table S2). Additionally, starting with the Beta variant spike protein sequence, we generated a variant pseudotype that contains two additional mutations associated with immune evasion (L452R<sub title="valid: False, node: 339, tag: sub, level: 16" node_number="339">RBD</sub> and N439K<sub title="valid: False, node: 340, tag: sub, level: 16" node_number="340">RBD</sub>) (<a title="valid: False, node: 341, tag: a, level: 16" node_number="341"><i title="valid: False, node: 342, tag: i, level: 17" node_number="342">40</i></a>, <a title="valid: False, node: 343, tag: a, level: 16" node_number="343"><i title="valid: False, node: 344, tag: i, level: 17" node_number="344">41</i></a>). This pseudotype is referred to as RBM-3 (<a title="valid: False, node: 345, tag: a, level: 16" node_number="345">Fig. 1A</a> and table S2). An ACE2-Fc fusion protein neutralized RBM-1, RBM-2, and RBM-3 pseudotypes, suggesting that all entered cells by binding ACE2 (<a title="valid: False, node: 346, tag: a, level: 16" node_number="346">Fig. 2B</a> and fig. S4A).</div><div title="valid: False, node: 347, tag: div, level: 15" node_number="347">We tested the activity of therapeutic antibodies against Delta AY.2, Delta +3, RBM-1, RBM-2, RBM-3, and additional variant pseudotypes with known resistance profiles to serve as comparators in the same assay (<a title="valid: False, node: 348, tag: a, level: 16" node_number="348">Fig. 2, A and B</a>, and fig. S4A). LY-CoV555 was the most impacted by escape mutations, followed by CB6 (from which LY-CoV016 is derived) (<a title="valid: False, node: 349, tag: a, level: 16" node_number="349">Fig. 2, A and B</a>, and fig. S4A). The Q493K<sub title="valid: False, node: 350, tag: sub, level: 16" node_number="350">RBD</sub> mutation conferred absolute resistance to LY-CoV555, generated eightyfold resistance to CB6, and also compromised REGN10933 activity, consistent with previous reports (<a title="valid: False, node: 351, tag: a, level: 16" node_number="351">Fig. 2, A and B</a>, and fig. S4A) (<a title="valid: False, node: 352, tag: a, level: 16" node_number="352"><i title="valid: False, node: 353, tag: i, level: 17" node_number="353">14</i></a>, <a title="valid: False, node: 354, tag: a, level: 16" node_number="354"><i title="valid: False, node: 355, tag: i, level: 17" node_number="355">16</i></a>, <a title="valid: False, node: 356, tag: a, level: 16" node_number="356"><i title="valid: False, node: 357, tag: i, level: 17" node_number="357">17</i></a>, <a title="valid: False, node: 358, tag: a, level: 16" node_number="358"><i title="valid: False, node: 359, tag: i, level: 17" node_number="359">26</i></a>). In addition to the expected loss of activity of LY-CoV555 and CB6 against Beta and Gamma variants (<a title="valid: False, node: 360, tag: a, level: 16" node_number="360"><i title="valid: False, node: 361, tag: i, level: 17" node_number="361">9</i></a>, <a title="valid: False, node: 362, tag: a, level: 16" node_number="362"><i title="valid: False, node: 363, tag: i, level: 17" node_number="363">11</i></a>, <a title="valid: False, node: 364, tag: a, level: 16" node_number="364"><i title="valid: False, node: 365, tag: i, level: 17" node_number="365">12</i></a>, <a title="valid: False, node: 366, tag: a, level: 16" node_number="366"><i title="valid: False, node: 367, tag: i, level: 17" node_number="367">42</i></a>), LY-CoV555 and CB6 lost all activity against day 146*, day 152*, RBM-1, RBM-2, and RBM-3 pseudotypes (<a title="valid: False, node: 368, tag: a, level: 16" node_number="368">Fig. 2, A and B</a>, and fig. S4A). While the Delta variant is known to resist neutralization by LY-CoV555 but retain sensitivity to neutralization by CB6/LY-CoV016 (<a title="valid: False, node: 369, tag: a, level: 16" node_number="369"><i title="valid: False, node: 370, tag: i, level: 17" node_number="370">38</i></a>), Delta AY.2 pseudotype was resistant to both agents (<a title="valid: False, node: 371, tag: a, level: 16" node_number="371">Fig. 2, A and B</a>, and fig. S4A). This is expected because CB6/LY-CoV016 is derived from a V<sub title="valid: False, node: 372, tag: sub, level: 16" node_number="372">H</sub>3-66 antibody (<a title="valid: False, node: 373, tag: a, level: 16" node_number="373"><i title="valid: False, node: 374, tag: i, level: 17" node_number="374">21</i></a>), and the additional mutation the Delta AY.2 variant contains with respect to Delta (K417N<sub title="valid: False, node: 375, tag: sub, level: 16" node_number="375">RBD</sub>) confers resistance to CB6/LY-CoV16 and other members of the V<sub title="valid: False, node: 376, tag: sub, level: 16" node_number="376">H</sub>3-53/V<sub title="valid: False, node: 377, tag: sub, level: 16" node_number="377">H</sub>3-66 class of neutralizing antibodies (<a title="valid: False, node: 378, tag: a, level: 16" node_number="378"><i title="valid: False, node: 379, tag: i, level: 17" node_number="379">9</i></a>, <a title="valid: False, node: 380, tag: a, level: 16" node_number="380"><i title="valid: False, node: 381, tag: i, level: 17" node_number="381">14</i></a>, <a title="valid: False, node: 382, tag: a, level: 16" node_number="382"><i title="valid: False, node: 383, tag: i, level: 17" node_number="383">16</i></a>, <a title="valid: False, node: 384, tag: a, level: 16" node_number="384"><i title="valid: False, node: 385, tag: i, level: 17" node_number="385">26</i></a>, <a title="valid: False, node: 386, tag: a, level: 16" node_number="386"><i title="valid: False, node: 387, tag: i, level: 17" node_number="387">43</i></a>). Delta +3 pseudotype, which despite containing six RBD mutations does not contain the K417N<sub title="valid: False, node: 388, tag: sub, level: 16" node_number="388">RBD</sub> substitution, only escaped neutralization by LY-CoV555 (<a title="valid: False, node: 389, tag: a, level: 16" node_number="389">Fig. 2, A and B</a>; fig. S4A; and table S2). Although the distribution of LY-CoV016 and LY-CoV555 was paused in the United States in the summer of 2021 as the prevalence of Gamma and Beta VOCs increased, the distribution of this antibody cocktail has since been resumed with the rise of Delta as the predominant strain. However, our findings emphasize the importance of close monitoring of Delta AY.2 and of other Delta variants for acquisition of the K417N<sub title="valid: False, node: 390, tag: sub, level: 16" node_number="390">RBD</sub> mutation.</div><div title="valid: False, node: 391, tag: div, level: 15" node_number="391">Although REGN10933 lost substantial activity against the Beta variant, which is consistent with other reports (<a title="valid: False, node: 392, tag: a, level: 16" node_number="392"><i title="valid: False, node: 393, tag: i, level: 17" node_number="393">9</i></a>, <a title="valid: False, node: 394, tag: a, level: 16" node_number="394"><i title="valid: False, node: 395, tag: i, level: 17" node_number="395">12</i></a>, <a title="valid: False, node: 396, tag: a, level: 16" node_number="396"><i title="valid: False, node: 397, tag: i, level: 17" node_number="397">42</i></a>), it still had an IC<sub title="valid: False, node: 398, tag: sub, level: 16" node_number="398">50</sub> value of less than 1 &#956;g ml<sup title="valid: False, node: 399, tag: sup, level: 16" node_number="399">&#8722;1</sup> in our assays (<a title="valid: False, node: 400, tag: a, level: 16" node_number="400">Fig. 2, A and B</a>, and fig. S4A). However, resistance markedly worsened with the day 146*, day 152*, RBM-1, RBM-2, and RBM-3 pseudotypes, with 800- to 1900-fold loss in neutralizing activity (IC<sub title="valid: False, node: 401, tag: sub, level: 16" node_number="401">50</sub> values ranging from 20 to 47 &#956;g ml<sup title="valid: False, node: 402, tag: sup, level: 16" node_number="402">&#8722;1</sup>). REGN10987 potently neutralized many of the variant pseudotypes we examined. While we observed expected resistance to REGN10987 neutralization by variants containing the N439K<sub title="valid: False, node: 403, tag: sub, level: 16" node_number="403">RBD</sub> or the adjacent N440D<sub title="valid: False, node: 404, tag: sub, level: 16" node_number="404">RBD</sub> substitutions (<a title="valid: False, node: 405, tag: a, level: 16" node_number="405"><i title="valid: False, node: 406, tag: i, level: 17" node_number="406">14</i></a>, <a title="valid: False, node: 407, tag: a, level: 16" node_number="407"><i title="valid: False, node: 408, tag: i, level: 17" node_number="408">16</i></a>), we also observed some loss of activity against Epsilon and B.1.617.1 (Kappa), which was less expected because none of their substitutions fall within the REGN10987 RBD footprint (<a title="valid: False, node: 409, tag: a, level: 16" node_number="409">Fig. 1A</a> and <a title="valid: False, node: 410, tag: a, level: 16" node_number="410">Movie 1</a>). Other reports, nonetheless, have also noted varying degrees of modest in vitro resistance of Epsilon and Kappa variants to REGN10987 neutralization (<a title="valid: False, node: 411, tag: a, level: 16" node_number="411"><i title="valid: False, node: 412, tag: i, level: 17" node_number="412">39</i></a>, <a title="valid: False, node: 413, tag: a, level: 16" node_number="413"><i title="valid: False, node: 414, tag: i, level: 17" node_number="414">42</i></a>). Notably, the day 146* and RBM-3 pseudotypes were the only ones to gain resistance to both antibodies in REGN-COV2 because they contain substitutions in the REGN10933 (e.g., Q493K<sub title="valid: False, node: 415, tag: sub, level: 16" node_number="415">RBD</sub>, or E484K<sub title="valid: False, node: 416, tag: sub, level: 16" node_number="416">RBD</sub> and K417N<sub title="valid: False, node: 417, tag: sub, level: 16" node_number="417">RBD</sub>) and the REGN10987 binding sites (N439K<sub title="valid: False, node: 418, tag: sub, level: 16" node_number="418">RBD</sub> or N440D<sub title="valid: False, node: 419, tag: sub, level: 16" node_number="419">RBD</sub>) (<a title="valid: False, node: 420, tag: a, level: 16" node_number="420">Fig. 2, A and B</a>; fig. S4A; and <a title="valid: False, node: 421, tag: a, level: 16" node_number="421">Movie 1</a>) (<a title="valid: False, node: 422, tag: a, level: 16" node_number="422"><i title="valid: False, node: 423, tag: i, level: 17" node_number="423">14</i></a>). We observed on GISAID instances of &#8220;day-146*-like&#8221; viruses that would be expected to resist neutralization by LY-CoV555, LY-CoV016, REGN10933, and REGN10987 because they contain the Q493K<sub title="valid: False, node: 424, tag: sub, level: 16" node_number="424">RBD</sub> and N439K<sub title="valid: False, node: 425, tag: sub, level: 16" node_number="425">RBD</sub> substitutions. One strain contains the N501Y<sub title="valid: False, node: 426, tag: sub, level: 16" node_number="426">RBD</sub>, Q493K<sub title="valid: False, node: 427, tag: sub, level: 16" node_number="427">RBD</sub>, and N439K<sub title="valid: False, node: 428, tag: sub, level: 16" node_number="428">RBD</sub> mutations (sequenced once in South Africa), and the other contains the N501Y<sub title="valid: False, node: 429, tag: sub, level: 16" node_number="429">RBD</sub>, Q493K<sub title="valid: False, node: 430, tag: sub, level: 16" node_number="430">RBD</sub>, L452R<sub title="valid: False, node: 431, tag: sub, level: 16" node_number="431">RBD</sub>, N439K<sub title="valid: False, node: 432, tag: sub, level: 16" node_number="432">RBD</sub>, and N440F<sub title="valid: False, node: 433, tag: sub, level: 16" node_number="433">RBD</sub> mutations (sequenced once in the United Kingdom) (table S1).</div><div title="valid: False, node: 434, tag: div, level: 15" node_number="434">The broadly neutralizing antibody S309 (<a title="valid: False, node: 435, tag: a, level: 16" node_number="435"><i title="valid: False, node: 436, tag: i, level: 17" node_number="436">44</i></a>), a class 3 antibody that binds the RBD but does not interfere with ACE2 binding, and from which the therapeutic antibody sotrovimab is derived, was active against all variants we tested (fig. S4A). However, we could not calculate reliable neutralization IC<sub title="valid: False, node: 437, tag: sub, level: 16" node_number="437">50</sub> values because of variable non-neutralizable pseudotype fractions (fig. S4A). The presence of a non-neutralizable fraction is unexplained but has been noted in other reports when human cells overexpressing ACE2, as opposed to African green monkey (Vero) target cells, were used to examine S309 neutralizing activity (<a title="valid: False, node: 438, tag: a, level: 16" node_number="438"><i title="valid: False, node: 439, tag: i, level: 17" node_number="439">45</i></a>, <a title="valid: False, node: 440, tag: a, level: 16" node_number="440"><i title="valid: False, node: 441, tag: i, level: 17" node_number="441">46</i></a>).</div></section><section class="valid" valid="valid" title="valid: True, node: 442, tag: section, level: 14" node_number="442"><h3 title="valid: False, node: 443, tag: h3, level: 15" node_number="443">Neutralization escape of mRNA vaccine recipient sera</h3><div title="valid: False, node: 444, tag: div, level: 15" node_number="444">Messenger RNA (mRNA)&#8211;based vaccines encoding the SARS-CoV-2 spike protein elicit robust neutralizing antibody responses (<a title="valid: False, node: 445, tag: a, level: 16" node_number="445"><i title="valid: False, node: 446, tag: i, level: 17" node_number="446">47</i></a>&#8211;<a title="valid: False, node: 447, tag: a, level: 16" node_number="447"><i title="valid: False, node: 448, tag: i, level: 17" node_number="448">49</i></a>). We directly compared immune evasion of the day 146*, day 152*, and RBM-2 pseudotypes to the B.1.1.7 (Alpha), Beta, and Gamma pseudotypes in sera obtained from individuals who had received a 2-dose series of an mRNA vaccine (BNT162b2 or mRNA-1273) (<a title="valid: False, node: 449, tag: a, level: 16" node_number="449">Fig. 2, C and D</a>, and fig. S5). In addition to RBD substitutions, day 146*, day 152*, RBM-1, and RBM-2 spike proteins all contain NTD deletions spanning residues 141&#8211;144, which are positioned near NTD mutations in Alpha, Beta, and Delta in a key antigenic supersite (table S2) (<a title="valid: False, node: 450, tag: a, level: 16" node_number="450"><i title="valid: False, node: 451, tag: i, level: 17" node_number="451">6</i></a>, <a title="valid: False, node: 452, tag: a, level: 16" node_number="452"><i title="valid: False, node: 453, tag: i, level: 17" node_number="453">7</i></a>). As similar NTD deletions found in Alpha, Beta, and Delta prevent binding of some neutralizing antibodies (<a title="valid: False, node: 454, tag: a, level: 16" node_number="454"><i title="valid: False, node: 455, tag: i, level: 17" node_number="455">6</i></a>, <a title="valid: False, node: 456, tag: a, level: 16" node_number="456"><i title="valid: False, node: 457, tag: i, level: 17" node_number="457">7</i></a>, <a title="valid: False, node: 458, tag: a, level: 16" node_number="458"><i title="valid: False, node: 459, tag: i, level: 17" node_number="459">46</i></a>), they would be expected to escape neutralization by some NTD-targeting antibodies in addition to escaping neutralization by RBD-targeting antibodies. After first immunization but prior to the second dose, we observed a loss in neutralizing activity for all variants, although the severity varied. Variants that contain any substitution at E484<sub title="valid: False, node: 460, tag: sub, level: 16" node_number="460">RBD,</sub> combined with an NTD deletion (Beta, day 152*, and RBM-2), were more effective at evading antibody responses than variants that had an E484<sub title="valid: False, node: 461, tag: sub, level: 16" node_number="461">RBD</sub> substitution without an NTD deletion (Gamma) or an NTD deletion but no E484<sub title="valid: False, node: 462, tag: sub, level: 16" node_number="462">RBD</sub> substitution (day 146*) (<a title="valid: False, node: 463, tag: a, level: 16" node_number="463">Fig. 2, C and D</a>; fig. S5; and table S2). These findings are consistent with the role of E484<sub title="valid: False, node: 464, tag: sub, level: 16" node_number="464">RBD</sub> as a major driver in neutralization escape of polyclonal antibody responses to SARS-CoV-2 (<a title="valid: False, node: 465, tag: a, level: 16" node_number="465"><i title="valid: False, node: 466, tag: i, level: 17" node_number="466">35</i></a>) and observations that Beta more robustly escapes antibody neutralization than Gamma (<a title="valid: False, node: 467, tag: a, level: 16" node_number="467"><i title="valid: False, node: 468, tag: i, level: 17" node_number="468">9</i></a>, <a title="valid: False, node: 469, tag: a, level: 16" node_number="469"><i title="valid: False, node: 470, tag: i, level: 17" node_number="470">13</i></a>). They further suggest that variants that have an NTD supersite deletion and an E484<sub title="valid: False, node: 471, tag: sub, level: 16" node_number="471">RBD</sub> substitution are the most concerning when it comes to resistance to polyclonal antibodies.</div><div title="valid: False, node: 472, tag: div, level: 15" node_number="472">One quarter of sampled individuals had no detectable activity against the Beta and RBM-2 pseudotypes after a single immunization (<a title="valid: False, node: 473, tag: a, level: 16" node_number="473">Fig. 2, C and D</a>). However, sampling at 7 and 28 days after the second immunization revealed detectable neutralizing activity against all variants in all vaccine recipients, including against the RBM-2 pseudotype, which contains seven RBD mutations (<a title="valid: False, node: 474, tag: a, level: 16" node_number="474">Fig. 2, C and D</a>, and fig. S5). Thus, repeated administration of an mRNA vaccine encoding constructs of the SARS-CoV-2 spike protein used in current formulations may provide sufficient neutralizing antibody breadth and potency to yield baseline serum neutralizing activity against variants that are more extensively mutated than the current dominant strains.</div></section><section class="valid" valid="valid" title="valid: True, node: 475, tag: section, level: 14" node_number="475"><h3 title="valid: False, node: 476, tag: h3, level: 15" node_number="476">Identification of SARS-CoV cross-reactive antibodies</h3><div title="valid: False, node: 477, tag: div, level: 15" node_number="477">The RBD is also the major target of neutralizing antibodies against SARS-CoV, which caused a small outbreak of viral pneumonia from 2003 to 2004, though with a much higher case fatality rate (<a title="valid: False, node: 478, tag: a, level: 16" node_number="478"><i title="valid: False, node: 479, tag: i, level: 17" node_number="479">50</i></a>, <a title="valid: False, node: 480, tag: a, level: 16" node_number="480"><i title="valid: False, node: 481, tag: i, level: 17" node_number="481">51</i></a>). Polyclonal antibody responses against SARS-CoV-2 poorly cross-neutralize SARS-CoV (<a title="valid: False, node: 482, tag: a, level: 16" node_number="482"><i title="valid: False, node: 483, tag: i, level: 17" node_number="483">52</i></a>, <a title="valid: False, node: 484, tag: a, level: 16" node_number="484"><i title="valid: False, node: 485, tag: i, level: 17" node_number="485">53</i></a>). To identify barriers that restrict neutralization breadth, we performed single memory B cell sorting with the SARS-CoV spike protein to mine the memory B cell repertoire of a COVID-19 convalescent individual (&#8220;C1&#8221;). Polyclonal IgG from C1 plasma neutralized SARS-CoV-2 pseudotype but had weak activity against SARS-CoV pseudotype (fig. S6A). From C1 peripheral blood mononuclear cells (PBMCs), using a pre-fusion stabilized SARS-CoV spike protein (S2P) (<a title="valid: False, node: 486, tag: a, level: 16" node_number="486"><i title="valid: False, node: 487, tag: i, level: 17" node_number="487">54</i></a>), we cloned 17 cross-reactive antibodies. Of these, 11 antibodies bound both SARS-CoV and SARS-CoV-2 spike protein in an ELISA (fig. S6C and table S5). Only the two RBD-binding antibodies, C1C-A3 (&#8220;A3&#8221;) and C1C-C6 (&#8220;C6&#8221;), neutralized SARS-CoV-2 pseudotypes in our assays (<a title="valid: False, node: 488, tag: a, level: 16" node_number="488">Figs. 2B</a> and <a title="valid: False, node: 489, tag: a, level: 16" node_number="489">3A</a> and fig. S6F). Despite binding to SARS-CoV spike protein and RBD by ELISA, A3 and C6 did not neutralize SARS-CoV pseudotype (fig. S6, F and G). We also included C1A-A6 (&#8220;A6&#8221;) in these assays, a SARS-CoV-2 neutralizing antibody we previously isolated from the C1 donor using pre-fusion stabilized SARS-CoV-2 S2P in single B cell sorting experiments (<a title="valid: False, node: 490, tag: a, level: 16" node_number="490"><i title="valid: False, node: 491, tag: i, level: 17" node_number="491">14</i></a>). Unlike A3 and C6, A6 neutralized SARS-CoV pseudotypes (<a title="valid: False, node: 492, tag: a, level: 16" node_number="492">Figs. 2B</a> and <a title="valid: False, node: 493, tag: a, level: 16" node_number="493">3A</a> and fig. S6F). We determined Fab RBD binding affinities using biolayer interferometry (BLI) (fig. S7 and table S3) and confirmed A3 and A6 activity against infectious SARS-CoV-2 in a plaque reduction neutralization assay (fig. S4B).</div><div title="valid: False, node: 494, tag: div, level: 15" node_number="494">A3 neutralized almost all SARS-CoV-2 variant pseudotypes with a neutralization IC<sub title="valid: False, node: 495, tag: sub, level: 16" node_number="495">50</sub> value of less than 1 &#956;g ml<sup title="valid: False, node: 496, tag: sup, level: 16" node_number="496">&#8722;1</sup>, including Beta, Gamma, Delta AY.2, Delta +3, RBM-1, RBM-2, and RBM-3 pseudotypes; the Epsilon variant was the only exception, with an IC<sub title="valid: False, node: 497, tag: sub, level: 16" node_number="497">50</sub> value of 1.9 &#956;g ml<sup title="valid: False, node: 498, tag: sup, level: 16" node_number="498">&#8722;1</sup> (<a title="valid: False, node: 499, tag: a, level: 16" node_number="499">Figs. 2B</a> and <a title="valid: False, node: 500, tag: a, level: 16" node_number="500">3A</a> and fig. S4A). C6 and A6 also broadly neutralized variants but with higher baseline IC<sub title="valid: False, node: 501, tag: sub, level: 16" node_number="501">50</sub> values, even against D614G<sub title="valid: False, node: 502, tag: sub, level: 16" node_number="502">S</sub> pseudotypes (ranging from 2.0 to 11.4 &#956;g ml<sup title="valid: False, node: 503, tag: sup, level: 16" node_number="503">&#8722;1</sup>) (<a title="valid: False, node: 504, tag: a, level: 16" node_number="504">Figs. 2B</a> and <a title="valid: False, node: 505, tag: a, level: 16" node_number="505">3A</a> and fig. S4A).</div><div title="valid: False, node: 506, tag: div, level: 15" node_number="506">To determine where on the RBD A3, C6, and A6 bind, we carried out competition studies with C1A-B12 (<a title="valid: False, node: 507, tag: a, level: 16" node_number="507"><i title="valid: False, node: 508, tag: i, level: 17" node_number="508">14</i></a>), a class 1 antibody; REGN10987 (<a title="valid: False, node: 509, tag: a, level: 16" node_number="509"><i title="valid: False, node: 510, tag: i, level: 17" node_number="510">17</i></a>, <a title="valid: False, node: 511, tag: a, level: 16" node_number="511"><i title="valid: False, node: 512, tag: i, level: 17" node_number="512">18</i></a>) and S309 (<a title="valid: False, node: 513, tag: a, level: 16" node_number="513"><i title="valid: False, node: 514, tag: i, level: 17" node_number="514">44</i></a>), two class 3 antibodies; and CR3022 (<a title="valid: False, node: 515, tag: a, level: 16" node_number="515"><i title="valid: False, node: 516, tag: i, level: 17" node_number="516">55</i></a>), a class 4 antibody (<a title="valid: False, node: 517, tag: a, level: 16" node_number="517">Fig. 3B</a>, fig. S8, and <a title="valid: False, node: 518, tag: a, level: 16" node_number="518">Movie 1</a>). A3 competed with CR3022 and REGN10987 for RBD binding, C6 competed with CR3022, and C6 and A6 competed with each other (<a title="valid: False, node: 519, tag: a, level: 16" node_number="519">Fig. 3B</a> and fig. S8). A6 did not compete with any of the other antibodies tested. Among A3, C6, and A6, only A3 competed with binding of an ACE2-Fc fusion protein, suggesting that A3 blocks cellular attachment.</div></section><section class="valid" valid="valid" title="valid: True, node: 520, tag: section, level: 14" node_number="520"><h3 title="valid: False, node: 521, tag: h3, level: 15" node_number="521">Antibody C1C-A3 binds the conserved RBD core</h3><div title="valid: False, node: 522, tag: div, level: 15" node_number="522">We determined the 3.1 &#197; cryo-EM structure of the A3 Fab bound to the SARS-CoV-2 spike protein ectodomain (<a title="valid: False, node: 523, tag: a, level: 16" node_number="523">Fig. 4A</a>, figs. S9 and S10, and table S6). A3 binds the RBD core with the spike protein trapped in the three open RBD conformation (<a title="valid: False, node: 524, tag: a, level: 16" node_number="524">Fig. 4A</a>). In agreement with competition assays (<a title="valid: False, node: 525, tag: a, level: 16" node_number="525">Fig. 3B</a>), A3 interacts with RBD residues that overlap significantly with those of CR3022 (<a title="valid: False, node: 526, tag: a, level: 16" node_number="526">Fig. 3, C, D, and F</a>, and <a title="valid: False, node: 527, tag: a, level: 16" node_number="527">Movie 1</a>). A3 is therefore a class 4 antibody, a class that includes CR3022, S2A4, S304, S2X35, H014, COVA1-16, S2X259, and DH1047 (<a title="valid: False, node: 528, tag: a, level: 16" node_number="528"><i title="valid: False, node: 529, tag: i, level: 17" node_number="529">4</i></a>, <a title="valid: False, node: 530, tag: a, level: 16" node_number="530"><i title="valid: False, node: 531, tag: i, level: 17" node_number="531">56</i></a>&#8211;<a title="valid: False, node: 532, tag: a, level: 16" node_number="532"><i title="valid: False, node: 533, tag: i, level: 17" node_number="533">59</i></a>) (<a title="valid: False, node: 534, tag: a, level: 16" node_number="534">Movie 1</a> and fig. S11). Although the A3 and S309 footprints on the RBD do not overlap and S309 (a class 3 antibody) can bind the closed spike protein trimer (<a title="valid: False, node: 535, tag: a, level: 16" node_number="535"><i title="valid: False, node: 536, tag: i, level: 17" node_number="536">44</i></a>), both antibodies contact the N-linked glycan attached to N343<sub title="valid: False, node: 537, tag: sub, level: 16" node_number="537">RBD</sub> but approach it from different faces (<a title="valid: False, node: 538, tag: a, level: 16" node_number="538">Fig. 3C</a> and <a title="valid: False, node: 539, tag: a, level: 16" node_number="539">Movie 1</a>).</div><div title="valid: False, node: 540, tag: div, level: 15" node_number="540">The A3 Fab avoids the RBD-ACE2 interface, which contains the majority of key antibody escape mutations, but like other class 4 antibodies, nonetheless binds the RBD in a manner that would sterically interfere with ACE2 binding (<a title="valid: False, node: 541, tag: a, level: 16" node_number="541">Fig. 4, B to E</a>, and fig. S11). Based on its epitope, in addition to retaining activity against all variants we tested, A3 would also have activity against emergent and pre-emergent SARS-CoV-2 variants; these include a virus sequenced from travelers from Tanzania that contains the E484K<sub title="valid: False, node: 542, tag: sub, level: 16" node_number="542">RBD</sub>, T478R<sub title="valid: False, node: 543, tag: sub, level: 16" node_number="543">RBD</sub>, and R346K<sub title="valid: False, node: 544, tag: sub, level: 16" node_number="544">RBD</sub> mutations, and B.1.621 (Mu), a variant detected early in 2021 in Colombia that has since spread internationally and contains the E484K<sub title="valid: False, node: 545, tag: sub, level: 16" node_number="545">RBD</sub>, N501Y<sub title="valid: False, node: 546, tag: sub, level: 16" node_number="546">RBD</sub>, and R346K<sub title="valid: False, node: 547, tag: sub, level: 16" node_number="547">RBD</sub> mutations (<a title="valid: False, node: 548, tag: a, level: 16" node_number="548">Figs. 1G</a> and <a title="valid: False, node: 549, tag: a, level: 16" node_number="549">4D</a> and table S1). The R346K<sub title="valid: False, node: 550, tag: sub, level: 16" node_number="550">RBD</sub> mutation falls within the RBD core and is in the S309 binding site but is not within A3&#8217;s footprint (<a title="valid: False, node: 551, tag: a, level: 16" node_number="551">Fig. 3, D and E</a>, and <a title="valid: False, node: 552, tag: a, level: 16" node_number="552">Movie 1</a>). However, S309 would likely retain activity against SARS-CoV-2 variants that contain the R346K<sub title="valid: False, node: 553, tag: sub, level: 16" node_number="553">RBD</sub> mutation, as the residue that is at the position analogous to SARS-CoV R346<sub title="valid: False, node: 554, tag: sub, level: 16" node_number="554">RBD</sub> is a lysine in SARS-CoV, and S309 neutralizes both SARS-CoV and SARS-CoV-2 (<a title="valid: False, node: 555, tag: a, level: 16" node_number="555"><i title="valid: False, node: 556, tag: i, level: 17" node_number="556">44</i></a>, <a title="valid: False, node: 557, tag: a, level: 16" node_number="557"><i title="valid: False, node: 558, tag: i, level: 17" node_number="558">60</i></a>).</div></section><section class="valid" valid="valid" title="valid: True, node: 559, tag: section, level: 14" node_number="559"><h3 title="valid: False, node: 560, tag: h3, level: 15" node_number="560">RBD core glycan addition drives neutralization escape</h3><div title="valid: False, node: 561, tag: div, level: 15" node_number="561">Despite A3&#8217;s breadth against SARS-CoV-2 variant pseudotypes (<a title="valid: False, node: 562, tag: a, level: 16" node_number="562">Figs. 2B</a> and <a title="valid: False, node: 563, tag: a, level: 16" node_number="563">3A</a>), A3 does not neutralize SARS-CoV pseudotype (fig. S6, F and G). The A3 epitope is highly conserved between SARS-CoV-2 and SARS-CoV; however, N370<sub title="valid: False, node: 564, tag: sub, level: 16" node_number="564">RBD</sub> is a site of N-linked glycosylation in SARS-CoV (N357<sub title="valid: False, node: 565, tag: sub, level: 16" node_number="565">RBD</sub> in SARS-CoV numbering) and in animal coronaviruses but not in SARS-CoV-2 (<a title="valid: False, node: 566, tag: a, level: 16" node_number="566">Fig. 5, A, B, C, and F</a>) (<a title="valid: False, node: 567, tag: a, level: 16" node_number="567"><i title="valid: False, node: 568, tag: i, level: 17" node_number="568">61</i></a>). An N-linked glycan attached to SARS-CoV-2 N370<sub title="valid: False, node: 569, tag: sub, level: 16" node_number="569">RBD</sub> would introduce steric clashes with the A3 antibody heavy and light chains (<a title="valid: False, node: 570, tag: a, level: 16" node_number="570">Fig. 5D</a>). Furthermore, calculations of antibody accessible surface areas using molecular dynamic trajectories of a fully glycosylated SARS-CoV-2 spike protein with a modeled N370<sub title="valid: False, node: 571, tag: sub, level: 16" node_number="571">RBD</sub> glycan suggest that its addition would restrict A3 epitope access and could also impact binding of other class 4 antibodies (fig. S12) (<a title="valid: False, node: 572, tag: a, level: 16" node_number="572"><i title="valid: False, node: 573, tag: i, level: 17" node_number="573">61</i></a>, <a title="valid: False, node: 574, tag: a, level: 16" node_number="574"><i title="valid: False, node: 575, tag: i, level: 17" node_number="575">62</i></a>).</div><div title="valid: False, node: 576, tag: div, level: 15" node_number="576">Partial occupancy of the glycan attached to SARS-CoV N357<sub title="valid: False, node: 577, tag: sub, level: 16" node_number="577">RBD</sub> in recombinant protein preparations may explain how we observed spike protein and RBD binding but lack of SARS-CoV pseudotype neutralization (fig. S6, F and G). In surface plasmon resonance binding assays, A3 IgG bound tightly to the SARS-CoV RBD only when the RBD was enzymatically deglycosylated (fig. S13 and table S7). Consistent with the role of the SARS-CoV N357<sub title="valid: False, node: 578, tag: sub, level: 16" node_number="578">RBD</sub> N-linked glycan as a barrier to A3 neutralization, introducing a substitution that would prevent its addition (T359A<sub title="valid: False, node: 579, tag: sub, level: 16" node_number="579">RBD</sub>) sensitized SARS-CoV pseudotypes to A3 neutralization (IC<sub title="valid: False, node: 580, tag: sub, level: 16" node_number="580">50</sub> value of 5 &#956;g ml<sup title="valid: False, node: 581, tag: sup, level: 16" node_number="581">&#8722;1</sup>) (<a title="valid: False, node: 582, tag: a, level: 16" node_number="582">Fig. 2B</a> and fig. S4A).</div><div title="valid: False, node: 583, tag: div, level: 15" node_number="583">The A372S/T<sub title="valid: False, node: 584, tag: sub, level: 16" node_number="584">RBD</sub> mutations, which would introduce an N-linked glycosylation motif and allow for modification of N370<sub title="valid: False, node: 585, tag: sub, level: 16" node_number="585">RBD</sub> in the SARS-CoV-2 spike protein, are found in human-derived SARS-CoV-2 sequences (GISAID) (<a title="valid: False, node: 586, tag: a, level: 16" node_number="586"><i title="valid: False, node: 587, tag: i, level: 17" node_number="587">27</i></a>), including on sequences for VOCs Alpha and Delta, without apparent geographic restriction (48 sequence counts as of 10 October 2021 and detected in at least 14 countries) (<a title="valid: False, node: 588, tag: a, level: 16" node_number="588">Fig. 5F</a> and table S8). Although the mutations are currently rare, their presence in sequence databases suggest that SARS-CoV-2 strains containing these mutations can replicate in humans. To confirm that an N-linked glycan could be added to N370<sub title="valid: False, node: 589, tag: sub, level: 16" node_number="589">RBD</sub>, we conducted glycan analysis on recombinant SARS-CoV-2 RBD containing the A372S<sub title="valid: False, node: 590, tag: sub, level: 16" node_number="590">RBD</sub> substitution and observed 90% occupancy of an N-linked glycan at position N370<sub title="valid: False, node: 591, tag: sub, level: 16" node_number="591">RBD</sub> (fig. S13B)</div><div title="valid: False, node: 592, tag: div, level: 15" node_number="592">Because acquisition of a putative N-linked glycan at N370<sub title="valid: False, node: 593, tag: sub, level: 16" node_number="593">RBD</sub> was the most frequent on the Alpha variant at the time of our initial analysis, we generated an Alpha pseudotype that contains the A372T<sub title="valid: False, node: 594, tag: sub, level: 16" node_number="594">RBD</sub> substitution (Alpha A372T). We tested the effect of this substitution on three class 4 antibodies: A3, the antibody we isolated here, S2A4, an antibody that does not cross-react with the SARS-CoV RBD (<a title="valid: False, node: 595, tag: a, level: 16" node_number="595"><i title="valid: False, node: 596, tag: i, level: 17" node_number="596">4</i></a>) and COVA1-16, an antibody that has weak cross-neutralizing activity against SARS-CoV (<a title="valid: False, node: 597, tag: a, level: 16" node_number="597"><i title="valid: False, node: 598, tag: i, level: 17" node_number="598">57</i></a>). The mutation resulted in eightfold resistance to A3 neutralization (IC<sub title="valid: False, node: 599, tag: sub, level: 16" node_number="599">50</sub> value of 1.1 &#956;g ml<sup title="valid: False, node: 600, tag: sup, level: 16" node_number="600">&#8722;1</sup>, as compared to 0.14 &#956;g ml<sup title="valid: False, node: 601, tag: sup, level: 16" node_number="601">&#8722;1</sup> with Alpha pseudotype) and complete resistance to S2A4 neutralization (<a title="valid: False, node: 602, tag: a, level: 16" node_number="602">Figs. 2B</a>, <a title="valid: False, node: 603, tag: a, level: 16" node_number="603">3A</a>, and <a title="valid: False, node: 604, tag: a, level: 16" node_number="604">5, G and H</a>, and fig. S4A). S2A4 and COVA1-16 neutralized variants with potency that was overall comparable to A3 in most cases (<a title="valid: False, node: 605, tag: a, level: 16" node_number="605">Figs. 2B</a> and <a title="valid: False, node: 606, tag: a, level: 16" node_number="606">3A</a> and fig. S4A). COVA1-16, probably because it has some activity against SARS-CoV (above the limit of detection in our assays but 29 &#956;g ml<sup title="valid: False, node: 607, tag: sup, level: 16" node_number="607">&#8722;1</sup> as reported by Liu <i title="valid: False, node: 608, tag: i, level: 16" node_number="608">et al</i>.) (<a title="valid: False, node: 609, tag: a, level: 16" node_number="609"><i title="valid: False, node: 610, tag: i, level: 17" node_number="610">57</i></a>), retained activity against Alpha A372T pseudotype (<a title="valid: False, node: 611, tag: a, level: 16" node_number="611">Figs. 2B</a>, <a title="valid: False, node: 612, tag: a, level: 16" node_number="612">3A</a>, and <a title="valid: False, node: 613, tag: a, level: 16" node_number="613">5H</a>, and fig. S4A). The Fab binding pose of certain class 4 antibodies, therefore, may allow them to avoid steric hindrance from an N-linked glycan attached to N370<sub title="valid: False, node: 614, tag: sub, level: 16" node_number="614">RBD</sub> (S2X259 is an example of one such antibody) (<a title="valid: False, node: 615, tag: a, level: 16" node_number="615">Movie 1</a>) (<a title="valid: False, node: 616, tag: a, level: 16" node_number="616"><i title="valid: False, node: 617, tag: i, level: 17" node_number="617">56</i></a>).</div></section><section class="valid" valid="valid" title="valid: True, node: 618, tag: section, level: 14" node_number="618"><h3 title="valid: False, node: 619, tag: h3, level: 15" node_number="619">Antibody C1C-A3 neutralizes a related coronavirus</h3><div title="valid: False, node: 620, tag: div, level: 15" node_number="620">Coronaviruses that circulate in animals and have spike protein RBDs that can bind human ACE2 are a continued threat. RaTG13 virus, which is closely related to SARS-CoV-2 phylogenetically, is an example of one such virus (<a title="valid: False, node: 621, tag: a, level: 16" node_number="621"><i title="valid: False, node: 622, tag: i, level: 17" node_number="622">63</i></a>). The RaTG13 virus spike protein contains a threonine at RBD position 372, which would allow for N370<sub title="valid: False, node: 623, tag: sub, level: 16" node_number="623">RBD</sub> glycosylation (<a title="valid: False, node: 624, tag: a, level: 16" node_number="624">Fig. 5F</a>). Despite the presence of the N-linked glycan, A3 potently neutralized RaTG13 virus pseudotype (neutralization IC<sub title="valid: False, node: 625, tag: sub, level: 16" node_number="625">50</sub> value of 21 ng ml<sup title="valid: False, node: 626, tag: sup, level: 16" node_number="626">&#8722;1</sup>), suggesting that A3 neutralization breadth extends to pre-emergent coronaviruses that are closely related to SARS-CoV-2 (<a title="valid: False, node: 627, tag: a, level: 16" node_number="627">Fig. 5, G and H</a>). Structural superposition reveals that the N370<sub title="valid: False, node: 628, tag: sub, level: 16" node_number="628">RBD</sub> glycan on the RaTG13 RBD is positioned in a manner that may not block A3 epitope access but, rather, could interfere with binding of other antibodies that bind nearby epitopes on the RBD core (<a title="valid: False, node: 629, tag: a, level: 16" node_number="629">Fig. 5E</a>).</div></section></section><section class="valid" valid="valid" title="valid: True, node: 630, tag: section, level: 13" node_number="630"><h2 class="valid" valid="valid" title="valid: True, node: 631, tag: h2, level: 14" node_number="631">Discussion</h2><div class="valid" valid="valid" title="valid: True, node: 632, tag: div, level: 14" node_number="632">As variants containing composite mutations begin to emerge, continued SARS-CoV-2 immune evasion will remain a significant concern. We found that accumulation of large numbers of RBD mutations, which mimics accelerated spike protein evolution occurring in a persistently infected immunocompromised host (<a title="valid: False, node: 633, tag: a, level: 15" node_number="633"><i title="valid: False, node: 634, tag: i, level: 16" node_number="634">14</i></a>&#8211;<a title="valid: False, node: 635, tag: a, level: 15" node_number="635"><i title="valid: False, node: 636, tag: i, level: 16" node_number="636">16</i></a>), is facilitated by structural plasticity at the ACE2-RBD interface (<a title="valid: False, node: 637, tag: a, level: 15" node_number="637">Fig. 1, B to F</a>). The severity of the phenotypes we observed in vitro suggest that further evolved variants will more adeptly escape therapeutic antibody neutralization than currently circulating variants of concern, with potential resistance to two-component antibody cocktails (<a title="valid: False, node: 638, tag: a, level: 15" node_number="638">Fig. 2, A and B</a>).</div><div class="valid" valid="valid" title="valid: True, node: 639, tag: div, level: 14" node_number="639">After two mRNA vaccine immunizations and as early as 7 days after the second dose, all mRNA vaccine recipients had detectable neutralizing activity against pseudotypes containing an NTD supersite deletion and RBDs with six to seven mutations (e.g., day 146*, day 152*, and RBM-2), with mean neutralization ID<sub title="valid: False, node: 640, tag: sub, level: 15" node_number="640">50</sub> values decreased by 2.3 to 6.1-fold (<a title="valid: False, node: 641, tag: a, level: 15" node_number="641">Fig. 2, C and D</a>, and fig. S5). While the precise epitopes targeted by this residual vaccine-elicited serum neutralizing activity remain to be determined, we surmise that antibodies targeting the RBD core (e.g., those that bind away from the RBM), at least in part account for some of this activity. As the RBD is a major target of vaccine elicited and naturally acquired humoral immunity to SARS-CoV-2 (<a title="valid: False, node: 642, tag: a, level: 15" node_number="642"><i title="valid: False, node: 643, tag: i, level: 16" node_number="643">4</i></a>, <a title="valid: False, node: 644, tag: a, level: 15" node_number="644"><i title="valid: False, node: 645, tag: i, level: 16" node_number="645">5</i></a>) and the RBM is a critical site of potent neutralizing antibody binding (<a title="valid: False, node: 646, tag: a, level: 15" node_number="646"><i title="valid: False, node: 647, tag: i, level: 16" node_number="647">19</i></a>, <a title="valid: False, node: 648, tag: a, level: 15" node_number="648"><i title="valid: False, node: 649, tag: i, level: 16" node_number="649">21</i></a>&#8211;<a title="valid: False, node: 650, tag: a, level: 15" node_number="650"><i title="valid: False, node: 651, tag: i, level: 16" node_number="651">25</i></a>, <a title="valid: False, node: 652, tag: a, level: 15" node_number="652"><i title="valid: False, node: 653, tag: i, level: 16" node_number="653">64</i></a>) that is the most antibody accessible and the least masked by glycan and conformational shielding (fig. S12), continued RBM evolution may guide antibody responses toward more conserved neutralizing epitopes on the RBD core.</div><div class="valid" valid="valid" title="valid: True, node: 654, tag: div, level: 14" node_number="654">We mined genome sequences in the GISAID database for substitutions that would introduce additional N-linked glycans onto the RBD. This analysis identified D364N<sub title="valid: False, node: 655, tag: sub, level: 15" node_number="655">RBD</sub> as an additional mutation that would introduce a putative N-linked glycosylation site in a surface exposed loop in the footprint of some class 4 antibodies (<a title="valid: False, node: 656, tag: a, level: 15" node_number="656">Movie 1</a>). The independent acquisition of N-linked glycosylation sites (through the A372S/T<sub title="valid: False, node: 657, tag: sub, level: 15" node_number="657">RBD</sub> and D364N<sub title="valid: False, node: 658, tag: sub, level: 15" node_number="658">RBD</sub> substitutions) on the same surface of the RBD core, but not on other RBD sites, suggests that this region may be a target of immune selective pressure.</div><div class="valid" valid="valid" title="valid: True, node: 659, tag: div, level: 14" node_number="659">While glycan addition may allow neutralization escape, this change could come at a cost to viral fitness and infectivity. Indeed, the A1114G:T372A mutation that removed the glycan in the SARS-CoV-2 RBD appeared under selective pressure, and addition of the glycan decreases viral replication in human lung epithelial (Calu-3) cells by over sixty-fold (<a title="valid: False, node: 660, tag: a, level: 15" node_number="660"><i title="valid: False, node: 661, tag: i, level: 16" node_number="661">65</i></a>). A recent molecular dynamics study suggests that introducing the glycan at N370<sub title="valid: False, node: 662, tag: sub, level: 15" node_number="662">RBD</sub> in SARS-CoV-2 would favor the closed conformation with the N370<sub title="valid: False, node: 663, tag: sub, level: 15" node_number="663">RBD</sub> glycan stabilizing the closed RBD structure on the trimeric spike protein (<a title="valid: False, node: 664, tag: a, level: 15" node_number="664"><i title="valid: False, node: 665, tag: i, level: 16" node_number="665">66</i></a>). A lack of a glycan at position N370<sub title="valid: False, node: 666, tag: sub, level: 15" node_number="666">RBD</sub>, therefore, may increase SARS-CoV-2 ACE2-binding and infectivity by favoring the open state, but may also make SARS-CoV-2 more vulnerable to neutralizing antibodies that can only bind the RBD in the open conformation.</div><div class="valid" valid="valid" title="valid: True, node: 667, tag: div, level: 14" node_number="667">Although addition of the N370<sub title="valid: False, node: 668, tag: sub, level: 15" node_number="668">RBD</sub> glycan may be associated with a cost to viral fitness, should the selective immune pressure be significant at this site over a long enough time scale, this may also afford the virus an opportunity to acquire permissive secondary mutations during evolution that restore viral fitness, as is observed in influenza virus drug resistance (<a title="valid: False, node: 669, tag: a, level: 15" node_number="669"><i title="valid: False, node: 670, tag: i, level: 16" node_number="670">67</i></a>). Such compensatory mutations would be ones that promote ACE2 binding and RBD opening; for example, the D614G<sub title="valid: False, node: 671, tag: sub, level: 15" node_number="671">S</sub> mutation (<a title="valid: False, node: 672, tag: a, level: 15" node_number="672"><i title="valid: False, node: 673, tag: i, level: 16" node_number="673">68</i></a>), which favors the open conformation, and the N501Y<sub title="valid: False, node: 674, tag: sub, level: 15" node_number="674">RBD</sub> mutation, which introduces more favorable interactions with ACE2 (<a title="valid: False, node: 675, tag: a, level: 15" node_number="675">Fig. 1D</a>).</div><div class="valid" valid="valid" title="valid: True, node: 676, tag: div, level: 14" node_number="676">As parts of the world continue to face waves of infection and mitigation strategies are relaxed, viral replication in human hosts under antibody selective pressure will continue to shape the antigenic landscape of the SARS-CoV-2 spike protein. With vigorous variant monitoring efforts underway to help design next-generation antibody-based therapeutics, and with mRNA- or DNA-based vaccines that can be updated to rapidly adapt to new variants, proactively examining the consequences of further viral evolution before the next highly antibody resistant strain emerges is of utmost importance.</div></section><section class="valid" valid="valid" title="valid: True, node: 677, tag: section, level: 13" node_number="677"><h2 class="valid" valid="valid" title="valid: True, node: 678, tag: h2, level: 14" node_number="678">Materials and methods summary</h2><div class="valid" valid="valid" title="valid: True, node: 679, tag: div, level: 14" node_number="679">We isolated monoclonal antibodies from the blood of a COVID-19 convalescent individual using single B cell sorting with prefusion stabilized SARS-CoV spike protein ectodomain as bait and using established protocols (<a title="valid: False, node: 680, tag: a, level: 15" node_number="680"><i title="valid: False, node: 681, tag: i, level: 16" node_number="681">14</i></a>, <a title="valid: False, node: 682, tag: a, level: 15" node_number="682"><i title="valid: False, node: 683, tag: i, level: 16" node_number="683">54</i></a>). We obtained venous blood samples from healthy mRNA-1273 and BNT162b2 vaccine recipients. We produced recombinant glycoproteins and antibodies or Fabs in transiently transfected mammalian cells grown in suspension culture and purified these proteins using affinity-based methods. We used ELISAs to measure antibody binding and biolayer interferometry or surface plasmon resonance to determine kinetic parameters of binding. We packaged lentivirus pseudotypes by transient transfection of HEK293T cells as previously described (<a title="valid: False, node: 684, tag: a, level: 15" node_number="684"><i title="valid: False, node: 685, tag: i, level: 16" node_number="685">14</i></a>). We used HEK293T cells expressing human ACE2 in pseudotype neutralization assays or Vero E6 cells and plaque reduction neutralization tests as previously described (<a title="valid: False, node: 686, tag: a, level: 15" node_number="686"><i title="valid: False, node: 687, tag: i, level: 16" node_number="687">14</i></a>). We collected X-ray diffraction data on crystals of a day 146*:SARS-CoV-2 RBD complex at the Advanced Photon Source (APS, Argonne, IL) NE-CAT beamline and used established procedures for data processing, molecular replacement, atomic model building, and refinement (<a title="valid: False, node: 688, tag: a, level: 15" node_number="688"><i title="valid: False, node: 689, tag: i, level: 16" node_number="689">37</i></a>, <a title="valid: False, node: 690, tag: a, level: 15" node_number="690"><i title="valid: False, node: 691, tag: i, level: 16" node_number="691">69</i></a>&#8211;<a title="valid: False, node: 692, tag: a, level: 15" node_number="692"><i title="valid: False, node: 693, tag: i, level: 16" node_number="693">73</i></a>). We used mass spectrometry to perform glycopeptide analysis. After data collection on a Titan Krios cryo-electron microscope equipped with a Gatan K3 camera, we used single-particle cryo-EM to determine the structure of a prefusion stabilized SARS-CoV-2 spike protein ectodomain (7) complexed with C1C-A3 Fab complex using established procedures for image processing, atomic model building, and refinement (<a title="valid: False, node: 694, tag: a, level: 15" node_number="694"><i title="valid: False, node: 695, tag: i, level: 16" node_number="695">72</i></a>&#8211;<a title="valid: False, node: 696, tag: a, level: 15" node_number="696"><i title="valid: False, node: 697, tag: i, level: 16" node_number="697">77</i></a>).</div></section><section class="valid" valid="valid" title="valid: True, node: 698, tag: section, level: 13" node_number="698"><h2 class="valid" valid="valid" title="valid: True, node: 699, tag: h2, level: 14" node_number="699">Acknowledgments</h2><div class="valid" valid="valid" title="valid: True, node: 700, tag: div, level: 14" node_number="700">This work is based upon research conducted at the Northeastern Collaborative Access Team (NE-CAT)beamlines, which are funded by the National Institute of General Medical Sciences from the NationalInstitutes of Health (P30 GM124165). The Pilatus 6M detector on 24-ID-C beam line is funded by aNIH-ORIP HEI grant (S10 RR029205). This research used resources of the Advanced Photon Source, aU.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office ofScience by Argonne National Laboratory under Contract No. DE-AC02-06CH11357. We thank the staff atNE-CAT for assistance with X-ray data collection. Cryo-EM data were collected at the HarvardCryo-Electron Microscopy Center for Structural Biology. We thank Harvard Cryo-EM Center staffmembers for assistance with cryo-EM data collection. We acknowledge support for COVID-19 relatedstructural biology research at Harvard from the Nancy Lurie Marks Family Foundation. We thank B.Chen for providing a human ACE2 ectodomain expressing cell line, and H. Choe for providing cDNAencoding the SARS-CoV spike protein. <b title="valid: False, node: 701, tag: b, level: 15" node_number="701">Funding:</b> This work was funded in part by theMassachusetts Consortium on Pathogen Readiness (MassCPR) (J.A.). J.A. was also supported by theStar-Friedman Award Challenge for Promising Scientific Research. L.R.B. is supported by the HarvardClinical and Translational Science Center, from the National Center for Advancing TranslationalScience (1UL1TR002541-01); by Barbara and Amos Hostetter; and by the Chleck Family Foundation.S.E.T., R.C.L., E.T.R., and R.C.C. receive grant support from the Centers for Disease Control andPrevention (U01CK000490). K.G.N., A.C., and H.H.V. are supported by Award Number T32GM007753 fromthe National Institute of General Medical Sciences. The content is solely the responsibility of theauthors and does not necessarily represent the official views of the National Institute of GeneralMedical Sciences or the National Institutes of Health. <b title="valid: False, node: 702, tag: b, level: 15" node_number="702">Author contributions:</b>Conceptualization: KGN, SAC, SS, JP, LEC, PY, AC, LGAM, NVT, MD, SET, SK, ACS, AD, CT, JFC, ATD,ATD, DT, AC, YF, AG, IRC, JS, LRB, RCC, JA. Methodology: KGN, SAC, SS, JP, LEC, PY, AC, LGAM, HHV,NVT, GZ, MD, SET, SK, ACS, AD, RCL, ETR, CT, JFC, ATD, DT, AC, YF, AG, IRC, JS, LRB, RC, JA.Investigation: KGN, SAC, SS, JP, LEC, PY, AC, LGAM, HHV, VB, NVT, SET, SK, MJ, ACS, CT, JFC, ATD,DT, AC, YF, AG, IRC, JS, LRB, RC, JA. Visualization: KGN, SAC, SS, JP, LEC, PY, AC, LGAM, HHV, NVT,GZ, MD, SET, SK, ACS, CT, JFC, ATD, DT, AC, YF, AG, IRC, JS, LRB, RCC, JA. Funding acquisition: RCL,ETR, RCC, JA. Project administration: KGN, SAC, SS, JP, NVT, MD, SET, SK, ACS, AG, IRC, JS, LRB,RCC, JA. Supervision: AD, JFC, YF, AG, IRC, JS, LRB, RCC, JA. Writing &#8211; original draft: JA.Writing &#8211; review editing: KGN, SAC, SS, JP, LEC, AC, LGAM, HHV, GZ, MD, SET, SK, ACS,RCL, ETR, CT, JFC, ATD, DT, AC, YF, AG, IRC, JS, LRB, RCC, JA. <b title="valid: False, node: 703, tag: b, level: 15" node_number="703">Competing interests:</b>SAC, LEC, and JA are inventors on a provisional patent application that covers antibodies describedin this publication filed by the President and Fellows of Harvard University. S.E.T. receivesmonetary compensation from UpToDate, which provides clinical decision support. <b title="valid: False, node: 704, tag: b, level: 15" node_number="704">Data andmaterials availability:</b> C1C-A3 antibody heavy chain and light chain variable region genesequences have been deposited in GenBank under accession codes OL621229 and OL621230, respectively.Protein Data Bank (PBD) identification numbers for the day 146* RBD human ACE2 ectodomain complex,the unliganded C1C-A3 Fab, the C1C-A3 Fab SARS-CoV-2 spike protein ectodomain complex, and focusedrefinement of the C1C-A3 Fab/RBD region are 7SN0, 7SN1, 7SN3, and 7SN2, respectively. ElectronMicroscopy Database (EMDB) accession numbers for the C1C-A3 Fab SARS-CoV-2 spike protein ectodomaincomplex and focused refinement of the C1C-A3 Fab/RBD region are EMD-25210 and EMD-2509,respectively. All materials are available upon request. This work is licensed under a CreativeCommons Attribution 4.0 International (CC BY 4.0) license, which permits unrestricted use,distribution, and reproduction in any medium, provided the original work is properly cited. To viewa copy of this license, visit <a title="valid: False, node: 705, tag: a, level: 15" node_number="705">https://creativecommons.org/licenses/by/4.0/</a>. This license does not apply tofigures/photos/artwork or other content included in the article that is credited to a third party;obtain authorization from the rights holder before using such material.</div></section> </div></section><section class="valid" valid="valid" title="valid: True, node: 706, tag: section, level: 11" node_number="706"><div class="valid" valid="valid" title="valid: True, node: 707, tag: div, level: 12" node_number="707"><section class="valid" valid="valid" title="valid: True, node: 708, tag: section, level: 13" node_number="708"><h2 class="valid" valid="valid" title="valid: True, node: 709, tag: h2, level: 14" node_number="709">Supplementary Material</h2><section class="valid" valid="valid" title="valid: True, node: 710, tag: section, level: 14" node_number="710"><h3 title="valid: False, node: 711, tag: h3, level: 15" node_number="711">Summary</h3><div title="valid: False, node: 712, tag: div, level: 15" node_number="712"><a title="valid: False, node: 713, tag: a, level: 16" node_number="713">science.org/doi/10.1126/science.abl6251</a></div><div title="valid: False, node: 714, tag: div, level: 15" node_number="714">Materials and Methods</div><div title="valid: False, node: 715, tag: div, level: 15" node_number="715">Figs. S1 to S13</div><div title="valid: False, node: 716, tag: div, level: 15" node_number="716">Tables S1 to S9</div><div title="valid: False, node: 717, tag: div, level: 15" node_number="717">References (<a title="valid: False, node: 718, tag: a, level: 16" node_number="718"><i title="valid: False, node: 719, tag: i, level: 17" node_number="719">80</i></a>&#8211;<a title="valid: False, node: 720, tag: a, level: 16" node_number="720"><i title="valid: False, node: 721, tag: i, level: 17" node_number="721">100</i></a>)</div><div title="valid: False, node: 722, tag: div, level: 15" node_number="722">MDAR Reproducibility Checklist</div></section><section class="valid" valid="valid" title="valid: True, node: 723, tag: section, level: 14" node_number="723"><h3 title="valid: False, node: 724, tag: h3, level: 15" node_number="724">Resources</h3><div title="valid: False, node: 725, tag: div, level: 15" node_number="725"><div title="valid: False, node: 726, tag: div, level: 16" node_number="726"><div title="valid: False, node: 727, tag: div, level: 17" node_number="727">File (science.abl6251-il1.tif)</div><div title="valid: False, node: 728, tag: div, level: 17" node_number="728">Download</div></div><div title="valid: False, node: 729, tag: div, level: 16" node_number="729"><div title="valid: False, node: 730, tag: div, level: 17" node_number="730">File (science.abl6251-il1.mp4)</div><div title="valid: False, node: 731, tag: div, level: 17" node_number="731">Download</div></div><div title="valid: False, node: 732, tag: div, level: 16" node_number="732"><div title="valid: False, node: 733, tag: div, level: 17" node_number="733">File (science.abl6251_mdar_reproducibility_checklist.pdf)</div><div title="valid: False, node: 734, tag: div, level: 17" node_number="734">Download</div></div><div title="valid: False, node: 735, tag: div, level: 16" node_number="735"><div title="valid: False, node: 736, tag: div, level: 17" node_number="736">File (science.abl6251_sm.pdf)</div><div title="valid: False, node: 737, tag: div, level: 17" node_number="737">Download</div></div><div title="valid: False, node: 738, tag: div, level: 16" node_number="738"><div title="valid: False, node: 739, tag: div, level: 17" node_number="739">File (thumbs.db)</div><div title="valid: False, node: 740, tag: div, level: 17" node_number="740">Download</div></div></div></section></section><section class="valid" valid="valid" title="valid: True, node: 741, tag: section, level: 13" node_number="741"><h2 class="valid" valid="valid" title="valid: True, node: 742, tag: h2, level: 14" node_number="742">References and Notes</h2><div class="valid" valid="valid" title="valid: True, node: 743, tag: div, level: 14" node_number="743"><div title="valid: False, node: 744, tag: div, level: 15" node_number="744">1</div><div title="valid: False, node: 745, tag: div, level: 15" node_number="745"><div title="valid: False, node: 746, tag: div, level: 16" node_number="746"><div title="valid: False, node: 747, tag: div, level: 17" node_number="747">W. T. Harvey, A. M. Carabelli, B. Jackson, R. K. Gupta, E. C. Thomson, E. M. Harrison, C. Ludden, R. Reeve, A. Rambaut, S. J. Peacock, D. L. Robertson; COVID-19 Genomics UK (COG-UK) Consortium, SARS-CoV-2 variants, spike mutations and immune escape. Nat. Rev. Microbiol. <b title="valid: False, node: 748, tag: b, level: 18" node_number="748">19</b>, 409&#8211;424 (2021).</div><div title="valid: False, node: 749, tag: div, level: 17" node_number="749"><div title="valid: False, node: 750, tag: div, level: 18" node_number="750">Crossref</div><div title="valid: False, node: 751, tag: div, level: 18" node_number="751">PubMed</div><div title="valid: False, node: 752, tag: div, level: 18" node_number="752"><a title="valid: False, node: 753, tag: a, level: 19" node_number="753">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 754, tag: div, level: 14" node_number="754"><div title="valid: False, node: 755, tag: div, level: 15" node_number="755">2</div><div title="valid: False, node: 756, tag: div, level: 15" node_number="756"><div title="valid: False, node: 757, tag: div, level: 16" node_number="757"><div title="valid: False, node: 758, tag: div, level: 17" node_number="758">J. Lan, J. Ge, J. Yu, S. Shan, H. Zhou, S. Fan, Q. Zhang, X. Shi, Q. Wang, L. Zhang, X. Wang, Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature <b title="valid: False, node: 759, tag: b, level: 18" node_number="759">581</b>, 215&#8211;220 (2020).</div><div title="valid: False, node: 760, tag: div, level: 17" node_number="760"><div title="valid: False, node: 761, tag: div, level: 18" node_number="761"><a title="valid: False, node: 762, tag: a, level: 19" node_number="762">Crossref</a></div><div title="valid: False, node: 763, tag: div, level: 18" node_number="763"><a title="valid: False, node: 764, tag: a, level: 19" node_number="764">PubMed</a></div><div title="valid: False, node: 765, tag: div, level: 18" node_number="765"><a title="valid: False, node: 766, tag: a, level: 19" node_number="766">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 767, tag: div, level: 14" node_number="767"><div title="valid: False, node: 768, tag: div, level: 15" node_number="768">3</div><div title="valid: False, node: 769, tag: div, level: 15" node_number="769"><div title="valid: False, node: 770, tag: div, level: 16" node_number="770"><div title="valid: False, node: 771, tag: div, level: 17" node_number="771">J. Shang, G. Ye, K. Shi, Y. Wan, C. Luo, H. Aihara, Q. Geng, A. Auerbach, F. Li, Structural basis of receptor recognition by SARS-CoV-2. Nature <b title="valid: False, node: 772, tag: b, level: 18" node_number="772">581</b>, 221&#8211;224 (2020).</div><div title="valid: False, node: 773, tag: div, level: 17" node_number="773"><div title="valid: False, node: 774, tag: div, level: 18" node_number="774"><a title="valid: False, node: 775, tag: a, level: 19" node_number="775">Crossref</a></div><div title="valid: False, node: 776, tag: div, level: 18" node_number="776"><a title="valid: False, node: 777, tag: a, level: 19" node_number="777">PubMed</a></div><div title="valid: False, node: 778, tag: div, level: 18" node_number="778"><a title="valid: False, node: 779, tag: a, level: 19" node_number="779">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 780, tag: div, level: 14" node_number="780"><div title="valid: False, node: 781, tag: div, level: 15" node_number="781">4</div><div title="valid: False, node: 782, tag: div, level: 15" node_number="782"><div title="valid: False, node: 783, tag: div, level: 16" node_number="783"><div title="valid: False, node: 784, tag: div, level: 17" node_number="784">L. Piccoli, Y.-J. Park, M. A. Tortorici, N. Czudnochowski, A. C. Walls, M. Beltramello, C. Silacci-Fregni, D. Pinto, L. E. Rosen, J. E. Bowen, O. J. Acton, S. Jaconi, B. Guarino, A. Minola, F. Zatta, N. Sprugasci, J. Bassi, A. Peter, A. De Marco, J. C. Nix, F. Mele, S. Jovic, B. F. Rodriguez, S. V. Gupta, F. Jin, G. Piumatti, G. Lo Presti, A. F. Pellanda, M. Biggiogero, M. Tarkowski, M. S. Pizzuto, E. Cameroni, C. Havenar-Daughton, M. Smithey, D. Hong, V. Lepori, E. Albanese, A. Ceschi, E. Bernasconi, L. Elzi, P. Ferrari, C. Garzoni, A. Riva, G. Snell, F. Sallusto, K. Fink, H. W. Virgin, A. Lanzavecchia, D. Corti, D. Veesler, Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology. Cell <b title="valid: False, node: 785, tag: b, level: 18" node_number="785">183</b>, 1024&#8211;1042.e21 (2020).</div><div title="valid: False, node: 786, tag: div, level: 17" node_number="786"><div title="valid: False, node: 787, tag: div, level: 18" node_number="787"><a title="valid: False, node: 788, tag: a, level: 19" node_number="788">Crossref</a></div><div title="valid: False, node: 789, tag: div, level: 18" node_number="789"><a title="valid: False, node: 790, tag: a, level: 19" node_number="790">PubMed</a></div><div title="valid: False, node: 791, tag: div, level: 18" node_number="791"><a title="valid: False, node: 792, tag: a, level: 19" node_number="792">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 793, tag: div, level: 14" node_number="793"><div title="valid: False, node: 794, tag: div, level: 15" node_number="794">5</div><div title="valid: False, node: 795, tag: div, level: 15" node_number="795"><div title="valid: False, node: 796, tag: div, level: 16" node_number="796"><div title="valid: False, node: 797, tag: div, level: 17" node_number="797">A. J. Greaney, A. N. Loes, L. E. Gentles, K. H. D. Crawford, T. N. Starr, K. D. Malone, H. Y. Chu, J. D. Bloom, Antibodies elicited by mRNA-1273 vaccination bind more broadly to the receptor binding domain than do those from SARS-CoV-2 infection. Sci. Transl. Med. <b title="valid: False, node: 798, tag: b, level: 18" node_number="798">13</b>, eabi9915 (2021).</div><div title="valid: False, node: 799, tag: div, level: 17" node_number="799"><div title="valid: False, node: 800, tag: div, level: 18" node_number="800"><a title="valid: False, node: 801, tag: a, level: 19" node_number="801">Crossref</a></div><div title="valid: False, node: 802, tag: div, level: 18" node_number="802"><a title="valid: False, node: 803, tag: a, level: 19" node_number="803">PubMed</a></div><div title="valid: False, node: 804, tag: div, level: 18" node_number="804"><a title="valid: False, node: 805, tag: a, level: 19" node_number="805">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 806, tag: div, level: 14" node_number="806"><div title="valid: False, node: 807, tag: div, level: 15" node_number="807">6</div><div title="valid: False, node: 808, tag: div, level: 15" node_number="808"><div title="valid: False, node: 809, tag: div, level: 16" node_number="809"><div title="valid: False, node: 810, tag: div, level: 17" node_number="810">K. R. McCarthy, L. J. Rennick, S. Nambulli, L. R. Robinson-McCarthy, W. G. Bain, G. Haidar, W. P. Duprex, Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape. Science <b title="valid: False, node: 811, tag: b, level: 18" node_number="811">371</b>, 1139&#8211;1142 (2021).</div><div title="valid: False, node: 812, tag: div, level: 17" node_number="812"><div title="valid: False, node: 813, tag: div, level: 18" node_number="813"><a title="valid: False, node: 814, tag: a, level: 19" node_number="814">Crossref</a></div><div title="valid: False, node: 815, tag: div, level: 18" node_number="815"><a title="valid: False, node: 816, tag: a, level: 19" node_number="816">PubMed</a></div><div title="valid: False, node: 817, tag: div, level: 18" node_number="817"><a title="valid: False, node: 818, tag: a, level: 19" node_number="818">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 819, tag: div, level: 14" node_number="819"><div title="valid: False, node: 820, tag: div, level: 15" node_number="820">7</div><div title="valid: False, node: 821, tag: div, level: 15" node_number="821"><div title="valid: False, node: 822, tag: div, level: 16" node_number="822"><div title="valid: False, node: 823, tag: div, level: 17" node_number="823">M. McCallum, A. De Marco, F. A. Lempp, M. A. Tortorici, D. Pinto, A. C. Walls, M. Beltramello, A. Chen, Z. Liu, F. Zatta, S. Zepeda, J. di Iulio, J. E. Bowen, M. Montiel-Ruiz, J. Zhou, L. E. Rosen, S. Bianchi, B. Guarino, C. S. Fregni, R. Abdelnabi, S. C. Foo, P. W. Rothlauf, L.-M. Bloyet, F. Benigni, E. Cameroni, J. Neyts, A. Riva, G. Snell, A. Telenti, S. P. J. Whelan, H. W. Virgin, D. Corti, M. S. Pizzuto, D. Veesler, N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2. Cell <b title="valid: False, node: 824, tag: b, level: 18" node_number="824">184</b>, 2332&#8211;2347.e16 (2021).</div><div title="valid: False, node: 825, tag: div, level: 17" node_number="825"><div title="valid: False, node: 826, tag: div, level: 18" node_number="826"><a title="valid: False, node: 827, tag: a, level: 19" node_number="827">Crossref</a></div><div title="valid: False, node: 828, tag: div, level: 18" node_number="828"><a title="valid: False, node: 829, tag: a, level: 19" node_number="829">PubMed</a></div><div title="valid: False, node: 830, tag: div, level: 18" node_number="830"><a title="valid: False, node: 831, tag: a, level: 19" node_number="831">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 832, tag: div, level: 14" node_number="832"><div title="valid: False, node: 833, tag: div, level: 15" node_number="833">8</div><div title="valid: False, node: 834, tag: div, level: 15" node_number="834"><div title="valid: False, node: 835, tag: div, level: 16" node_number="835"><div title="valid: False, node: 836, tag: div, level: 17" node_number="836">P. Supasa, D. Zhou, W. Dejnirattisai, C. Liu, A. J. Mentzer, H. M. Ginn, Y. Zhao, H. M. E. Duyvesteyn, R. Nutalai, A. Tuekprakhon, B. Wang, G. C. Paesen, J. Slon-Campos, C. L&#243;pez-Camacho, B. Hallis, N. Coombes, K. R. Bewley, S. Charlton, T. S. Walter, E. Barnes, S. J. Dunachie, D. Skelly, S. F. Lumley, N. Baker, I. Shaik, H. E. Humphries, K. Godwin, N. Gent, A. Sienkiewicz, C. Dold, R. Levin, T. Dong, A. J. Pollard, J. C. Knight, P. Klenerman, D. Crook, T. Lambe, E. Clutterbuck, S. Bibi, A. Flaxman, M. Bittaye, S. Belij-Rammerstorfer, S. Gilbert, D. R. Hall, M. A. Williams, N. G. Paterson, W. James, M. W. Carroll, E. E. Fry, J. Mongkolsapaya, J. Ren, D. I. Stuart, G. R. Screaton, Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera. Cell <b title="valid: False, node: 837, tag: b, level: 18" node_number="837">184</b>, 2201&#8211;2211.e7 (2021).</div><div title="valid: False, node: 838, tag: div, level: 17" node_number="838"><div title="valid: False, node: 839, tag: div, level: 18" node_number="839"><a title="valid: False, node: 840, tag: a, level: 19" node_number="840">Crossref</a></div><div title="valid: False, node: 841, tag: div, level: 18" node_number="841"><a title="valid: False, node: 842, tag: a, level: 19" node_number="842">PubMed</a></div><div title="valid: False, node: 843, tag: div, level: 18" node_number="843"><a title="valid: False, node: 844, tag: a, level: 19" node_number="844">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 845, tag: div, level: 14" node_number="845"><div title="valid: False, node: 846, tag: div, level: 15" node_number="846">9</div><div title="valid: False, node: 847, tag: div, level: 15" node_number="847"><div title="valid: False, node: 848, tag: div, level: 16" node_number="848"><div title="valid: False, node: 849, tag: div, level: 17" node_number="849">W. Dejnirattisai, D. Zhou, P. Supasa, C. Liu, A. J. Mentzer, H. M. Ginn, Y. Zhao, H. M. E. Duyvesteyn, A. Tuekprakhon, R. Nutalai, B. Wang, C. L&#243;pez-Camacho, J. Slon-Campos, T. S. Walter, D. Skelly, S. A. Costa Clemens, F. G. Naveca, V. Nascimento, F. Nascimento, C. Fernandes da Costa, P. C. Resende, A. Pauvolid-Correa, M. M. Siqueira, C. Dold, R. Levin, T. Dong, A. J. Pollard, J. C. Knight, D. Crook, T. Lambe, E. Clutterbuck, S. Bibi, A. Flaxman, M. Bittaye, S. Belij-Rammerstorfer, S. C. Gilbert, M. W. Carroll, P. Klenerman, E. Barnes, S. J. Dunachie, N. G. Paterson, M. A. Williams, D. R. Hall, R. J. G. Hulswit, T. A. Bowden, E. E. Fry, J. Mongkolsapaya, J. Ren, D. I. Stuart, G. R. Screaton, Antibody evasion by the P.1 strain of SARS-CoV-2. Cell <b title="valid: False, node: 850, tag: b, level: 18" node_number="850">184</b>, 2939&#8211;2954.e9 (2021).</div><div title="valid: False, node: 851, tag: div, level: 17" node_number="851"><div title="valid: False, node: 852, tag: div, level: 18" node_number="852"><a title="valid: False, node: 853, tag: a, level: 19" node_number="853">Crossref</a></div><div title="valid: False, node: 854, tag: div, level: 18" node_number="854"><a title="valid: False, node: 855, tag: a, level: 19" node_number="855">PubMed</a></div><div title="valid: False, node: 856, tag: div, level: 18" node_number="856"><a title="valid: False, node: 857, tag: a, level: 19" node_number="857">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 858, tag: div, level: 14" node_number="858"><div title="valid: False, node: 859, tag: div, level: 15" node_number="859">10</div><div title="valid: False, node: 860, tag: div, level: 15" node_number="860"><div title="valid: False, node: 861, tag: div, level: 16" node_number="861"><div title="valid: False, node: 862, tag: div, level: 17" node_number="862">D. Planas, T. Bruel, L. Grzelak, F. Guivel-Benhassine, I. Staropoli, F. Porrot, C. Planchais, J. Buchrieser, M. M. Rajah, E. Bishop, M. Albert, F. Donati, M. Prot, S. Behillil, V. Enouf, M. Maquart, M. Smati-Lafarge, E. Varon, F. Schortgen, L. Yahyaoui, M. Gonzalez, J. De S&#232;ze, H. P&#233;r&#233;, D. Veyer, A. S&#232;ve, E. Simon-Lori&#232;re, S. Fafi-Kremer, K. Stefic, H. Mouquet, L. Hocqueloux, S. van der Werf, T. Prazuck, O. Schwartz, Sensitivity of infectious SARS-CoV-2 B.1.1.7 and B.1.351 variants to neutralizing antibodies. Nat. Med. <b title="valid: False, node: 863, tag: b, level: 18" node_number="863">27</b>, 917&#8211;924 (2021).</div><div title="valid: False, node: 864, tag: div, level: 17" node_number="864"><div title="valid: False, node: 865, tag: div, level: 18" node_number="865"><a title="valid: False, node: 866, tag: a, level: 19" node_number="866">Crossref</a></div><div title="valid: False, node: 867, tag: div, level: 18" node_number="867"><a title="valid: False, node: 868, tag: a, level: 19" node_number="868">PubMed</a></div><div title="valid: False, node: 869, tag: div, level: 18" node_number="869"><a title="valid: False, node: 870, tag: a, level: 19" node_number="870">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 871, tag: div, level: 14" node_number="871"><div title="valid: False, node: 872, tag: div, level: 15" node_number="872">11</div><div title="valid: False, node: 873, tag: div, level: 15" node_number="873"><div title="valid: False, node: 874, tag: div, level: 16" node_number="874"><div title="valid: False, node: 875, tag: div, level: 17" node_number="875">P. Wang, R. G. Casner, M. S. Nair, M. Wang, J. Yu, G. Cerutti, L. Liu, P. D. Kwong, Y. Huang, L. Shapiro, D. D. Ho, Increased resistance of SARS-CoV-2 variant P.1 to antibody neutralization. Cell Host Microbe <b title="valid: False, node: 876, tag: b, level: 18" node_number="876">29</b>, 747&#8211;751.e4 (2021).</div><div title="valid: False, node: 877, tag: div, level: 17" node_number="877"><div title="valid: False, node: 878, tag: div, level: 18" node_number="878"><a title="valid: False, node: 879, tag: a, level: 19" node_number="879">Crossref</a></div><div title="valid: False, node: 880, tag: div, level: 18" node_number="880"><a title="valid: False, node: 881, tag: a, level: 19" node_number="881">PubMed</a></div><div title="valid: False, node: 882, tag: div, level: 18" node_number="882"><a title="valid: False, node: 883, tag: a, level: 19" node_number="883">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 884, tag: div, level: 14" node_number="884"><div title="valid: False, node: 885, tag: div, level: 15" node_number="885">12</div><div title="valid: False, node: 886, tag: div, level: 15" node_number="886"><div title="valid: False, node: 887, tag: div, level: 16" node_number="887"><div title="valid: False, node: 888, tag: div, level: 17" node_number="888">P. Wang, M. S. Nair, L. Liu, S. Iketani, Y. Luo, Y. Guo, M. Wang, J. Yu, B. Zhang, P. D. Kwong, B. S. Graham, J. R. Mascola, J. Y. Chang, M. T. Yin, M. Sobieszczyk, C. A. Kyratsous, L. Shapiro, Z. Sheng, Y. Huang, D. D. Ho, Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7. Nature <b title="valid: False, node: 889, tag: b, level: 18" node_number="889">593</b>, 130&#8211;135 (2021).</div><div title="valid: False, node: 890, tag: div, level: 17" node_number="890"><div title="valid: False, node: 891, tag: div, level: 18" node_number="891"><a title="valid: False, node: 892, tag: a, level: 19" node_number="892">Crossref</a></div><div title="valid: False, node: 893, tag: div, level: 18" node_number="893"><a title="valid: False, node: 894, tag: a, level: 19" node_number="894">PubMed</a></div><div title="valid: False, node: 895, tag: div, level: 18" node_number="895"><a title="valid: False, node: 896, tag: a, level: 19" node_number="896">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 897, tag: div, level: 14" node_number="897"><div title="valid: False, node: 898, tag: div, level: 15" node_number="898">13</div><div title="valid: False, node: 899, tag: div, level: 15" node_number="899"><div title="valid: False, node: 900, tag: div, level: 16" node_number="900"><div title="valid: False, node: 901, tag: div, level: 17" node_number="901">W. F. Garcia-Beltran, E. C. Lam, K. St. Denis, A. D. Nitido, Z. H. Garcia, B. M. Hauser, J. Feldman, M. N. Pavlovic, D. J. Gregory, M. C. Poznansky, A. Sigal, A. G. Schmidt, A. J. Iafrate, V. Naranbhai, A. B. Balazs, Multiple SARS-CoV-2 variants escape neutralization by vaccine-induced humoral immunity. Cell <b title="valid: False, node: 902, tag: b, level: 18" node_number="902">184</b>, 2523 (2021).</div><div title="valid: False, node: 903, tag: div, level: 17" node_number="903"><div title="valid: False, node: 904, tag: div, level: 18" node_number="904"><a title="valid: False, node: 905, tag: a, level: 19" node_number="905">Crossref</a></div><div title="valid: False, node: 906, tag: div, level: 18" node_number="906"><a title="valid: False, node: 907, tag: a, level: 19" node_number="907">PubMed</a></div><div title="valid: False, node: 908, tag: div, level: 18" node_number="908"><a title="valid: False, node: 909, tag: a, level: 19" node_number="909">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 910, tag: div, level: 14" node_number="910"><div title="valid: False, node: 911, tag: div, level: 15" node_number="911">14</div><div title="valid: False, node: 912, tag: div, level: 15" node_number="912"><div title="valid: False, node: 913, tag: div, level: 16" node_number="913"><div title="valid: False, node: 914, tag: div, level: 17" node_number="914">S. A. Clark, L. E. Clark, J. Pan, A. Coscia, L. G. A. McKay, S. Shankar, R. I. Johnson, V. Brusic, M. C. Choudhary, J. Regan, J. Z. Li, A. Griffiths, J. Abraham, SARS-CoV-2 evolution in an immunocompromised host reveals shared neutralization escape mechanisms. Cell <b title="valid: False, node: 915, tag: b, level: 18" node_number="915">184</b>, 2605&#8211;2617.e18 (2021).</div><div title="valid: False, node: 916, tag: div, level: 17" node_number="916"><div title="valid: False, node: 917, tag: div, level: 18" node_number="917"><a title="valid: False, node: 918, tag: a, level: 19" node_number="918">Crossref</a></div><div title="valid: False, node: 919, tag: div, level: 18" node_number="919"><a title="valid: False, node: 920, tag: a, level: 19" node_number="920">PubMed</a></div><div title="valid: False, node: 921, tag: div, level: 18" node_number="921"><a title="valid: False, node: 922, tag: a, level: 19" node_number="922">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 923, tag: div, level: 14" node_number="923"><div title="valid: False, node: 924, tag: div, level: 15" node_number="924">15</div><div title="valid: False, node: 925, tag: div, level: 15" node_number="925"><div title="valid: False, node: 926, tag: div, level: 16" node_number="926"><div title="valid: False, node: 927, tag: div, level: 17" node_number="927">B. Choi, M. C. Choudhary, J. Regan, J. A. Sparks, R. F. Padera, X. Qiu, I. H. Solomon, H.-H. Kuo, J. Boucau, K. Bowman, U. D. Adhikari, M. L. Winkler, A. A. Mueller, T. Y.-T. Hsu, M. Desjardins, L. R. Baden, B. T. Chan, B. D. Walker, M. Lichterfeld, M. Brigl, D. S. Kwon, S. Kanjilal, E. T. Richardson, A. H. Jonsson, G. Alter, A. K. Barczak, W. P. Hanage, X. G. Yu, G. D. Gaiha, M. S. Seaman, M. Cernadas, J. Z. Li, Persistence and evolution of SARS-CoV-2 in an immunocompromised host. N. Engl. J. Med. <b title="valid: False, node: 928, tag: b, level: 18" node_number="928">383</b>, 2291&#8211;2293 (2020).</div><div title="valid: False, node: 929, tag: div, level: 17" node_number="929"><div title="valid: False, node: 930, tag: div, level: 18" node_number="930"><a title="valid: False, node: 931, tag: a, level: 19" node_number="931">Crossref</a></div><div title="valid: False, node: 932, tag: div, level: 18" node_number="932"><a title="valid: False, node: 933, tag: a, level: 19" node_number="933">PubMed</a></div><div title="valid: False, node: 934, tag: div, level: 18" node_number="934"><a title="valid: False, node: 935, tag: a, level: 19" node_number="935">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 936, tag: div, level: 14" node_number="936"><div title="valid: False, node: 937, tag: div, level: 15" node_number="937">16</div><div title="valid: False, node: 938, tag: div, level: 15" node_number="938"><div title="valid: False, node: 939, tag: div, level: 16" node_number="939"><div title="valid: False, node: 940, tag: div, level: 17" node_number="940">T. N. Starr, A. J. Greaney, A. Addetia, W. W. Hannon, M. C. Choudhary, A. S. Dingens, J. Z. Li, J. D. Bloom, Prospective mapping of viral mutations that escape antibodies used to treat COVID-19. Science <b title="valid: False, node: 941, tag: b, level: 18" node_number="941">371</b>, 850&#8211;854 (2021).</div><div title="valid: False, node: 942, tag: div, level: 17" node_number="942"><div title="valid: False, node: 943, tag: div, level: 18" node_number="943"><a title="valid: False, node: 944, tag: a, level: 19" node_number="944">Crossref</a></div><div title="valid: False, node: 945, tag: div, level: 18" node_number="945"><a title="valid: False, node: 946, tag: a, level: 19" node_number="946">PubMed</a></div><div title="valid: False, node: 947, tag: div, level: 18" node_number="947"><a title="valid: False, node: 948, tag: a, level: 19" node_number="948">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 949, tag: div, level: 14" node_number="949"><div title="valid: False, node: 950, tag: div, level: 15" node_number="950">17</div><div title="valid: False, node: 951, tag: div, level: 15" node_number="951"><div title="valid: False, node: 952, tag: div, level: 16" node_number="952"><div title="valid: False, node: 953, tag: div, level: 17" node_number="953">A. Baum, B. O. Fulton, E. Wloga, R. Copin, K. E. Pascal, V. Russo, S. Giordano, K. Lanza, N. Negron, M. Ni, Y. Wei, G. S. Atwal, A. J. Murphy, N. Stahl, G. D. Yancopoulos, C. A. Kyratsous, Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies. Science <b title="valid: False, node: 954, tag: b, level: 18" node_number="954">369</b>, 1014&#8211;1018 (2020).</div><div title="valid: False, node: 955, tag: div, level: 17" node_number="955"><div title="valid: False, node: 956, tag: div, level: 18" node_number="956"><a title="valid: False, node: 957, tag: a, level: 19" node_number="957">Crossref</a></div><div title="valid: False, node: 958, tag: div, level: 18" node_number="958"><a title="valid: False, node: 959, tag: a, level: 19" node_number="959">PubMed</a></div><div title="valid: False, node: 960, tag: div, level: 18" node_number="960"><a title="valid: False, node: 961, tag: a, level: 19" node_number="961">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 962, tag: div, level: 14" node_number="962"><div title="valid: False, node: 963, tag: div, level: 15" node_number="963">18</div><div title="valid: False, node: 964, tag: div, level: 15" node_number="964"><div title="valid: False, node: 965, tag: div, level: 16" node_number="965"><div title="valid: False, node: 966, tag: div, level: 17" node_number="966">J. Hansen, A. Baum, K. E. Pascal, V. Russo, S. Giordano, E. Wloga, B. O. Fulton, Y. Yan, K. Koon, K. Patel, K. M. Chung, A. Hermann, E. Ullman, J. Cruz, A. Rafique, T. Huang, J. Fairhurst, C. Libertiny, M. Malbec, W. Y. Lee, R. Welsh, G. Farr, S. Pennington, D. Deshpande, J. Cheng, A. Watty, P. Bouffard, R. Babb, N. Levenkova, C. Chen, B. Zhang, A. Romero Hernandez, K. Saotome, Y. Zhou, M. Franklin, S. Sivapalasingam, D. C. Lye, S. Weston, J. Logue, R. Haupt, M. Frieman, G. Chen, W. Olson, A. J. Murphy, N. Stahl, G. D. Yancopoulos, C. A. Kyratsous, Studies in humanized mice and convalescent humans yield a SARS-CoV-2 antibody cocktail. Science <b title="valid: False, node: 967, tag: b, level: 18" node_number="967">369</b>, 1010&#8211;1014 (2020).</div><div title="valid: False, node: 968, tag: div, level: 17" node_number="968"><div title="valid: False, node: 969, tag: div, level: 18" node_number="969"><a title="valid: False, node: 970, tag: a, level: 19" node_number="970">Crossref</a></div><div title="valid: False, node: 971, tag: div, level: 18" node_number="971"><a title="valid: False, node: 972, tag: a, level: 19" node_number="972">PubMed</a></div><div title="valid: False, node: 973, tag: div, level: 18" node_number="973"><a title="valid: False, node: 974, tag: a, level: 19" node_number="974">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 975, tag: div, level: 14" node_number="975"><div title="valid: False, node: 976, tag: div, level: 15" node_number="976">19</div><div title="valid: False, node: 977, tag: div, level: 15" node_number="977"><div title="valid: False, node: 978, tag: div, level: 16" node_number="978"><div title="valid: False, node: 979, tag: div, level: 17" node_number="979">M. Yuan, H. Liu, N. C. Wu, C. D. Lee, X. Zhu, F. Zhao, D. Huang, W. Yu, Y. Hua, H. Tien, T. F. Rogers, E. Landais, D. Sok, J. G. Jardine, D. R. Burton, I. A. Wilson, Structural basis of a shared antibody response to SARS-CoV-2. Science <b title="valid: False, node: 980, tag: b, level: 18" node_number="980">369</b>, 1119&#8211;1123 (2020).</div><div title="valid: False, node: 981, tag: div, level: 17" node_number="981"><div title="valid: False, node: 982, tag: div, level: 18" node_number="982"><a title="valid: False, node: 983, tag: a, level: 19" node_number="983">Crossref</a></div><div title="valid: False, node: 984, tag: div, level: 18" node_number="984"><a title="valid: False, node: 985, tag: a, level: 19" node_number="985">PubMed</a></div><div title="valid: False, node: 986, tag: div, level: 18" node_number="986"><a title="valid: False, node: 987, tag: a, level: 19" node_number="987">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 988, tag: div, level: 14" node_number="988"><div title="valid: False, node: 989, tag: div, level: 15" node_number="989">20</div><div title="valid: False, node: 990, tag: div, level: 15" node_number="990"><div title="valid: False, node: 991, tag: div, level: 16" node_number="991"><div title="valid: False, node: 992, tag: div, level: 17" node_number="992">T. F. Rogers, F. Zhao, D. Huang, N. Beutler, A. Burns, W. T. He, O. Limbo, C. Smith, G. Song, J. Woehl, L. Yang, R. K. Abbott, S. Callaghan, E. Garcia, J. Hurtado, M. Parren, L. Peng, S. Ramirez, J. Ricketts, M. J. Ricciardi, S. A. Rawlings, N. C. Wu, M. Yuan, D. M. Smith, D. Nemazee, J. R. Teijaro, J. E. Voss, I. A. Wilson, R. Andrabi, B. Briney, E. Landais, D. Sok, J. G. Jardine, D. R. Burton, Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model. Science <b title="valid: False, node: 993, tag: b, level: 18" node_number="993">369</b>, 956&#8211;963 (2020).</div><div title="valid: False, node: 994, tag: div, level: 17" node_number="994"><div title="valid: False, node: 995, tag: div, level: 18" node_number="995"><a title="valid: False, node: 996, tag: a, level: 19" node_number="996">Crossref</a></div><div title="valid: False, node: 997, tag: div, level: 18" node_number="997"><a title="valid: False, node: 998, tag: a, level: 19" node_number="998">PubMed</a></div><div title="valid: False, node: 999, tag: div, level: 18" node_number="999"><a title="valid: False, node: 1000, tag: a, level: 19" node_number="1000">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1001, tag: div, level: 14" node_number="1001"><div title="valid: False, node: 1002, tag: div, level: 15" node_number="1002">21</div><div title="valid: False, node: 1003, tag: div, level: 15" node_number="1003"><div title="valid: False, node: 1004, tag: div, level: 16" node_number="1004"><div title="valid: False, node: 1005, tag: div, level: 17" node_number="1005">R. Shi, C. Shan, X. Duan, Z. Chen, P. Liu, J. Song, T. Song, X. Bi, C. Han, L. Wu, G. Gao, X. Hu, Y. Zhang, Z. Tong, W. Huang, W. J. Liu, G. Wu, B. Zhang, L. Wang, J. Qi, H. Feng, F.-S. Wang, Q. Wang, G. F. Gao, Z. Yuan, J. Yan, A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2. Nature <b title="valid: False, node: 1006, tag: b, level: 18" node_number="1006">584</b>, 120&#8211;124 (2020).</div><div title="valid: False, node: 1007, tag: div, level: 17" node_number="1007"><div title="valid: False, node: 1008, tag: div, level: 18" node_number="1008"><a title="valid: False, node: 1009, tag: a, level: 19" node_number="1009">Crossref</a></div><div title="valid: False, node: 1010, tag: div, level: 18" node_number="1010"><a title="valid: False, node: 1011, tag: a, level: 19" node_number="1011">PubMed</a></div><div title="valid: False, node: 1012, tag: div, level: 18" node_number="1012"><a title="valid: False, node: 1013, tag: a, level: 19" node_number="1013">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1014, tag: div, level: 14" node_number="1014"><div title="valid: False, node: 1015, tag: div, level: 15" node_number="1015">22</div><div title="valid: False, node: 1016, tag: div, level: 15" node_number="1016"><div title="valid: False, node: 1017, tag: div, level: 16" node_number="1017"><div title="valid: False, node: 1018, tag: div, level: 17" node_number="1018">E. Seydoux, L. J. Homad, A. J. MacCamy, K. R. Parks, N. K. Hurlburt, M. F. Jennewein, N. R. Akins, A. B. Stuart, Y.-H. Wan, J. Feng, R. E. Whaley, S. Singh, M. Boeckh, K. W. Cohen, M. J. McElrath, J. A. Englund, H. Y. Chu, M. Pancera, A. T. McGuire, L. Stamatatos, Analysis of a SARS-CoV-2-infected individual reveals development of potent neutralizing antibodies with limited somatic mutation. Immunity <b title="valid: False, node: 1019, tag: b, level: 18" node_number="1019">53</b>, 98&#8211;105.e5 (2020).</div><div title="valid: False, node: 1020, tag: div, level: 17" node_number="1020"><div title="valid: False, node: 1021, tag: div, level: 18" node_number="1021"><a title="valid: False, node: 1022, tag: a, level: 19" node_number="1022">Crossref</a></div><div title="valid: False, node: 1023, tag: div, level: 18" node_number="1023"><a title="valid: False, node: 1024, tag: a, level: 19" node_number="1024">PubMed</a></div><div title="valid: False, node: 1025, tag: div, level: 18" node_number="1025"><a title="valid: False, node: 1026, tag: a, level: 19" node_number="1026">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1027, tag: div, level: 14" node_number="1027"><div title="valid: False, node: 1028, tag: div, level: 15" node_number="1028">23</div><div title="valid: False, node: 1029, tag: div, level: 15" node_number="1029"><div title="valid: False, node: 1030, tag: div, level: 16" node_number="1030"><div title="valid: False, node: 1031, tag: div, level: 17" node_number="1031">D. F. Robbiani, C. Gaebler, F. Muecksch, J. C. C. Lorenzi, Z. Wang, A. Cho, M. Agudelo, C. O. Barnes, A. Gazumyan, S. Finkin, T. H&#228;ggl&#246;f, T. Y. Oliveira, C. Viant, A. Hurley, H.-H. Hoffmann, K. G. Millard, R. G. Kost, M. Cipolla, K. Gordon, F. Bianchini, S. T. Chen, V. Ramos, R. Patel, J. Dizon, I. Shimeliovich, P. Mendoza, H. Hartweger, L. Nogueira, M. Pack, J. Horowitz, F. Schmidt, Y. Weisblum, E. Michailidis, A. W. Ashbrook, E. Waltari, J. E. Pak, K. E. Huey-Tubman, N. Koranda, P. R. Hoffman, A. P. West Jr., C. M. Rice, T. Hatziioannou, P. J. Bjorkman, P. D. Bieniasz, M. Caskey, M. C. Nussenzweig, Convergent antibody responses to SARS-CoV-2 in convalescent individuals. Nature <b title="valid: False, node: 1032, tag: b, level: 18" node_number="1032">584</b>, 437&#8211;442 (2020).</div><div title="valid: False, node: 1033, tag: div, level: 17" node_number="1033"><div title="valid: False, node: 1034, tag: div, level: 18" node_number="1034"><a title="valid: False, node: 1035, tag: a, level: 19" node_number="1035">Crossref</a></div><div title="valid: False, node: 1036, tag: div, level: 18" node_number="1036"><a title="valid: False, node: 1037, tag: a, level: 19" node_number="1037">PubMed</a></div><div title="valid: False, node: 1038, tag: div, level: 18" node_number="1038"><a title="valid: False, node: 1039, tag: a, level: 19" node_number="1039">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1040, tag: div, level: 14" node_number="1040"><div title="valid: False, node: 1041, tag: div, level: 15" node_number="1041">24</div><div title="valid: False, node: 1042, tag: div, level: 15" node_number="1042"><div title="valid: False, node: 1043, tag: div, level: 16" node_number="1043"><div title="valid: False, node: 1044, tag: div, level: 17" node_number="1044">S. Du, Y. Cao, Q. Zhu, P. Yu, F. Qi, G. Wang, X. Du, L. Bao, W. Deng, H. Zhu, J. Liu, J. Nie, Y. Zheng, H. Liang, R. Liu, S. Gong, H. Xu, A. Yisimayi, Q. Lv, B. Wang, R. He, Y. Han, W. Zhao, Y. Bai, Y. Qu, X. Gao, C. Ji, Q. Wang, N. Gao, W. Huang, Y. Wang, X. S. Xie, X. D. Su, J. Xiao, C. Qin, Structurally resolved SARS-CoV-2 antibody shows high efficacy in severely infected hamsters and provides a potent cocktail pairing strategy. Cell <b title="valid: False, node: 1045, tag: b, level: 18" node_number="1045">183</b>, 1013&#8211;1023.e13 (2020).</div><div title="valid: False, node: 1046, tag: div, level: 17" node_number="1046"><div title="valid: False, node: 1047, tag: div, level: 18" node_number="1047"><a title="valid: False, node: 1048, tag: a, level: 19" node_number="1048">Crossref</a></div><div title="valid: False, node: 1049, tag: div, level: 18" node_number="1049"><a title="valid: False, node: 1050, tag: a, level: 19" node_number="1050">PubMed</a></div><div title="valid: False, node: 1051, tag: div, level: 18" node_number="1051"><a title="valid: False, node: 1052, tag: a, level: 19" node_number="1052">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1053, tag: div, level: 14" node_number="1053"><div title="valid: False, node: 1054, tag: div, level: 15" node_number="1054">25</div><div title="valid: False, node: 1055, tag: div, level: 15" node_number="1055"><div title="valid: False, node: 1056, tag: div, level: 16" node_number="1056"><div title="valid: False, node: 1057, tag: div, level: 17" node_number="1057">Y. Wu, F. Wang, C. Shen, W. Peng, D. Li, C. Zhao, Z. Li, S. Li, Y. Bi, Y. Yang, Y. Gong, H. Xiao, Z. Fan, S. Tan, G. Wu, W. Tan, X. Lu, C. Fan, Q. Wang, Y. Liu, C. Zhang, J. Qi, G. F. Gao, F. Gao, L. Liu, A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2. Science <b title="valid: False, node: 1058, tag: b, level: 18" node_number="1058">368</b>, 1274&#8211;1278 (2020).</div><div title="valid: False, node: 1059, tag: div, level: 17" node_number="1059"><div title="valid: False, node: 1060, tag: div, level: 18" node_number="1060"><a title="valid: False, node: 1061, tag: a, level: 19" node_number="1061">Crossref</a></div><div title="valid: False, node: 1062, tag: div, level: 18" node_number="1062"><a title="valid: False, node: 1063, tag: a, level: 19" node_number="1063">PubMed</a></div><div title="valid: False, node: 1064, tag: div, level: 18" node_number="1064"><a title="valid: False, node: 1065, tag: a, level: 19" node_number="1065">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1066, tag: div, level: 14" node_number="1066"><div title="valid: False, node: 1067, tag: div, level: 15" node_number="1067">26</div><div title="valid: False, node: 1068, tag: div, level: 15" node_number="1068"><div title="valid: False, node: 1069, tag: div, level: 16" node_number="1069"><div title="valid: False, node: 1070, tag: div, level: 17" node_number="1070">T. N. Starr, A. J. Greaney, A. S. Dingens, J. D. Bloom, Complete map of SARS-CoV-2 RBD mutations that escape the monoclonal antibody LY-CoV555 and its cocktail with LY-CoV016. Cell Rep. Med. <b title="valid: False, node: 1071, tag: b, level: 18" node_number="1071">2</b>, 100255 (2021).</div><div title="valid: False, node: 1072, tag: div, level: 17" node_number="1072"><div title="valid: False, node: 1073, tag: div, level: 18" node_number="1073"><a title="valid: False, node: 1074, tag: a, level: 19" node_number="1074">Crossref</a></div><div title="valid: False, node: 1075, tag: div, level: 18" node_number="1075"><a title="valid: False, node: 1076, tag: a, level: 19" node_number="1076">PubMed</a></div><div title="valid: False, node: 1077, tag: div, level: 18" node_number="1077"><a title="valid: False, node: 1078, tag: a, level: 19" node_number="1078">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1079, tag: div, level: 14" node_number="1079"><div title="valid: False, node: 1080, tag: div, level: 15" node_number="1080">27</div><div title="valid: False, node: 1081, tag: div, level: 15" node_number="1081"><div title="valid: False, node: 1082, tag: div, level: 16" node_number="1082"><div title="valid: False, node: 1083, tag: div, level: 17" node_number="1083">S. Elbe, G. Buckland-Merrett, Data, disease and diplomacy: GISAID&#8217;s innovative contribution to global health. Glob. Chall. <b title="valid: False, node: 1084, tag: b, level: 18" node_number="1084">1</b>, 33&#8211;46 (2017).</div><div title="valid: False, node: 1085, tag: div, level: 17" node_number="1085"><div title="valid: False, node: 1086, tag: div, level: 18" node_number="1086"><a title="valid: False, node: 1087, tag: a, level: 19" node_number="1087">Crossref</a></div><div title="valid: False, node: 1088, tag: div, level: 18" node_number="1088"><a title="valid: False, node: 1089, tag: a, level: 19" node_number="1089">PubMed</a></div><div title="valid: False, node: 1090, tag: div, level: 18" node_number="1090"><a title="valid: False, node: 1091, tag: a, level: 19" node_number="1091">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1092, tag: div, level: 14" node_number="1092"><div title="valid: False, node: 1093, tag: div, level: 15" node_number="1093">28</div><div title="valid: False, node: 1094, tag: div, level: 15" node_number="1094"><div title="valid: False, node: 1095, tag: div, level: 16" node_number="1095"><div title="valid: False, node: 1096, tag: div, level: 17" node_number="1096">Y. Weisblum, F. Schmidt, F. Zhang, J. DaSilva, D. Poston, J. C. C. Lorenzi, F. Muecksch, M. Rutkowska, H.-H. Hoffmann, E. Michailidis, C. Gaebler, M. Agudelo, A. Cho, Z. Wang, A. Gazumyan, M. Cipolla, L. Luchsinger, C. D. Hillyer, M. Caskey, D. F. Robbiani, C. M. Rice, M. C. Nussenzweig, T. Hatziioannou, P. D. Bieniasz, Escape from neutralizing antibodies by SARS-CoV-2 spike protein variants. eLife <b title="valid: False, node: 1097, tag: b, level: 18" node_number="1097">9</b>, e61312 (2020).</div><div title="valid: False, node: 1098, tag: div, level: 17" node_number="1098"><div title="valid: False, node: 1099, tag: div, level: 18" node_number="1099"><a title="valid: False, node: 1100, tag: a, level: 19" node_number="1100">Crossref</a></div><div title="valid: False, node: 1101, tag: div, level: 18" node_number="1101"><a title="valid: False, node: 1102, tag: a, level: 19" node_number="1102">PubMed</a></div><div title="valid: False, node: 1103, tag: div, level: 18" node_number="1103"><a title="valid: False, node: 1104, tag: a, level: 19" node_number="1104">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1105, tag: div, level: 14" node_number="1105"><div title="valid: False, node: 1106, tag: div, level: 15" node_number="1106">29</div><div title="valid: False, node: 1107, tag: div, level: 15" node_number="1107"><div title="valid: False, node: 1108, tag: div, level: 16" node_number="1108"><div title="valid: False, node: 1109, tag: div, level: 17" node_number="1109">D. Wrapp, N. Wang, K. S. Corbett, J. A. Goldsmith, C.-L. Hsieh, O. Abiona, B. S. Graham, J. S. McLellan, Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science <b title="valid: False, node: 1110, tag: b, level: 18" node_number="1110">367</b>, 1260&#8211;1263 (2020).</div><div title="valid: False, node: 1111, tag: div, level: 17" node_number="1111"><div title="valid: False, node: 1112, tag: div, level: 18" node_number="1112"><a title="valid: False, node: 1113, tag: a, level: 19" node_number="1113">Crossref</a></div><div title="valid: False, node: 1114, tag: div, level: 18" node_number="1114"><a title="valid: False, node: 1115, tag: a, level: 19" node_number="1115">PubMed</a></div><div title="valid: False, node: 1116, tag: div, level: 18" node_number="1116"><a title="valid: False, node: 1117, tag: a, level: 19" node_number="1117">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1118, tag: div, level: 14" node_number="1118"><div title="valid: False, node: 1119, tag: div, level: 15" node_number="1119">30</div><div title="valid: False, node: 1120, tag: div, level: 15" node_number="1120"><div title="valid: False, node: 1121, tag: div, level: 16" node_number="1121"><div title="valid: False, node: 1122, tag: div, level: 17" node_number="1122">K. Liu, X. Pan, L. Li, F. Yu, A. Zheng, P. Du, P. Han, Y. Meng, Y. Zhang, L. Wu, Q. Chen, C. Song, Y. Jia, S. Niu, D. Lu, C. Qiao, Z. Chen, D. Ma, X. Ma, S. Tan, X. Zhao, J. Qi, G. F. Gao, Q. Wang, Binding and molecular basis of the bat coronavirus RaTG13 virus to ACE2 in humans and other species. Cell <b title="valid: False, node: 1123, tag: b, level: 18" node_number="1123">184</b>, 3438&#8211;3451.e10 (2021).</div><div title="valid: False, node: 1124, tag: div, level: 17" node_number="1124"><div title="valid: False, node: 1125, tag: div, level: 18" node_number="1125"><a title="valid: False, node: 1126, tag: a, level: 19" node_number="1126">Crossref</a></div><div title="valid: False, node: 1127, tag: div, level: 18" node_number="1127"><a title="valid: False, node: 1128, tag: a, level: 19" node_number="1128">PubMed</a></div><div title="valid: False, node: 1129, tag: div, level: 18" node_number="1129"><a title="valid: False, node: 1130, tag: a, level: 19" node_number="1130">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1131, tag: div, level: 14" node_number="1131"><div title="valid: False, node: 1132, tag: div, level: 15" node_number="1132">31</div><div title="valid: False, node: 1133, tag: div, level: 15" node_number="1133"><div title="valid: False, node: 1134, tag: div, level: 16" node_number="1134"><div title="valid: False, node: 1135, tag: div, level: 17" node_number="1135">K. Suryamohan, D. Diwanji, E. W. Stawiski, R. Gupta, S. Miersch, J. Liu, C. Chen, Y.-P. Jiang, F. A. Fellouse, J. F. Sathirapongsasuti, P. K. Albers, T. Deepak, R. Saberianfar, A. Ratan, G. Washburn, M. Mis, D. Santhosh, S. Somasekar, G. H. Hiranjith, D. Vargas, S. Mohan, S. Phalke, B. Kuriakose, A. Antony, M. Ustav Jr., S. C. Schuster, S. Sidhu, J. R. Junutula, N. Jura, S. Seshagiri, Human ACE2 receptor polymorphisms and altered susceptibility to SARS-CoV-2. Commun. Biol. <b title="valid: False, node: 1136, tag: b, level: 18" node_number="1136">4</b>, 475 (2021).</div><div title="valid: False, node: 1137, tag: div, level: 17" node_number="1137"><div title="valid: False, node: 1138, tag: div, level: 18" node_number="1138"><a title="valid: False, node: 1139, tag: a, level: 19" node_number="1139">Crossref</a></div><div title="valid: False, node: 1140, tag: div, level: 18" node_number="1140"><a title="valid: False, node: 1141, tag: a, level: 19" node_number="1141">PubMed</a></div><div title="valid: False, node: 1142, tag: div, level: 18" node_number="1142"><a title="valid: False, node: 1143, tag: a, level: 19" node_number="1143">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1144, tag: div, level: 14" node_number="1144"><div title="valid: False, node: 1145, tag: div, level: 15" node_number="1145">32</div><div title="valid: False, node: 1146, tag: div, level: 15" node_number="1146"><div title="valid: False, node: 1147, tag: div, level: 16" node_number="1147"><div title="valid: False, node: 1148, tag: div, level: 17" node_number="1148">A. R. Mehdipour, G. Hummer, Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike. Proc. Natl. Acad. Sci. U.S.A. <b title="valid: False, node: 1149, tag: b, level: 18" node_number="1149">118</b>, e2100425118 (2021).</div><div title="valid: False, node: 1150, tag: div, level: 17" node_number="1150"><div title="valid: False, node: 1151, tag: div, level: 18" node_number="1151"><a title="valid: False, node: 1152, tag: a, level: 19" node_number="1152">Crossref</a></div><div title="valid: False, node: 1153, tag: div, level: 18" node_number="1153"><a title="valid: False, node: 1154, tag: a, level: 19" node_number="1154">PubMed</a></div><div title="valid: False, node: 1155, tag: div, level: 18" node_number="1155"><a title="valid: False, node: 1156, tag: a, level: 19" node_number="1156">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1157, tag: div, level: 14" node_number="1157"><div title="valid: False, node: 1158, tag: div, level: 15" node_number="1158">33</div><div title="valid: False, node: 1159, tag: div, level: 15" node_number="1159"><div title="valid: False, node: 1160, tag: div, level: 16" node_number="1160"><div title="valid: False, node: 1161, tag: div, level: 17" node_number="1161">X. Zhu, D. Mannar, S. S. Srivastava, A. M. Berezuk, J.-P. Demers, J. W. Saville, K. Leopold, W. Li, D. S. Dimitrov, K. S. Tuttle, S. Zhou, S. Chittori, S. Subramaniam, Cryo-electron microscopy structures of the N501Y SARS-CoV-2 spike protein in complex with ACE2 and 2 potent neutralizing antibodies. PLOS Biol. <b title="valid: False, node: 1162, tag: b, level: 18" node_number="1162">19</b>, e3001237 (2021).</div><div title="valid: False, node: 1163, tag: div, level: 17" node_number="1163"><div title="valid: False, node: 1164, tag: div, level: 18" node_number="1164"><a title="valid: False, node: 1165, tag: a, level: 19" node_number="1165">Crossref</a></div><div title="valid: False, node: 1166, tag: div, level: 18" node_number="1166"><a title="valid: False, node: 1167, tag: a, level: 19" node_number="1167">PubMed</a></div><div title="valid: False, node: 1168, tag: div, level: 18" node_number="1168"><a title="valid: False, node: 1169, tag: a, level: 19" node_number="1169">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1170, tag: div, level: 14" node_number="1170"><div title="valid: False, node: 1171, tag: div, level: 15" node_number="1171">34</div><div title="valid: False, node: 1172, tag: div, level: 15" node_number="1172"><div title="valid: False, node: 1173, tag: div, level: 16" node_number="1173"><div title="valid: False, node: 1174, tag: div, level: 17" node_number="1174">R. E. Chen, X. Zhang, J. B. Case, E. S. Winkler, Y. Liu, L. A. VanBlargan, J. Liu, J. M. Errico, X. Xie, N. Suryadevara, P. Gilchuk, S. J. Zost, S. Tahan, L. Droit, J. S. Turner, W. Kim, A. J. Schmitz, M. Thapa, D. Wang, A. C. M. Boon, R. M. Presti, J. A. O&#8217;Halloran, A. H. J. Kim, P. Deepak, D. Pinto, D. H. Fremont, J. E. Crowe Jr., D. Corti, H. W. Virgin, A. H. Ellebedy, P.-Y. Shi, M. S. Diamond, Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies. Nat. Med. <b title="valid: False, node: 1175, tag: b, level: 18" node_number="1175">27</b>, 717&#8211;726 (2021).</div><div title="valid: False, node: 1176, tag: div, level: 17" node_number="1176"><div title="valid: False, node: 1177, tag: div, level: 18" node_number="1177"><a title="valid: False, node: 1178, tag: a, level: 19" node_number="1178">Crossref</a></div><div title="valid: False, node: 1179, tag: div, level: 18" node_number="1179"><a title="valid: False, node: 1180, tag: a, level: 19" node_number="1180">PubMed</a></div><div title="valid: False, node: 1181, tag: div, level: 18" node_number="1181"><a title="valid: False, node: 1182, tag: a, level: 19" node_number="1182">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1183, tag: div, level: 14" node_number="1183"><div title="valid: False, node: 1184, tag: div, level: 15" node_number="1184">35</div><div title="valid: False, node: 1185, tag: div, level: 15" node_number="1185"><div title="valid: False, node: 1186, tag: div, level: 16" node_number="1186"><div title="valid: False, node: 1187, tag: div, level: 17" node_number="1187">A. J. Greaney, A. N. Loes, K. H. D. Crawford, T. N. Starr, K. D. Malone, H. Y. Chu, J. D. Bloom, Comprehensive mapping of mutations in the SARS-CoV-2 receptor-binding domain that affect recognition by polyclonal human plasma antibodies. Cell Host Microbe <b title="valid: False, node: 1188, tag: b, level: 18" node_number="1188">29</b>, 463&#8211;476.e6 (2021).</div><div title="valid: False, node: 1189, tag: div, level: 17" node_number="1189"><div title="valid: False, node: 1190, tag: div, level: 18" node_number="1190"><a title="valid: False, node: 1191, tag: a, level: 19" node_number="1191">Crossref</a></div><div title="valid: False, node: 1192, tag: div, level: 18" node_number="1192"><a title="valid: False, node: 1193, tag: a, level: 19" node_number="1193">PubMed</a></div><div title="valid: False, node: 1194, tag: div, level: 18" node_number="1194"><a title="valid: False, node: 1195, tag: a, level: 19" node_number="1195">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1196, tag: div, level: 14" node_number="1196"><div title="valid: False, node: 1197, tag: div, level: 15" node_number="1197">36</div><div title="valid: False, node: 1198, tag: div, level: 15" node_number="1198"><div title="valid: False, node: 1199, tag: div, level: 16" node_number="1199"><div title="valid: False, node: 1200, tag: div, level: 17" node_number="1200">C. O. Barnes, C. A. Jette, M. E. Abernathy, K. A. Dam, S. R. Esswein, H. B. Gristick, A. G. Malyutin, N. G. Sharaf, K. E. Huey-Tubman, Y. E. Lee, D. F. Robbiani, M. C. Nussenzweig, A. P. West Jr., P. J. Bjorkman, SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies. Nature <b title="valid: False, node: 1201, tag: b, level: 18" node_number="1201">588</b>, 682&#8211;687 (2020).</div><div title="valid: False, node: 1202, tag: div, level: 17" node_number="1202"><div title="valid: False, node: 1203, tag: div, level: 18" node_number="1203"><a title="valid: False, node: 1204, tag: a, level: 19" node_number="1204">Crossref</a></div><div title="valid: False, node: 1205, tag: div, level: 18" node_number="1205"><a title="valid: False, node: 1206, tag: a, level: 19" node_number="1206">PubMed</a></div><div title="valid: False, node: 1207, tag: div, level: 18" node_number="1207"><a title="valid: False, node: 1208, tag: a, level: 19" node_number="1208">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1209, tag: div, level: 14" node_number="1209"><div title="valid: False, node: 1210, tag: div, level: 15" node_number="1210">37</div><div title="valid: False, node: 1211, tag: div, level: 15" node_number="1211"><div title="valid: False, node: 1212, tag: div, level: 16" node_number="1212"><div title="valid: False, node: 1213, tag: div, level: 17" node_number="1213">B. E. Jones, P. L. Brown-Augsburger, K. S. Corbett, K. Westendorf, J. Davies, T. P. Cujec, C. M. Wiethoff, J. L. Blackbourne, B. A. Heinz, D. Foster, R. E. Higgs, D. Balasubramaniam, L. Wang, Y. Zhang, E. S. Yang, R. Bidshahri, L. Kraft, Y. Hwang, S. &#381;entelis, K. R. Jepson, R. Goya, M. A. Smith, D. W. Collins, S. J. Hinshaw, S. A. Tycho, D. Pellacani, P. Xiang, K. Muthuraman, S. Sobhanifar, M. H. Piper, F. J. Triana, J. Hendle, A. Pustilnik, A. C. Adams, S. J. Berens, R. S. Baric, D. R. Martinez, R. W. Cross, T. W. Geisbert, V. Borisevich, O. Abiona, H. M. Belli, M. de Vries, A. Mohamed, M. Dittmann, M. I. Samanovic, M. J. Mulligan, J. A. Goldsmith, C.-L. Hsieh, N. V. Johnson, D. Wrapp, J. S. McLellan, B. C. Barnhart, B. S. Graham, J. R. Mascola, C. L. Hansen, E. Falconer, The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates. Sci. Transl. Med. <b title="valid: False, node: 1214, tag: b, level: 18" node_number="1214">13</b>, eabf1906 (2021).</div><div title="valid: False, node: 1215, tag: div, level: 17" node_number="1215"><div title="valid: False, node: 1216, tag: div, level: 18" node_number="1216"><a title="valid: False, node: 1217, tag: a, level: 19" node_number="1217">Crossref</a></div><div title="valid: False, node: 1218, tag: div, level: 18" node_number="1218"><a title="valid: False, node: 1219, tag: a, level: 19" node_number="1219">PubMed</a></div><div title="valid: False, node: 1220, tag: div, level: 18" node_number="1220"><a title="valid: False, node: 1221, tag: a, level: 19" node_number="1221">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1222, tag: div, level: 14" node_number="1222"><div title="valid: False, node: 1223, tag: div, level: 15" node_number="1223">38</div><div title="valid: False, node: 1224, tag: div, level: 15" node_number="1224"><div title="valid: False, node: 1225, tag: div, level: 16" node_number="1225"><div title="valid: False, node: 1226, tag: div, level: 17" node_number="1226">D. Planas, D. Veyer, A. Baidaliuk, I. Staropoli, F. Guivel-Benhassine, M. M. Rajah, C. Planchais, F. Porrot, N. Robillard, J. Puech, M. Prot, F. Gallais, P. Gantner, A. Velay, J. Le Guen, N. Kassis-Chikhani, D. Edriss, L. Belec, A. Seve, L. Courtellemont, H. P&#233;r&#233;, L. Hocqueloux, S. Fafi-Kremer, T. Prazuck, H. Mouquet, T. Bruel, E. Simon-Lori&#232;re, F. A. Rey, O. Schwartz, Reduced sensitivity of SARS-CoV-2 variant Delta to antibody neutralization. Nature <b title="valid: False, node: 1227, tag: b, level: 18" node_number="1227">596</b>, 276&#8211;280 (2021).</div><div title="valid: False, node: 1228, tag: div, level: 17" node_number="1228"><div title="valid: False, node: 1229, tag: div, level: 18" node_number="1229"><a title="valid: False, node: 1230, tag: a, level: 19" node_number="1230">Crossref</a></div><div title="valid: False, node: 1231, tag: div, level: 18" node_number="1231"><a title="valid: False, node: 1232, tag: a, level: 19" node_number="1232">PubMed</a></div><div title="valid: False, node: 1233, tag: div, level: 18" node_number="1233"><a title="valid: False, node: 1234, tag: a, level: 19" node_number="1234">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1235, tag: div, level: 14" node_number="1235"><div title="valid: False, node: 1236, tag: div, level: 15" node_number="1236">39</div><div title="valid: False, node: 1237, tag: div, level: 15" node_number="1237"><div title="valid: False, node: 1238, tag: div, level: 16" node_number="1238"><div title="valid: False, node: 1239, tag: div, level: 17" node_number="1239">R. E. Chen, E. S. Winkler, J. B. Case, I. D. Aziati, T. L. Bricker, A. Joshi, T. L. Darling, B. Ying, J. M. Errico, S. Shrihari, L. A. VanBlargan, X. Xie, P. Gilchuk, S. J. Zost, L. Droit, Z. Liu, S. Stumpf, D. Wang, S. A. Handley, W. B. Stine Jr., P.-Y. Shi, M. E. Davis-Gardner, M. S. Suthar, M. G. Knight, R. Andino, C. Y. Chiu, A. H. Ellebedy, D. H. Fremont, S. P. J. Whelan, J. E. Crowe Jr., L. Purcell, D. Corti, A. C. M. Boon, M. S. Diamond, In vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains. Nature <b title="valid: False, node: 1240, tag: b, level: 18" node_number="1240">596</b>, 103&#8211;108 (2021).</div><div title="valid: False, node: 1241, tag: div, level: 17" node_number="1241"><div title="valid: False, node: 1242, tag: div, level: 18" node_number="1242"><a title="valid: False, node: 1243, tag: a, level: 19" node_number="1243">Crossref</a></div><div title="valid: False, node: 1244, tag: div, level: 18" node_number="1244"><a title="valid: False, node: 1245, tag: a, level: 19" node_number="1245">PubMed</a></div><div title="valid: False, node: 1246, tag: div, level: 18" node_number="1246"><a title="valid: False, node: 1247, tag: a, level: 19" node_number="1247">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1248, tag: div, level: 14" node_number="1248"><div title="valid: False, node: 1249, tag: div, level: 15" node_number="1249">40</div><div title="valid: False, node: 1250, tag: div, level: 15" node_number="1250"><div title="valid: False, node: 1251, tag: div, level: 16" node_number="1251"><div title="valid: False, node: 1252, tag: div, level: 17" node_number="1252">M. McCallum, J. Bassi, A. De Marco, A. Chen, A. C. Walls, J. Di Iulio, M. A. Tortorici, M.-J. Navarro, C. Silacci-Fregni, C. Saliba, K. R. Sprouse, M. Agostini, D. Pinto, K. Culap, S. Bianchi, S. Jaconi, E. Cameroni, J. E. Bowen, S. W. Tilles, M. S. Pizzuto, S. B. Guastalla, G. Bona, A. F. Pellanda, C. Garzoni, W. C. Van Voorhis, L. E. Rosen, G. Snell, A. Telenti, H. W. Virgin, L. Piccoli, D. Corti, D. Veesler, SARS-CoV-2 immune evasion by the B.1.427/B.1.429 variant of concern. Science <b title="valid: False, node: 1253, tag: b, level: 18" node_number="1253">373</b>, 648&#8211;654 (2021).</div><div title="valid: False, node: 1254, tag: div, level: 17" node_number="1254"><div title="valid: False, node: 1255, tag: div, level: 18" node_number="1255"><a title="valid: False, node: 1256, tag: a, level: 19" node_number="1256">Crossref</a></div><div title="valid: False, node: 1257, tag: div, level: 18" node_number="1257"><a title="valid: False, node: 1258, tag: a, level: 19" node_number="1258">PubMed</a></div><div title="valid: False, node: 1259, tag: div, level: 18" node_number="1259"><a title="valid: False, node: 1260, tag: a, level: 19" node_number="1260">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1261, tag: div, level: 14" node_number="1261"><div title="valid: False, node: 1262, tag: div, level: 15" node_number="1262">41</div><div title="valid: False, node: 1263, tag: div, level: 15" node_number="1263"><div title="valid: False, node: 1264, tag: div, level: 16" node_number="1264"><div title="valid: False, node: 1265, tag: div, level: 17" node_number="1265">E. C. Thomson, L. E. Rosen, J. G. Shepherd, R. Spreafico, A. da Silva Filipe, J. A. Wojcechowskyj, C. Davis, L. Piccoli, D. J. Pascall, J. Dillen, S. Lytras, N. Czudnochowski, R. Shah, M. Meury, N. Jesudason, A. De Marco, K. Li, J. Bassi, A. O&#8217;Toole, D. Pinto, R. M. Colquhoun, K. Culap, B. Jackson, F. Zatta, A. Rambaut, S. Jaconi, V. B. Sreenu, J. Nix, I. Zhang, R. F. Jarrett, W. G. Glass, M. Beltramello, K. Nomikou, M. Pizzuto, L. Tong, E. Cameroni, T. I. Croll, N. Johnson, J. Di Iulio, A. Wickenhagen, A. Ceschi, A. M. Harbison, D. Mair, P. Ferrari, K. Smollett, F. Sallusto, S. Carmichael, C. Garzoni, J. Nichols, M. Galli, J. Hughes, A. Riva, A. Ho, M. Schiuma, M. G. Semple, P. J. M. Openshaw, E. Fadda, J. K. Baillie, J. D. Chodera, S. J. Rihn, S. J. Lycett, H. W. Virgin, A. Telenti, D. Corti, D. L. Robertson, G. Snell; ISARIC4C Investigators; COVID-19 Genomics UK (COG-UK) Consortium, Circulating SARS-CoV-2 spike N439K variants maintain fitness while evading antibody-mediated immunity. Cell <b title="valid: False, node: 1266, tag: b, level: 18" node_number="1266">184</b>, 1171&#8211;1187.e20 (2021).</div><div title="valid: False, node: 1267, tag: div, level: 17" node_number="1267"><div title="valid: False, node: 1268, tag: div, level: 18" node_number="1268"><a title="valid: False, node: 1269, tag: a, level: 19" node_number="1269">Crossref</a></div><div title="valid: False, node: 1270, tag: div, level: 18" node_number="1270"><a title="valid: False, node: 1271, tag: a, level: 19" node_number="1271">PubMed</a></div><div title="valid: False, node: 1272, tag: div, level: 18" node_number="1272"><a title="valid: False, node: 1273, tag: a, level: 19" node_number="1273">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1274, tag: div, level: 14" node_number="1274"><div title="valid: False, node: 1275, tag: div, level: 15" node_number="1275">42</div><div title="valid: False, node: 1276, tag: div, level: 15" node_number="1276"><div title="valid: False, node: 1277, tag: div, level: 16" node_number="1277"><div title="valid: False, node: 1278, tag: div, level: 17" node_number="1278">L. Wang, T. Zhou, Y. Zhang, E. S. Yang, C. A. Schramm, W. Shi, A. Pegu, O. K. Oloniniyi, A. R. Henry, S. Darko, S. R. Narpala, C. Hatcher, D. R. Martinez, Y. Tsybovsky, E. Phung, O. M. Abiona, A. Antia, E. M. Cale, L. A. Chang, M. Choe, K. S. Corbett, R. L. Davis, A. T. DiPiazza, I. J. Gordon, S. H. Hait, T. Hermanus, P. Kgagudi, F. Laboune, K. Leung, T. Liu, R. D. Mason, A. F. Nazzari, L. Novik, S. O&#8217;Connell, S. O&#8217;Dell, A. S. Olia, S. D. Schmidt, T. Stephens, C. D. Stringham, C. A. Talana, I.-T. Teng, D. A. Wagner, A. T. Widge, B. Zhang, M. Roederer, J. E. Ledgerwood, T. J. Ruckwardt, M. R. Gaudinski, P. L. Moore, N. A. Doria-Rose, R. S. Baric, B. S. Graham, A. B. McDermott, D. C. Douek, P. D. Kwong, J. R. Mascola, N. J. Sullivan, J. Misasi, Ultrapotent antibodies against diverse and highly transmissible SARS-CoV-2 variants. Science <b title="valid: False, node: 1279, tag: b, level: 18" node_number="1279">373</b>, eabh1766 (2021).</div><div title="valid: False, node: 1280, tag: div, level: 17" node_number="1280"><div title="valid: False, node: 1281, tag: div, level: 18" node_number="1281"><a title="valid: False, node: 1282, tag: a, level: 19" node_number="1282">Crossref</a></div><div title="valid: False, node: 1283, tag: div, level: 18" node_number="1283"><a title="valid: False, node: 1284, tag: a, level: 19" node_number="1284">PubMed</a></div><div title="valid: False, node: 1285, tag: div, level: 18" node_number="1285"><a title="valid: False, node: 1286, tag: a, level: 19" node_number="1286">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1287, tag: div, level: 14" node_number="1287"><div title="valid: False, node: 1288, tag: div, level: 15" node_number="1288">43</div><div title="valid: False, node: 1289, tag: div, level: 15" node_number="1289"><div title="valid: False, node: 1290, tag: div, level: 16" node_number="1290"><div title="valid: False, node: 1291, tag: div, level: 17" node_number="1291">M. Yuan, D. Huang, C. D. Lee, N. C. Wu, A. M. Jackson, X. Zhu, H. Liu, L. Peng, M. J. van Gils, R. W. Sanders, D. R. Burton, S. M. Reincke, H. Pr&#252;ss, J. Kreye, D. Nemazee, A. B. Ward, I. A. Wilson, Structural and functional ramifications of antigenic drift in recent SARS-CoV-2 variants. Science <b title="valid: False, node: 1292, tag: b, level: 18" node_number="1292">373</b>, 818&#8211;823 (2021).</div><div title="valid: False, node: 1293, tag: div, level: 17" node_number="1293"><div title="valid: False, node: 1294, tag: div, level: 18" node_number="1294"><a title="valid: False, node: 1295, tag: a, level: 19" node_number="1295">Crossref</a></div><div title="valid: False, node: 1296, tag: div, level: 18" node_number="1296"><a title="valid: False, node: 1297, tag: a, level: 19" node_number="1297">PubMed</a></div><div title="valid: False, node: 1298, tag: div, level: 18" node_number="1298"><a title="valid: False, node: 1299, tag: a, level: 19" node_number="1299">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1300, tag: div, level: 14" node_number="1300"><div title="valid: False, node: 1301, tag: div, level: 15" node_number="1301">44</div><div title="valid: False, node: 1302, tag: div, level: 15" node_number="1302"><div title="valid: False, node: 1303, tag: div, level: 16" node_number="1303"><div title="valid: False, node: 1304, tag: div, level: 17" node_number="1304">D. Pinto, Y.-J. Park, M. Beltramello, A. C. Walls, M. A. Tortorici, S. Bianchi, S. Jaconi, K. Culap, F. Zatta, A. De Marco, A. Peter, B. Guarino, R. Spreafico, E. Cameroni, J. B. Case, R. E. Chen, C. Havenar-Daughton, G. Snell, A. Telenti, H. W. Virgin, A. Lanzavecchia, M. S. Diamond, K. Fink, D. Veesler, D. Corti, Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody. Nature <b title="valid: False, node: 1305, tag: b, level: 18" node_number="1305">583</b>, 290&#8211;295 (2020).</div><div title="valid: False, node: 1306, tag: div, level: 17" node_number="1306"><div title="valid: False, node: 1307, tag: div, level: 18" node_number="1307"><a title="valid: False, node: 1308, tag: a, level: 19" node_number="1308">Crossref</a></div><div title="valid: False, node: 1309, tag: div, level: 18" node_number="1309"><a title="valid: False, node: 1310, tag: a, level: 19" node_number="1310">PubMed</a></div><div title="valid: False, node: 1311, tag: div, level: 18" node_number="1311"><a title="valid: False, node: 1312, tag: a, level: 19" node_number="1312">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1313, tag: div, level: 14" node_number="1313"><div title="valid: False, node: 1314, tag: div, level: 15" node_number="1314">45</div><div title="valid: False, node: 1315, tag: div, level: 15" node_number="1315"><div title="valid: False, node: 1316, tag: div, level: 16" node_number="1316"><div title="valid: False, node: 1317, tag: div, level: 17" node_number="1317">C. G. Rappazzo, L. V. Tse, C. I. Kaku, D. Wrapp, M. Sakharkar, D. Huang, L. M. Deveau, T. J. Yockachonis, A. S. Herbert, M. B. Battles, C. M. O&#8217;Brien, M. E. Brown, J. C. Geoghegan, J. Belk, L. Peng, L. Yang, Y. Hou, T. D. Scobey, D. R. Burton, D. Nemazee, J. M. Dye, J. E. Voss, B. M. Gunn, J. S. McLellan, R. S. Baric, L. E. Gralinski, L. M. Walker, Broad and potent activity against SARS-like viruses by an engineered human monoclonal antibody. Science <b title="valid: False, node: 1318, tag: b, level: 18" node_number="1318">371</b>, 823&#8211;829 (2021).</div><div title="valid: False, node: 1319, tag: div, level: 17" node_number="1319"><div title="valid: False, node: 1320, tag: div, level: 18" node_number="1320"><a title="valid: False, node: 1321, tag: a, level: 19" node_number="1321">Crossref</a></div><div title="valid: False, node: 1322, tag: div, level: 18" node_number="1322"><a title="valid: False, node: 1323, tag: a, level: 19" node_number="1323">PubMed</a></div><div title="valid: False, node: 1324, tag: div, level: 18" node_number="1324"><a title="valid: False, node: 1325, tag: a, level: 19" node_number="1325">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1326, tag: div, level: 14" node_number="1326"><div title="valid: False, node: 1327, tag: div, level: 15" node_number="1327">46</div><div title="valid: False, node: 1328, tag: div, level: 15" node_number="1328"><div title="valid: False, node: 1329, tag: div, level: 16" node_number="1329"><div title="valid: False, node: 1330, tag: div, level: 17" node_number="1330">C. Liu, H. M. Ginn, W. Dejnirattisai, P. Supasa, B. Wang, A. Tuekprakhon, R. Nutalai, D. Zhou, A. J. Mentzer, Y. Zhao, H. M. E. Duyvesteyn, C. L&#243;pez-Camacho, J. Slon-Campos, T. S. Walter, D. Skelly, S. A. Johnson, T. G. Ritter, C. Mason, S. A. Costa Clemens, F. Gomes Naveca, V. Nascimento, F. Nascimento, C. Fernandes da Costa, P. C. Resende, A. Pauvolid-Correa, M. M. Siqueira, C. Dold, N. Temperton, T. Dong, A. J. Pollard, J. C. Knight, D. Crook, T. Lambe, E. Clutterbuck, S. Bibi, A. Flaxman, M. Bittaye, S. Belij-Rammerstorfer, S. C. Gilbert, T. Malik, M. W. Carroll, P. Klenerman, E. Barnes, S. J. Dunachie, V. Baillie, N. Serafin, Z. Ditse, K. Da Silva, N. G. Paterson, M. A. Williams, D. R. Hall, S. Madhi, M. C. Nunes, P. Goulder, E. E. Fry, J. Mongkolsapaya, J. Ren, D. I. Stuart, G. R. Screaton, Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum. Cell <b title="valid: False, node: 1331, tag: b, level: 18" node_number="1331">184</b>, 4220&#8211;4236.e13 (2021).</div><div title="valid: False, node: 1332, tag: div, level: 17" node_number="1332"><div title="valid: False, node: 1333, tag: div, level: 18" node_number="1333"><a title="valid: False, node: 1334, tag: a, level: 19" node_number="1334">Crossref</a></div><div title="valid: False, node: 1335, tag: div, level: 18" node_number="1335"><a title="valid: False, node: 1336, tag: a, level: 19" node_number="1336">PubMed</a></div><div title="valid: False, node: 1337, tag: div, level: 18" node_number="1337"><a title="valid: False, node: 1338, tag: a, level: 19" node_number="1338">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1339, tag: div, level: 14" node_number="1339"><div title="valid: False, node: 1340, tag: div, level: 15" node_number="1340">47</div><div title="valid: False, node: 1341, tag: div, level: 15" node_number="1341"><div title="valid: False, node: 1342, tag: div, level: 16" node_number="1342"><div title="valid: False, node: 1343, tag: div, level: 17" node_number="1343">L. R. Baden, H. M. El Sahly, B. Essink, K. Kotloff, S. Frey, R. Novak, D. Diemert, S. A. Spector, N. Rouphael, C. B. Creech, J. McGettigan, S. Khetan, N. Segall, J. Solis, A. Brosz, C. Fierro, H. Schwartz, K. Neuzil, L. Corey, P. Gilbert, H. Janes, D. Follmann, M. Marovich, J. Mascola, L. Polakowski, J. Ledgerwood, B. S. Graham, H. Bennett, R. Pajon, C. Knightly, B. Leav, W. Deng, H. Zhou, S. Han, M. Ivarsson, J. Miller, T. Zaks; COVE Study Group, Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine. N. Engl. J. Med. <b title="valid: False, node: 1344, tag: b, level: 18" node_number="1344">384</b>, 403&#8211;416 (2021).</div><div title="valid: False, node: 1345, tag: div, level: 17" node_number="1345"><div title="valid: False, node: 1346, tag: div, level: 18" node_number="1346"><a title="valid: False, node: 1347, tag: a, level: 19" node_number="1347">Crossref</a></div><div title="valid: False, node: 1348, tag: div, level: 18" node_number="1348"><a title="valid: False, node: 1349, tag: a, level: 19" node_number="1349">PubMed</a></div><div title="valid: False, node: 1350, tag: div, level: 18" node_number="1350"><a title="valid: False, node: 1351, tag: a, level: 19" node_number="1351">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1352, tag: div, level: 14" node_number="1352"><div title="valid: False, node: 1353, tag: div, level: 15" node_number="1353">48</div><div title="valid: False, node: 1354, tag: div, level: 15" node_number="1354"><div title="valid: False, node: 1355, tag: div, level: 16" node_number="1355"><div title="valid: False, node: 1356, tag: div, level: 17" node_number="1356">F. P. Polack, S. J. Thomas, N. Kitchin, J. Absalon, A. Gurtman, S. Lockhart, J. L. Perez, G. P&#233;rez Marc, E. D. Moreira, C. Zerbini, R. Bailey, K. A. Swanson, S. Roychoudhury, K. Koury, P. Li, W. V. Kalina, D. Cooper, R. W. Frenck Jr., L. L. Hammitt, &#214;. T&#252;reci, H. Nell, A. Schaefer, S. &#220;nal, D. B. Tresnan, S. Mather, P. R. Dormitzer, U. &#350;ahin, K. U. Jansen, W. C. Gruber; C4591001 Clinical Trial Group, Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine. N. Engl. J. Med. <b title="valid: False, node: 1357, tag: b, level: 18" node_number="1357">383</b>, 2603&#8211;2615 (2020).</div><div title="valid: False, node: 1358, tag: div, level: 17" node_number="1358"><div title="valid: False, node: 1359, tag: div, level: 18" node_number="1359"><a title="valid: False, node: 1360, tag: a, level: 19" node_number="1360">Crossref</a></div><div title="valid: False, node: 1361, tag: div, level: 18" node_number="1361"><a title="valid: False, node: 1362, tag: a, level: 19" node_number="1362">PubMed</a></div><div title="valid: False, node: 1363, tag: div, level: 18" node_number="1363"><a title="valid: False, node: 1364, tag: a, level: 19" node_number="1364">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1365, tag: div, level: 14" node_number="1365"><div title="valid: False, node: 1366, tag: div, level: 15" node_number="1366">49</div><div title="valid: False, node: 1367, tag: div, level: 15" node_number="1367"><div title="valid: False, node: 1368, tag: div, level: 16" node_number="1368"><div title="valid: False, node: 1369, tag: div, level: 17" node_number="1369">L. A. Jackson, E. J. Anderson, N. G. Rouphael, P. C. Roberts, M. Makhene, R. N. Coler, M. P. McCullough, J. D. Chappell, M. R. Denison, L. J. Stevens, A. J. Pruijssers, A. McDermott, B. Flach, N. A. Doria-Rose, K. S. Corbett, K. M. Morabito, S. O&#8217;Dell, S. D. Schmidt, P. A. Swanson 2nd, M. Padilla, J. R. Mascola, K. M. Neuzil, H. Bennett, W. Sun, E. Peters, M. Makowski, J. Albert, K. Cross, W. Buchanan, R. Pikaart-Tautges, J. E. Ledgerwood, B. S. Graham, J. H. Beigel; mRNA-1273 Study Group, An mRNA vaccine against SARS-CoV-2 &#8212; Preliminary report. N. Engl. J. Med. <b title="valid: False, node: 1370, tag: b, level: 18" node_number="1370">383</b>, 1920&#8211;1931 (2020).</div><div title="valid: False, node: 1371, tag: div, level: 17" node_number="1371"><div title="valid: False, node: 1372, tag: div, level: 18" node_number="1372"><a title="valid: False, node: 1373, tag: a, level: 19" node_number="1373">Crossref</a></div><div title="valid: False, node: 1374, tag: div, level: 18" node_number="1374"><a title="valid: False, node: 1375, tag: a, level: 19" node_number="1375">PubMed</a></div><div title="valid: False, node: 1376, tag: div, level: 18" node_number="1376"><a title="valid: False, node: 1377, tag: a, level: 19" node_number="1377">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1378, tag: div, level: 14" node_number="1378"><div title="valid: False, node: 1379, tag: div, level: 15" node_number="1379">50</div><div title="valid: False, node: 1380, tag: div, level: 15" node_number="1380"><div title="valid: False, node: 1381, tag: div, level: 16" node_number="1381"><div title="valid: False, node: 1382, tag: div, level: 17" node_number="1382">T. G. Ksiazek, D. Erdman, C. S. Goldsmith, S. R. Zaki, T. Peret, S. Emery, S. Tong, C. Urbani, J. A. Comer, W. Lim, P. E. Rollin, S. F. Dowell, A.-E. Ling, C. D. Humphrey, W.-J. Shieh, J. Guarner, C. D. Paddock, P. Rota, B. Fields, J. DeRisi, J.-Y. Yang, N. Cox, J. M. Hughes, J. W. LeDuc, W. J. Bellini, L. J. Anderson; SARS Working Group, A novel coronavirus associated with severe acute respiratory syndrome. N. Engl. J. Med. <b title="valid: False, node: 1383, tag: b, level: 18" node_number="1383">348</b>, 1953&#8211;1966 (2003).</div><div title="valid: False, node: 1384, tag: div, level: 17" node_number="1384"><div title="valid: False, node: 1385, tag: div, level: 18" node_number="1385"><a title="valid: False, node: 1386, tag: a, level: 19" node_number="1386">Crossref</a></div><div title="valid: False, node: 1387, tag: div, level: 18" node_number="1387"><a title="valid: False, node: 1388, tag: a, level: 19" node_number="1388">PubMed</a></div><div title="valid: False, node: 1389, tag: div, level: 18" node_number="1389"><a title="valid: False, node: 1390, tag: a, level: 19" node_number="1390">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1391, tag: div, level: 14" node_number="1391"><div title="valid: False, node: 1392, tag: div, level: 15" node_number="1392">51</div><div title="valid: False, node: 1393, tag: div, level: 15" node_number="1393"><div title="valid: False, node: 1394, tag: div, level: 16" node_number="1394"><div title="valid: False, node: 1395, tag: div, level: 17" node_number="1395">Z. Chen, L. Zhang, C. Qin, L. Ba, C. E. Yi, F. Zhang, Q. Wei, T. He, W. Yu, J. Yu, H. Gao, X. Tu, A. Gettie, M. Farzan, K. Y. Yuen, D. D. Ho, Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region. J. Virol. <b title="valid: False, node: 1396, tag: b, level: 18" node_number="1396">79</b>, 2678&#8211;2688 (2005).</div><div title="valid: False, node: 1397, tag: div, level: 17" node_number="1397"><div title="valid: False, node: 1398, tag: div, level: 18" node_number="1398"><a title="valid: False, node: 1399, tag: a, level: 19" node_number="1399">Crossref</a></div><div title="valid: False, node: 1400, tag: div, level: 18" node_number="1400"><a title="valid: False, node: 1401, tag: a, level: 19" node_number="1401">PubMed</a></div><div title="valid: False, node: 1402, tag: div, level: 18" node_number="1402"><a title="valid: False, node: 1403, tag: a, level: 19" node_number="1403">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1404, tag: div, level: 14" node_number="1404"><div title="valid: False, node: 1405, tag: div, level: 15" node_number="1405">52</div><div title="valid: False, node: 1406, tag: div, level: 15" node_number="1406"><div title="valid: False, node: 1407, tag: div, level: 16" node_number="1407"><div title="valid: False, node: 1408, tag: div, level: 17" node_number="1408">Y. Zhu, D. Yu, Y. Han, H. Yan, H. Chong, L. Ren, J. Wang, T. Li, Y. He, Cross-reactive neutralization of SARS-CoV-2 by serum antibodies from recovered SARS patients and immunized animals. Sci. Adv. <b title="valid: False, node: 1409, tag: b, level: 18" node_number="1409">6</b>, eabc9999 (2020).</div><div title="valid: False, node: 1410, tag: div, level: 17" node_number="1410"><div title="valid: False, node: 1411, tag: div, level: 18" node_number="1411"><a title="valid: False, node: 1412, tag: a, level: 19" node_number="1412">Crossref</a></div><div title="valid: False, node: 1413, tag: div, level: 18" node_number="1413"><a title="valid: False, node: 1414, tag: a, level: 19" node_number="1414">PubMed</a></div><div title="valid: False, node: 1415, tag: div, level: 18" node_number="1415"><a title="valid: False, node: 1416, tag: a, level: 19" node_number="1416">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1417, tag: div, level: 14" node_number="1417"><div title="valid: False, node: 1418, tag: div, level: 15" node_number="1418">53</div><div title="valid: False, node: 1419, tag: div, level: 15" node_number="1419"><div title="valid: False, node: 1420, tag: div, level: 16" node_number="1420"><div title="valid: False, node: 1421, tag: div, level: 17" node_number="1421">H. Lv, N. C. Wu, O. T.-Y. Tsang, M. Yuan, R. A. P. M. Perera, W. S. Leung, R. T. Y. So, J. M. C. Chan, G. K. Yip, T. S. H. Chik, Y. Wang, C. Y. C. Choi, Y. Lin, W. W. Ng, J. Zhao, L. L. M. Poon, J. S. M. Peiris, I. A. Wilson, C. K. P. Mok, Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections. Cell Rep. <b title="valid: False, node: 1422, tag: b, level: 18" node_number="1422">31</b>, 107725 (2020).</div><div title="valid: False, node: 1423, tag: div, level: 17" node_number="1423"><div title="valid: False, node: 1424, tag: div, level: 18" node_number="1424"><a title="valid: False, node: 1425, tag: a, level: 19" node_number="1425">Crossref</a></div><div title="valid: False, node: 1426, tag: div, level: 18" node_number="1426"><a title="valid: False, node: 1427, tag: a, level: 19" node_number="1427">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1428, tag: div, level: 14" node_number="1428"><div title="valid: False, node: 1429, tag: div, level: 15" node_number="1429">54</div><div title="valid: False, node: 1430, tag: div, level: 15" node_number="1430"><div title="valid: False, node: 1431, tag: div, level: 16" node_number="1431"><div title="valid: False, node: 1432, tag: div, level: 17" node_number="1432">J. Pallesen, N. Wang, K. S. Corbett, D. Wrapp, R. N. Kirchdoerfer, H. L. Turner, C. A. Cottrell, M. M. Becker, L. Wang, W. Shi, W.-P. Kong, E. L. Andres, A. N. Kettenbach, M. R. Denison, J. D. Chappell, B. S. Graham, A. B. Ward, J. S. McLellan, Immunogenicity and structures of a rationally designed prefusion MERS-CoV spike antigen. Proc. Natl. Acad. Sci. U.S.A. <b title="valid: False, node: 1433, tag: b, level: 18" node_number="1433">114</b>, E7348&#8211;E7357 (2017).</div><div title="valid: False, node: 1434, tag: div, level: 17" node_number="1434"><div title="valid: False, node: 1435, tag: div, level: 18" node_number="1435"><a title="valid: False, node: 1436, tag: a, level: 19" node_number="1436">Crossref</a></div><div title="valid: False, node: 1437, tag: div, level: 18" node_number="1437"><a title="valid: False, node: 1438, tag: a, level: 19" node_number="1438">PubMed</a></div><div title="valid: False, node: 1439, tag: div, level: 18" node_number="1439"><a title="valid: False, node: 1440, tag: a, level: 19" node_number="1440">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1441, tag: div, level: 14" node_number="1441"><div title="valid: False, node: 1442, tag: div, level: 15" node_number="1442">55</div><div title="valid: False, node: 1443, tag: div, level: 15" node_number="1443"><div title="valid: False, node: 1444, tag: div, level: 16" node_number="1444"><div title="valid: False, node: 1445, tag: div, level: 17" node_number="1445">M. Yuan, N. C. Wu, X. Zhu, C. D. Lee, R. T. Y. So, H. Lv, C. K. P. Mok, I. A. Wilson, A highly conserved cryptic epitope in the receptor binding domains of SARS-CoV-2 and SARS-CoV. Science <b title="valid: False, node: 1446, tag: b, level: 18" node_number="1446">368</b>, 630&#8211;633 (2020).</div><div title="valid: False, node: 1447, tag: div, level: 17" node_number="1447"><div title="valid: False, node: 1448, tag: div, level: 18" node_number="1448"><a title="valid: False, node: 1449, tag: a, level: 19" node_number="1449">Crossref</a></div><div title="valid: False, node: 1450, tag: div, level: 18" node_number="1450"><a title="valid: False, node: 1451, tag: a, level: 19" node_number="1451">PubMed</a></div><div title="valid: False, node: 1452, tag: div, level: 18" node_number="1452"><a title="valid: False, node: 1453, tag: a, level: 19" node_number="1453">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1454, tag: div, level: 14" node_number="1454"><div title="valid: False, node: 1455, tag: div, level: 15" node_number="1455">56</div><div title="valid: False, node: 1456, tag: div, level: 15" node_number="1456"><div title="valid: False, node: 1457, tag: div, level: 16" node_number="1457"><div title="valid: False, node: 1458, tag: div, level: 17" node_number="1458">M. A. Tortorici, N. Czudnochowski, T. N. Starr, R. Marzi, A. C. Walls, F. Zatta, J. E. Bowen, S. Jaconi, J. Di Iulio, Z. Wang, A. De Marco, S. K. Zepeda, D. Pinto, Z. Liu, M. Beltramello, I. Bartha, M. P. Housley, F. A. Lempp, L. E. Rosen, E. Dellota Jr., H. Kaiser, M. Montiel-Ruiz, J. Zhou, A. Addetia, B. Guarino, K. Culap, N. Sprugasci, C. Saliba, E. Vetti, I. Giacchetto-Sasselli, C. S. Fregni, R. Abdelnabi, S. C. Foo, C. Havenar-Daughton, M. A. Schmid, F. Benigni, E. Cameroni, J. Neyts, A. Telenti, H. W. Virgin, S. P. J. Whelan, G. Snell, J. D. Bloom, D. Corti, D. Veesler, M. S. Pizzuto, Broad sarbecovirus neutralization by a human monoclonal antibody. Nature <b title="valid: False, node: 1459, tag: b, level: 18" node_number="1459">597</b>, 103&#8211;108 (2021).</div><div title="valid: False, node: 1460, tag: div, level: 17" node_number="1460"><div title="valid: False, node: 1461, tag: div, level: 18" node_number="1461"><a title="valid: False, node: 1462, tag: a, level: 19" node_number="1462">Crossref</a></div><div title="valid: False, node: 1463, tag: div, level: 18" node_number="1463"><a title="valid: False, node: 1464, tag: a, level: 19" node_number="1464">PubMed</a></div><div title="valid: False, node: 1465, tag: div, level: 18" node_number="1465"><a title="valid: False, node: 1466, tag: a, level: 19" node_number="1466">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1467, tag: div, level: 14" node_number="1467"><div title="valid: False, node: 1468, tag: div, level: 15" node_number="1468">57</div><div title="valid: False, node: 1469, tag: div, level: 15" node_number="1469"><div title="valid: False, node: 1470, tag: div, level: 16" node_number="1470"><div title="valid: False, node: 1471, tag: div, level: 17" node_number="1471">H. Liu, N. C. Wu, M. Yuan, S. Bangaru, J. L. Torres, T. G. Caniels, J. van Schooten, X. Zhu, C. D. Lee, P. J. M. Brouwer, M. J. van Gils, R. W. Sanders, A. B. Ward, I. A. Wilson, Cross-neutralization of a SARS-CoV-2 antibody to a functionally conserved site is mediated by avidity. Immunity <b title="valid: False, node: 1472, tag: b, level: 18" node_number="1472">53</b>, 1272&#8211;1280.e5 (2020).</div><div title="valid: False, node: 1473, tag: div, level: 17" node_number="1473"><div title="valid: False, node: 1474, tag: div, level: 18" node_number="1474"><a title="valid: False, node: 1475, tag: a, level: 19" node_number="1475">Crossref</a></div><div title="valid: False, node: 1476, tag: div, level: 18" node_number="1476"><a title="valid: False, node: 1477, tag: a, level: 19" node_number="1477">PubMed</a></div><div title="valid: False, node: 1478, tag: div, level: 18" node_number="1478"><a title="valid: False, node: 1479, tag: a, level: 19" node_number="1479">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1480, tag: div, level: 14" node_number="1480"><div title="valid: False, node: 1481, tag: div, level: 15" node_number="1481">58</div><div title="valid: False, node: 1482, tag: div, level: 15" node_number="1482"><div title="valid: False, node: 1483, tag: div, level: 16" node_number="1483"><div title="valid: False, node: 1484, tag: div, level: 17" node_number="1484">Z. Lv, Y.-Q. Deng, Q. Ye, L. Cao, C.-Y. Sun, C. Fan, W. Huang, S. Sun, Y. Sun, L. Zhu, Q. Chen, N. Wang, J. Nie, Z. Cui, D. Zhu, N. Shaw, X.-F. Li, Q. Li, L. Xie, Y. Wang, Z. Rao, C.-F. Qin, X. Wang, Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody. Science <b title="valid: False, node: 1485, tag: b, level: 18" node_number="1485">369</b>, 1505&#8211;1509 (2020).</div><div title="valid: False, node: 1486, tag: div, level: 17" node_number="1486"><div title="valid: False, node: 1487, tag: div, level: 18" node_number="1487"><a title="valid: False, node: 1488, tag: a, level: 19" node_number="1488">Crossref</a></div><div title="valid: False, node: 1489, tag: div, level: 18" node_number="1489"><a title="valid: False, node: 1490, tag: a, level: 19" node_number="1490">PubMed</a></div><div title="valid: False, node: 1491, tag: div, level: 18" node_number="1491"><a title="valid: False, node: 1492, tag: a, level: 19" node_number="1492">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1493, tag: div, level: 14" node_number="1493"><div title="valid: False, node: 1494, tag: div, level: 15" node_number="1494">59</div><div title="valid: False, node: 1495, tag: div, level: 15" node_number="1495"><div title="valid: False, node: 1496, tag: div, level: 16" node_number="1496"><div title="valid: False, node: 1497, tag: div, level: 17" node_number="1497">D. Li, R. J. Edwards, K. Manne, D. R. Martinez, A. Sch&#228;fer, S. M. Alam, K. Wiehe, X. Lu, R. Parks, L. L. Sutherland, T. H. Oguin 3rd, C. McDanal, L. G. Perez, K. Mansouri, S. M. C. Gobeil, K. Janowska, V. Stalls, M. Kopp, F. Cai, E. Lee, A. Foulger, G. E. Hernandez, A. Sanzone, K. Tilahun, C. Jiang, L. V. Tse, K. W. Bock, M. Minai, B. M. Nagata, K. Cronin, V. Gee-Lai, M. Deyton, M. Barr, T. Von Holle, A. N. Macintyre, E. Stover, J. Feldman, B. M. Hauser, T. M. Caradonna, T. D. Scobey, W. Rountree, Y. Wang, M. A. Moody, D. W. Cain, C. T. DeMarco, T. N. Denny, C. W. Woods, E. W. Petzold, A. G. Schmidt, I.-T. Teng, T. Zhou, P. D. Kwong, J. R. Mascola, B. S. Graham, I. N. Moore, R. Seder, H. Andersen, M. G. Lewis, D. C. Montefiori, G. D. Sempowski, R. S. Baric, P. Acharya, B. F. Haynes, K. O. Saunders, In&#160;vitro and in&#160;vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies. Cell <b title="valid: False, node: 1498, tag: b, level: 18" node_number="1498">184</b>, 4203&#8211;4219.e32 (2021).</div><div title="valid: False, node: 1499, tag: div, level: 17" node_number="1499"><div title="valid: False, node: 1500, tag: div, level: 18" node_number="1500"><a title="valid: False, node: 1501, tag: a, level: 19" node_number="1501">Crossref</a></div><div title="valid: False, node: 1502, tag: div, level: 18" node_number="1502"><a title="valid: False, node: 1503, tag: a, level: 19" node_number="1503">PubMed</a></div><div title="valid: False, node: 1504, tag: div, level: 18" node_number="1504"><a title="valid: False, node: 1505, tag: a, level: 19" node_number="1505">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1506, tag: div, level: 14" node_number="1506"><div title="valid: False, node: 1507, tag: div, level: 15" node_number="1507">60</div><div title="valid: False, node: 1508, tag: div, level: 15" node_number="1508"><div title="valid: False, node: 1509, tag: div, level: 16" node_number="1509"><div title="valid: False, node: 1510, tag: div, level: 17" node_number="1510">T. N. Starr, N. Czudnochowski, Z. Liu, F. Zatta, Y.-J. Park, A. Addetia, D. Pinto, M. Beltramello, P. Hernandez, A. J. Greaney, R. Marzi, W. G. Glass, I. Zhang, A. S. Dingens, J. E. Bowen, M. A. Tortorici, A. C. Walls, J. A. Wojcechowskyj, A. De Marco, L. E. Rosen, J. Zhou, M. Montiel-Ruiz, H. Kaiser, J. R. Dillen, H. Tucker, J. Bassi, C. Silacci-Fregni, M. P. Housley, J. di Iulio, G. Lombardo, M. Agostini, N. Sprugasci, K. Culap, S. Jaconi, M. Meury, E. Dellota Jr., R. Abdelnabi, S. C. Foo, E. Cameroni, S. Stumpf, T. I. Croll, J. C. Nix, C. Havenar-Daughton, L. Piccoli, F. Benigni, J. Neyts, A. Telenti, F. A. Lempp, M. S. Pizzuto, J. D. Chodera, C. M. Hebner, H. W. Virgin, S. P. J. Whelan, D. Veesler, D. Corti, J. D. Bloom, G. Snell, SARS-CoV-2 RBD antibodies that maximize breadth and resistance to escape. Nature <b title="valid: False, node: 1511, tag: b, level: 18" node_number="1511">597</b>, 97&#8211;102 (2021).</div><div title="valid: False, node: 1512, tag: div, level: 17" node_number="1512"><div title="valid: False, node: 1513, tag: div, level: 18" node_number="1513"><a title="valid: False, node: 1514, tag: a, level: 19" node_number="1514">Crossref</a></div><div title="valid: False, node: 1515, tag: div, level: 18" node_number="1515"><a title="valid: False, node: 1516, tag: a, level: 19" node_number="1516">PubMed</a></div><div title="valid: False, node: 1517, tag: div, level: 18" node_number="1517"><a title="valid: False, node: 1518, tag: a, level: 19" node_number="1518">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1519, tag: div, level: 14" node_number="1519"><div title="valid: False, node: 1520, tag: div, level: 15" node_number="1520">61</div><div title="valid: False, node: 1521, tag: div, level: 15" node_number="1521"><div title="valid: False, node: 1522, tag: div, level: 16" node_number="1522"><div title="valid: False, node: 1523, tag: div, level: 17" node_number="1523">Y. Watanabe, Z. T. Berndsen, J. Raghwani, G. E. Seabright, J. D. Allen, O. G. Pybus, J. S. McLellan, I. A. Wilson, T. A. Bowden, A. B. Ward, M. Crispin, Vulnerabilities in coronavirus glycan shields despite extensive glycosylation. Nat. Commun. <b title="valid: False, node: 1524, tag: b, level: 18" node_number="1524">11</b>, 2688 (2020).</div><div title="valid: False, node: 1525, tag: div, level: 17" node_number="1525"><div title="valid: False, node: 1526, tag: div, level: 18" node_number="1526"><a title="valid: False, node: 1527, tag: a, level: 19" node_number="1527">Crossref</a></div><div title="valid: False, node: 1528, tag: div, level: 18" node_number="1528"><a title="valid: False, node: 1529, tag: a, level: 19" node_number="1529">PubMed</a></div><div title="valid: False, node: 1530, tag: div, level: 18" node_number="1530"><a title="valid: False, node: 1531, tag: a, level: 19" node_number="1531">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1532, tag: div, level: 14" node_number="1532"><div title="valid: False, node: 1533, tag: div, level: 15" node_number="1533">62</div><div title="valid: False, node: 1534, tag: div, level: 15" node_number="1534"><div title="valid: False, node: 1535, tag: div, level: 16" node_number="1535"><div title="valid: False, node: 1536, tag: div, level: 17" node_number="1536">O. C. Grant, D. Montgomery, K. Ito, R. J. Woods, Analysis of the SARS-CoV-2 spike protein glycan shield reveals implications for immune recognition. Sci. Rep. <b title="valid: False, node: 1537, tag: b, level: 18" node_number="1537">10</b>, 14991 (2020).</div><div title="valid: False, node: 1538, tag: div, level: 17" node_number="1538"><div title="valid: False, node: 1539, tag: div, level: 18" node_number="1539"><a title="valid: False, node: 1540, tag: a, level: 19" node_number="1540">Crossref</a></div><div title="valid: False, node: 1541, tag: div, level: 18" node_number="1541"><a title="valid: False, node: 1542, tag: a, level: 19" node_number="1542">PubMed</a></div><div title="valid: False, node: 1543, tag: div, level: 18" node_number="1543"><a title="valid: False, node: 1544, tag: a, level: 19" node_number="1544">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1545, tag: div, level: 14" node_number="1545"><div title="valid: False, node: 1546, tag: div, level: 15" node_number="1546">63</div><div title="valid: False, node: 1547, tag: div, level: 15" node_number="1547"><div title="valid: False, node: 1548, tag: div, level: 16" node_number="1548"><div title="valid: False, node: 1549, tag: div, level: 17" node_number="1549">M. F. Boni, P. Lemey, X. Jiang, T. T.-Y. Lam, B. W. Perry, T. A. Castoe, A. Rambaut, D. L. Robertson, Evolutionary origins of the SARS-CoV-2 sarbecovirus lineage responsible for the COVID-19 pandemic. Nat. Microbiol. <b title="valid: False, node: 1550, tag: b, level: 18" node_number="1550">5</b>, 1408&#8211;1417 (2020).</div><div title="valid: False, node: 1551, tag: div, level: 17" node_number="1551"><div title="valid: False, node: 1552, tag: div, level: 18" node_number="1552"><a title="valid: False, node: 1553, tag: a, level: 19" node_number="1553">Crossref</a></div><div title="valid: False, node: 1554, tag: div, level: 18" node_number="1554"><a title="valid: False, node: 1555, tag: a, level: 19" node_number="1555">PubMed</a></div><div title="valid: False, node: 1556, tag: div, level: 18" node_number="1556"><a title="valid: False, node: 1557, tag: a, level: 19" node_number="1557">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1558, tag: div, level: 14" node_number="1558"><div title="valid: False, node: 1559, tag: div, level: 15" node_number="1559">64</div><div title="valid: False, node: 1560, tag: div, level: 15" node_number="1560"><div title="valid: False, node: 1561, tag: div, level: 16" node_number="1561"><div title="valid: False, node: 1562, tag: div, level: 17" node_number="1562">N. K. Hurlburt, E. Seydoux, Y.-H. Wan, V. V. Edara, A. B. Stuart, J. Feng, M. S. Suthar, A. T. McGuire, L. Stamatatos, M. Pancera, Structural basis for potent neutralization of SARS-CoV-2 and role of antibody affinity maturation. Nat. Commun. <b title="valid: False, node: 1563, tag: b, level: 18" node_number="1563">11</b>, 5413 (2020).</div><div title="valid: False, node: 1564, tag: div, level: 17" node_number="1564"><div title="valid: False, node: 1565, tag: div, level: 18" node_number="1565"><a title="valid: False, node: 1566, tag: a, level: 19" node_number="1566">Crossref</a></div><div title="valid: False, node: 1567, tag: div, level: 18" node_number="1567"><a title="valid: False, node: 1568, tag: a, level: 19" node_number="1568">PubMed</a></div><div title="valid: False, node: 1569, tag: div, level: 18" node_number="1569"><a title="valid: False, node: 1570, tag: a, level: 19" node_number="1570">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1571, tag: div, level: 14" node_number="1571"><div title="valid: False, node: 1572, tag: div, level: 15" node_number="1572">65</div><div title="valid: False, node: 1573, tag: div, level: 15" node_number="1573"><div title="valid: False, node: 1574, tag: div, level: 16" node_number="1574"><div title="valid: False, node: 1575, tag: div, level: 17" node_number="1575">L. Kang, G. He, A. K. Sharp, X. Wang, A. M. Brown, P. Michalak, J. Weger-Lucarelli, A selective sweep in the Spike gene has driven SARS-CoV-2 human adaptation. Cell <b title="valid: False, node: 1576, tag: b, level: 18" node_number="1576">184</b>, 4392&#8211;4400.e4 (2021).</div><div title="valid: False, node: 1577, tag: div, level: 17" node_number="1577"><div title="valid: False, node: 1578, tag: div, level: 18" node_number="1578"><a title="valid: False, node: 1579, tag: a, level: 19" node_number="1579">Crossref</a></div><div title="valid: False, node: 1580, tag: div, level: 18" node_number="1580"><a title="valid: False, node: 1581, tag: a, level: 19" node_number="1581">PubMed</a></div><div title="valid: False, node: 1582, tag: div, level: 18" node_number="1582"><a title="valid: False, node: 1583, tag: a, level: 19" node_number="1583">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1584, tag: div, level: 14" node_number="1584"><div title="valid: False, node: 1585, tag: div, level: 15" node_number="1585">66</div><div title="valid: False, node: 1586, tag: div, level: 15" node_number="1586"><div title="valid: False, node: 1587, tag: div, level: 16" node_number="1587"><div title="valid: False, node: 1588, tag: div, level: 17" node_number="1588">A. M. Harbison, C. A. Fogarty, T. Phung, A. Satheesan, B. L. Schulz, E. Fadda, Fine-tuning the Spike: Role of the nature and topology of the glycan shield in the structure and dynamics of SARS-CoV-2 S. Chem. Sci. 10.1039/D1SC04832E (2021).</div><div title="valid: False, node: 1589, tag: div, level: 17" node_number="1589"><div title="valid: False, node: 1590, tag: div, level: 18" node_number="1590"><a title="valid: False, node: 1591, tag: a, level: 19" node_number="1591">Crossref</a></div><div title="valid: False, node: 1592, tag: div, level: 18" node_number="1592"><a title="valid: False, node: 1593, tag: a, level: 19" node_number="1593">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1594, tag: div, level: 14" node_number="1594"><div title="valid: False, node: 1595, tag: div, level: 15" node_number="1595">67</div><div title="valid: False, node: 1596, tag: div, level: 15" node_number="1596"><div title="valid: False, node: 1597, tag: div, level: 16" node_number="1597"><div title="valid: False, node: 1598, tag: div, level: 17" node_number="1598">J. D. Bloom, L. I. Gong, D. Baltimore, Permissive secondary mutations enable the evolution of influenza oseltamivir resistance. Science <b title="valid: False, node: 1599, tag: b, level: 18" node_number="1599">328</b>, 1272&#8211;1275 (2010).</div><div title="valid: False, node: 1600, tag: div, level: 17" node_number="1600"><div title="valid: False, node: 1601, tag: div, level: 18" node_number="1601"><a title="valid: False, node: 1602, tag: a, level: 19" node_number="1602">Crossref</a></div><div title="valid: False, node: 1603, tag: div, level: 18" node_number="1603"><a title="valid: False, node: 1604, tag: a, level: 19" node_number="1604">PubMed</a></div><div title="valid: False, node: 1605, tag: div, level: 18" node_number="1605"><a title="valid: False, node: 1606, tag: a, level: 19" node_number="1606">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1607, tag: div, level: 14" node_number="1607"><div title="valid: False, node: 1608, tag: div, level: 15" node_number="1608">68</div><div title="valid: False, node: 1609, tag: div, level: 15" node_number="1609"><div title="valid: False, node: 1610, tag: div, level: 16" node_number="1610"><div title="valid: False, node: 1611, tag: div, level: 17" node_number="1611">L. Yurkovetskiy, X. Wang, K. E. Pascal, C. Tomkins-Tinch, T. P. Nyalile, Y. Wang, A. Baum, W. E. Diehl, A. Dauphin, C. Carbone, K. Veinotte, S. B. Egri, S. F. Schaffner, J. E. Lemieux, J. B. Munro, A. Rafique, A. Barve, P. C. Sabeti, C. A. Kyratsous, N. V. Dudkina, K. Shen, J. Luban, Structural and functional analysis of the D614G SARS-CoV-2 spike protein variant. Cell <b title="valid: False, node: 1612, tag: b, level: 18" node_number="1612">183</b>, 739&#8211;751.e8 (2020).</div><div title="valid: False, node: 1613, tag: div, level: 17" node_number="1613"><div title="valid: False, node: 1614, tag: div, level: 18" node_number="1614"><a title="valid: False, node: 1615, tag: a, level: 19" node_number="1615">Crossref</a></div><div title="valid: False, node: 1616, tag: div, level: 18" node_number="1616"><a title="valid: False, node: 1617, tag: a, level: 19" node_number="1617">PubMed</a></div><div title="valid: False, node: 1618, tag: div, level: 18" node_number="1618"><a title="valid: False, node: 1619, tag: a, level: 19" node_number="1619">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1620, tag: div, level: 14" node_number="1620"><div title="valid: False, node: 1621, tag: div, level: 15" node_number="1621">69</div><div title="valid: False, node: 1622, tag: div, level: 15" node_number="1622"><div title="valid: False, node: 1623, tag: div, level: 16" node_number="1623"><div title="valid: False, node: 1624, tag: div, level: 17" node_number="1624">W. Kabsch, XDS. Acta Crystallogr. D <b title="valid: False, node: 1625, tag: b, level: 18" node_number="1625">66</b>, 125&#8211;132 (2010).</div><div title="valid: False, node: 1626, tag: div, level: 17" node_number="1626"><div title="valid: False, node: 1627, tag: div, level: 18" node_number="1627"><a title="valid: False, node: 1628, tag: a, level: 19" node_number="1628">Crossref</a></div><div title="valid: False, node: 1629, tag: div, level: 18" node_number="1629"><a title="valid: False, node: 1630, tag: a, level: 19" node_number="1630">PubMed</a></div><div title="valid: False, node: 1631, tag: div, level: 18" node_number="1631"><a title="valid: False, node: 1632, tag: a, level: 19" node_number="1632">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1633, tag: div, level: 14" node_number="1633"><div title="valid: False, node: 1634, tag: div, level: 15" node_number="1634">70</div><div title="valid: False, node: 1635, tag: div, level: 15" node_number="1635"><div title="valid: False, node: 1636, tag: div, level: 16" node_number="1636"><div title="valid: False, node: 1637, tag: div, level: 17" node_number="1637">P. R. Evans, G. N. Murshudov, How good are my data and what is the resolution? Acta Crystallogr. D <b title="valid: False, node: 1638, tag: b, level: 18" node_number="1638">69</b>, 1204&#8211;1214 (2013).</div><div title="valid: False, node: 1639, tag: div, level: 17" node_number="1639"><div title="valid: False, node: 1640, tag: div, level: 18" node_number="1640"><a title="valid: False, node: 1641, tag: a, level: 19" node_number="1641">Crossref</a></div><div title="valid: False, node: 1642, tag: div, level: 18" node_number="1642"><a title="valid: False, node: 1643, tag: a, level: 19" node_number="1643">PubMed</a></div><div title="valid: False, node: 1644, tag: div, level: 18" node_number="1644"><a title="valid: False, node: 1645, tag: a, level: 19" node_number="1645">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1646, tag: div, level: 14" node_number="1646"><div title="valid: False, node: 1647, tag: div, level: 15" node_number="1647">71</div><div title="valid: False, node: 1648, tag: div, level: 15" node_number="1648"><div title="valid: False, node: 1649, tag: div, level: 16" node_number="1649"><div title="valid: False, node: 1650, tag: div, level: 17" node_number="1650">G. Bricogne, E. Blanc, M. Brandl, C. Flensburg, P. Keller, W. Paciorek, P. Roversi, A. Sharff, O. S. Smart, C. Vonrhein, T. O. Womack, BUSTER version 2.10.3 (Global Phasing Ltd., 2017).</div><div title="valid: False, node: 1651, tag: div, level: 17" node_number="1651"><div title="valid: False, node: 1652, tag: div, level: 18" node_number="1652"><a title="valid: False, node: 1653, tag: a, level: 19" node_number="1653">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1654, tag: div, level: 14" node_number="1654"><div title="valid: False, node: 1655, tag: div, level: 15" node_number="1655">72</div><div title="valid: False, node: 1656, tag: div, level: 15" node_number="1656"><div title="valid: False, node: 1657, tag: div, level: 16" node_number="1657"><div title="valid: False, node: 1658, tag: div, level: 17" node_number="1658">P. Emsley, B. Lohkamp, W. G. Scott, K. Cowtan, Features and development of <i title="valid: False, node: 1659, tag: i, level: 18" node_number="1659">Coot</i>. Acta Crystallogr. D <b title="valid: False, node: 1660, tag: b, level: 18" node_number="1660">66</b>, 486&#8211;501 (2010).</div><div title="valid: False, node: 1661, tag: div, level: 17" node_number="1661"><div title="valid: False, node: 1662, tag: div, level: 18" node_number="1662"><a title="valid: False, node: 1663, tag: a, level: 19" node_number="1663">Crossref</a></div><div title="valid: False, node: 1664, tag: div, level: 18" node_number="1664"><a title="valid: False, node: 1665, tag: a, level: 19" node_number="1665">PubMed</a></div><div title="valid: False, node: 1666, tag: div, level: 18" node_number="1666"><a title="valid: False, node: 1667, tag: a, level: 19" node_number="1667">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1668, tag: div, level: 14" node_number="1668"><div title="valid: False, node: 1669, tag: div, level: 15" node_number="1669">73</div><div title="valid: False, node: 1670, tag: div, level: 15" node_number="1670"><div title="valid: False, node: 1671, tag: div, level: 16" node_number="1671"><div title="valid: False, node: 1672, tag: div, level: 17" node_number="1672">P. D. Adams, P. V. Afonine, G. Bunk&#243;czi, V. B. Chen, I. W. Davis, N. Echols, J. J. Headd, L.-W. Hung, G. J. Kapral, R. W. Grosse-Kunstleve, A. J. McCoy, N. W. Moriarty, R. Oeffner, R. J. Read, D. C. Richardson, J. S. Richardson, T. C. Terwilliger, P. H. Zwart, <i title="valid: False, node: 1673, tag: i, level: 18" node_number="1673">PHENIX</i>: A comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D <b title="valid: False, node: 1674, tag: b, level: 18" node_number="1674">66</b>, 213&#8211;221 (2010).</div><div title="valid: False, node: 1675, tag: div, level: 17" node_number="1675"><div title="valid: False, node: 1676, tag: div, level: 18" node_number="1676"><a title="valid: False, node: 1677, tag: a, level: 19" node_number="1677">Crossref</a></div><div title="valid: False, node: 1678, tag: div, level: 18" node_number="1678"><a title="valid: False, node: 1679, tag: a, level: 19" node_number="1679">PubMed</a></div><div title="valid: False, node: 1680, tag: div, level: 18" node_number="1680"><a title="valid: False, node: 1681, tag: a, level: 19" node_number="1681">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1682, tag: div, level: 14" node_number="1682"><div title="valid: False, node: 1683, tag: div, level: 15" node_number="1683">74</div><div title="valid: False, node: 1684, tag: div, level: 15" node_number="1684"><div title="valid: False, node: 1685, tag: div, level: 16" node_number="1685"><div title="valid: False, node: 1686, tag: div, level: 17" node_number="1686">S. Q. Zheng, E. Palovcak, J.-P. Armache, K. A. Verba, Y. Cheng, D. A. Agard, MotionCor2: Anisotropic correction of beam-induced motion for improved cryo-electron microscopy. Nat. Methods <b title="valid: False, node: 1687, tag: b, level: 18" node_number="1687">14</b>, 331&#8211;332 (2017).</div><div title="valid: False, node: 1688, tag: div, level: 17" node_number="1688"><div title="valid: False, node: 1689, tag: div, level: 18" node_number="1689"><a title="valid: False, node: 1690, tag: a, level: 19" node_number="1690">Crossref</a></div><div title="valid: False, node: 1691, tag: div, level: 18" node_number="1691"><a title="valid: False, node: 1692, tag: a, level: 19" node_number="1692">PubMed</a></div><div title="valid: False, node: 1693, tag: div, level: 18" node_number="1693"><a title="valid: False, node: 1694, tag: a, level: 19" node_number="1694">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1695, tag: div, level: 14" node_number="1695"><div title="valid: False, node: 1696, tag: div, level: 15" node_number="1696">75</div><div title="valid: False, node: 1697, tag: div, level: 15" node_number="1697"><div title="valid: False, node: 1698, tag: div, level: 16" node_number="1698"><div title="valid: False, node: 1699, tag: div, level: 17" node_number="1699">A. Rohou, N. Grigorieff, CTFFIND4: Fast and accurate defocus estimation from electron micrographs. J. Struct. Biol. <b title="valid: False, node: 1700, tag: b, level: 18" node_number="1700">192</b>, 216&#8211;221 (2015).</div><div title="valid: False, node: 1701, tag: div, level: 17" node_number="1701"><div title="valid: False, node: 1702, tag: div, level: 18" node_number="1702"><a title="valid: False, node: 1703, tag: a, level: 19" node_number="1703">Crossref</a></div><div title="valid: False, node: 1704, tag: div, level: 18" node_number="1704"><a title="valid: False, node: 1705, tag: a, level: 19" node_number="1705">PubMed</a></div><div title="valid: False, node: 1706, tag: div, level: 18" node_number="1706"><a title="valid: False, node: 1707, tag: a, level: 19" node_number="1707">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1708, tag: div, level: 14" node_number="1708"><div title="valid: False, node: 1709, tag: div, level: 15" node_number="1709">76</div><div title="valid: False, node: 1710, tag: div, level: 15" node_number="1710"><div title="valid: False, node: 1711, tag: div, level: 16" node_number="1711"><div title="valid: False, node: 1712, tag: div, level: 17" node_number="1712">T. Wagner, F. Merino, M. Stabrin, T. Moriya, C. Antoni, A. Apelbaum, P. Hagel, O. Sitsel, T. Raisch, D. Prumbaum, D. Quentin, D. Roderer, S. Tacke, B. Siebolds, E. Schubert, T. R. Shaikh, P. Lill, C. Gatsogiannis, S. Raunser, SPHIRE-crYOLO is a fast and accurate fully automated particle picker for cryo-EM. Commun. Biol. <b title="valid: False, node: 1713, tag: b, level: 18" node_number="1713">2</b>, 218 (2019).</div><div title="valid: False, node: 1714, tag: div, level: 17" node_number="1714"><div title="valid: False, node: 1715, tag: div, level: 18" node_number="1715"><a title="valid: False, node: 1716, tag: a, level: 19" node_number="1716">Crossref</a></div><div title="valid: False, node: 1717, tag: div, level: 18" node_number="1717"><a title="valid: False, node: 1718, tag: a, level: 19" node_number="1718">PubMed</a></div><div title="valid: False, node: 1719, tag: div, level: 18" node_number="1719"><a title="valid: False, node: 1720, tag: a, level: 19" node_number="1720">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1721, tag: div, level: 14" node_number="1721"><div title="valid: False, node: 1722, tag: div, level: 15" node_number="1722">77</div><div title="valid: False, node: 1723, tag: div, level: 15" node_number="1723"><div title="valid: False, node: 1724, tag: div, level: 16" node_number="1724"><div title="valid: False, node: 1725, tag: div, level: 17" node_number="1725">A. Punjani, J. L. Rubinstein, D. J. Fleet, M. A. Brubaker, cryoSPARC: Algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods <b title="valid: False, node: 1726, tag: b, level: 18" node_number="1726">14</b>, 290&#8211;296 (2017).</div><div title="valid: False, node: 1727, tag: div, level: 17" node_number="1727"><div title="valid: False, node: 1728, tag: div, level: 18" node_number="1728"><a title="valid: False, node: 1729, tag: a, level: 19" node_number="1729">Crossref</a></div><div title="valid: False, node: 1730, tag: div, level: 18" node_number="1730"><a title="valid: False, node: 1731, tag: a, level: 19" node_number="1731">PubMed</a></div><div title="valid: False, node: 1732, tag: div, level: 18" node_number="1732"><a title="valid: False, node: 1733, tag: a, level: 19" node_number="1733">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1734, tag: div, level: 14" node_number="1734"><div title="valid: False, node: 1735, tag: div, level: 15" node_number="1735">78</div><div title="valid: False, node: 1736, tag: div, level: 15" node_number="1736"><div title="valid: False, node: 1737, tag: div, level: 16" node_number="1737"><div title="valid: False, node: 1738, tag: div, level: 17" node_number="1738">A. C. Walls, Y.-J. Park, M. A. Tortorici, A. Wall, A. T. McGuire, D. Veesler, Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell <b title="valid: False, node: 1739, tag: b, level: 18" node_number="1739">181</b>, 281&#8211;292.e6 (2020).</div><div title="valid: False, node: 1740, tag: div, level: 17" node_number="1740"><div title="valid: False, node: 1741, tag: div, level: 18" node_number="1741"><a title="valid: False, node: 1742, tag: a, level: 19" node_number="1742">Crossref</a></div><div title="valid: False, node: 1743, tag: div, level: 18" node_number="1743"><a title="valid: False, node: 1744, tag: a, level: 19" node_number="1744">PubMed</a></div><div title="valid: False, node: 1745, tag: div, level: 18" node_number="1745"><a title="valid: False, node: 1746, tag: a, level: 19" node_number="1746">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1747, tag: div, level: 14" node_number="1747"><div title="valid: False, node: 1748, tag: div, level: 15" node_number="1748">79</div><div title="valid: False, node: 1749, tag: div, level: 15" node_number="1749"><div title="valid: False, node: 1750, tag: div, level: 16" node_number="1750"><div title="valid: False, node: 1751, tag: div, level: 17" node_number="1751">S. Zhang, S. Qiao, J. Yu, J. Zeng, S. Shan, L. Tian, J. Lan, L. Zhang, X. Wang, Bat and pangolin coronavirus spike glycoprotein structures provide insights into SARS-CoV-2 evolution. Nat. Commun. <b title="valid: False, node: 1752, tag: b, level: 18" node_number="1752">12</b>, 1607 (2021).</div><div title="valid: False, node: 1753, tag: div, level: 17" node_number="1753"><div title="valid: False, node: 1754, tag: div, level: 18" node_number="1754"><a title="valid: False, node: 1755, tag: a, level: 19" node_number="1755">Crossref</a></div><div title="valid: False, node: 1756, tag: div, level: 18" node_number="1756"><a title="valid: False, node: 1757, tag: a, level: 19" node_number="1757">PubMed</a></div><div title="valid: False, node: 1758, tag: div, level: 18" node_number="1758"><a title="valid: False, node: 1759, tag: a, level: 19" node_number="1759">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1760, tag: div, level: 14" node_number="1760"><div title="valid: False, node: 1761, tag: div, level: 15" node_number="1761">80</div><div title="valid: False, node: 1762, tag: div, level: 15" node_number="1762"><div title="valid: False, node: 1763, tag: div, level: 16" node_number="1763"><div title="valid: False, node: 1764, tag: div, level: 17" node_number="1764">T. Xiao, J. Lu, J. Zhang, R. I. Johnson, L. G. A. McKay, N. Storm, C. L. Lavine, H. Peng, Y. Cai, S. Rits-Volloch, S. Lu, B. D. Quinlan, M. Farzan, M. S. Seaman, A. Griffiths, B. Chen, A trimeric human angiotensin-converting enzyme 2 as an anti-SARS-CoV-2 agent. Nat. Struct. Mol. Biol. <b title="valid: False, node: 1765, tag: b, level: 18" node_number="1765">28</b>, 202&#8211;209 (2021).</div><div title="valid: False, node: 1766, tag: div, level: 17" node_number="1766"><div title="valid: False, node: 1767, tag: div, level: 18" node_number="1767"><a title="valid: False, node: 1768, tag: a, level: 19" node_number="1768">Crossref</a></div><div title="valid: False, node: 1769, tag: div, level: 18" node_number="1769"><a title="valid: False, node: 1770, tag: a, level: 19" node_number="1770">PubMed</a></div><div title="valid: False, node: 1771, tag: div, level: 18" node_number="1771"><a title="valid: False, node: 1772, tag: a, level: 19" node_number="1772">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1773, tag: div, level: 14" node_number="1773"><div title="valid: False, node: 1774, tag: div, level: 15" node_number="1774">81</div><div title="valid: False, node: 1775, tag: div, level: 15" node_number="1775"><div title="valid: False, node: 1776, tag: div, level: 16" node_number="1776"><div title="valid: False, node: 1777, tag: div, level: 17" node_number="1777">J. Harcourt, A. Tamin, X. Lu, S. Kamili, S. K. Sakthivel, J. Murray, K. Queen, Y. Tao, C. R. Paden, J. Zhang, Y. Li, A. Uehara, H. Wang, C. Goldsmith, H. A. Bullock, L. Wang, B. Whitaker, B. Lynch, R. Gautam, C. Schindewolf, K. G. Lokugamage, D. Scharton, J. A. Plante, D. Mirchandani, S. G. Widen, K. Narayanan, S. Makino, T. G. Ksiazek, K. S. Plante, S. C. Weaver, S. Lindstrom, S. Tong, V. D. Menachery, N. J. Thornburg, Severe acute respiratory syndrome coronavirus 2 from patient with coronavirus disease, United States. Emerg. Infect. Dis. <b title="valid: False, node: 1778, tag: b, level: 18" node_number="1778">26</b>, 1266&#8211;1273 (2020).</div><div title="valid: False, node: 1779, tag: div, level: 17" node_number="1779"><div title="valid: False, node: 1780, tag: div, level: 18" node_number="1780"><a title="valid: False, node: 1781, tag: a, level: 19" node_number="1781">Crossref</a></div><div title="valid: False, node: 1782, tag: div, level: 18" node_number="1782"><a title="valid: False, node: 1783, tag: a, level: 19" node_number="1783">PubMed</a></div><div title="valid: False, node: 1784, tag: div, level: 18" node_number="1784"><a title="valid: False, node: 1785, tag: a, level: 19" node_number="1785">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1786, tag: div, level: 14" node_number="1786"><div title="valid: False, node: 1787, tag: div, level: 15" node_number="1787">82</div><div title="valid: False, node: 1788, tag: div, level: 15" node_number="1788"><div title="valid: False, node: 1789, tag: div, level: 16" node_number="1789"><div title="valid: False, node: 1790, tag: div, level: 17" node_number="1790">A. R. Aricescu, W. Lu, E. Y. Jones, A time- and cost-efficient system for high-level protein production in mammalian cells. Acta Crystallogr. D <b title="valid: False, node: 1791, tag: b, level: 18" node_number="1791">62</b>, 1243&#8211;1250 (2006).</div><div title="valid: False, node: 1792, tag: div, level: 17" node_number="1792"><div title="valid: False, node: 1793, tag: div, level: 18" node_number="1793"><a title="valid: False, node: 1794, tag: a, level: 19" node_number="1794">Crossref</a></div><div title="valid: False, node: 1795, tag: div, level: 18" node_number="1795"><a title="valid: False, node: 1796, tag: a, level: 19" node_number="1796">PubMed</a></div><div title="valid: False, node: 1797, tag: div, level: 18" node_number="1797"><a title="valid: False, node: 1798, tag: a, level: 19" node_number="1798">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1799, tag: div, level: 14" node_number="1799"><div title="valid: False, node: 1800, tag: div, level: 15" node_number="1800">83</div><div title="valid: False, node: 1801, tag: div, level: 15" node_number="1801"><div title="valid: False, node: 1802, tag: div, level: 16" node_number="1802"><div title="valid: False, node: 1803, tag: div, level: 17" node_number="1803">C. L. Hsieh, J. A. Goldsmith, J. M. Schaub, A. M. DiVenere, H.-C. Kuo, K. Javanmardi, K. C. Le, D. Wrapp, A. G. Lee, Y. Liu, C.-W. Chou, P. O. Byrne, C. K. Hjorth, N. V. Johnson, J. Ludes-Meyers, A. W. Nguyen, J. Park, N. Wang, D. Amengor, J. J. Lavinder, G. C. Ippolito, J. A. Maynard, I. J. Finkelstein, J. S. McLellan, Structure-based design of prefusion-stabilized SARS-CoV-2 spikes. Science <b title="valid: False, node: 1804, tag: b, level: 18" node_number="1804">369</b>, 1501&#8211;1505 (2020).</div><div title="valid: False, node: 1805, tag: div, level: 17" node_number="1805"><div title="valid: False, node: 1806, tag: div, level: 18" node_number="1806"><a title="valid: False, node: 1807, tag: a, level: 19" node_number="1807">Crossref</a></div><div title="valid: False, node: 1808, tag: div, level: 18" node_number="1808"><a title="valid: False, node: 1809, tag: a, level: 19" node_number="1809">PubMed</a></div><div title="valid: False, node: 1810, tag: div, level: 18" node_number="1810"><a title="valid: False, node: 1811, tag: a, level: 19" node_number="1811">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1812, tag: div, level: 14" node_number="1812"><div title="valid: False, node: 1813, tag: div, level: 15" node_number="1813">84</div><div title="valid: False, node: 1814, tag: div, level: 15" node_number="1814"><div title="valid: False, node: 1815, tag: div, level: 16" node_number="1815"><div title="valid: False, node: 1816, tag: div, level: 17" node_number="1816">J. Misasi, M. S. A. Gilman, M. Kanekiyo, M. Gui, A. Cagigi, S. Mulangu, D. Corti, J. E. Ledgerwood, A. Lanzavecchia, J. Cunningham, J. J. Muyembe-Tamfun, U. Baxa, B. S. Graham, Y. Xiang, N. J. Sullivan, J. S. McLellan, Structural and molecular basis for Ebola virus neutralization by protective human antibodies. Science <b title="valid: False, node: 1817, tag: b, level: 18" node_number="1817">351</b>, 1343&#8211;1346 (2016).</div><div title="valid: False, node: 1818, tag: div, level: 17" node_number="1818"><div title="valid: False, node: 1819, tag: div, level: 18" node_number="1819"><a title="valid: False, node: 1820, tag: a, level: 19" node_number="1820">Crossref</a></div><div title="valid: False, node: 1821, tag: div, level: 18" node_number="1821"><a title="valid: False, node: 1822, tag: a, level: 19" node_number="1822">PubMed</a></div><div title="valid: False, node: 1823, tag: div, level: 18" node_number="1823"><a title="valid: False, node: 1824, tag: a, level: 19" node_number="1824">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1825, tag: div, level: 14" node_number="1825"><div title="valid: False, node: 1826, tag: div, level: 15" node_number="1826">85</div><div title="valid: False, node: 1827, tag: div, level: 15" node_number="1827"><div title="valid: False, node: 1828, tag: div, level: 16" node_number="1828"><div title="valid: False, node: 1829, tag: div, level: 17" node_number="1829">X. Brochet, M. P. Lefranc, V. Giudicelli, IMGT/V-QUEST: The highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis. Nucleic Acids Res. <b title="valid: False, node: 1830, tag: b, level: 18" node_number="1830">36</b> (suppl. 2), W503&#8211;W508 (2008).</div><div title="valid: False, node: 1831, tag: div, level: 17" node_number="1831"><div title="valid: False, node: 1832, tag: div, level: 18" node_number="1832"><a title="valid: False, node: 1833, tag: a, level: 19" node_number="1833">Crossref</a></div><div title="valid: False, node: 1834, tag: div, level: 18" node_number="1834"><a title="valid: False, node: 1835, tag: a, level: 19" node_number="1835">PubMed</a></div><div title="valid: False, node: 1836, tag: div, level: 18" node_number="1836"><a title="valid: False, node: 1837, tag: a, level: 19" node_number="1837">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1838, tag: div, level: 14" node_number="1838"><div title="valid: False, node: 1839, tag: div, level: 15" node_number="1839">86</div><div title="valid: False, node: 1840, tag: div, level: 15" node_number="1840"><div title="valid: False, node: 1841, tag: div, level: 16" node_number="1841"><div title="valid: False, node: 1842, tag: div, level: 17" node_number="1842">A. J. McCoy, R. W. Grosse-Kunstleve, P. D. Adams, M. D. Winn, L. C. Storoni, R. J. Read, Phaser crystallographic software. J. Appl. Crystallogr. <b title="valid: False, node: 1843, tag: b, level: 18" node_number="1843">40</b>, 658&#8211;674 (2007).</div><div title="valid: False, node: 1844, tag: div, level: 17" node_number="1844"><div title="valid: False, node: 1845, tag: div, level: 18" node_number="1845"><a title="valid: False, node: 1846, tag: a, level: 19" node_number="1846">Crossref</a></div><div title="valid: False, node: 1847, tag: div, level: 18" node_number="1847"><a title="valid: False, node: 1848, tag: a, level: 19" node_number="1848">PubMed</a></div><div title="valid: False, node: 1849, tag: div, level: 18" node_number="1849"><a title="valid: False, node: 1850, tag: a, level: 19" node_number="1850">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1851, tag: div, level: 14" node_number="1851"><div title="valid: False, node: 1852, tag: div, level: 15" node_number="1852">87</div><div title="valid: False, node: 1853, tag: div, level: 15" node_number="1853"><div title="valid: False, node: 1854, tag: div, level: 16" node_number="1854"><div title="valid: False, node: 1855, tag: div, level: 17" node_number="1855">T. A. Jones, J. Y. Zou, S. W. Cowan, M. Kjeldgaard, Improved methods for building protein models in electron density maps and the location of errors in these models. Acta Crystallogr. A <b title="valid: False, node: 1856, tag: b, level: 18" node_number="1856">47</b>, 110&#8211;119 (1991).</div><div title="valid: False, node: 1857, tag: div, level: 17" node_number="1857"><div title="valid: False, node: 1858, tag: div, level: 18" node_number="1858"><a title="valid: False, node: 1859, tag: a, level: 19" node_number="1859">Crossref</a></div><div title="valid: False, node: 1860, tag: div, level: 18" node_number="1860"><a title="valid: False, node: 1861, tag: a, level: 19" node_number="1861">PubMed</a></div><div title="valid: False, node: 1862, tag: div, level: 18" node_number="1862"><a title="valid: False, node: 1863, tag: a, level: 19" node_number="1863">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1864, tag: div, level: 14" node_number="1864"><div title="valid: False, node: 1865, tag: div, level: 15" node_number="1865">88</div><div title="valid: False, node: 1866, tag: div, level: 15" node_number="1866"><div title="valid: False, node: 1867, tag: div, level: 16" node_number="1867"><div title="valid: False, node: 1868, tag: div, level: 17" node_number="1868">C. J. Williams, J. J. Headd, N. W. Moriarty, M. G. Prisant, L. L. Videau, L. N. Deis, V. Verma, D. A. Keedy, B. J. Hintze, V. B. Chen, S. Jain, S. M. Lewis, W. B. Arendall 3rd, J. Snoeyink, P. D. Adams, S. C. Lovell, J. S. Richardson, D. C. Richardson, MolProbity: More and better reference data for improved all-atom structure validation. Protein Sci. <b title="valid: False, node: 1869, tag: b, level: 18" node_number="1869">27</b>, 293&#8211;315 (2018).</div><div title="valid: False, node: 1870, tag: div, level: 17" node_number="1870"><div title="valid: False, node: 1871, tag: div, level: 18" node_number="1871"><a title="valid: False, node: 1872, tag: a, level: 19" node_number="1872">Crossref</a></div><div title="valid: False, node: 1873, tag: div, level: 18" node_number="1873"><a title="valid: False, node: 1874, tag: a, level: 19" node_number="1874">PubMed</a></div><div title="valid: False, node: 1875, tag: div, level: 18" node_number="1875"><a title="valid: False, node: 1876, tag: a, level: 19" node_number="1876">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1877, tag: div, level: 14" node_number="1877"><div title="valid: False, node: 1878, tag: div, level: 15" node_number="1878">89</div><div title="valid: False, node: 1879, tag: div, level: 15" node_number="1879"><div title="valid: False, node: 1880, tag: div, level: 16" node_number="1880"><div title="valid: False, node: 1881, tag: div, level: 17" node_number="1881">D. D. Pless, W. J. Lennarz, Enzymatic conversion of proteins to glycoproteins. Proc. Natl. Acad. Sci. U.S.A. <b title="valid: False, node: 1882, tag: b, level: 18" node_number="1882">74</b>, 134&#8211;138 (1977).</div><div title="valid: False, node: 1883, tag: div, level: 17" node_number="1883"><div title="valid: False, node: 1884, tag: div, level: 18" node_number="1884"><a title="valid: False, node: 1885, tag: a, level: 19" node_number="1885">Crossref</a></div><div title="valid: False, node: 1886, tag: div, level: 18" node_number="1886"><a title="valid: False, node: 1887, tag: a, level: 19" node_number="1887">PubMed</a></div><div title="valid: False, node: 1888, tag: div, level: 18" node_number="1888"><a title="valid: False, node: 1889, tag: a, level: 19" node_number="1889">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1890, tag: div, level: 14" node_number="1890"><div title="valid: False, node: 1891, tag: div, level: 15" node_number="1891">90</div><div title="valid: False, node: 1892, tag: div, level: 15" node_number="1892"><div title="valid: False, node: 1893, tag: div, level: 16" node_number="1893"><div title="valid: False, node: 1894, tag: div, level: 17" node_number="1894">Y. Watanabe, J. D. Allen, D. Wrapp, J. S. McLellan, M. Crispin, Site-specific glycan analysis of the SARS-CoV-2 spike. Science <b title="valid: False, node: 1895, tag: b, level: 18" node_number="1895">369</b>, 330&#8211;333 (2020).</div><div title="valid: False, node: 1896, tag: div, level: 17" node_number="1896"><div title="valid: False, node: 1897, tag: div, level: 18" node_number="1897"><a title="valid: False, node: 1898, tag: a, level: 19" node_number="1898">Crossref</a></div><div title="valid: False, node: 1899, tag: div, level: 18" node_number="1899"><a title="valid: False, node: 1900, tag: a, level: 19" node_number="1900">PubMed</a></div><div title="valid: False, node: 1901, tag: div, level: 18" node_number="1901"><a title="valid: False, node: 1902, tag: a, level: 19" node_number="1902">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1903, tag: div, level: 14" node_number="1903"><div title="valid: False, node: 1904, tag: div, level: 15" node_number="1904">91</div><div title="valid: False, node: 1905, tag: div, level: 15" node_number="1905"><div title="valid: False, node: 1906, tag: div, level: 16" node_number="1906"><div title="valid: False, node: 1907, tag: div, level: 17" node_number="1907">J. Zivanov, T. Nakane, B. O. Forsberg, D. Kimanius, W. J. H. Hagen, E. Lindahl, S. H. W. Scheres, New tools for automated high-resolution cryo-EM structure determination in RELION-3. eLife <b title="valid: False, node: 1908, tag: b, level: 18" node_number="1908">7</b>, e42166 (2018).</div><div title="valid: False, node: 1909, tag: div, level: 17" node_number="1909"><div title="valid: False, node: 1910, tag: div, level: 18" node_number="1910"><a title="valid: False, node: 1911, tag: a, level: 19" node_number="1911">Crossref</a></div><div title="valid: False, node: 1912, tag: div, level: 18" node_number="1912"><a title="valid: False, node: 1913, tag: a, level: 19" node_number="1913">PubMed</a></div><div title="valid: False, node: 1914, tag: div, level: 18" node_number="1914"><a title="valid: False, node: 1915, tag: a, level: 19" node_number="1915">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1916, tag: div, level: 14" node_number="1916"><div title="valid: False, node: 1917, tag: div, level: 15" node_number="1917">92</div><div title="valid: False, node: 1918, tag: div, level: 15" node_number="1918"><div title="valid: False, node: 1919, tag: div, level: 16" node_number="1919"><div title="valid: False, node: 1920, tag: div, level: 17" node_number="1920">T. Zhou, Y. Tsybovsky, J. Gorman, M. Rapp, G. Cerutti, G.-Y. Chuang, P. S. Katsamba, J. M. Sampson, A. Sch&#246;n, J. Bimela, J. C. Boyington, A. Nazzari, A. S. Olia, W. Shi, M. Sastry, T. Stephens, J. Stuckey, I.-T. Teng, P. Wang, S. Wang, B. Zhang, R. A. Friesner, D. D. Ho, J. R. Mascola, L. Shapiro, P. D. Kwong, Cryo-EM structures of SARS-CoV-2 spike without and with ACE2 reveal a pH-dependent switch to mediate endosomal positioning of receptor-binding domains. Cell Host Microbe <b title="valid: False, node: 1921, tag: b, level: 18" node_number="1921">28</b>, 867&#8211;879.e5 (2020).</div><div title="valid: False, node: 1922, tag: div, level: 17" node_number="1922"><div title="valid: False, node: 1923, tag: div, level: 18" node_number="1923"><a title="valid: False, node: 1924, tag: a, level: 19" node_number="1924">Crossref</a></div><div title="valid: False, node: 1925, tag: div, level: 18" node_number="1925"><a title="valid: False, node: 1926, tag: a, level: 19" node_number="1926">PubMed</a></div><div title="valid: False, node: 1927, tag: div, level: 18" node_number="1927"><a title="valid: False, node: 1928, tag: a, level: 19" node_number="1928">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1929, tag: div, level: 14" node_number="1929"><div title="valid: False, node: 1930, tag: div, level: 15" node_number="1930">93</div><div title="valid: False, node: 1931, tag: div, level: 15" node_number="1931"><div title="valid: False, node: 1932, tag: div, level: 16" node_number="1932"><div title="valid: False, node: 1933, tag: div, level: 17" node_number="1933">S. Mitternacht, FreeSASA: An open source C library for solvent accessible surface area calculations. F1000Res. <b title="valid: False, node: 1934, tag: b, level: 18" node_number="1934">5</b>, 189 (2016).</div><div title="valid: False, node: 1935, tag: div, level: 17" node_number="1935"><div title="valid: False, node: 1936, tag: div, level: 18" node_number="1936"><a title="valid: False, node: 1937, tag: a, level: 19" node_number="1937">Crossref</a></div><div title="valid: False, node: 1938, tag: div, level: 18" node_number="1938"><a title="valid: False, node: 1939, tag: a, level: 19" node_number="1939">PubMed</a></div><div title="valid: False, node: 1940, tag: div, level: 18" node_number="1940"><a title="valid: False, node: 1941, tag: a, level: 19" node_number="1941">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1942, tag: div, level: 14" node_number="1942"><div title="valid: False, node: 1943, tag: div, level: 15" node_number="1943">94</div><div title="valid: False, node: 1944, tag: div, level: 15" node_number="1944"><div title="valid: False, node: 1945, tag: div, level: 16" node_number="1945"><div title="valid: False, node: 1946, tag: div, level: 17" node_number="1946">B. Lee, F. M. Richards, The interpretation of protein structures: Estimation of static accessibility. J. Mol. Biol. <b title="valid: False, node: 1947, tag: b, level: 18" node_number="1947">55</b>, 379&#8211;400 (1971).</div><div title="valid: False, node: 1948, tag: div, level: 17" node_number="1948"><div title="valid: False, node: 1949, tag: div, level: 18" node_number="1949"><a title="valid: False, node: 1950, tag: a, level: 19" node_number="1950">Crossref</a></div><div title="valid: False, node: 1951, tag: div, level: 18" node_number="1951"><a title="valid: False, node: 1952, tag: a, level: 19" node_number="1952">PubMed</a></div><div title="valid: False, node: 1953, tag: div, level: 18" node_number="1953"><a title="valid: False, node: 1954, tag: a, level: 19" node_number="1954">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1955, tag: div, level: 14" node_number="1955"><div title="valid: False, node: 1956, tag: div, level: 15" node_number="1956">95</div><div title="valid: False, node: 1957, tag: div, level: 15" node_number="1957"><div title="valid: False, node: 1958, tag: div, level: 16" node_number="1958"><div title="valid: False, node: 1959, tag: div, level: 17" node_number="1959">J. Novotn&#253;, C. Auffray, A program for prediction of protein secondary structure from nucleotide sequence data: Application to histocompatibility antigens. Nucleic Acids Res. <b title="valid: False, node: 1960, tag: b, level: 18" node_number="1960">12</b>, 243&#8211;255 (1984).</div><div title="valid: False, node: 1961, tag: div, level: 17" node_number="1961"><div title="valid: False, node: 1962, tag: div, level: 18" node_number="1962"><a title="valid: False, node: 1963, tag: a, level: 19" node_number="1963">Crossref</a></div><div title="valid: False, node: 1964, tag: div, level: 18" node_number="1964"><a title="valid: False, node: 1965, tag: a, level: 19" node_number="1965">PubMed</a></div><div title="valid: False, node: 1966, tag: div, level: 18" node_number="1966"><a title="valid: False, node: 1967, tag: a, level: 19" node_number="1967">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1968, tag: div, level: 14" node_number="1968"><div title="valid: False, node: 1969, tag: div, level: 15" node_number="1969">96</div><div title="valid: False, node: 1970, tag: div, level: 15" node_number="1970"><div title="valid: False, node: 1971, tag: div, level: 16" node_number="1971"><div title="valid: False, node: 1972, tag: div, level: 17" node_number="1972">A. Pavlova, Z. Zhang, A. Acharya, D. L. Lynch, Y. T. Pang, Z. Mou, J. M. Parks, C. Chipot, J. C. Gumbart, Machine learning reveals the critical interactions for SARS-CoV-2 spike protein binding to ACE2. J. Phys. Chem. Lett. <b title="valid: False, node: 1973, tag: b, level: 18" node_number="1973">12</b>, 5494&#8211;5502 (2021).</div><div title="valid: False, node: 1974, tag: div, level: 17" node_number="1974"><div title="valid: False, node: 1975, tag: div, level: 18" node_number="1975"><a title="valid: False, node: 1976, tag: a, level: 19" node_number="1976">Crossref</a></div><div title="valid: False, node: 1977, tag: div, level: 18" node_number="1977"><a title="valid: False, node: 1978, tag: a, level: 19" node_number="1978">PubMed</a></div><div title="valid: False, node: 1979, tag: div, level: 18" node_number="1979"><a title="valid: False, node: 1980, tag: a, level: 19" node_number="1980">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1981, tag: div, level: 14" node_number="1981"><div title="valid: False, node: 1982, tag: div, level: 15" node_number="1982">97</div><div title="valid: False, node: 1983, tag: div, level: 15" node_number="1983"><div title="valid: False, node: 1984, tag: div, level: 16" node_number="1984"><div title="valid: False, node: 1985, tag: div, level: 17" node_number="1985">F. Li, W. Li, M. Farzan, S. C. Harrison, Structure of SARS coronavirus spike receptor-binding domain complexed with receptor. Science <b title="valid: False, node: 1986, tag: b, level: 18" node_number="1986">309</b>, 1864&#8211;1868 (2005).</div><div title="valid: False, node: 1987, tag: div, level: 17" node_number="1987"><div title="valid: False, node: 1988, tag: div, level: 18" node_number="1988"><a title="valid: False, node: 1989, tag: a, level: 19" node_number="1989">Crossref</a></div><div title="valid: False, node: 1990, tag: div, level: 18" node_number="1990"><a title="valid: False, node: 1991, tag: a, level: 19" node_number="1991">PubMed</a></div><div title="valid: False, node: 1992, tag: div, level: 18" node_number="1992"><a title="valid: False, node: 1993, tag: a, level: 19" node_number="1993">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 1994, tag: div, level: 14" node_number="1994"><div title="valid: False, node: 1995, tag: div, level: 15" node_number="1995">98</div><div title="valid: False, node: 1996, tag: div, level: 15" node_number="1996"><div title="valid: False, node: 1997, tag: div, level: 16" node_number="1997"><div title="valid: False, node: 1998, tag: div, level: 17" node_number="1998">M. Mirdita, S. Ovchinnikov, M. Steinegger, ColabFold - Making protein folding accessible to all. bioRxiv 2021.2008.2015.456425 [Preprint] (2021). <a title="valid: False, node: 1999, tag: a, level: 18" node_number="1999">https://doi.org/10.1101/2021.08.15.456425</a>.</div><div title="valid: False, node: 2000, tag: div, level: 17" node_number="2000"><div title="valid: False, node: 2001, tag: div, level: 18" node_number="2001"><a title="valid: False, node: 2002, tag: a, level: 19" node_number="2002">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 2003, tag: div, level: 14" node_number="2003"><div title="valid: False, node: 2004, tag: div, level: 15" node_number="2004">99</div><div title="valid: False, node: 2005, tag: div, level: 15" node_number="2005"><div title="valid: False, node: 2006, tag: div, level: 16" node_number="2006"><div title="valid: False, node: 2007, tag: div, level: 17" node_number="2007">M. A. Tortorici, M. Beltramello, F. A. Lempp, D. Pinto, H. V. Dang, L. E. Rosen, M. McCallum, J. Bowen, A. Minola, S. Jaconi, F. Zatta, A. De Marco, B. Guarino, S. Bianchi, E. J. Lauron, H. Tucker, J. Zhou, A. Peter, C. Havenar-Daughton, J. A. Wojcechowskyj, J. B. Case, R. E. Chen, H. Kaiser, M. Montiel-Ruiz, M. Meury, N. Czudnochowski, R. Spreafico, J. Dillen, C. Ng, N. Sprugasci, K. Culap, F. Benigni, R. Abdelnabi, S. C. Foo, M. A. Schmid, E. Cameroni, A. Riva, A. Gabrieli, M. Galli, M. S. Pizzuto, J. Neyts, M. S. Diamond, H. W. Virgin, G. Snell, D. Corti, K. Fink, D. Veesler, Ultrapotent human antibodies protect against SARS-CoV-2 challenge via multiple mechanisms. Science <b title="valid: False, node: 2008, tag: b, level: 18" node_number="2008">370</b>, 950&#8211;957 (2020).</div><div title="valid: False, node: 2009, tag: div, level: 17" node_number="2009"><div title="valid: False, node: 2010, tag: div, level: 18" node_number="2010"><a title="valid: False, node: 2011, tag: a, level: 19" node_number="2011">Crossref</a></div><div title="valid: False, node: 2012, tag: div, level: 18" node_number="2012"><a title="valid: False, node: 2013, tag: a, level: 19" node_number="2013">PubMed</a></div><div title="valid: False, node: 2014, tag: div, level: 18" node_number="2014"><a title="valid: False, node: 2015, tag: a, level: 19" node_number="2015">Google Scholar</a></div></div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 2016, tag: div, level: 14" node_number="2016"><div title="valid: False, node: 2017, tag: div, level: 15" node_number="2017">100</div><div title="valid: False, node: 2018, tag: div, level: 15" node_number="2018"><div title="valid: False, node: 2019, tag: div, level: 16" node_number="2019"><div title="valid: False, node: 2020, tag: div, level: 17" node_number="2020">Z. Ke, J. Oton, K. Qu, M. Cortese, V. Zila, L. McKeane, T. Nakane, J. Zivanov, C. J. Neufeldt, B. Cerikan, J. M. Lu, J. Peukes, X. Xiong, H.-G. Kr&#228;usslich, S. H. W. Scheres, R. Bartenschlager, J. A. G. Briggs, Structures and distributions of SARS-CoV-2 spike proteins on intact virions. Nature <b title="valid: False, node: 2021, tag: b, level: 18" node_number="2021">588</b>, 498&#8211;502 (2020).</div><div title="valid: False, node: 2022, tag: div, level: 17" node_number="2022"><div title="valid: False, node: 2023, tag: div, level: 18" node_number="2023"><a title="valid: False, node: 2024, tag: a, level: 19" node_number="2024">Crossref</a></div><div title="valid: False, node: 2025, tag: div, level: 18" node_number="2025"><a title="valid: False, node: 2026, tag: a, level: 19" node_number="2026">PubMed</a></div><div title="valid: False, node: 2027, tag: div, level: 18" node_number="2027"><a title="valid: False, node: 2028, tag: a, level: 19" node_number="2028">Google Scholar</a></div></div></div></div></div></section></div></section><div class="valid" valid="valid" title="valid: True, node: 2029, tag: div, level: 11" node_number="2029"><div class="valid" valid="valid" title="valid: True, node: 2030, tag: div, level: 12" node_number="2030"><header class="valid" valid="valid" title="valid: True, node: 2031, tag: header, level: 13" node_number="2031"><h2 class="valid" valid="valid" title="valid: True, node: 2032, tag: h2, level: 14" node_number="2032">Information Authors</h2></header><section class="valid" valid="valid" title="valid: True, node: 2033, tag: section, level: 13" node_number="2033"><h3 class="valid" valid="valid" title="valid: True, node: 2034, tag: h3, level: 14" node_number="2034">Information</h3><section class="valid" valid="valid" title="valid: True, node: 2035, tag: section, level: 14" node_number="2035"><h4 title="valid: False, node: 2036, tag: h4, level: 15" node_number="2036">Published In</h4><div title="valid: False, node: 2037, tag: div, level: 15" node_number="2037"> <div title="valid: False, node: 2038, tag: div, level: 16" node_number="2038"><div title="valid: False, node: 2039, tag: div, level: 17" node_number="2039">Science</div><div title="valid: False, node: 2040, tag: div, level: 17" node_number="2040">First Release</div></div></div></section><section class="valid" valid="valid" title="valid: True, node: 2041, tag: section, level: 14" node_number="2041"><h4 title="valid: False, node: 2042, tag: h4, level: 15" node_number="2042">Copyright</h4><div title="valid: False, node: 2043, tag: div, level: 15" node_number="2043"> Copyright &#169; 2021 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works. Distributed under a Creative Commons Attribution License 4.0 (CC BY).</div><div title="valid: False, node: 2044, tag: div, level: 15" node_number="2044">https://creativecommons.org/licenses/by/4.0/</div><div title="valid: False, node: 2045, tag: div, level: 15" node_number="2045">This is an open-access article distributed under the terms of the <a title="valid: False, node: 2046, tag: a, level: 16" node_number="2046">Creative Commons Attribution license</a>, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</div></section><section class="valid" valid="valid" title="valid: True, node: 2047, tag: section, level: 14" node_number="2047"><h4 title="valid: False, node: 2048, tag: h4, level: 15" node_number="2048">Submission history</h4><div title="valid: False, node: 2049, tag: div, level: 15" node_number="2049"><b title="valid: False, node: 2050, tag: b, level: 16" node_number="2050">Received</b>: 28 July 2021</div><div title="valid: False, node: 2051, tag: div, level: 15" node_number="2051"><b title="valid: False, node: 2052, tag: b, level: 16" node_number="2052">Accepted</b>: 29 November 2021</div></section><section class="valid" valid="valid" title="valid: True, node: 2053, tag: section, level: 14" node_number="2053"><h4 title="valid: False, node: 2054, tag: h4, level: 15" node_number="2054">Permissions</h4><div title="valid: False, node: 2055, tag: div, level: 15" node_number="2055">Request permissions for this article.</div><div title="valid: False, node: 2056, tag: div, level: 15" node_number="2056"><a title="valid: False, node: 2057, tag: a, level: 16" node_number="2057">Request Permissions</a></div></section><section class="valid" valid="valid" title="valid: True, node: 2058, tag: section, level: 14" node_number="2058"><h4 title="valid: False, node: 2059, tag: h4, level: 15" node_number="2059">Acknowledgments</h4><div title="valid: False, node: 2060, tag: div, level: 15" node_number="2060">This work is based upon research conducted at the Northeastern Collaborative Access Team (NE-CAT)beamlines, which are funded by the National Institute of General Medical Sciences from the NationalInstitutes of Health (P30 GM124165). The Pilatus 6M detector on 24-ID-C beam line is funded by aNIH-ORIP HEI grant (S10 RR029205). This research used resources of the Advanced Photon Source, aU.S. Department of Energy (DOE) Office of Science User Facility operated for the DOE Office ofScience by Argonne National Laboratory under Contract No. DE-AC02-06CH11357. We thank the staff atNE-CAT for assistance with X-ray data collection. Cryo-EM data were collected at the HarvardCryo-Electron Microscopy Center for Structural Biology. We thank Harvard Cryo-EM Center staffmembers for assistance with cryo-EM data collection. We acknowledge support for COVID-19 relatedstructural biology research at Harvard from the Nancy Lurie Marks Family Foundation. We thank B.Chen for providing a human ACE2 ectodomain expressing cell line, and H. Choe for providing cDNAencoding the SARS-CoV spike protein. <b title="valid: False, node: 2061, tag: b, level: 16" node_number="2061">Funding:</b> This work was funded in part by theMassachusetts Consortium on Pathogen Readiness (MassCPR) (J.A.). J.A. was also supported by theStar-Friedman Award Challenge for Promising Scientific Research. L.R.B. is supported by the HarvardClinical and Translational Science Center, from the National Center for Advancing TranslationalScience (1UL1TR002541-01); by Barbara and Amos Hostetter; and by the Chleck Family Foundation.S.E.T., R.C.L., E.T.R., and R.C.C. receive grant support from the Centers for Disease Control andPrevention (U01CK000490). K.G.N., A.C., and H.H.V. are supported by Award Number T32GM007753 fromthe National Institute of General Medical Sciences. The content is solely the responsibility of theauthors and does not necessarily represent the official views of the National Institute of GeneralMedical Sciences or the National Institutes of Health. <b title="valid: False, node: 2062, tag: b, level: 16" node_number="2062">Author contributions:</b>Conceptualization: KGN, SAC, SS, JP, LEC, PY, AC, LGAM, NVT, MD, SET, SK, ACS, AD, CT, JFC, ATD,ATD, DT, AC, YF, AG, IRC, JS, LRB, RCC, JA. Methodology: KGN, SAC, SS, JP, LEC, PY, AC, LGAM, HHV,NVT, GZ, MD, SET, SK, ACS, AD, RCL, ETR, CT, JFC, ATD, DT, AC, YF, AG, IRC, JS, LRB, RC, JA.Investigation: KGN, SAC, SS, JP, LEC, PY, AC, LGAM, HHV, VB, NVT, SET, SK, MJ, ACS, CT, JFC, ATD,DT, AC, YF, AG, IRC, JS, LRB, RC, JA. Visualization: KGN, SAC, SS, JP, LEC, PY, AC, LGAM, HHV, NVT,GZ, MD, SET, SK, ACS, CT, JFC, ATD, DT, AC, YF, AG, IRC, JS, LRB, RCC, JA. Funding acquisition: RCL,ETR, RCC, JA. Project administration: KGN, SAC, SS, JP, NVT, MD, SET, SK, ACS, AG, IRC, JS, LRB,RCC, JA. Supervision: AD, JFC, YF, AG, IRC, JS, LRB, RCC, JA. Writing &#8211; original draft: JA.Writing &#8211; review editing: KGN, SAC, SS, JP, LEC, AC, LGAM, HHV, GZ, MD, SET, SK, ACS,RCL, ETR, CT, JFC, ATD, DT, AC, YF, AG, IRC, JS, LRB, RCC, JA. <b title="valid: False, node: 2063, tag: b, level: 16" node_number="2063">Competing interests:</b>SAC, LEC, and JA are inventors on a provisional patent application that covers antibodies describedin this publication filed by the President and Fellows of Harvard University. S.E.T. receivesmonetary compensation from UpToDate, which provides clinical decision support. <b title="valid: False, node: 2064, tag: b, level: 16" node_number="2064">Data andmaterials availability:</b> C1C-A3 antibody heavy chain and light chain variable region genesequences have been deposited in GenBank under accession codes OL621229 and OL621230, respectively.Protein Data Bank (PBD) identification numbers for the day 146* RBD human ACE2 ectodomain complex,the unliganded C1C-A3 Fab, the C1C-A3 Fab SARS-CoV-2 spike protein ectodomain complex, and focusedrefinement of the C1C-A3 Fab/RBD region are 7SN0, 7SN1, 7SN3, and 7SN2, respectively. ElectronMicroscopy Database (EMDB) accession numbers for the C1C-A3 Fab SARS-CoV-2 spike protein ectodomaincomplex and focused refinement of the C1C-A3 Fab/RBD region are EMD-25210 and EMD-2509,respectively. All materials are available upon request. This work is licensed under a CreativeCommons Attribution 4.0 International (CC BY 4.0) license, which permits unrestricted use,distribution, and reproduction in any medium, provided the original work is properly cited. To viewa copy of this license, visit <a title="valid: False, node: 2065, tag: a, level: 16" node_number="2065">https://creativecommons.org/licenses/by/4.0/</a>. This license does not apply tofigures/photos/artwork or other content included in the article that is credited to a third party;obtain authorization from the rights holder before using such material.</div></section></section><section class="valid" valid="valid" title="valid: True, node: 2066, tag: section, level: 13" node_number="2066"><h3 class="valid" valid="valid" title="valid: True, node: 2067, tag: h3, level: 14" node_number="2067">Authors</h3><section class="valid" valid="valid" title="valid: True, node: 2068, tag: section, level: 14" node_number="2068"><h4 title="valid: False, node: 2069, tag: h4, level: 15" node_number="2069">Affiliations</h4><div title="valid: False, node: 2070, tag: div, level: 15" node_number="2070"><div title="valid: False, node: 2071, tag: div, level: 16" node_number="2071">Katherine G. Nabel<sup title="valid: False, node: 2072, tag: sup, level: 17" node_number="2072">&#8224;</sup> <a title="valid: False, node: 2073, tag: a, level: 17" node_number="2073">https://orcid.org/0000-0002-4429-7075</a></div><div title="valid: False, node: 2074, tag: div, level: 16" node_number="2074"><div title="valid: False, node: 2075, tag: div, level: 17" node_number="2075"><div title="valid: False, node: 2076, tag: div, level: 18" node_number="2076">Department of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA.</div></div><div title="valid: False, node: 2077, tag: div, level: 17" node_number="2077"><a title="valid: False, node: 2078, tag: a, level: 18" node_number="2078">View all articles by this author</a></div></div></div><div title="valid: False, node: 2079, tag: div, level: 15" node_number="2079"><div title="valid: False, node: 2080, tag: div, level: 16" node_number="2080">Sarah A. Clark<sup title="valid: False, node: 2081, tag: sup, level: 17" node_number="2081">&#8224;</sup> https://orcid.org/0000-0001-9944-0919</div><div title="valid: False, node: 2082, tag: div, level: 16" node_number="2082"><div title="valid: False, node: 2083, tag: div, level: 17" node_number="2083"><div title="valid: False, node: 2084, tag: div, level: 18" node_number="2084">Department of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA.</div></div><div title="valid: False, node: 2085, tag: div, level: 17" node_number="2085"><a title="valid: False, node: 2086, tag: a, level: 18" node_number="2086">View all articles by this author</a></div></div></div><div title="valid: False, node: 2087, tag: div, level: 15" node_number="2087"><div title="valid: False, node: 2088, tag: div, level: 16" node_number="2088">Sundaresh Shankar<sup title="valid: False, node: 2089, tag: sup, level: 17" node_number="2089">&#8224;</sup> <a title="valid: False, node: 2090, tag: a, level: 17" node_number="2090">https://orcid.org/0000-0001-9340-9945</a></div><div title="valid: False, node: 2091, tag: div, level: 16" node_number="2091"><div title="valid: False, node: 2092, tag: div, level: 17" node_number="2092"><div title="valid: False, node: 2093, tag: div, level: 18" node_number="2093">Department of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA.</div></div><div title="valid: False, node: 2094, tag: div, level: 17" node_number="2094"><a title="valid: False, node: 2095, tag: a, level: 18" node_number="2095">View all articles by this author</a></div></div></div><div title="valid: False, node: 2096, tag: div, level: 15" node_number="2096"><div title="valid: False, node: 2097, tag: div, level: 16" node_number="2097">Junhua Pan<sup title="valid: False, node: 2098, tag: sup, level: 17" node_number="2098">&#8224;</sup> https://orcid.org/0000-0002-0070-955X</div><div title="valid: False, node: 2099, tag: div, level: 16" node_number="2099"><div title="valid: False, node: 2100, tag: div, level: 17" node_number="2100"><div title="valid: False, node: 2101, tag: div, level: 18" node_number="2101">Department of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA.</div></div><div title="valid: False, node: 2102, tag: div, level: 17" node_number="2102"><a title="valid: False, node: 2103, tag: a, level: 18" node_number="2103">View all articles by this author</a></div></div></div><div title="valid: False, node: 2104, tag: div, level: 15" node_number="2104"><div title="valid: False, node: 2105, tag: div, level: 16" node_number="2105">Lars E. Clark https://orcid.org/0000-0002-6093-7597</div><div title="valid: False, node: 2106, tag: div, level: 16" node_number="2106"><div title="valid: False, node: 2107, tag: div, level: 17" node_number="2107"><div title="valid: False, node: 2108, tag: div, level: 18" node_number="2108">Department of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA.</div></div><div title="valid: False, node: 2109, tag: div, level: 17" node_number="2109"><a title="valid: False, node: 2110, tag: a, level: 18" node_number="2110">View all articles by this author</a></div></div></div><div title="valid: False, node: 2111, tag: div, level: 15" node_number="2111"><div title="valid: False, node: 2112, tag: div, level: 16" node_number="2112">Pan Yang</div><div title="valid: False, node: 2113, tag: div, level: 16" node_number="2113"><div title="valid: False, node: 2114, tag: div, level: 17" node_number="2114"><div title="valid: False, node: 2115, tag: div, level: 18" node_number="2115">Department of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA.</div></div><div title="valid: False, node: 2116, tag: div, level: 17" node_number="2116">View all articles by this author</div></div></div><div title="valid: False, node: 2117, tag: div, level: 15" node_number="2117"><div title="valid: False, node: 2118, tag: div, level: 16" node_number="2118">Adrian Coscia https://orcid.org/0000-0002-6836-9993</div><div title="valid: False, node: 2119, tag: div, level: 16" node_number="2119"><div title="valid: False, node: 2120, tag: div, level: 17" node_number="2120"><div title="valid: False, node: 2121, tag: div, level: 18" node_number="2121">Department of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA.</div></div><div title="valid: False, node: 2122, tag: div, level: 17" node_number="2122">View all articles by this author</div></div></div><div title="valid: False, node: 2123, tag: div, level: 15" node_number="2123"><div title="valid: False, node: 2124, tag: div, level: 16" node_number="2124">Lindsay G. A. McKay https://orcid.org/0000-0003-0369-9067</div><div title="valid: False, node: 2125, tag: div, level: 16" node_number="2125"><div title="valid: False, node: 2126, tag: div, level: 17" node_number="2126"><div title="valid: False, node: 2127, tag: div, level: 18" node_number="2127">Department of Microbiology and National Emerging Infectious Diseases Laboratories, Boston University School of Medicine, Boston, MA 02118, USA.</div></div><div title="valid: False, node: 2128, tag: div, level: 17" node_number="2128">View all articles by this author</div></div></div><div title="valid: False, node: 2129, tag: div, level: 15" node_number="2129"><div title="valid: False, node: 2130, tag: div, level: 16" node_number="2130">Haley H. Varnum</div><div title="valid: False, node: 2131, tag: div, level: 16" node_number="2131"><div title="valid: False, node: 2132, tag: div, level: 17" node_number="2132"><div title="valid: False, node: 2133, tag: div, level: 18" node_number="2133">Department of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA.</div></div><div title="valid: False, node: 2134, tag: div, level: 17" node_number="2134">View all articles by this author</div></div></div><div title="valid: False, node: 2135, tag: div, level: 15" node_number="2135"><div title="valid: False, node: 2136, tag: div, level: 16" node_number="2136">Vesna Brusic</div><div title="valid: False, node: 2137, tag: div, level: 16" node_number="2137"><div title="valid: False, node: 2138, tag: div, level: 17" node_number="2138"><div title="valid: False, node: 2139, tag: div, level: 18" node_number="2139">Department of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA.</div></div><div title="valid: False, node: 2140, tag: div, level: 17" node_number="2140">View all articles by this author</div></div></div><div title="valid: False, node: 2141, tag: div, level: 15" node_number="2141"><div title="valid: False, node: 2142, tag: div, level: 16" node_number="2142">Nicole V. Tolan</div><div title="valid: False, node: 2143, tag: div, level: 16" node_number="2143"><div title="valid: False, node: 2144, tag: div, level: 17" node_number="2144"><div title="valid: False, node: 2145, tag: div, level: 18" node_number="2145">Department of Pathology, Brigham and Women&#8217;s Hospital, Boston, MA 02115, USA.</div></div><div title="valid: False, node: 2146, tag: div, level: 17" node_number="2146">View all articles by this author</div></div></div><div title="valid: False, node: 2147, tag: div, level: 15" node_number="2147"><div title="valid: False, node: 2148, tag: div, level: 16" node_number="2148">Guohai Zhou</div><div title="valid: False, node: 2149, tag: div, level: 16" node_number="2149"><div title="valid: False, node: 2150, tag: div, level: 17" node_number="2150"><div title="valid: False, node: 2151, tag: div, level: 18" node_number="2151">Center for Clinical Investigation, Brigham and Women&#8217;s Hospital, Boston, MA 02115, USA.</div></div><div title="valid: False, node: 2152, tag: div, level: 17" node_number="2152">View all articles by this author</div></div></div><div title="valid: False, node: 2153, tag: div, level: 15" node_number="2153"><div title="valid: False, node: 2154, tag: div, level: 16" node_number="2154">Micha&#235;l Desjardins https://orcid.org/0000-0003-4028-8507</div><div title="valid: False, node: 2155, tag: div, level: 16" node_number="2155"><div title="valid: False, node: 2156, tag: div, level: 17" node_number="2156"><div title="valid: False, node: 2157, tag: div, level: 18" node_number="2157">Division of Infectious Diseases, Department of Medicine, Brigham and Women&#8217;s Hospital, Boston, MA 02115, USA.</div><div title="valid: False, node: 2158, tag: div, level: 18" node_number="2158">Division of Infectious Diseases, Department of Medicine, Centre Hospitalier de l&#8217;Universit&#233; de Montr&#233;al, Montreal QC H2X 0C1, Canada.</div></div><div title="valid: False, node: 2159, tag: div, level: 17" node_number="2159">View all articles by this author</div></div></div><div title="valid: False, node: 2160, tag: div, level: 15" node_number="2160"><div title="valid: False, node: 2161, tag: div, level: 16" node_number="2161">Sarah E. Turbett https://orcid.org/0000-0002-3603-8110</div><div title="valid: False, node: 2162, tag: div, level: 16" node_number="2162"><div title="valid: False, node: 2163, tag: div, level: 17" node_number="2163"><div title="valid: False, node: 2164, tag: div, level: 18" node_number="2164">Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA.</div><div title="valid: False, node: 2165, tag: div, level: 18" node_number="2165">Department of Pathology, Massachusetts General Hospital, Boston, MA 02114, USA.</div></div><div title="valid: False, node: 2166, tag: div, level: 17" node_number="2166">View all articles by this author</div></div></div><div title="valid: False, node: 2167, tag: div, level: 15" node_number="2167"><div title="valid: False, node: 2168, tag: div, level: 16" node_number="2168">Sanjat Kanjilal https://orcid.org/0000-0002-1221-5725</div><div title="valid: False, node: 2169, tag: div, level: 16" node_number="2169"><div title="valid: False, node: 2170, tag: div, level: 17" node_number="2170"><div title="valid: False, node: 2171, tag: div, level: 18" node_number="2171">Division of Infectious Diseases, Department of Medicine, Brigham and Women&#8217;s Hospital, Boston, MA 02115, USA.</div><div title="valid: False, node: 2172, tag: div, level: 18" node_number="2172">Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, MA 02215, USA.</div></div><div title="valid: False, node: 2173, tag: div, level: 17" node_number="2173">View all articles by this author</div></div></div><div title="valid: False, node: 2174, tag: div, level: 15" node_number="2174"><div title="valid: False, node: 2175, tag: div, level: 16" node_number="2175">Amy C. Sherman https://orcid.org/0000-0002-6075-3990</div><div title="valid: False, node: 2176, tag: div, level: 16" node_number="2176"><div title="valid: False, node: 2177, tag: div, level: 17" node_number="2177"><div title="valid: False, node: 2178, tag: div, level: 18" node_number="2178">Division of Infectious Diseases, Department of Medicine, Brigham and Women&#8217;s Hospital, Boston, MA 02115, USA.</div></div><div title="valid: False, node: 2179, tag: div, level: 17" node_number="2179">View all articles by this author</div></div></div><div title="valid: False, node: 2180, tag: div, level: 15" node_number="2180"><div title="valid: False, node: 2181, tag: div, level: 16" node_number="2181">Anand Dighe</div><div title="valid: False, node: 2182, tag: div, level: 16" node_number="2182"><div title="valid: False, node: 2183, tag: div, level: 17" node_number="2183"><div title="valid: False, node: 2184, tag: div, level: 18" node_number="2184">Department of Pathology, Massachusetts General Hospital, Boston, MA 02114, USA.</div></div><div title="valid: False, node: 2185, tag: div, level: 17" node_number="2185">View all articles by this author</div></div></div><div title="valid: False, node: 2186, tag: div, level: 15" node_number="2186"><div title="valid: False, node: 2187, tag: div, level: 16" node_number="2187">Regina C. LaRocque https://orcid.org/0000-0003-4558-0339</div><div title="valid: False, node: 2188, tag: div, level: 16" node_number="2188"><div title="valid: False, node: 2189, tag: div, level: 17" node_number="2189"><div title="valid: False, node: 2190, tag: div, level: 18" node_number="2190">Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA.</div></div><div title="valid: False, node: 2191, tag: div, level: 17" node_number="2191">View all articles by this author</div></div></div><div title="valid: False, node: 2192, tag: div, level: 15" node_number="2192"><div title="valid: False, node: 2193, tag: div, level: 16" node_number="2193">Edward T. Ryan</div><div title="valid: False, node: 2194, tag: div, level: 16" node_number="2194"><div title="valid: False, node: 2195, tag: div, level: 17" node_number="2195"><div title="valid: False, node: 2196, tag: div, level: 18" node_number="2196">Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA.</div><div title="valid: False, node: 2197, tag: div, level: 18" node_number="2197">Department of Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health, Boston, MA 02215, USA.</div></div><div title="valid: False, node: 2198, tag: div, level: 17" node_number="2198">View all articles by this author</div></div></div><div title="valid: False, node: 2199, tag: div, level: 15" node_number="2199"><div title="valid: False, node: 2200, tag: div, level: 16" node_number="2200">Casey Tylek</div><div title="valid: False, node: 2201, tag: div, level: 16" node_number="2201"><div title="valid: False, node: 2202, tag: div, level: 17" node_number="2202"><div title="valid: False, node: 2203, tag: div, level: 18" node_number="2203">AbbVie Bioresearch Center, Worcester, MA 01605, USA.</div></div><div title="valid: False, node: 2204, tag: div, level: 17" node_number="2204">View all articles by this author</div></div></div><div title="valid: False, node: 2205, tag: div, level: 15" node_number="2205"><div title="valid: False, node: 2206, tag: div, level: 16" node_number="2206">Joel F. Cohen-Solal https://orcid.org/0000-0002-1385-2566</div><div title="valid: False, node: 2207, tag: div, level: 16" node_number="2207"><div title="valid: False, node: 2208, tag: div, level: 17" node_number="2208"><div title="valid: False, node: 2209, tag: div, level: 18" node_number="2209">AbbVie Bioresearch Center, Worcester, MA 01605, USA.</div></div><div title="valid: False, node: 2210, tag: div, level: 17" node_number="2210">View all articles by this author</div></div></div><div title="valid: False, node: 2211, tag: div, level: 15" node_number="2211"><div title="valid: False, node: 2212, tag: div, level: 16" node_number="2212">Anhdao T. Darcy</div><div title="valid: False, node: 2213, tag: div, level: 16" node_number="2213"><div title="valid: False, node: 2214, tag: div, level: 17" node_number="2214"><div title="valid: False, node: 2215, tag: div, level: 18" node_number="2215">AbbVie Bioresearch Center, Worcester, MA 01605, USA.</div></div><div title="valid: False, node: 2216, tag: div, level: 17" node_number="2216">View all articles by this author</div></div></div><div title="valid: False, node: 2217, tag: div, level: 15" node_number="2217"><div title="valid: False, node: 2218, tag: div, level: 16" node_number="2218">Davide Tavella https://orcid.org/0000-0002-2030-2087</div><div title="valid: False, node: 2219, tag: div, level: 16" node_number="2219"><div title="valid: False, node: 2220, tag: div, level: 17" node_number="2220"><div title="valid: False, node: 2221, tag: div, level: 18" node_number="2221">AbbVie Bioresearch Center, Worcester, MA 01605, USA.</div></div><div title="valid: False, node: 2222, tag: div, level: 17" node_number="2222">View all articles by this author</div></div></div><div title="valid: False, node: 2223, tag: div, level: 15" node_number="2223"><div title="valid: False, node: 2224, tag: div, level: 16" node_number="2224">Anca Clabbers https://orcid.org/0000-0002-4258-9680</div><div title="valid: False, node: 2225, tag: div, level: 16" node_number="2225"><div title="valid: False, node: 2226, tag: div, level: 17" node_number="2226"><div title="valid: False, node: 2227, tag: div, level: 18" node_number="2227">AbbVie Bioresearch Center, Worcester, MA 01605, USA.</div></div><div title="valid: False, node: 2228, tag: div, level: 17" node_number="2228">View all articles by this author</div></div></div><div title="valid: False, node: 2229, tag: div, level: 15" node_number="2229"><div title="valid: False, node: 2230, tag: div, level: 16" node_number="2230">Yao Fan</div><div title="valid: False, node: 2231, tag: div, level: 16" node_number="2231"><div title="valid: False, node: 2232, tag: div, level: 17" node_number="2232"><div title="valid: False, node: 2233, tag: div, level: 18" node_number="2233">AbbVie Bioresearch Center, Worcester, MA 01605, USA.</div></div><div title="valid: False, node: 2234, tag: div, level: 17" node_number="2234">View all articles by this author</div></div></div><div title="valid: False, node: 2235, tag: div, level: 15" node_number="2235"><div title="valid: False, node: 2236, tag: div, level: 16" node_number="2236">Anthony Griffiths https://orcid.org/0000-0001-5435-8364</div><div title="valid: False, node: 2237, tag: div, level: 16" node_number="2237"><div title="valid: False, node: 2238, tag: div, level: 17" node_number="2238"><div title="valid: False, node: 2239, tag: div, level: 18" node_number="2239">Department of Microbiology and National Emerging Infectious Diseases Laboratories, Boston University School of Medicine, Boston, MA 02118, USA.</div></div><div title="valid: False, node: 2240, tag: div, level: 17" node_number="2240">View all articles by this author</div></div></div><div title="valid: False, node: 2241, tag: div, level: 15" node_number="2241"><div title="valid: False, node: 2242, tag: div, level: 16" node_number="2242">Ivan R. Correia https://orcid.org/0000-0003-2295-7199</div><div title="valid: False, node: 2243, tag: div, level: 16" node_number="2243"><div title="valid: False, node: 2244, tag: div, level: 17" node_number="2244"><div title="valid: False, node: 2245, tag: div, level: 18" node_number="2245">AbbVie Bioresearch Center, Worcester, MA 01605, USA.</div></div><div title="valid: False, node: 2246, tag: div, level: 17" node_number="2246">View all articles by this author</div></div></div><div title="valid: False, node: 2247, tag: div, level: 15" node_number="2247"><div title="valid: False, node: 2248, tag: div, level: 16" node_number="2248">Jane Seagal https://orcid.org/0000-0002-5959-5139</div><div title="valid: False, node: 2249, tag: div, level: 16" node_number="2249"><div title="valid: False, node: 2250, tag: div, level: 17" node_number="2250"><div title="valid: False, node: 2251, tag: div, level: 18" node_number="2251">AbbVie Bioresearch Center, Worcester, MA 01605, USA.</div></div><div title="valid: False, node: 2252, tag: div, level: 17" node_number="2252">View all articles by this author</div></div></div><div title="valid: False, node: 2253, tag: div, level: 15" node_number="2253"><div title="valid: False, node: 2254, tag: div, level: 16" node_number="2254">Lindsey R. Baden</div><div title="valid: False, node: 2255, tag: div, level: 16" node_number="2255"><div title="valid: False, node: 2256, tag: div, level: 17" node_number="2256"><div title="valid: False, node: 2257, tag: div, level: 18" node_number="2257">Center for Clinical Investigation, Brigham and Women&#8217;s Hospital, Boston, MA 02115, USA.</div><div title="valid: False, node: 2258, tag: div, level: 18" node_number="2258">Division of Infectious Diseases, Department of Medicine, Brigham and Women&#8217;s Hospital, Boston, MA 02115, USA.</div><div title="valid: False, node: 2259, tag: div, level: 18" node_number="2259">Massachusetts Consortium on Pathogen Readiness, Boston, MA, USA.</div></div><div title="valid: False, node: 2260, tag: div, level: 17" node_number="2260">View all articles by this author</div></div></div><div title="valid: False, node: 2261, tag: div, level: 15" node_number="2261"><div title="valid: False, node: 2262, tag: div, level: 16" node_number="2262">Richelle C. Charles</div><div title="valid: False, node: 2263, tag: div, level: 16" node_number="2263"><div title="valid: False, node: 2264, tag: div, level: 17" node_number="2264"><div title="valid: False, node: 2265, tag: div, level: 18" node_number="2265">Division of Infectious Diseases, Department of Medicine, Massachusetts General Hospital, Boston, MA 02114, USA.</div></div><div title="valid: False, node: 2266, tag: div, level: 17" node_number="2266">View all articles by this author</div></div></div><div title="valid: False, node: 2267, tag: div, level: 15" node_number="2267"><div title="valid: False, node: 2268, tag: div, level: 16" node_number="2268">Jonathan Abraham<sup title="valid: False, node: 2269, tag: sup, level: 17" node_number="2269">*</sup> https://orcid.org/0000-0002-7937-3920 [email&#160;protected]</div><div title="valid: False, node: 2270, tag: div, level: 16" node_number="2270"><div title="valid: False, node: 2271, tag: div, level: 17" node_number="2271"><div title="valid: False, node: 2272, tag: div, level: 18" node_number="2272">Department of Microbiology, Blavatnik Institute, Harvard Medical School, Boston, MA 02115, USA.</div><div title="valid: False, node: 2273, tag: div, level: 18" node_number="2273">Division of Infectious Diseases, Department of Medicine, Brigham and Women&#8217;s Hospital, Boston, MA 02115, USA.</div><div title="valid: False, node: 2274, tag: div, level: 18" node_number="2274">Massachusetts Consortium on Pathogen Readiness, Boston, MA, USA.</div><div title="valid: False, node: 2275, tag: div, level: 18" node_number="2275">Broad Institute of Harvard and MIT, Cambridge, MA 02142, USA.</div></div><div title="valid: False, node: 2276, tag: div, level: 17" node_number="2276">View all articles by this author</div></div></div></section><section class="valid" valid="valid" title="valid: True, node: 2277, tag: section, level: 14" node_number="2277"><h4 title="valid: False, node: 2278, tag: h4, level: 15" node_number="2278">Funding Information</h4><div title="valid: False, node: 2279, tag: div, level: 15" node_number="2279">National Institutes of Health: T32GM007753</div><div title="valid: False, node: 2280, tag: div, level: 15" node_number="2280">Centers for Disease Control and Prevention: U01CK000490</div><div title="valid: False, node: 2281, tag: div, level: 15" node_number="2281">National Center for Advancing Translational Sciences: 1UL1TR002541-01</div><div title="valid: False, node: 2282, tag: div, level: 15" node_number="2282"><a title="valid: False, node: 2283, tag: a, level: 16" node_number="2283">Translational Science Center, Wake Forest University</a>: 1UL1TR002541-01</div><div title="valid: False, node: 2284, tag: div, level: 15" node_number="2284">Massachusetts Consortium on Pathogen Readiness: No grant number</div><div title="valid: False, node: 2285, tag: div, level: 15" node_number="2285">Barbara and Amos Hostetter and the Chleck Foundation: N/A</div><div title="valid: False, node: 2286, tag: div, level: 15" node_number="2286"><a title="valid: False, node: 2287, tag: a, level: 16" node_number="2287">Translational Science Center, Wake Forest University</a>: T32GM007753</div></section><section class="valid" valid="valid" title="valid: True, node: 2288, tag: section, level: 14" node_number="2288"><h4 title="valid: False, node: 2289, tag: h4, level: 15" node_number="2289">Notes</h4><div title="valid: False, node: 2290, tag: div, level: 15" node_number="2290"><div title="valid: False, node: 2291, tag: div, level: 16" node_number="2291">&#8224;</div><div title="valid: False, node: 2292, tag: div, level: 16" node_number="2292">These authors contributed equally to this work.</div></div><div title="valid: False, node: 2293, tag: div, level: 15" node_number="2293">*Corresponding author. Email: <a title="valid: False, node: 2294, tag: a, level: 16" node_number="2294">[email&#160;protected]</a></div></section></section></div><div class="valid" valid="valid" title="valid: True, node: 2295, tag: div, level: 12" node_number="2295"><header class="valid" valid="valid" title="valid: True, node: 2296, tag: header, level: 13" node_number="2296"><h2 class="valid" valid="valid" title="valid: True, node: 2297, tag: h2, level: 14" node_number="2297">Metrics Citations</h2></header><section class="valid" valid="valid" title="valid: True, node: 2298, tag: section, level: 13" node_number="2298"><h3 class="valid" valid="valid" title="valid: True, node: 2299, tag: h3, level: 14" node_number="2299">Metrics</h3><section class="valid" valid="valid" title="valid: True, node: 2300, tag: section, level: 14" node_number="2300"> <h5 title="valid: False, node: 2301, tag: h5, level: 15" node_number="2301"> Article Usage </h5> </section><section class="valid" valid="valid" title="valid: True, node: 2302, tag: section, level: 14" node_number="2302"> <h5 title="valid: False, node: 2303, tag: h5, level: 15" node_number="2303"> Altmetrics </h5> </section></section><section class="valid" valid="valid" title="valid: True, node: 2304, tag: section, level: 13" node_number="2304"><h3 class="valid" valid="valid" title="valid: True, node: 2305, tag: h3, level: 14" node_number="2305">Citations</h3><section class="valid" valid="valid" title="valid: True, node: 2306, tag: section, level: 14" node_number="2306"> <div title="valid: False, node: 2307, tag: div, level: 15" node_number="2307"> <h5 title="valid: False, node: 2308, tag: h5, level: 16" node_number="2308">Export citation</h5> <p title="valid: False, node: 2309, tag: p, level: 16" node_number="2309">Select the format you want to export the citation of this publication.</p> </div> </section></section></div><div class="valid" valid="valid" title="valid: True, node: 2310, tag: div, level: 12" node_number="2310"><header class="valid" valid="valid" title="valid: True, node: 2311, tag: header, level: 13" node_number="2311"><h2 class="valid" valid="valid" title="valid: True, node: 2312, tag: h2, level: 14" node_number="2312">View Options</h2></header><div class="valid" valid="valid" title="valid: True, node: 2313, tag: div, level: 13" node_number="2313"><h3 class="valid" valid="valid" title="valid: True, node: 2314, tag: h3, level: 14" node_number="2314">View options</h3><section class="valid" valid="valid" title="valid: True, node: 2315, tag: section, level: 14" node_number="2315"><h4 title="valid: False, node: 2316, tag: h4, level: 15" node_number="2316">PDF format</h4><p title="valid: False, node: 2317, tag: p, level: 15" node_number="2317">Download this article as a PDF file</p><a title="valid: False, node: 2318, tag: a, level: 15" node_number="2318">Download PDF</a></section></div><div class="valid" valid="valid" title="valid: True, node: 2319, tag: div, level: 13" node_number="2319"><h3 class="valid" valid="valid" title="valid: True, node: 2320, tag: h3, level: 14" node_number="2320">Get Access</h3><section class="valid" valid="valid" title="valid: True, node: 2321, tag: section, level: 14" node_number="2321"> <div title="valid: False, node: 2322, tag: div, level: 15" node_number="2322"><h5 title="valid: False, node: 2323, tag: h5, level: 16" node_number="2323">Log in to view the full text</h5> <p title="valid: False, node: 2324, tag: p, level: 16" node_number="2324"><a title="valid: False, node: 2325, tag: a, level: 17" node_number="2325">AAAS Log in</a></p> <p title="valid: False, node: 2326, tag: p, level: 16" node_number="2326">AAAS login provides access to Science for AAAS members, and access to other journals in the Science family to users who have purchased individual subscriptions.</p> <ul title="valid: False, node: 2327, tag: ul, level: 16" node_number="2327"> <li title="valid: False, node: 2328, tag: li, level: 17" node_number="2328">Become a AAAS Member</li> <li title="valid: False, node: 2329, tag: li, level: 17" node_number="2329"><a title="valid: False, node: 2330, tag: a, level: 18" node_number="2330">Activate your Account</a></li> <li title="valid: False, node: 2331, tag: li, level: 17" node_number="2331"><a title="valid: False, node: 2332, tag: a, level: 18" node_number="2332">Purchase Access to Other Journals in the Science Family</a></li> <li title="valid: False, node: 2333, tag: li, level: 17" node_number="2333"><a title="valid: False, node: 2334, tag: a, level: 18" node_number="2334">Account Help</a></li> </ul> <div title="valid: False, node: 2335, tag: div, level: 16" node_number="2335"> <div title="valid: False, node: 2336, tag: div, level: 17" node_number="2336">Log in via OpenAthens. <div title="valid: False, node: 2337, tag: div, level: 18" node_number="2337"><a title="valid: False, node: 2338, tag: a, level: 19" node_number="2338">via OpenAthens</a></div> </div> <div title="valid: False, node: 2339, tag: div, level: 17" node_number="2339">Log in via Shibboleth. <div title="valid: False, node: 2340, tag: div, level: 18" node_number="2340"><a title="valid: False, node: 2341, tag: a, level: 19" node_number="2341">via Shibboleth</a></div> </div> </div> </div> <div title="valid: False, node: 2342, tag: div, level: 15" node_number="2342"><h5 title="valid: False, node: 2343, tag: h5, level: 16" node_number="2343">More options</h5><p title="valid: False, node: 2344, tag: p, level: 16" node_number="2344"><a title="valid: False, node: 2345, tag: a, level: 17" node_number="2345">Purchase digital access to this article</a></p><p title="valid: False, node: 2346, tag: p, level: 16" node_number="2346">Download and print this article for your personal scholarly, research, and educational use.</p><p title="valid: False, node: 2347, tag: p, level: 16" node_number="2347"><a title="valid: False, node: 2348, tag: a, level: 17" node_number="2348">Purchase this issue in print</a></p><p title="valid: False, node: 2349, tag: p, level: 16" node_number="2349">Buy a single issue of Science for just $15 USD.</p></div> </section></div></div><div class="valid" valid="valid" title="valid: True, node: 2350, tag: div, level: 12" node_number="2350"><header class="valid" valid="valid" title="valid: True, node: 2351, tag: header, level: 13" node_number="2351"><h2 class="valid" valid="valid" title="valid: True, node: 2352, tag: h2, level: 14" node_number="2352">Media</h2></header><section class="valid" valid="valid" title="valid: True, node: 2353, tag: section, level: 13" node_number="2353"><h3 class="valid" valid="valid" title="valid: True, node: 2354, tag: h3, level: 14" node_number="2354">Figures</h3></section><section class="valid" valid="valid" title="valid: True, node: 2355, tag: section, level: 13" node_number="2355"><h3 class="valid" valid="valid" title="valid: True, node: 2356, tag: h3, level: 14" node_number="2356">Multimedia</h3></section></div><div class="valid" valid="valid" title="valid: True, node: 2357, tag: div, level: 12" node_number="2357"><header class="valid" valid="valid" title="valid: True, node: 2358, tag: header, level: 13" node_number="2358"><h2 class="valid" valid="valid" title="valid: True, node: 2359, tag: h2, level: 14" node_number="2359">Tables</h2></header></div><div class="valid" valid="valid" title="valid: True, node: 2360, tag: div, level: 12" node_number="2360"><header class="valid" valid="valid" title="valid: True, node: 2361, tag: header, level: 13" node_number="2361"><h2 class="valid" valid="valid" title="valid: True, node: 2362, tag: h2, level: 14" node_number="2362">Share</h2></header><h3 class="valid" valid="valid" title="valid: True, node: 2363, tag: h3, level: 13" node_number="2363">Share</h3><div class="valid" valid="valid" title="valid: True, node: 2364, tag: div, level: 13" node_number="2364"><section class="valid" valid="valid" title="valid: True, node: 2365, tag: section, level: 14" node_number="2365"><h4 title="valid: False, node: 2366, tag: h4, level: 15" node_number="2366">Share article link</h4><div title="valid: False, node: 2367, tag: div, level: 15" node_number="2367"><a title="valid: False, node: 2368, tag: a, level: 16" node_number="2368">Copy Link</a><div title="valid: False, node: 2369, tag: div, level: 16" node_number="2369"><p title="valid: False, node: 2370, tag: p, level: 17" node_number="2370">Copied!</p><p title="valid: False, node: 2371, tag: p, level: 17" node_number="2371">Copying failed.</p></div></div></section><section class="valid" valid="valid" title="valid: True, node: 2372, tag: section, level: 14" node_number="2372"><h4 title="valid: False, node: 2373, tag: h4, level: 15" node_number="2373">Share on social media</h4><div title="valid: False, node: 2374, tag: div, level: 15" node_number="2374"><a title="valid: False, node: 2375, tag: a, level: 16" node_number="2375">facebook</a><a title="valid: False, node: 2376, tag: a, level: 16" node_number="2376">twitter</a><a title="valid: False, node: 2377, tag: a, level: 16" node_number="2377">linkedin</a><a title="valid: False, node: 2378, tag: a, level: 16" node_number="2378">email</a></div></section></div></div></div></article><section class="valid" valid="valid" title="valid: True, node: 2379, tag: section, level: 10" node_number="2379"><div class="valid" valid="valid" title="valid: True, node: 2380, tag: div, level: 11" node_number="2380"><div class="valid" valid="valid" title="valid: True, node: 2381, tag: div, level: 12" node_number="2381"><div class="valid" valid="valid" title="valid: True, node: 2382, tag: div, level: 13" node_number="2382"><div class="valid" valid="valid" title="valid: True, node: 2383, tag: div, level: 14" node_number="2383"><h3 title="valid: False, node: 2384, tag: h3, level: 15" node_number="2384">Submit a Response to This Article</h3></div></div></div></div> <div class="valid" valid="valid" title="valid: True, node: 2385, tag: div, level: 11" node_number="2385"> <div class="valid" valid="valid" title="valid: True, node: 2386, tag: div, level: 12" node_number="2386"> <h2 class="valid" valid="valid" title="valid: True, node: 2387, tag: h2, level: 13" node_number="2387">(0)eLetters</h2> </div> <p class="valid" valid="valid" title="valid: True, node: 2388, tag: p, level: 12" node_number="2388">eLetters is an online forum for ongoing peer review. Submission of eLetters are open to all. eLetters are not edited, proofread, or indexed. Please read our Terms of Service before submitting your own eLetter.</p> Log In to Submit a Response <p class="valid" valid="valid" title="valid: True, node: 2389, tag: p, level: 12" node_number="2389">No eLetters have been published for this article yet.</p> </div> </section> <div class="valid" valid="valid" title="valid: True, node: 2390, tag: div, level: 10" node_number="2390"><a class="valid" valid="valid" title="valid: True, node: 2391, tag: a, level: 11" node_number="2391">View Full Text</a><a class="valid" valid="valid" title="valid: True, node: 2392, tag: a, level: 11" node_number="2392">Download PDF</a></div> </div></div></div></div><div class="valid" valid="valid" title="valid: True, node: 2393, tag: div, level: 6" node_number="2393"><div class="valid" valid="valid" title="valid: True, node: 2394, tag: div, level: 7" node_number="2394"><div class="valid" valid="valid" title="valid: True, node: 2395, tag: div, level: 8" node_number="2395"><div class="valid" valid="valid" title="valid: True, node: 2396, tag: div, level: 9" node_number="2396"><section class="valid" valid="valid" title="valid: True, node: 2397, tag: section, level: 10" node_number="2397"><div class="valid" valid="valid" title="valid: True, node: 2398, tag: div, level: 11" node_number="2398"><h4 class="valid" valid="valid" title="valid: True, node: 2399, tag: h4, level: 12" node_number="2399"> Current Issue </h4><div class="valid" valid="valid" title="valid: True, node: 2400, tag: div, level: 12" node_number="2400"><div class="valid" valid="valid" title="valid: True, node: 2401, tag: div, level: 13" node_number="2401"> <div class="valid" valid="valid" title="valid: True, node: 2402, tag: div, level: 14" node_number="2402"><div title="valid: False, node: 2403, tag: div, level: 15" node_number="2403"><article title="valid: False, node: 2404, tag: article, level: 16" node_number="2404"><div title="valid: False, node: 2405, tag: div, level: 17" node_number="2405"><div title="valid: False, node: 2406, tag: div, level: 18" node_number="2406"><h3 title="valid: False, node: 2407, tag: h3, level: 19" node_number="2407"><a title="valid: False, node: 2408, tag: a, level: 20" node_number="2408">Cell-by-cell dissection of phloem development links a maturation gradient to cell specialization</a></h3><ul title="valid: False, node: 2409, tag: ul, level: 19" node_number="2409"><li title="valid: False, node: 2410, tag: li, level: 20" node_number="2410">By<ul title="valid: False, node: 2411, tag: ul, level: 21" node_number="2411"> <li title="valid: False, node: 2412, tag: li, level: 22" node_number="2412">Pawel Roszak</li> <li title="valid: False, node: 2413, tag: li, level: 22" node_number="2413">Jung-ok Heo</li> <li title="valid: False, node: 2414, tag: li, level: 22" node_number="2414">et al.</li> </ul> </li></ul></div></div></article><article title="valid: False, node: 2415, tag: article, level: 16" node_number="2415"><div title="valid: False, node: 2416, tag: div, level: 17" node_number="2416"><div title="valid: False, node: 2417, tag: div, level: 18" node_number="2417"><h3 title="valid: False, node: 2418, tag: h3, level: 19" node_number="2418">The energetics of uniquely human subsistence strategies</h3><ul title="valid: False, node: 2419, tag: ul, level: 19" node_number="2419"><li title="valid: False, node: 2420, tag: li, level: 20" node_number="2420">By<ul title="valid: False, node: 2421, tag: ul, level: 21" node_number="2421"> <li title="valid: False, node: 2422, tag: li, level: 22" node_number="2422">Thomas S. Kraft</li> <li title="valid: False, node: 2423, tag: li, level: 22" node_number="2423">Vivek V. Venkataraman</li> <li title="valid: False, node: 2424, tag: li, level: 22" node_number="2424">et al.</li> </ul> </li></ul></div></div></article><article title="valid: False, node: 2425, tag: article, level: 16" node_number="2425"><div title="valid: False, node: 2426, tag: div, level: 17" node_number="2426"><div title="valid: False, node: 2427, tag: div, level: 18" node_number="2427"><h3 title="valid: False, node: 2428, tag: h3, level: 19" node_number="2428">Early giant reveals faster evolution of large body size in ichthyosaurs than in cetaceans</h3><ul title="valid: False, node: 2429, tag: ul, level: 19" node_number="2429"><li title="valid: False, node: 2430, tag: li, level: 20" node_number="2430">By<ul title="valid: False, node: 2431, tag: ul, level: 21" node_number="2431"> <li title="valid: False, node: 2432, tag: li, level: 22" node_number="2432">P. Martin Sander</li> <li title="valid: False, node: 2433, tag: li, level: 22" node_number="2433">Eva Maria Griebeler</li> <li title="valid: False, node: 2434, tag: li, level: 22" node_number="2434">et al.</li> </ul> </li></ul></div></div></article></div><div title="valid: False, node: 2435, tag: div, level: 15" node_number="2435">Table of Contents</div></div> </div></div></div></section><section class="valid" valid="valid" title="valid: True, node: 2436, tag: section, level: 10" node_number="2436"> <h4 class="valid" valid="valid" title="valid: True, node: 2437, tag: h4, level: 11" node_number="2437">LATEST NEWS</h4> <div class="valid" valid="valid" title="valid: True, node: 2438, tag: div, level: 11" node_number="2438"> <div class="valid" valid="valid" title="valid: True, node: 2439, tag: div, level: 12" node_number="2439"><div class="valid" valid="valid" title="valid: True, node: 2440, tag: div, level: 13" node_number="2440"> <article class="valid" valid="valid" title="valid: True, node: 2441, tag: article, level: 14" node_number="2441"> <div title="valid: False, node: 2442, tag: div, level: 15" node_number="2442"> <div title="valid: False, node: 2443, tag: div, level: 16" node_number="2443"> News<time title="valid: False, node: 2444, tag: time, level: 17" node_number="2444">30 Dec 2021</time> </div> <div title="valid: False, node: 2445, tag: div, level: 16" node_number="2445"> Airborne DNA from plants could reveal invasive species, impact of climate change </div> </div> </article> <article class="valid" valid="valid" title="valid: True, node: 2446, tag: article, level: 14" node_number="2446"> <div title="valid: False, node: 2447, tag: div, level: 15" node_number="2447"> <div title="valid: False, node: 2448, tag: div, level: 16" node_number="2448"> ScienceInsider<time title="valid: False, node: 2449, tag: time, level: 17" node_number="2449">29 Dec 2021</time> </div> <div title="valid: False, node: 2450, tag: div, level: 16" node_number="2450"> <a title="valid: False, node: 2451, tag: a, level: 17" node_number="2451"> Once a &#8216;crazy idea,&#8217; patent-pooling nonprofit will help bring COVID-19 pills to world&#8217;s poor </a> </div> </div> </article> <article class="valid" valid="valid" title="valid: True, node: 2452, tag: article, level: 14" node_number="2452"> <div title="valid: False, node: 2453, tag: div, level: 15" node_number="2453"> <div title="valid: False, node: 2454, tag: div, level: 16" node_number="2454"> ScienceInsider<time title="valid: False, node: 2455, tag: time, level: 17" node_number="2455">28 Dec 2021</time> </div> <div title="valid: False, node: 2456, tag: div, level: 16" node_number="2456"> The natural world loses two of its biggest advocates </div> </div> </article> <article class="valid" valid="valid" title="valid: True, node: 2457, tag: article, level: 14" node_number="2457"> <div title="valid: False, node: 2458, tag: div, level: 15" node_number="2458"> <div title="valid: False, node: 2459, tag: div, level: 16" node_number="2459"> ScienceInsider<time title="valid: False, node: 2460, tag: time, level: 17" node_number="2460">28 Dec 2021</time> </div> <div title="valid: False, node: 2461, tag: div, level: 16" node_number="2461"> <a title="valid: False, node: 2462, tag: a, level: 17" node_number="2462"> What the Charles Lieber verdict says about U.S. China Initiative </a> </div> </div> </article> <article class="valid" valid="valid" title="valid: True, node: 2463, tag: article, level: 14" node_number="2463"> <div title="valid: False, node: 2464, tag: div, level: 15" node_number="2464"> <div title="valid: False, node: 2465, tag: div, level: 16" node_number="2465"> ScienceInsider<time title="valid: False, node: 2466, tag: time, level: 17" node_number="2466">25 Dec 2021</time> </div> <div title="valid: False, node: 2467, tag: div, level: 16" node_number="2467"> NASA&#8217;s Webb telescope takes flight&#8212;a Christmas gift to astronomers everywhere </div> </div> </article> <article class="valid" valid="valid" title="valid: True, node: 2468, tag: article, level: 14" node_number="2468"> <div title="valid: False, node: 2469, tag: div, level: 15" node_number="2469"> <div title="valid: False, node: 2470, tag: div, level: 16" node_number="2470"> News<time title="valid: False, node: 2471, tag: time, level: 17" node_number="2471">23 Dec 2021</time> </div> <div title="valid: False, node: 2472, tag: div, level: 16" node_number="2472"> <a title="valid: False, node: 2473, tag: a, level: 17" node_number="2473"> More than a virus: Science&#8217;s areas to watch in 2022 </a> </div> </div> </article> </div></div> </div></section></div></div></div></div> </main> </div> </div> </div> </body>
        <style tyle='text/css'>
body{
    position: relative;
    padding-left: 30px;
    top: 60px;
}
* {
    border: 1px solid #eee;
    padding: 5px 12px;
    margin: 3px 0;
    box-sizing: content-box;
    background-color: #fff;
    cursor: no-drop;
}
main:hover > *, section:hover > *, header:hover > *, nav:hover > *, a:hover > *, div:hover > *, p:hover > *, ul:hover > *, h1:hover > *, h2:hover > *, h3:hover > *, li:hover > *, span:hover > *{
    border: 2px solid green;
    background-color: #fffeee;
    padding: 5px 23px !important;
    margin: 1px 0;
    color: green;
}
main:hover, section:hover, header:hover, nav:hover, a:hover, div:hover, p:hover, ul:hover, h1:hover, h2:hover, h3:hover, li:hover, span:hover{
    border: 1px solid #fff;
    background-color: #eee;
}
a, span {
    display: block;
}
.selected {
    border: 2px solid orchid !important;
    opacity: 0.8;
    color: orchid !important;
}
.selected * {
    padding: 2px !important;
    color: orchid !important;
}
.valid {
  cursor: pointer;
}
.btn{
  cursor: pointer;
  font-weight: bolder;
  padding: 8px;
}
</style> 
        <script>function OpenOriginalLink($event){
    $event.stopPropagation();
    console.log(url);
}

function removeItem($event){
    $event.stopPropagation();
    console.log('Remove item: ', url)
    localStorage.removeItem(url)
}

function exportData($event){
    $event.stopPropagation();

    result = []
    for(let i=0; i<localStorage.length; i++) {
        let key = localStorage.key(i);
        result.push(localStorage.getItem(key))
    }
    const _url = URL.createObjectURL(new Blob([result.join("\n")], {type: 'text/plain'}))
    $event.target.href = _url;
    localStorage.clear()
}

var removeItemBtn = document.createElement("BUTTON");   // Create a <button> element
removeItemBtn.innerHTML = "Remove Item";
removeItemBtn.classList.add('btn');
removeItemBtn.style.position = "fixed";
removeItemBtn.style.left = '5px';
removeItemBtn.style.top = 0;
removeItemBtn.style.border = "1px solid";
removeItemBtn.style.boxShadow = "3px 3px #888";
removeItemBtn.onclick = removeItem;
document.body.appendChild(removeItemBtn);

var goToOriginLink = document.createElement("A");   // Create a <button> element
goToOriginLink.innerHTML = "GoToOrigin";
goToOriginLink.classList.add('btn');
goToOriginLink.style.position = "fixed"
goToOriginLink.style.left = '115px'
goToOriginLink.style.top = 0;
goToOriginLink.onclick = OpenOriginalLink;
goToOriginLink.setAttribute('href', decodeURIComponent(url));
goToOriginLink.target = '_blank';
document.body.appendChild(goToOriginLink);

var current = new Date
var exportDataLink = document.createElement("A");   // Create a <button> element
exportDataLink.innerHTML = "Export data";
exportDataLink.classList.add('btn');
exportDataLink.download = current.toISOString() + '.exported.txt';
exportDataLink.style.position = "fixed";
exportDataLink.style.right = '5px';
exportDataLink.style.top = 0;
exportDataLink.style.border = "1px solid #888";
exportDataLink.style.boxShadow = "3px 3px #888";
exportDataLink.onclick = exportData;
document.body.appendChild(exportDataLink);

data = {
    'title': null ,
    'article': null
}

var body = document.getElementsByTagName("body")[0];

body.onclick = function($e){
    var num = $e.target.getAttribute('node_number')
    var valid = $e.target.getAttribute('valid')

    if(!valid){
        console.log("Element is invalid")
        return
    }

    if(data.length > 2){
        data = data.splice(0, 2)
    }

    console.log("node:", $e.target)

    if(!data.title && !data.article){
        data.title = num;
        console.log("data:", data)
        $e.target.classList.add('selected')
    }else if (data.title && !data.article){
        data.article = num;
        console.log("data:", data)
        $e.target.classList.add('selected')
    }else{
        selected = Array.from(document.getElementsByClassName("selected"))
        selected.forEach(function(el){
            el.classList.remove('selected')
        })

        data.title = num;
        data.article = null;
        $e.target.classList.add('selected')

    }

    if(data.title && data.article){
        var obj = {
            url: url,
            text: body_html,
            title: data.title,
            article: data.article,
        }

        var datasetItem = JSON.stringify(obj)
        localStorage.setItem(url, datasetItem)
    }
}
</script> 
      </html>